Compound,CAS,log_AC10,log_AC50,Slope,Top_curve,Endpoints,Viability
"1,1-Dimethylpiperidinium chloride",24307-26-4,0.160657629323436,0.788337536155088,1.52026932685494,100,NVS_LGIC_rNNR_BungSens,FALSE
1-Benzylquinolinium chloride,15619-48-4,0.0436815236360714,1.18869967945166,0.834546496145443,100,NVS_GPCR_gMPeripheral_NonSelective|NVS_GPCR_gOpiateK|NVS_GPCR_hM2|NVS_GPCR_hM4|NVS_GPCR_hM5|NVS_GPCR_rAdra1A|NVS_GPCR_rmAdra2B|NVS_IC_rNaCh_site2|NVS_TR_gDAT|NVS_TR_hDAT,FALSE
1-Hexadecyl-3-methylimidazolium chloride,61546-01-8,0.509390835900058,1.32909137446544,1.16584312823942,100,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
1-Methyl-3-tetradecylimidazolium chloride,171058-21-2,0.399443834418075,1.2121205945748,1.19022290458807,98.434399335084,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
Benzethonium chloride,121-54-0,-0.615979304568779,0.226605016431246,1.68634941078704,100,NVS_IC_rCaBTZCHL|NVS_TR_gDAT|NVS_TR_hDAT|NVS_TR_hNET,FALSE
Benzylhexadecyldimethylammonium chloride,122-18-9,-0.113166897895833,0.302324181624531,2.05398431758639,98.566765738035,NVS_GPCR_hDRD1|NVS_GPCR_hM2|NVS_GPCR_hOpiate_mu|NVS_TR_hDAT|NVS_TR_hNET|TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
Cetylpyridinium chloride,123-03-5,2.87073148471399,2.97337769516933,9.29642219821247,100,TOX21_MMP_rhodamine,FALSE
Didodecyldimethylammonium bromide,3282-73-3,1.24600078723328,1.46764847959842,4.30522194594891,94.1479953141481,TOX21_MMP_ratio_down,FALSE
Dodecyltrimethylammonium chloride,112-00-5,0.0142826277087302,0.795399658435255,1.08819859252509,98.8250952548321,NVS_ENZ_rMAOBC|NVS_GPCR_gMPeripheral_NonSelective|NVS_GPCR_hDRD1|NVS_GPCR_hDRD2s|NVS_GPCR_hM1|NVS_GPCR_hM2|NVS_GPCR_hM3|NVS_GPCR_hM4|NVS_GPCR_hM5|NVS_IC_hKhERGCh|NVS_IC_rCaBTZCHL|NVS_IC_rNaCh_site2|NVS_TR_hNET|NVS_TR_rSERT,FALSE
Estrone,53-16-7,0.413770579885683,1.06322538892297,1.46929778047811,46.8586091197286,TOX21_MMP_ratio_down,FALSE
Ethylhexadecyldimethylammonium bromide,124-03-8,-0.173598532145039,0.324697985911042,1.90920353922986,98.7553525610058,NVS_GPCR_hDRD1|NVS_GPCR_hM2|NVS_GPCR_hOpiate_mu|NVS_TR_hDAT|NVS_TR_hNET,FALSE
Hexadecyltrimethylammonium bromide,57-09-0,0.471315194059044,1.19731067974805,1.34716429276607,89.2190429677289,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
Lynestrenol,52-76-6,0.222508683357115,0.952252180327525,1.3134020427088,74.3479312989956,TOX21_MMP_fitc|TOX21_MMP_ratio_down,FALSE
Methylene blue,61-73-4,-0.499447731072248,0.458852744799495,0.995765455058627,76.3146758730662,TOX21_MMP_rhodamine,FALSE
Miripirium chloride,2748-88-1,0.744005428400078,1.16988861428256,2.24652560185021,87.1117662198556,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
"Myristyltrimethylammonium chlorideN,N,N-Trimethyltetradecan-1-aminium chloride",4574-04-03,0.750077654281305,1.17081484808046,2.26802508431153,51.0222917250346,TOX21_MMP_ratio_down,FALSE
"N,N,N-Trimethyloctadecan-1-aminium chloride",112-03-8,-0.476211817789131,-0.0637048874685021,2.37415633989065,68.8150480506264,NVS_GPCR_hDRD1|NVS_GPCR_hM2,FALSE
"N,N-Dimethyl-N-benzyl-N-octadecylammonium chloride",122-19-0,-0.307374498017784,0.349852763645418,1.73317098939543,98.6197966302132,NVS_GPCR_hDRD1|NVS_GPCR_hM2|NVS_GPCR_hOpiate_mu|NVS_TR_hNET,FALSE
Rhodamine B,81-88-9,-0.336104962182893,0.0874151716817138,2.66930504605148,100,TOX21_MMP_fitc|TOX21_MMP_ratio_up,FALSE
Rotenone,83-79-4,-1.66321531859989,-1.22872847300971,1.77887904869271,100,APR_HepG2_MitoMembPot_72h_dn|NCCT_MITO_inhib_resp_rate_OCR_dn|NCCT_MITO_max_resp_rate_OCR_dn|NVS_GPCR_h5HT6|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX|bursts per minute|percent spikes in network spike|number active electrodes|mean correlation|percent spikes in burst|mean firing rate|b excitatory distmoved 1dpf|a background distmoved 1dpf|CNS neurite outgrowth|LD movement pattern (pearson) 1dpf|LD movement pattern (cosine) 1dpf|percent affected 1dpf|percent affected 3dpf|percent affected 4dpf|percent affected 5dpf|percent affected 1dpf|percent affected 2dpf|number actively bursting electrodes|number network spikes|total branches|SH-S5Y5 neurite outgrowth,FALSE
Tetra-N-octylammonium bromide,14866-33-2,-1.62562114976477,-0.980240585379928,1.51725826336695,88.9738132327129,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
Tetradonium bromide,1119-97-7,0.00353374179261157,0.597579822971119,1.16617222423608,97.7510552617741,NVS_GPCR_hDRD1|NVS_GPCR_hM2|NVS_GPCR_hOpiate_mu|NVS_IC_rNaCh_site2|NVS_TR_hDAT|NVS_TR_hNET|TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
Tetraoctylphosphonium bromide,23906-97-0,-1.42989356534992,-0.852691454302146,1.65322075435089,100.087654134811,TOX21_MMP_rhodamine,FALSE
Tributyltetradecylphosphonium chloride,81741-28-8,-0.430518096516012,0.0119433901360177,2.17318237462152,90.2758612069726,NVS_GPCR_hM1|NVS_GPCR_hORL1|NVS_GPCR_hOpiate_mu|TOX21_MMP_rhodamine,FALSE
Trihexyltetradecylphosphonium bromide,654057-97-3,-0.462140055969757,-0.0767184813622327,2.47584092927603,86.232938730335,TOX21_MMP_ratio_down,FALSE
Acenocoumarol,152-72-7,0.228393276743038,0.787217198296209,1.70759066073468,77.9594497122662,TOX21_MMP_rhodamine,FALSE
Cyproterone acetate,427-51-0,-0.448764267307227,0.510378455214867,0.997842041547722,36.8929922112676,NCCT_MITO_basal_resp_rate_OCR_dn|NVS_GPCR_rOpiate_NonSelective,FALSE
Diacetone alcohol,123-42-2,-0.230061293883429,0.96783068910887,0.796601465731205,1.24550044728297,APR_HepG2_MitoMass_24h_dn,FALSE
Ketoconazole,65277-42-1,0.457930766560675,1.14785309885844,1,100,NCCT_MITO_inhib_resp_rate_OCR_dn|NVS_TR_hDAT|TOX21_MMP_fitc|NVS_TR_hSERT|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION,FALSE
Warfarin,81-81-2,0.62127006641697,1.60214019320295,0.972853065233103,112.38340801508,TOX21_MMP_ratio_down,FALSE
"2,4,6-Tris(tert-butyl)phenol",732-26-3,-1.09433602843932,-0.140093519,1,100,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NETWORK_BURST_PERCENTAGE|SYNCHRONY_INDEX,FALSE
"2,6-Di-tert-butyl-4-nitrophenol",728-40-5,-1.2636992229713,-0.900223507591302,2.78600654618301,100.171761148672,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
Bitertanol,55179-31-2,0.34599789302338,1.6203314864149,0.748816883104913,100,NVS_TR_hDAT,FALSE
Paclobutrazol,76738-62-0,-0.0491299544393249,0.905112555,1,100,APR_HepG2_MitoMembPot_24h_dn|NVS_TR_gDAT|NVS_TR_hDAT|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION,FALSE
Pindone,83-26-1,0.839751796459268,1.32298906551865,1.9781297534928,94.9574199111884,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
Tebuconazole,107534-96-3,0.0117046195606751,0.8002521155,1,100,NVS_TR_gDAT|NVS_TR_hDAT|CCTE_Mundy_HCI_Cortical_NOG_NeuronCount_loss|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_SynapseCount_loss|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|INTER_BURST_INTERVAL_AVG_(SEC)|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|MFR|BR|ISI|%SiB|BD|IBI|#AE|#ABE|#NS|NSP|NSD|%SiNS|NS-ISI|NSDsd|#SiNS|r|MI|number network spikes|bursts per minute|mutual information,FALSE
Triadimenol,55219-65-3,-1.87058127885759,-0.452475230734981,0.676916093535403,91.6540006454717,NVS_TR_gDAT|NVS_TR_hDAT,FALSE
"2,2',6,6'-Tetrachlorobisphenol A",79-95-8,-0.374008533151798,0.390513617020281,1.77273618781481,100,TOX21_MMP_fitc|TOX21_MMP_ratio_down,FALSE
"2,6-Di-tert-butylphenol",128-39-2,1.74488096884608,2.54619496031467,1.40865282736928,1.84857867468888,APR_HepG2_MitoMass_24h_up|APR_HepG2_MitoMembPot_72h_dn,FALSE
"3,3',5,5'-Tetrabromobisphenol A",79-94-7,0.155401767156986,0.400283754715242,1.1827345475748,100,APR_HepG2_MitoMembPot_24h_dn|NCCT_MITO_basal_resp_rate_OCR_dn|NCCT_MITO_max_resp_rate_OCR_dn|TOX21_MMP_ratio_down|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NETWORK_BURST_PERCENTAGE|SYNCHRONY_INDEX|percent affected 2dpf|percent affected 3dpf|percent affected 5dpf|percent affected 1dpf|a background distmoved 1dpf|b excitatory distmoved 1dpf|percent affected 1dpf|percent affected 4dpf|percent affected 5dpf|SH-S5Y5 neurite outgrowth,FALSE
"4-(1,1,3,3-Tetramethylbutyl)phenol",140-66-9,0.121163446031826,1.149463063,1,100,NCCT_MITO_basal_resp_rate_OCR_dn|NCCT_MITO_max_resp_rate_OCR_dn|NVS_GPCR_hOpiate_D1|NVS_TR_hDAT|NVS_TR_hNET|TOX21_MMP_ratio_down|TOX21_MMP_rhodamine|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|INTER_BURST_INTERVAL_AVG_(SEC)|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION,FALSE
4-Cumylphenol,599-64-4,0.0391003818070319,1.24846431056535,1.16260612115471,100,NCCT_MITO_basal_resp_rate_OCR_dn|NVS_GPCR_hAdra2C|NVS_TR_gDAT|NVS_TR_hDAT|NVS_TR_hNET|TOX21_MMP_fitc|TOX21_MMP_ratio_down,FALSE
Bisphenol A,1980-05-07,0.189485541745482,1.0257440317094,1,100,APR_HepG2_MitoMembPot_72h_dn|NCCT_MITO_basal_resp_rate_OCR_dn|NCCT_MITO_max_resp_rate_OCR_dn|NVS_GPCR_hOpiate_D1|NVS_GPCR_rOpiate_NonSelective|NVS_GPCR_rOpiate_NonSelectiveNa|NVS_TR_gDAT|NVS_TR_hDAT|TOX21_MMP_fitc|NVS_GPCR_h5HT6|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_PERCENTAGE_AVG_(SEC)|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|MFR|BR|BD|#NS|NS-ISI|NSDsd|#SiNS|MI|mean firing rate|bursts per minute|number network spikes|percent affected 4dpf|SH-S5Y5 neurite outgrowth,FALSE
CP-457677,214535-77-0,0.930062389666349,2.68766679929138,0.542922232223408,0.962214731028935,NCCT_MITO_max_resp_rate_OCR_dn,FALSE
Clofoctol,37693-01-9,-0.156233261475252,0.285278659652612,2.16130632894728,85.6762039147532,TOX21_MMP_rhodamine,FALSE
Dicumyl peroxide,80-43-3,0.496452008060675,1.3925591395,1,100,APR_HepG2_MitoMass_24h_dn|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|AREA_UNDER_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Hydroxyflutamide,52806-53-8,-0.858864857008794,-0.0905286611800302,1.24195959349544,1.87635620636903,APR_HepG2_MitoMass_72h_up|APR_HepG2_MitoMembPot_72h_dn|TOX21_MMP_ratio_down,FALSE
Octrizole,3147-75-9,1.45754869814504,1.55671526096948,9.62262361688085,69.5603374625633,TOX21_MMP_ratio_down,FALSE
Tetrabromobisphenol A bis(2-hydroxyethyl) ether,4162-45-2,0.359573557705729,0.766985056349473,2.27107815321956,98.1874244080418,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine|NVS_TR_rSERT,FALSE
tert-Butyl 4-hydroxybenzoate,25804-49-3,0.70729046382067,1.01376699013397,3.11359085447168,22.7237874655751,TOX21_MMP_fitc,FALSE
Bromocriptine,25614-03-3,-0.361065072901911,0.947388974447985,0.729290043752029,100,TOX21_MMP_rhodamine,FALSE
Flutamide,13311-84-7,-0.180170532248467,0.892951587364916,1,100,NVS_ENZ_rMAOAP|TOX21_MMP_ratio_down|NVS_GPCR_g5HT4|NVS_GPCR_h5HT6|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
"4,4'-(4-Methylpentane-2,2-diyl)diphenol",6807-17-6,0.3436387997237,0.919127413644907,1.65814316105649,104.936279753429,TOX21_MMP_ratio_down,FALSE
6-Chlorothymol,89-68-9,-0.0999345664357631,0.663661846458664,1.2906291873082,104.81428676935,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
CP-863187,668981-02-0,0.78896629398053,2.25864961550286,0.649284437990967,0.971487628413159,NCCT_MITO_basal_resp_rate_OCR_dn,FALSE
Menthyl anthranilate,134-09-8,0.216914383711959,0.83100069442496,1.55392245811729,100,TOX21_MMP_rhodamine,FALSE
"N-(1,3-Dimethylbutyl)-N'-phenyl-p-phenylenediamine",793-24-8,0.674766523696079,1.31856248607708,1.48267419102115,98.9350872757514,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
"4,4',4''-Ethane-1,1,1-triyltriphenol",27955-94-8,0.361157167560675,1.35338842334269,1,100,NCCT_MITO_basal_resp_rate_OCR_dn|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Alaproclate,60719-82-6,0.702150113032637,1.26206377409592,1.70426723939403,75.31635838332,TOX21_MMP_ratio_up,FALSE
Bicalutamide,90357-06-5,0.648981504241286,1.22687485921304,1.64298977362571,90.4366889108783,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine|SH-S5Y5 neurite outgrowth,FALSE
Bisphenol E,2081-08-05,0.0829181534766224,1.0831689695253,0.954003230118721,100,TOX21_MMP_fitc,FALSE
Cyproconazole,94361-06-5,-1.54579771076065,-0.757348248639748,1.210277329472,94.7792719644256,NVS_TR_hDAT,FALSE
Myralact,15518-87-3,0.605996516365818,1.47086766199692,1.10333488897125,88.6118538712815,TOX21_MMP_ratio_up,FALSE
Cyfluthrin,68359-37-5,-0.971285314939325,-0.0170428055,1,100,NVS_TR_hDAT|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Tamoxifen,10540-29-1,-0.00533299993932485,0.979873295872948,1,100,NVS_GPCR_hDRD1|NVS_IC_rCaBTZCHL|NVS_TR_hDAT|NUMBER_OF_SPIKES|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION,FALSE
Transfluthrin,118712-89-3,0.736420292110687,1.31119434606605,1.66020456712096,76.1275854053193,TOX21_MMP_ratio_down,FALSE
Triticonazole,131983-72-7,-0.831755786521149,-0.0850303188294868,1.28066713136748,73.3096977999986,NVS_TR_gDAT|NVS_TR_hDAT,FALSE
meso-Hexestrol,84-16-2,0.19224853603806,1.37326001753261,0.729844500593505,100,NCCT_MITO_basal_resp_rate_OCR_dn|NCCT_MITO_max_resp_rate_OCR_dn|NVS_GPCR_hAdoRA1|NVS_GPCR_hAdoRA2a|NVS_GPCR_hOpiate_D1|NVS_GPCR_rOpiate_NonSelective|NVS_TR_gDAT,FALSE
"2,6-Dinitrotoluene",606-20-2,0.0463992752557429,1.23685361137028,0.801578423036225,100,NVS_ENZ_rMAOBC,FALSE
3-Chloro-7-hydroxy-4-methyl-2-benzopyrone,6174-86-3,0.171879281074834,1.2989954596282,0.84662302573287,100,NVS_ENZ_rMAOAC,FALSE
"3-Methyl-4,6-di-tert-butylphenol",497-39-2,-0.427084848541683,0.441500502710589,1.11557185873523,69.7212810761236,NVS_TR_hNET|TOX21_MMP_ratio_down,FALSE
4-Chloro-3-methylphenol,59-50-7,-1.25936989459137,-0.298199987861883,0.992844317134858,100,TOX21_MMP_ratio_down|SH-S5Y5 neurite outgrowth,FALSE
"5,5-Dimethyl-3-(alpha,alpha,alpha-trifluoro-4-nitro-m-tolyl)hydantoin",63612-50-0,0.601036250316009,1.66982072335985,1.33540689136402,54.5385509550799,NCCT_MITO_max_resp_rate_OCR_dn|NVS_GPCR_bAdoR_NonSelective,FALSE
Ciglitizone,74772-77-3,0.433763947669189,0.871264895027917,1.91862848929921,105.548966630749,TOX21_MMP_fitc|TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
Clomazone,81777-89-1,-1.31087846606964,-0.330170315636086,0.973722865686659,101.071801094897,NVS_TR_hDAT|SH-S5Y5 neurite outgrowth,FALSE
FR167356,174185-16-1,0.16099847779274,1.83751232933348,0.569182597902406,109.578498249183,NVS_TR_rVMAT2,FALSE
Famoxadone,131807-57-3,0.188245961987951,0.574186028875932,2.47251475373842,0.679649957007497,APR_HepG2_MitoMembPot_24h_dn|NCCT_MITO_basal_resp_rate_OCR_dn|NCCT_MITO_max_resp_rate_OCR_dn,FALSE
Fenhexamid,126833-17-8,0.485546757639781,1.50092037885784,1.1667801821996,86.5000427367889,NCCT_MITO_basal_resp_rate_OCR_dn|NCCT_MITO_max_resp_rate_OCR_dn|NVS_TR_hDAT|TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
Leflunomide,75706-12-6,0.393520887613332,1.16233482129768,1.2411878448487,102.210255783945,TOX21_MMP_ratio_down,FALSE
Methaqualone,72-44-6,0.737549284302602,1.43036217912902,1.37734519170345,97.6229559665113,TOX21_MMP_fitc,FALSE
"3,3'-Dimethylbisphenol A",79-97-0,-0.129034016508396,0.534905390376437,1.44596440372362,94.6396117259092,NVS_TR_gDAT|NVS_TR_hDAT,FALSE
"4,4'-Diamino-3,3'-dimethyldiphenylmethane",838-88-0,0.529528590560675,1.44259208910381,1,100,APR_HepG2_MitoMass_72h_up|NCCT_MITO_basal_resp_rate_OCR_dn|NVS_TR_hDAT|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
"4,4'-Propane-2,2-diylbis(2,6-dimethylphenol)",5613-46-7,0.791781406261431,1.50289659530945,1.57551548340937,82.7282338467556,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
"4-Methyl-2,6-dinitrophenol",609-93-8,0.770440612765301,1.44563673898615,1.41328196709351,103.167455428499,TOX21_MMP_rhodamine,FALSE
4-Methyl-2-nitroaniline,89-62-3,0.20159414712736,1.28443424842444,0.881240460430206,114.397976993786,NVS_ENZ_rMAOAC,FALSE
Butylated hydroxytoluene,128-37-0,0.905520408269751,1.41617325859601,1.8686716598755,51.8329983851657,TOX21_MMP_ratio_down,FALSE
Carboxin,5234-68-4,0.335830035490221,1.4791241102706,0.834660384643709,103.836959969875,NVS_TR_gDAT|NVS_TR_hNET,FALSE
o-Aminoazotoluene,97-56-3,0.536074634560675,1.423397395,1,100,APR_HepG2_MitoMembPot_24h_dn|NCCT_MITO_basal_resp_rate_OCR_dn|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
"1,2-Dinitrobenzene",528-29-0,0.0505645801363574,0.7241655862339,1.81621316225722,49.9411721064362,APR_HepG2_MitoMass_24h_dn|NVS_ENZ_rMAOAP,FALSE
"1,3-Dinitrobenzene",99-65-0,-0.670543976620369,0.393556140727875,0.897692266477774,101.678471923554,NVS_ENZ_rMAOAC|NVS_ENZ_rMAOAP|NVS_ENZ_rMAOBC|NVS_ENZ_rMAOBP,FALSE
"1-Chloro-2,4-dinitrobenzene",97-00-7,0.698261693569244,1.05290663322924,2.69069822441051,88.9652681542303,TOX21_MMP_ratio_down,FALSE
"1-Fluoro-2,4-dinitrobenzene",70-34-8,-0.461339684190477,0.337368288580116,1.19473267072721,114.683944073426,TOX21_MMP_ratio_down,FALSE
9-Nitroanthracene,602-60-8,0.676731047213998,1.38582207173906,1.48238736671576,81.7241119211923,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
Ammonium carbamate,1111-78-0,1.23306794040002,1.607479582602,2.5486453995588,1.07421136534885,APR_HepG2_MitoMass_24h_up,FALSE
Fluazinam,79622-59-6,-1.24762564643933,-0.344782919,1,100,NCCT_MITO_basal_resp_rate_OCR_up|TOX21_MMP_ratio_down|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Imidacloprid,138261-41-3,-0.317123074698343,0.916775789319651,1,100,NVS_LGIC_hNNR_NBungSens|#SiNS|SH-S5Y5 neurite outgrowth,FALSE
1-Amino-2-methylanthraquinone,82-28-0,-0.25447427818386,0.695648984751559,0.936909700178957,87.5547851286376,NVS_GPCR_hAdoRA2a|NVS_TR_hNET|TOX21_MMP_rhodamine,FALSE
"2,3,6-Trimethylphenol",2416-94-6,0.442105439698261,1.393709725,1,100,APR_HepG2_MitoMass_72h_dn|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
"2,4-Dichloro-3,5-dimethylphenol",133-53-9,-0.353540336588846,0.79175574426198,0.86732559907991,98.2212032323633,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
2-Tert-Butyl-5-methylphenol,88-60-8,0.419751613560675,1.359797354,1,100,NCCT_MITO_max_resp_rate_OCR_dn|TOX21_MMP_ratio_down|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_PERCENTAGE_AVG_(SEC)|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION,FALSE
"3,4-Dinitrotoluene",610-39-9,0.115123681813668,1.07293600286061,0.996272952927023,100,NVS_ENZ_rMAOAC,FALSE
"4-Chloro-3,5-dimethylphenol",88-04-0,0.650662002705811,1.17248796048805,1.82866048575822,100,TOX21_MMP_ratio_down,FALSE
"5,7-Dichloro-8-hydroxy-2-methylquinoline",72-80-0,0.634626288329386,1.07461676970565,2.46638432327041,71.6775614309613,TOX21_MMP_fitc|TOX21_MMP_rhodamine,FALSE
Celecoxib,169590-42-5,0.222795392060675,1.144198289,1,100,APR_HepG2_MitoMass_24h_dn|TOX21_MMP_rhodamine|NUMBER_OF_BURSTS|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Diiodomethyl 4-methylphenyl sulfone,20018-09-1,-0.357121159003705,0.465161699409514,1.5133965634735,93.7053039615739,NVS_GPCR_hDRD1|NVS_TR_rVMAT2,FALSE
Emodin,518-82-1,-0.815646493782917,0.00983969034013366,1.1560119217667,100.223475063763,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
Pyrimethanil,53112-28-0,0.372923007286682,1.02622401455741,2.42237288222588,50.2930684925584,APR_HepG2_MitoMembPot_24h_dn|NVS_TR_hNET,FALSE
"2,3-Dinitrotoluene",602-01-7,-0.381929950982148,0.179479849150304,1.09807473936953,90.9503825958748,NVS_ENZ_rMAOAC|NVS_ENZ_rMAOAP|NVS_ENZ_rMAOBC,FALSE
Cyprodinil,121552-61-2,-0.403440020971739,1.08706208921598,0.636296690236125,100,APR_HepG2_MitoMembPot_1h_dn|NVS_GPCR_hM1|NVS_GPCR_hM2|NVS_GPCR_hM3|NVS_GPCR_hM4|NVS_TR_hNET|NVS_TR_rNET,FALSE
1-Phenyl-3-methyl-5-pyrazolone,89-25-8,0.833150943863733,1.16886285851436,2.84244457165724,100.828097277979,TOX21_MMP_rhodamine,FALSE
Benoxacor,98730-04-2,0.529194290873893,1.43627346624349,1.05199472697685,26.2139777085838,TOX21_MMP_fitc,FALSE
Chlormidazole,3689-76-7,-0.511459085062286,-0.0500307440670274,2.0680188550645,100,TOX21_MMP_fitc,FALSE
Difenoconazole,119446-68-3,-0.106981827439325,0.810825166847176,1,100,APR_HepG2_MitoMass_72h_dn|APR_HepG2_MitoMembPot_72h_dn|NCCT_MITO_inhib_resp_rate_OCR_dn|NVS_GPCR_rAdra2_NonSelective|NVS_GPCR_rmAdra2B|NVS_TR_hDAT|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Mecloqualone,340-57-8,0.567265873919676,1.09593560406628,1.80498798214662,100,TOX21_MMP_fitc,FALSE
1-(2-Chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide,85532-75-8,-0.440250233033015,0.435722701459548,0.969874790977447,92.9559712440935,NVS_ENZ_hES|NVS_GPCR_gOpiateK|NVS_GPCR_hAdoRA1|NVS_GPCR_mCKKBCentral|NVS_IC_rCaBTZCHL,FALSE
"2,6-Di(butan-2-yl)phenol",5510-99-6,0.598012445099475,1.23583036014742,1.49798375586164,78.8430627810286,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
"4-(Butan-2-yl)-2,6-di-tert-butylphenol",17540-75-9,0.957850184637745,1.44620531665117,1.95680904653333,82.6891199751984,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
Bisphenol B,77-40-7,0.379212393949076,1.31140656871419,1,100,APR_HepG2_MitoMembPot_24h_dn|NCCT_MITO_basal_resp_rate_OCR_dn|NCCT_MITO_max_resp_rate_OCR_dn|NVS_GPCR_hDRD1|NVS_GPCR_hOpiate_D1|NVS_GPCR_hOpiate_mu|NVS_GPCR_rOpiate_NonSelective|NVS_TR_gDAT|NVS_TR_hDAT|NVS_TR_hNET|NVS_TR_rVMAT2|TOX21_MMP_ratio_down|NVS_GPCR_h5HT5A|NVS_GPCR_h5HT6|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Flopropione,2295-58-1,0.304382208764259,1.22246006044654,1.03939171137913,100,TOX21_MMP_ratio_down,FALSE
"N,N'-Bis(1-methylpropyl)-1,4-benzenediamine",101-96-2,0.780095288418181,1.07655991591272,3.24074502404089,94.4568712262142,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
Propanil,709-98-8,0.10116357938775,1.11875311003809,1.01634903818596,100,NCCT_MITO_max_resp_rate_OCR_dn|NVS_ENZ_rMAOAC|NVS_ENZ_rMAOAP|NVS_ENZ_rMAOBC|NVS_TR_hNET|NVS_GPCR_g5HT4,FALSE
Simvastatin,79902-63-9,-0.166660658407961,0.539065412923802,1.35214291805685,1.30765612994751,APR_HepG2_MitoMass_24h_dn,FALSE
sec-Butylparaben,17696-61-6,0.818809459390598,1.79266988672915,0.979855513841092,100,TOX21_MMP_fitc,FALSE
"2,2'-Methylenebis(ethyl-6-tert-butylphenol)",88-24-4,-0.409133332543899,0.183042447014033,1.61141766073527,108.977692006773,TOX21_MMP_rhodamine,FALSE
"2,6-Di-tert-butyl-4-ethylphenol",4130-42-1,0.455913832935879,1.802315420448,0.716045339997384,100,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
2-tert-Butyl-4-ethylphenol,96-70-8,-0.708813775439325,0.245428734,1,100,APR_HepG2_MitoMembPot_24h_dn|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION,FALSE
"4,4'-Methylenebis(2,6-diethylaniline)",13680-35-8,1.10746652258051,1.5486256202201,2.16303486552806,111.799196935091,TOX21_MMP_ratio_down,FALSE
Alachlor,15972-60-8,0.579076738160904,1.47259790550957,1.06797774787837,0.382454777034187,NCCT_MITO_basal_resp_rate_OCR_dn|NCCT_MITO_max_resp_rate_OCR_dn,FALSE
Atipamezole,104054-27-5,-0.0663535665291564,0.530315411241708,1.59945899614747,79.7238293537405,TOX21_MMP_fitc|TOX21_MMP_ratio_down,FALSE
Metolachlor,51218-45-2,0.279281907060675,1.2335244165,1,100,NCCT_MITO_basal_resp_rate_OCR_dn|NVS_GPCR_gOpiateK|NVS_GPCR_rOpiate_NonSelective|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Pyrimethamine,58-14-0,-0.392842706741115,0.799809273271719,0.959325226618748,94.2362026008342,NVS_GPCR_hAdra2A|NVS_GPCR_hDRD1|NVS_GPCR_rAdra1A|NVS_GPCR_rAdra1B|NVS_GPCR_rAdra1_NonSelective|NVS_GPCR_rAdra2_NonSelective|NVS_GPCR_rmAdra2B|NVS_IC_rCaBTZCHL|NVS_IC_rNaCh_site2|NVS_TR_gDAT|NVS_TR_hDAT|NVS_TR_hNET|NVS_GPCR_g5HT4|NVS_GPCR_h5HT2A|NVS_GPCR_h5HT7|NVS_GPCR_p5HT2C,FALSE
Tebufenozide,112410-23-8,-1.10640390680691,-0.757153698912446,2.73226039060136,49.1427231979536,NVS_GPCR_hM3,FALSE
"p,p'-Ethyl-DDD",72-56-0,0.944777358583418,1.94395546014848,0.955027445001692,95.641773430482,TOX21_MMP_rhodamine,FALSE
2-(1-Methylbutyl)phenol,87-26-3,1.25038625738563,1.52570946267896,3.46589931794051,77.4863869025453,TOX21_MMP_rhodamine,FALSE
Propiconazole,60207-90-1,0.203059336560675,1.22026367615089,1,100,NCCT_MITO_basal_resp_rate_OCR_dn|NCCT_MITO_max_resp_rate_OCR_dn|NVS_GPCR_gOpiateK|NVS_GPCR_hOpiate_D1|NVS_GPCR_hOpiate_mu|NVS_GPCR_rOpiate_NonSelective|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX|SH-S5Y5 neurite outgrowth,FALSE
2-Ethylhexyl p-hydroxybenzoate,5153-25-3,0.581782089413483,1.01579487705899,2.53459886519991,90.32204415934,TOX21_MMP_fitc|TOX21_MMP_rhodamine,FALSE
Bupirimate,41483-43-6,0.481641322894533,1.48754804413642,0.948639162348199,90.2629396358457,TOX21_MMP_rhodamine,FALSE
Hexaconazole,79983-71-4,-0.140010689939325,0.8142318195,1,100,NVS_LGIC_rGABARa6|NVS_TR_hDAT|NVS_TR_hNET|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
MEHP,4376-20-9,-0.204967230271452,0.631952931817082,1.14018344002851,0.312105943971172,NCCT_MITO_basal_resp_rate_OCR_dn,FALSE
Myclobutanil,88671-89-0,0.113947060194095,1.41127137243411,0.797474558504907,107.230048056237,NVS_GPCR_hM3|NVS_TR_gDAT,FALSE
Parbendazole,14255-87-9,-1.412634217015,0.167243888608705,0.603997552749556,50.2925947480771,TOX21_MMP_ratio_down,FALSE
4-Hexylresorcinol,136-77-6,0.252168598560675,1.133439232,1,100,TOX21_MMP_rhodamine|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
4-Pentylphenol,14938-35-3,0.00635486907681604,0.944793418096905,1.00031581064184,100,NVS_TR_gDAT|NVS_TR_hDAT|NVS_TR_hNET|SH-S5Y5 neurite outgrowth,FALSE
Bromoxynil octanoate,1689-99-2,0.852184613018015,1.27357429210979,3.11196393693521,91.71397342576,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
Olivetol,500-66-3,0.673378880391534,1.38635808285058,1.4946937761897,100,TOX21_MMP_fitc|TOX21_MMP_ratio_down,FALSE
(Z)-N-[(4-Hydroxy-3-methoxyphenyl)methyl]octadec-9-enamide,58493-49-5,0.786686349699886,1.05184499337198,3.60226297968559,69.524973506851,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
4-Heptylphenol,1987-50-4,0.716861049291885,1.43817532073082,1.38412206774686,54.1808356216774,NCCT_MITO_basal_resp_rate_OCR_dn|TOX21_MMP_ratio_down,FALSE
4-Nonylphenol,104-40-5,0.428284274435304,1.206521193,1,100,TOX21_MMP_fitc|TOX21_MMP_ratio_down|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
"N,N-Dimethyldecylamine oxide",2605-79-0,0.695165220127226,1.28028433660528,1.63085170620147,35.3991969589432,TOX21_MMP_ratio_up,FALSE
"1,8-Dinitronaphthalene",602-38-0,0.316238363027113,1.77022394955255,0.656294339010374,100,TOX21_MMP_rhodamine,FALSE
1-Nitropyrene,5522-43-0,-0.787377365241345,0.19462809289859,0.972010490317905,95.5931108067823,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
"2,4-Dinitrophenyl thiocyanate",1594-56-5,0.712512456355421,1.2362940394674,1.83738498437157,101.05617951779,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
2-Nitrofluorene,607-57-8,0.217335340677559,1.0715861129542,1.13295251212228,56.6767539427012,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
4-Nitro-N-phenylaniline,836-30-6,-0.0769030995209293,0.43467606322046,1.86528807062009,18.7278754996667,NVS_GPCR_hDRD1,FALSE
5-Nitroacenaphthene,602-87-9,-0.0695348536187342,0.85781430071334,1.02900024762154,101.011082066483,NVS_ENZ_rMAOAC,FALSE
Methyltrioctylammonium trifluoromethanesulfonate,121107-18-4,-0.025326736653175,0.418277320638584,2.15111312386333,97.9820899675112,TOX21_MMP_rhodamine,FALSE
Tibrofan,15686-72-3,0.364493027966035,0.870119977818634,1.88724614009895,100,TOX21_MMP_fitc,FALSE
1-Dodecyl-2-pyrrolidinone,2687-96-9,-3.07228072843933,-2.118038219,1,100,APR_HepG2_MitoMass_24h_dn|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|AREA_UNDER_CROSS_CORRELATION,FALSE
1-Tetradecanol,112-72-1,1.10087803724363,1.41827444300016,3.00646917272064,0.131328278339609,APR_HepG2_MitoMass_24h_dn,FALSE
Lauryl gallate,1166-52-5,0.299970344251567,0.633818602022805,2.85831208408821,98.1665077914208,TOX21_MMP_ratio_down,FALSE
"1-O-Hexyl-2,3,5-trimethylhydroquinone",148081-72-5,0.589810943133417,1.53561252181393,1.22406435488953,82.3252175537886,TOX21_MMP_fitc|TOX21_MMP_rhodamine,FALSE
4-(Hexyloxy)phenol,18979-55-0,0.556843151686259,1.02685558102277,2.03024952081879,100,TOX21_MMP_ratio_down,FALSE
Heptyl p-hydroxybenzoate,1085-12-7,0.552012469336671,1.12101817770805,1.67715905291376,89.0881886469018,TOX21_MMP_fitc|TOX21_MMP_ratio_down,FALSE
Octhilinone,26530-20-1,0.0589585335606752,1.013201043,1,100,APR_HepG2_MitoMembPot_72h_dn|NVS_GPCR_hDRD1|NVS_GPCR_hDRD2s|NVS_GPCR_hORL1|NVS_GPCR_hOpiate_mu|NVS_GPCR_h5HT7|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Octyl gallate,1034-01-1,0.0344717425606751,0.988714252,1,100,NCCT_MITO_basal_resp_rate_OCR_dn|NCCT_MITO_max_resp_rate_OCR_dn|NVS_ENZ_rCOMT|NVS_GPCR_hAdoRA2a|NVS_GPCR_hAdra2C|NVS_GPCR_hOpiate_D1|NVS_TR_hNET|TOX21_MMP_ratio_down|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION,FALSE
Octylparaben,1219-38-1,1.00684337891131,1.57621030697643,1.67597108718997,59.2403228938702,TOX21_MMP_fitc,FALSE
Pentylparaben,6521-29-5,0.632502674389089,1.28713798458184,1.45767039232631,66.6940418367932,TOX21_MMP_fitc,FALSE
3-Iodo-2-propynyl-N-butylcarbamate,55406-53-6,0.292683463398039,0.940558563,1,100,APR_HepG2_MitoMass_1h_dn|APR_HepG2_MitoMass_72h_dn|NVS_GPCR_hAdoRA1|NVS_GPCR_hOpiate_mu|NVS_IC_rKATPCh|NVS_TR_hNET|NVS_TR_rVMAT2|TOX21_MMP_rhodamine|BURST_DURATION_AVG_ (SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX|percent affected 4dpf|a background distmoved 1dpf|b excitatory distmoved 1dpf|percent affected 1dpf|LD movement pattern (spearman) 1dpf|LD movement pattern (pearson) 1dpf|LD movement pattern (cosine) 1dpf|CNS neurite outgrowth,FALSE
Acetyl tributyl citrate,77-90-7,1.1251101832508,2.94755707742884,0.523605111615452,3.88090221125258,APR_HepG2_MitoMembPot_24h_dn,FALSE
Alpidem,82626-01-5,0.121186880864923,0.487988003580241,2.60152559614691,60.5624273345847,TOX21_MMP_ratio_up,FALSE
Butylparaben,94-26-8,0.294513184560675,1.22989247961866,1,100,TOX21_MMP_ratio_down|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
"Dipropyl 2,5-pyridinedicarboxylate",136-45-8,0.740662679484602,1.53535471085787,1.20077019998596,100,NVS_GPCR_hAdoRA2a,FALSE
Isopropalin,33820-53-0,1.07538835610952,1.64309870138076,1.60032463323981,1.58259438124147,APR_HepG2_MitoMass_24h_dn|APR_HepG2_MitoMembPot_24h_dn|APR_HepG2_MitoMembPot_72h_dn,FALSE
Oryzalin,19044-88-3,0.168934281560675,1.07887954038152,1,100,TOX21_MMP_rhodamine|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Prochloraz,67747-09-5,-0.347098407795651,0.633889132944736,1,100,NCCT_MITO_inhib_resp_rate_OCR_dn|NCCT_MITO_max_resp_rate_OCR_dn|NVS_ENZ_rMAOAC|NVS_GPCR_rAdra2_NonSelective|NVS_GPCR_rmAdra2B|NVS_TR_gDAT|NVS_TR_hDAT|NVS_TR_rVMAT2|NVS_GPCR_h5HT7|NVS_TR_hSERT|NVS_TR_rSERT|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|INTER_BURST_INTERVAL_AVG_(SEC)|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION,FALSE
Propyl gallate,121-79-9,-0.564219592708401,0.351570978804787,1.22968282124607,93.7951346340137,NVS_ENZ_rCOMT|NVS_TR_hDAT,FALSE
Propylparaben,94-13-3,-0.146850146691097,1.59779519411628,0.547054897007211,100,NVS_GPCR_hAdoRA1|NVS_TR_hDAT,FALSE
Tributyl phosphate,126-73-8,0.319310458560675,1.273552968,1,100,NCCT_MITO_basal_resp_rate_OCR_dn|NCCT_MITO_max_resp_rate_OCR_dn|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|INTER_BURST_INTERVAL_AVG_(SEC)|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION,FALSE
Triclopyr butotyl,64700-56-7,0.989478227399536,1.72104141507457,1.30438836387049,31.1671171882657,TOX21_MMP_fitc,FALSE
3-Amino-9-ethylcarbazole,132-32-1,0.199993144486471,1.20931557404793,0.955913656846442,77.8131226574184,NVS_TR_hNET|TOX21_MMP_ratio_down,FALSE
7-Diethylamino-4-methylcoumarin,91-44-1,-0.129553740751697,0.715098036257356,1.12053443023841,96.1265428645535,NVS_ENZ_rMAOAC|NVS_TR_gDAT|TOX21_MMP_ratio_down|SH-S5Y5 neurite outgrowth,FALSE
Ethoprop,13194-48-4,0.766069631951694,1.53620998964054,1.23905012886607,0.552165263202492,NCCT_MITO_basal_resp_rate_OCR_dn,FALSE
Tetraethylthiuram disulfide,97-77-8,-1.1555844553802,-0.983718892401109,7.46147338613415,99.6066238115765,APR_HepG2_MitoMass_72h_up|NVS_GPCR_hDRD1|NVS_GPCR_hORL1|NVS_GPCR_h5HT6|NVS_GPCR_h5HT7|number active electrodes|number network spikes|percent affected 5dpf|percent affected 2dpf|percent affected 3dpf|percent affected 4dpf|percent spikes in burst|mean firing rate|percent affected 5dpf|percent affected 2dpf|number actively bursting electrodes|percent spikes in network spike|bursts per minute|mean correlation,FALSE
Thiobencarb,28249-77-6,-0.095116729017729,1.25866608955592,0.79727240930775,30.763290165179,APR_HepG2_MitoMembPot_24h_dn|NVS_TR_hDAT|TOX21_MMP_fitc,FALSE
Tioxidazole,61570-90-9,0.757969982854681,0.923100925895693,5.77870199168138,22.1095979644649,TOX21_MMP_fitc,FALSE
Triflumizole,68694-11-1,-0.631669993439325,0.322572516,1,100,NCCT_MITO_max_resp_rate_OCR_dn|NVS_GPCR_hOpiate_mu|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Ametryn,834-12-8,0.292882414314767,1.48725489596066,0.805155007759433,100,NVS_GPCR_bAdoR_NonSelective|NVS_GPCR_hAdoRA1,FALSE
Atrazine,1912-24-9,0.269732496500561,1.11082696978558,1,100,NVS_GPCR_bAdoR_NonSelective|NUMBER_OF_BURSTS|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX|SH-S5Y5 neurite outgrowth,FALSE
Cinromide,58473-74-8,0.683263212649984,1.56632143717379,1.08061108875795,35.2425594217092,TOX21_MMP_fitc,FALSE
Cyanazine,21725-46-2,0.213201616817161,1.13199646733753,1.145529360645,87.1109526755388,NVS_GPCR_bAdoR_NonSelective|NVS_GPCR_hAdoRA1,FALSE
Fenoxaprop-(2S)-ethyl,113776-20-8,0.59890168917001,0.756274811205453,6.06356725403474,25.3026514748686,APR_HepG2_MitoMembPot_24h_dn|NVS_ENZ_rMAOBC|NVS_ENZ_rMAOBP,FALSE
Mefenpyr-diethyl,135590-91-9,0.393822331157423,1.97802357076395,0.602349301075117,98.9555782108521,NVS_GPCR_gOpiateK,FALSE
N-Ethylperfluorooctanesulfonamide,4151-50-2,1.2655543777902,1.45774226939813,5.62060581737681,0.430022179683802,APR_HepG2_MitoMembPot_24h_dn|APR_HepG2_MitoMembPot_72h_dn,FALSE
Propetamphos,31218-83-4,0.786097788191123,1.52810185472357,1.4908799993881,0.401076253846501,NCCT_MITO_basal_resp_rate_OCR_dn|NCCT_MITO_max_resp_rate_OCR_dn,FALSE
Terbutylazine,5915-41-3,1.12911158986564,2.21575511649756,0.878155978526855,53.0097018116247,TOX21_MMP_fitc,FALSE
2-Ethoxy-5-(1-propenyl)phenol,94-86-0,-0.137557381407265,0.694844132540346,1.14637286627927,95.948029131209,NVS_TR_hNET,FALSE
Acetochlor,34256-82-1,1.03476684708679,1.88657821900905,1.12025096270541,1.69971444700615,APR_HepG2_MitoMass_24h_dn,FALSE
Benfuracarb,82560-54-1,0.737093865121868,1.66896826130094,1.02400335640937,108.898855386396,NVS_ENZ_hES,FALSE
Chlorfenvinphos,470-90-6,-0.0235412269999576,0.756634166301082,1.22328170442787,61.2514237669867,NVS_TR_rVMAT2|TOX21_MMP_fitc,FALSE
Ethoxyquin,91-53-2,0.688569394109147,0.785011509189797,9.89445854273657,14.4913304276116,NVS_ENZ_rMAOAC,FALSE
Fenamiphos,22224-92-6,0.195635596560675,1.149878106,1,100,APR_HepG2_MitoMembPot_72h_dn|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION,FALSE
Fenoxycarb,72490-01-8,0.659826809451681,1.33726695415783,1.36606223383933,0.619961056374176,APR_HepG2_MitoMembPot_24h_dn|APR_HepG2_MitoMembPot_72h_dn|NCCT_MITO_basal_resp_rate_OCR_dn|NCCT_MITO_max_resp_rate_OCR_dn|NVS_TR_hDAT,FALSE
Oxyfluorfen,42874-03-3,0.310903406549686,1.29997149589185,0.964789502079676,100,TOX21_MMP_rhodamine,FALSE
Tralkoxydim,87820-88-0,-0.360668732553771,0.639377733531648,0.959200736183784,71.7014944931159,NVS_GPCR_hAdra2A|NVS_GPCR_rmAdra2B,FALSE
"1,3-Dichloro-6,7,8,9,10,12-hexahydroazepino[2,1-b]quinazoline hydrochloride (1:1)",149062-75-9,-0.619760861657961,0.368426311165327,0.917600490476446,100,NVS_ENZ_hAChE|NVS_ENZ_rAChE|NVS_ENZ_rMAOAC|NVS_ENZ_rMAOAP|NVS_GPCR_gMPeripheral_NonSelective|NVS_GPCR_hAdra2A|NVS_GPCR_hM1|NVS_GPCR_hM2|NVS_GPCR_hM3|NVS_GPCR_hM4|NVS_GPCR_hM5|NVS_GPCR_rAdra1A|NVS_GPCR_rAdra1_NonSelective|NVS_GPCR_rAdra2_NonSelective|NVS_GPCR_rOpiate_NonSelective|NVS_GPCR_rmAdra2B|NVS_LGIC_hNNR_NBungSens|NVS_LGIC_rNNR_BungSens|NVS_TR_hNET,FALSE
"3,3'-Dichlorobenzidine dihydrochloride",612-83-9,-0.367270760225604,0.495373825857197,1.20100004442429,69.5570939590703,NVS_TR_gDAT|NVS_TR_hDAT|NVS_TR_hNET,FALSE
Atipamezole hydrochloride,104075-48-1,0.394611625926948,1.01647068263017,1.53449965736324,104.333813318235,TOX21_MMP_fitc,FALSE
Chlorpyrifos,2921-88-2,0.149561211560675,1.104145551,1,100,NVS_LGIC_rGABAR_NonSelective|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_BPCount_loss|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteSpotCountPerNeuron_loss|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_SynapseCount_loss|CCTE_Mundy_HCI_hN2_NOG_NeuriteCount_loss|CCTE_Mundy_HCI_hN2_NOG_NeuriteLength_loss|MFR|BR|ISI|%SiB|BD|IBI|#AE|#ABE|#NS|NSP|NSD|%SiNS|NS-ISI|NSDsd|#SiNS|r|MI|LD movement pattern (spearman) 5dpf|LD movement pattern (pearson) 5dpf,FALSE
Coumaphos,56-72-4,-0.108854386439325,0.845388123,1,100,TOX21_MMP_ratio_down|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Diphenoxylate hydrochloride,3810-80-8,1.25495780824784,1.37671061237029,7.83754030403756,55.0449844723282,TOX21_MMP_ratio_down,FALSE
Disulfoton,298-04-4,0.608616801822825,1.36741291028695,1.25757433228118,22.6000936102661,TOX21_MMP_fitc,FALSE
Isazofos,42509-80-8,0.386558846335136,1.0966084675903,1.38901889935715,50.0324368142879,NCCT_MITO_basal_resp_rate_OCR_dn|NVS_ENZ_hES,FALSE
Isofenphos,25311-71-1,0.836037417074816,1.34658808428568,1.86904566132947,51.0508533910786,TOX21_MMP_ratio_down,FALSE
Isoproterenol hydrochloride,51-30-9,0.150030434560675,1.68715625562652,1,100,NVS_GPCR_rAdrb_NonSelective|NVS_TR_hDAT|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NETWORK_BURST_PERCENTAGE,FALSE
Isoxathion,18854-01-8,0.32030197995253,1.10699418665348,1.42303855858977,100,TOX21_MMP_fitc|TOX21_MMP_ratio_down,FALSE
Molinate,2212-67-1,-0.219513690017247,1.50878387504831,0.552128596792377,100,NVS_GPCR_hM2,FALSE
Oxybutynin hydrochloride,1508-65-2,0.750218669958056,0.887827605861695,6.93445162680083,29.7718384626983,TOX21_MMP_ratio_up,FALSE
Phosalone,2310-17-0,0.353697144560675,1.307939654,1,100,TOX21_MMP_fitc|TOX21_MMP_ratio_down|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|SYNCHRONY_INDEX,FALSE
Pioglitazone hydrochloride,112529-15-4,0.539922232870253,1.29770805298111,1.38950352857916,50.4722588120186,APR_HepG2_MitoMass_72h_up|NVS_ENZ_rMAOBC,FALSE
SB243213A,200940-23-4,0.399241472642513,0.890378423100386,2.11814037650579,73.5142234359464,NVS_LGIC_rGABAR_NonSelective|TOX21_MMP_rhodamine|NVS_GPCR_h5HT6,FALSE
C.I. Basic Orange 2,532-82-1,-0.0631502406825021,0.890156357331996,1.00098175280311,83.6017639365942,TOX21_MMP_ratio_down,FALSE
Captafol,2425-06-01,0.424125884560675,1.37661913,1,100,TOX21_MMP_rhodamine|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION,FALSE
Captan,133-06-2,1.06203131062346,1.4048185384586,3.16548500661219,107.149135082192,TOX21_MMP_ratio_down|percent affected 4dpf,FALSE
Diphenhydramine hydrochloride,147-24-0,-0.217883425007063,0.778169929278623,1,100,NVS_ENZ_hES|NVS_GPCR_gMPeripheral_NonSelective|NVS_GPCR_gOpiateK|NVS_GPCR_hAdra2A|NVS_GPCR_hAdra2C|NVS_GPCR_hDRD1|NVS_GPCR_hM1|NVS_GPCR_hM2|NVS_GPCR_hM3|NVS_GPCR_hM4|NVS_GPCR_hM5|NVS_GPCR_rAdra1A|NVS_GPCR_rAdra1B|NVS_GPCR_rAdra1_NonSelective|NVS_GPCR_rAdra2_NonSelective|NVS_GPCR_rOpiate_NonSelective|NVS_GPCR_rmAdra2B|NVS_IC_rCaBTZCHL|NVS_IC_rNaCh_site2|NVS_TR_gDAT|NVS_TR_hDAT|NVS_TR_hNET|NVS_TR_rNET|NVS_GPCR_h5HT2A|NVS_GPCR_h5HT7|NVS_GPCR_p5HT2C|NVS_GPCR_r5HT_NonSelective|NVS_TR_rSERT|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Fluoxetine hydrochloride,56296-78-7,0.523896488370118,0.805336405861768,3.39057273020853,87.7798719063191,TOX21_MMP_ratio_up|CCTE_Mundy_HCI_Cortical_NOG_BPCount_loss|CCTE_Mundy_HCI_Cortical_NOG_NeuriteLength_loss|CCTE_Mundy_HCI_Cortical_NOG_NeuronCount_loss|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteLength_loss|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteSpotCountPerNeuron_loss|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuronCount_loss,FALSE
Pimobendan hydrochloride,77469-98-8,0.303488631794347,0.74128269717503,2.1796606781537,100,TOX21_MMP_fitc,FALSE
"S-(+)-2,5-Dimethoxy-4-bromoamphetamine hydrochloride",50505-93-6,0.945889651812154,1.71010942375967,1.24864933421909,63.7994286886968,TOX21_MMP_ratio_up,FALSE
"p,p'-DDD",72-54-8,0.0362022345606752,0.990444744,1,100,APR_HepG2_MitoMembPot_24h_dn|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
"p,p'-DDE",72-55-9,0.382096891560675,1.336339401,1,100,APR_HepG2_MitoMass_24h_dn|APR_HepG2_MitoMembPot_24h_dn|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|SYNCHRONY_INDEX,FALSE
DDT,50-29-3,0.340450078939494,0.933068426532349,1,100,TOX21_MMP_ratio_down|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX|percent spikes in network spike|NCC migration|percent affected 4dpf|percent affected 5dpf|LD movement pattern (pearson) 5dpf|mutual information|SH-S5Y5 neurite outgrowth,FALSE
Diclazuril,101831-37-2,0.576347193052889,1.01709125053609,1.99133952081042,105.783969778477,TOX21_MMP_fitc|TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
Endosulfan sulfate,1031-07-8,0.557361831499309,1.23793174402651,1.40212267964635,108.032597808716,TOX21_MMP_rhodamine,FALSE
Imazalil,35554-44-0,-0.0640968505412319,1.02478173286673,0.968545558197743,100,NCCT_MITO_basal_resp_rate_OCR_dn|NVS_GPCR_gOpiateK|NVS_GPCR_hM1|NVS_GPCR_hM2|NVS_GPCR_hM3|NVS_GPCR_hM4|NVS_GPCR_hOpiate_mu|NVS_GPCR_rOpiate_NonSelective|NVS_IC_rNaCh_site2|NVS_TR_gDAT|NVS_TR_hDAT|NVS_TR_hNET|NVS_TR_rVMAT2|NVS_TR_hSERT|NVS_TR_rSERT|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Thiacloprid,111988-49-9,-0.240839356695383,0.701028099490463,1.01313884790498,100,NVS_LGIC_hNNR_NBungSens|NVS_LGIC_rNNR_BungSens|SH-S5Y5 neurite outgrowth,FALSE
Chlorfenson,80-33-1,1.17288651009176,1.7922869996441,1.54059049925675,100,TOX21_MMP_ratio_down,FALSE
Cypromid,2759-71-9,0.552296115184183,1.12268413127317,1.67298422367524,94.2959843233463,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
Forchlorfenuron,68157-60-8,0.0743783359487972,0.733355909330517,1.17158008315633,83.1047443813008,APR_HepG2_MitoMass_24h_dn|APR_HepG2_MitoMembPot_1h_dn|NVS_GPCR_hAdra2A|NVS_GPCR_hAdra2C|NVS_GPCR_hDRD1|NVS_GPCR_rAdra2_NonSelective|NVS_TR_rVMAT2|TOX21_MMP_fitc|TOX21_MMP_ratio_down|NVS_GPCR_h5HT5A,FALSE
Triclocarban,101-20-2,0.524000498717518,1.04013139418751,1.84883818778254,6.84436991830244,APR_HepG2_MitoMembPot_24h_dn|APR_HepG2_MitoMembPot_72h_dn|TOX21_MMP_rhodamine,FALSE
"Tris(1,3-dichloro-2-propyl) phosphate",13674-87-8,0.182347969560675,1.136428422,1,100,APR_HepG2_MitoMass_24h_dn|APR_HepG2_MitoMembPot_72h_dn|NVS_IC_rCaDHPRCh_L|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|NS-ISI|NSDsd|#SiNS,FALSE
"1,2-Dibromo-2,4-dicyanobutane",35691-65-7,0.325571566971874,0.921962930304822,1.73301387320927,79.922474183138,NVS_GPCR_hDRD1|NVS_GPCR_hORL1|NVS_TR_gDAT,FALSE
"2,2',4,4',5-Pentabromodiphenyl ether",60348-60-9,-0.275588353231991,0.358549529507795,1.50478710610464,100,TOX21_MMP_fitc,FALSE
"4,4'-Dibromodiphenyl ether",2050-47-7,0.445519418728809,1.29359141081339,1.12519045357668,24.065696945514,TOX21_MMP_fitc,FALSE
3-Dimethylaminophenol,99-07-0,0.0970107895316092,1.53707113254143,0.662640641464297,100,TOX21_MMP_rhodamine,FALSE
Diuron,330-54-1,0.359881987082094,0.652898784368417,4.2359751786897,0.162877813333337,APR_HepG2_MitoMembPot_72h_dn|NVS_ENZ_rMAOAC,FALSE
Pirimicarb,23103-98-2,0.023323196857565,0.863623478323726,1,100,NVS_ENZ_rMAOAC|NVS_ENZ_rMAOAP|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|SYNCHRONY_INDEX,FALSE
Tetramethylthiuram monosulfide,97-74-5,0.367779671617825,0.792133289479016,2.24869653344505,86.6852825995713,NVS_TR_gDAT,FALSE
Thiram,137-26-8,0.0149902333796932,0.785481163246544,1.38161315676215,87.8952031758118,APR_HepG2_MitoMembPot_72h_dn|NVS_GPCR_hDRD1|NVS_GPCR_hOpiate_mu|NVS_GPCR_h5HT6,FALSE
Acetamiprid,135410-20-7,-0.643199073112308,0.467818527512195,1,100,NVS_LGIC_hNNR_NBungSens|NVS_LGIC_rNNR_BungSens|SH-S5Y5 neurite outgrowth,FALSE
Butafenacil,134605-64-4,0.918410917635541,1.80941709963839,1.07097181670988,0.950631440235196,APR_HepG2_MitoMembPot_72h_up,FALSE
Clothianidin,210880-92-5,-0.113535640069116,1.37297578913537,0.700461013728744,100,NVS_GPCR_rmAdra2B|NVS_LGIC_hNNR_NBungSens|SH-S5Y5 neurite outgrowth,FALSE
Meloxicam,71125-38-7,0.291252875793892,1.10007173000674,1.73507499829353,89.0121643684115,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
Tolylfluanid,731-27-1,0.627223970461454,1.46993246844613,1.13235182951327,110.868771606475,TOX21_MMP_ratio_down,FALSE
Aldicarb,116-06-3,0.140197285414118,0.476052308736367,4.4864689289706,83.4246633714745,APR_HepG2_MitoMembPot_72h_dn|NVS_ENZ_rAChE|#SiNS|r|percent affected 4dpf|LD movement pattern (pearson) 5dpf|LD movement pattern (spearman) 4dpf|mean correlation|a L1 distmoved 4dpf|b D1 distmoved 4dpf|number network spikes|b D1 distmoved 5dpf|percent affected 4dpf|LD movement pattern (spearman) 5dpf,FALSE
Carbofuran,1563-66-2,-1.06912211163358,-0.327194445875674,1.28616672765094,86.9172931478727,NVS_ENZ_hAChE|NVS_ENZ_rAChE,FALSE
Methiocarb,2032-65-7,-1.67140609894708,-0.689915753743376,0.972988198247612,100,NVS_ENZ_rMAOAC|SH-S5Y5 neurite outgrowth,FALSE
"N-(3,4-Dichlorophenyl)-N'-methylurea",3567-62-2,0.845693122042885,1.42860268920604,1.63703353520741,100,TOX21_MMP_rhodamine,FALSE
Oxamyl,23135-22-0,0.432085749757274,1.40011054397688,0.985762467177928,103.910134952582,APR_HepG2_MitoMass_72h_up|NVS_ENZ_hAChE|NVS_ENZ_rAChE,FALSE
Propoxur,114-26-1,0.199860307268214,1.19864900386939,0.969383539634875,100.372721842007,NVS_ENZ_hAChE|NVS_ENZ_rAChE,FALSE
Theophylline,58-55-9,-0.0801855119839434,1.13354924627786,0.743664569313502,103.323001934772,NVS_GPCR_bAdoR_NonSelective|NVS_GPCR_hAdoRA1|NVS_GPCR_hAdoRA2a,FALSE
(N-6)-Methyladenine,443-72-1,-0.377303599669048,1.09256609547852,0.649202111309277,100,TOX21_MMP_ratio_down,FALSE
Azoxystrobin,131860-33-8,0.133279901474582,0.988523192526188,1,100,APR_HepG2_MitoMass_72h_up|NCCT_MITO_basal_resp_rate_OCR_dn|NCCT_MITO_max_resp_rate_OCR_dn|NVS_GPCR_hAdoRA1|NVS_IC_rCaBTZCHL|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|SYNCHRONY_INDEX|SH-S5Y5 neurite outgrowth,FALSE
CP-607366,289716-94-5,-0.284352403939325,0.7362419,1,100,NVS_GPCR_gOpiateK|NVS_GPCR_rmAdra2B|NVS_IC_hKhERGCh|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION,FALSE
Fluoxastrobin,361377-29-9,0.152063935540645,0.882653196,1,100,NCCT_MITO_basal_resp_rate_OCR_dn|NCCT_MITO_inhib_resp_rate_OCR_dn|NCCT_MITO_max_resp_rate_OCR_dn|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX|SH-S5Y5 neurite outgrowth,FALSE
Methyl 3-methylorsellinate,4707-47-5,0.536027784415278,1.27728222842919,1.28733462193101,105.889156975104,TOX21_MMP_ratio_down,FALSE
Picoxystrobin,117428-22-5,-0.443825409104295,0.19997868328767,1,100,APR_HepG2_MitoMass_72h_up|APR_HepG2_MitoMembPot_24h_dn|NCCT_MITO_basal_resp_rate_OCR_dn|NCCT_MITO_max_resp_rate_OCR_dn|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX|SH-S5Y5 neurite outgrowth,FALSE
Rifabutin,72559-06-9,0.583807468860267,0.815063631967307,4.12634412254622,100,TOX21_MMP_ratio_up,FALSE
Rifampicin,13292-46-1,0.713136421179855,1.2303269692497,1.8450501715481,93.1948864672402,TOX21_MMP_rhodamine,FALSE
Triflusulfuron-methyl,126535-15-7,-0.103073221491655,1.16953885948954,0.755603348227081,100,NVS_GPCR_hAdoRA1|NVS_GPCR_hAdoRA2a,FALSE
"2,2-Dimethoxy-1,2-diphenylethanone",24650-42-8,0.116565618613519,1.17642355443919,0.900349449849555,100,NVS_GPCR_gOpiateK,FALSE
"2,4-D-methyl",1928-38-7,0.277793973489092,0.946154696115151,1.42773576773035,83.7544070381272,NVS_ENZ_rMAOAC,FALSE
Carbendazim,10605-21-7,-0.0231285374797385,0.706648837887452,1.30758028632937,1.24468880314948,APR_HepG2_MitoMass_72h_up,FALSE
Fluthiacet-methyl,117337-19-6,1.61650833287119,1.79680382571667,5.29265870365993,0.682103083495374,APR_HepG2_MitoMass_72h_up,FALSE
Swep,1918-18-9,0.834181926580899,1.09378521775383,3.6757720024576,12.1070929695098,TOX21_MMP_fitc,FALSE
Thiophanate-methyl,23564-05-8,0.842720141830391,1.45177752400685,1.60187516818376,1.10499499664321,APR_HepG2_MitoMass_72h_up|APR_HepG2_MitoMembPot_24h_dn,FALSE
Zafirlukast,107753-78-6,0.624432499731421,1.02852016570994,2.45118876813542,94.743122483228,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
2-Methoxy-4-vinylphenol,7786-61-0,0.55785539946292,1.43282871927074,1.09059612200395,100,NVS_TR_hNET,FALSE
Chloroneb,2675-77-6,0.468972272549689,1.4415357050406,0.981162233290364,88.1373127601703,TOX21_MMP_ratio_down,FALSE
Griseofulvin,126-07-8,-0.289225968430827,0.718412759045315,1.05466175300368,78.3437500124961,NVS_GPCR_rAdra2_NonSelective|NVS_TR_gDAT,FALSE
Teniposide,29767-20-2,0.266652426892995,0.87079200342909,1.57950670093588,43.4552578429662,TOX21_MMP_ratio_up,FALSE
"1-(4-tert-Butylphenyl)-3-(4-methoxyphenyl)propane-1,3-dione",70356-09-1,0.796762838058364,1.38059587242152,1.63444418742116,107.745353669743,TOX21_MMP_ratio_down,FALSE
"2,2'-Dihydroxy-4-methoxybenzophenone",131-53-3,0.495687815268462,1.02221951988698,1.81231728511142,91.6937149062992,TOX21_MMP_rhodamine,FALSE
2-tert-Butyl-4-methoxyphenol,121-00-6,0.606583352560675,1.560825862,1,100,NCCT_MITO_max_resp_rate_OCR_dn|NVS_GPCR_h5HT6|NVS_GPCR_p5HT2C|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
3-Hydroxy-2-naphthoic o-anisidide,135-62-6,-0.943223159272434,-0.535058938436888,2.34611193317937,91.6634305870111,TOX21_MMP_fitc|TOX21_MMP_rhodamine,FALSE
Biochanin A,491-80-5,0.300383236249077,0.684313158694278,2.12986800419662,100.399878865631,TOX21_MMP_fitc|TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
Chlorotrianisene,569-57-3,0.842148640701209,1.5118945427196,1.42478290134147,59.2508823333482,TOX21_MMP_ratio_down,FALSE
Difpas-pyrazole,151506-44-4,0.71957027499304,1.56743887110188,1.12546037654734,1.31136875254512,APR_HepG2_MitoMass_72h_up|APR_HepG2_MitoMembPot_72h_dn|NVS_TR_rVMAT2,FALSE
Formononetin,485-72-3,0.650294735161802,1.15076670067947,1.90668523950646,87.0917589391301,TOX21_MMP_ratio_down,FALSE
Methoxychlor,72-43-5,0.410426388560675,1.364668898,1,100,APR_HepG2_MitoMembPot_1h_dn|NUMBER_OF_BURSTS|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|SYNCHRONY_INDEX,FALSE
Azamethiphos,35575-96-3,-0.307313696259163,0.683674806592615,0.963888513236823,98.6202075405863,NVS_ENZ_hAChE|NVS_ENZ_rAChE,FALSE
Dicrotophos,141-66-2,0.474839062350667,1.39318812427415,1.03908475437506,100,NVS_ENZ_hES,FALSE
Fluvoxamine,54739-18-3,0.849628443332585,0.963562187590459,8.37541604249856,100,TOX21_MMP_ratio_up,FALSE
Linuron,330-55-2,0.229009178560675,1.149566455,1,100,APR_HepG2_MitoMass_72h_up|APR_HepG2_MitoMembPot_24h_dn|NCCT_MITO_basal_resp_rate_OCR_dn|NVS_ENZ_rMAOBC|NVS_TR_hDAT|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
"N-(3-Chlorophenyl)-6,7-dimethoxyquinazolin-4-amine",175178-82-2,-0.534332285088795,0.201112070784502,1.29750470150283,87.1319527996934,NVS_TR_hNET,FALSE
Prometon,1610-18-0,-0.0155378246838208,1.01832359944859,0.929472289602361,51.5408547334741,NCCT_MITO_basal_resp_rate_OCR_dn|NVS_ENZ_rMAOBC,FALSE
Tetrachlorovinphos,961-11-5,-1.15003007070227,-0.331208438137269,1.29676288586644,85.4571129766063,TOX21_MMP_fitc|TOX21_MMP_ratio_down,FALSE
Z-Tetrachlorvinphos,22248-79-9,-0.318046742851412,0.214918920294337,3.96584842744091,91.606546906134,TOX21_MMP_ratio_down|CCTE_Mundy_HCI_hN2_NOG_BPCount_loss,FALSE
1-Decyl-3-methylimidazolium hexafluorophosphate,362043-46-7,0.388694829497634,1.52378188422359,0.840677818909412,100,TOX21_MMP_rhodamine,FALSE
1-Dodecyl-3-methylimidazolium tetrafluoroborate,244193-59-7,0.245054719057338,1.20191574032056,0.997263435581856,78.1256346467715,TOX21_MMP_ratio_down,FALSE
1-Methyl-3-octadecylimidazolium hexafluorophosphate,219947-96-3,0.700749199951084,1.15411018815851,2.10481831092784,55.968832748909,TOX21_MMP_ratio_down,FALSE
3-Methyl-4-(methylthio)phenol,3120-74-9,0.651145958423773,1.19047747111427,3.61156223967381,58.8432297404012,NVS_ENZ_rMAOAC|NVS_TR_gDAT,FALSE
Acibenzolar-S-methyl,135158-54-2,-0.550840115439325,0.403402394,1,100,NVS_ENZ_rAChE|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|AREA_UNDER_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Cybutryne,28159-98-0,-0.188843666911428,1.13183256377085,0.722540837239381,44.3829422257959,TOX21_MMP_fitc,FALSE
Difenzoquat metilsulfate,43222-48-6,0.0511098263341049,1.115460919,1,100,NCCT_MITO_max_resp_rate_OCR_dn|NVS_ENZ_hES|NVS_GPCR_gOpiateK|NVS_GPCR_hAdra2A|NVS_GPCR_hAdra2C|NVS_GPCR_hM1|NVS_GPCR_hM2|NVS_GPCR_hM3|NVS_GPCR_hM4|NVS_GPCR_rAdra1A|NVS_GPCR_rAdra1B|NVS_GPCR_rAdra1_NonSelective|NVS_GPCR_rAdra2_NonSelective|NVS_GPCR_rmAdra2B|NVS_IC_rNaCh_site2|NVS_TR_hNET|NVS_GPCR_g5HT4|NVS_GPCR_h5HT7|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
PharmaGSID_48506,588941-45-1,-0.332484846049304,1.31287202339361,0.57996081407094,66.6517431827559,NVS_TR_rVMAT2,FALSE
Piragliatin,625114-41-2,0.637712995705154,1.52827437173318,1.07150673173738,1.19055814551355,APR_HepG2_MitoMass_72h_up,FALSE
Thiodicarb,59669-26-0,0.486031461560675,1.440273971,1,100,NVS_ENZ_hES|NVS_ENZ_rAChE|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|SYNCHRONY_INDEX,FALSE
Trihexyltetradecylphosphonium hexafluorophosphate,374683-44-0,-0.81170607028924,-0.413879901201102,2.44931408730867,101.478836111262,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
"4,4,4-Trifluoro-1-phenyl-1,3-butanedione",326-06-7,0.456343307994817,1.18500994193919,1.30959087484997,100,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
Efavirenz,154598-52-4,0.352535869966844,1.24036480499616,1.07480447166077,49.185026872351,TOX21_MMP_fitc,FALSE
Fludioxonil,131341-86-1,0.104237009013809,1.058456579,1.16762694461405,100,APR_HepG2_MitoMass_72h_up|APR_HepG2_MitoMembPot_24h_dn|TOX21_MMP_fitc|TOX21_MMP_ratio_down|TOX21_MMP_rhodamine|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION,FALSE
Hexaflumuron,86479-06-3,0.381453531560675,1.24212437873787,1,100,TOX21_MMP_ratio_down|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|INTER_BURST_INTERVAL_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION,FALSE
Tetraconazole,112281-77-3,0.254035343680776,1.16439064599274,0.846995690136423,25.6187764712956,NCCT_MITO_basal_resp_rate_OCR_dn|NCCT_MITO_max_resp_rate_OCR_dn|NVS_IC_rCaBTZCHL|NVS_IC_rCaDHPRCh_L|NVS_TR_hDAT,FALSE
(-)Carophyllene oxide,1139-30-6,0.612947490923261,1.23526106873688,1.5333789000585,95.4255102235655,NVS_LGIC_rNNR_BungSens,FALSE
"1,2-Dibromo-4-(1,2-dibromoethyl)cyclohexane",3322-93-8,0.87914631876522,1.57136631570045,1.37852491067028,98.4328332536786,TOX21_MMP_ratio_down,FALSE
4-Styrylpyridine,103-31-1,0.744891506306823,1.17620486009315,2.21241123434369,64.357960399741,TOX21_MMP_rhodamine,FALSE
Cantharidin,56-25-7,-1.48350689017797,-0.834945034505704,1.47263344880154,69.3840466251398,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
Valerenic acid,3569-10-06,-0.0334314914527875,0.903554580570524,1.01841696256888,81.7146352084785,TOX21_MMP_ratio_down,FALSE
2-(Thiocyanomethylthio)benzothiazole,21564-17-0,0.369038909060675,1.3232814185,1,100,APR_HepG2_MitoMass_1h_dn|NCCT_MITO_basal_resp_rate_OCR_dn|NCCT_MITO_max_resp_rate_OCR_dn|NVS_GPCR_hAdra2A|NVS_GPCR_hDRD1|NVS_TR_hNET|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
9-Cyanoanthracene,1210-12-4,0.0207701192280214,1.70590617741846,0.566270304882105,80.0102974870871,TOX21_MMP_ratio_down,FALSE
Benodanil,15310-01-7,0.141982898036339,1.47359857702092,0.716605041904418,100,NVS_TR_hNET,FALSE
Chlorfluazuron,71422-67-8,0.56067030384941,1.6442331006317,0.880652706306463,100,TOX21_MMP_fitc,FALSE
Diphenylamine,122-39-4,-0.422272635962914,0.00418988704290596,3.18521529618624,54.7414611068663,NVS_TR_hDAT|NVS_TR_hNET,FALSE
"N,N'-Diphenyl-p-phenylenediamine",74-31-7,0.596824605296735,0.985586143373835,2.45457025959723,92.1586448375662,TOX21_MMP_ratio_down,FALSE
N-Phenyl-2-naphthylamine,135-88-6,0.270479573751636,1.53054245197156,0.757297533268633,100,NVS_TR_hDAT,FALSE
"1,3-Diiminobenz(f)isoindoline",65558-69-2,0.0819659298754287,1.28643880870336,0.793889813630505,92.2070068778937,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
"1,3-Diphenylguanidine",102-06-7,-0.297627557689059,0.878433606776293,1,100,NVS_GPCR_hM4|NVS_GPCR_rAdra1A|NVS_GPCR_rmAdra2B|NVS_GPCR_h5HT7|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION,FALSE
Carbazole,86-74-8,0.628743611990079,1.4250170849469,1.16056291026538,80.5067982533742,NVS_ENZ_rMAOAC|NVS_TR_hNET|TOX21_MMP_fitc|TOX21_MMP_ratio_down,FALSE
Fuberidazole,3878-19-1,0.552707821068352,1.40708712472998,1.11688392421225,52.2744793052164,TOX21_MMP_fitc,FALSE
Phenothiazine,92-84-2,0.302893830827909,1.155619847,1,100,NVS_ENZ_rMAOAC|TOX21_MMP_rhodamine|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
CJ-013790,179465-71-5,0.0262796805606751,0.94335552,1,100,NVS_TR_gDAT|NVS_TR_hDAT|NVS_TR_hNET|NVS_GPCR_g5HT4|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Diphenan,101-71-3,0.790536500441425,1.4191397151458,1.6015260833772,100,TOX21_MMP_fitc|TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
"1,3-Benzenediamine",108-45-2,0.218698864171039,1.64278455299766,0.670862182857624,35.8207073274005,NCCT_MITO_inhib_resp_rate_OCR_up|NVS_ENZ_rMAOAC,FALSE
"2-Amino-4,6-dinitrophenol",96-91-3,-0.23409621259438,0.547152217577867,1.23242340938607,103.488700210247,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
2-Amino-4-chloro-5-nitrophenol,6358-07-02,0.298824103542568,1.28714841885161,0.965747156441907,100,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
2-Amino-4-chlorophenol,95-85-2,0.24724750184298,2.0950207320229,0.516428365696373,100,TOX21_MMP_ratio_down,FALSE
2-Chloro-4-nitroaniline,121-87-9,0.524225894624344,1.36120560615213,1.14010231824794,105.471068250543,NVS_ENZ_rMAOAC,FALSE
"2-Nitro-1,4-phenylenediamine",5307-14-2,-0.0837538087967755,0.865151001953631,1.00562511500463,80.7347347217827,TOX21_MMP_ratio_down,FALSE
"3,3'-Dichlorobenzidine",91-94-1,0.893088069050966,1.42049670638865,1.81445903986485,94.8904112934294,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
"4,4'-Diaminoazobenzene",538-41-0,-0.855046775588126,1.00570261533869,0.512941694837196,100,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
4-Amino-2-nitrophenol,119-34-6,0.31034465001844,1.19130062107123,1.08318978563589,73.2333764471708,TOX21_MMP_ratio_down,FALSE
4-Aminoazobenzene,1960-09-03,-0.209548139221338,0.837062765699952,0.987341888971457,95.7254784708538,NVS_ENZ_rMAOAC|NVS_TR_gDAT|NVS_TR_hDAT|NVS_TR_hNET,FALSE
4-Aminobenzoic acid,150-13-0,-0.480704839690821,0.450011425583236,1.02527756851691,93.5694407806166,NVS_LGIC_rGABAR_NonSelective,FALSE
Benzidine,92-87-5,0.477662328371864,1.37329939299619,0.901910265914595,100,NVS_TR_gDAT|NVS_TR_hNET|NVS_TR_rNET,FALSE
Cinnamyl anthranilate,87-29-6,1.05008555496601,1.56589663931607,1.84998449702123,99.8904351250096,TOX21_MMP_ratio_down,FALSE
Dapsone,80-08-0,-0.44555490851431,0.782997667425125,0.776720938222482,100,NVS_TR_gDAT|NVS_TR_hDAT|NVS_GPCR_h5HT6,FALSE
"1,3-Phenylenedi(4-aminophenyl ether)",2479-46-1,-0.247852738797468,0.285102839087628,2.03101210223262,76.5848875804693,NVS_TR_gDAT|NVS_TR_hDAT,FALSE
"1,4-Diaminoanthraquinone",128-95-0,-2.43319012421465,-1.48232008089197,1.00386235288835,86.8315296303264,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
"1,5-Naphthalenediamine",2243-62-1,-0.475293976130632,1.16143769411605,0.583017074078798,100,NVS_TR_hDAT,FALSE
1-Naphthylamine,134-32-7,0.701718172103154,1.65143514016107,1.00476514744247,100,NVS_TR_hNET,FALSE
2-Amino-5-chlorobenzophenone,719-59-5,-0.212722236841428,0.827583529950178,0.915071201036375,100,NVS_TR_gDAT|NVS_TR_hDAT|NVS_TR_hNET,FALSE
2-Aminoanthraquinone,117-79-3,-0.757917464625279,0.588549303183747,0.831970238492247,81.6008976842105,NVS_ENZ_rMAOAC|NVS_ENZ_rMAOAP|NVS_GPCR_hAdoRA2a|TOX21_MMP_rhodamine,FALSE
2-Naphthylamine,91-59-8,-0.364566218666386,0.85921636749694,1,100,APR_HepG2_MitoMass_72h_up|APR_HepG2_MitoMembPot_24h_dn|NVS_TR_hNET|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG,FALSE
"4,4'-Diaminobiphenyl methane",101-77-9,0.00640530183558807,1.1279745633776,0.850810148030777,114.295721533897,NVS_TR_hDAT,FALSE
"4,4'-Oxydianiline",101-80-4,-0.883248415144617,0.523672400786008,0.681449089371049,98.5443699089614,NVS_TR_gDAT|NVS_TR_hDAT,FALSE
"6-Phenyl-1,3,5-triazine-2,4-diamine",91-76-9,-0.652137575680537,0.453219481051041,0.882535481256413,100.273837384242,NVS_GPCR_hAdoRA1|NVS_GPCR_hAdoRA2a,FALSE
"1,2-Diphenylethanedione",134-81-6,-0.499074038279333,0.309892380891297,1.20161754008024,85.7103026664286,NVS_TR_gDAT|NVS_TR_hDAT,FALSE
"9-Aminoacridine, monohydrochloride, monohydrate",52417-22-8,0.0951499618611341,1.00816979608915,1.04800037560214,79.5457198509302,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
Benzyldimethyltetradecylammonium chloride dihydrate,147228-81-7,0.63972579915837,1.15733412146439,1.84356098678639,109.152801415723,TOX21_MMP_rhodamine,FALSE
Perfluorooctanesulfonamide,754-91-6,0.136682857814377,0.428786349252016,3.26679597269738,84.5809740388454,NCCT_MITO_basal_resp_rate_OCR_up|TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
"2,2'-Dibenzoylaminodiphenyl disulfide",135-57-9,0.490712087881616,1.0182216316967,1.81425880850541,85.0173412245285,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
"5,6-Benzoflavone",6051-87-2,0.198439560749241,1.01242978982679,1.17230216696914,88.4766002696528,TOX21_MMP_rhodamine,FALSE
"9,10-Dihydrobenzo[a]pyren-7(8H)-one",3331-46-2,0.658188069162702,1.03284881775055,2.5469508429586,70.0893536904975,TOX21_MMP_rhodamine,FALSE
Bismaleimide,13676-54-5,0.745094549712917,1.39161772047839,1.47596026343421,84.0276533918022,TOX21_MMP_rhodamine,FALSE
Diethylene glycol dibenzoate,120-55-8,-0.677798122952406,0.0579145811053717,1.29703144199666,79.2918764270141,NVS_LGIC_bGABARa1,FALSE
Diphenyl phthalate,84-62-8,-0.469746528881488,0.217717527812193,1.43958821804376,79.4144939002328,NVS_TR_gDAT|NVS_TR_hDAT,FALSE
Diphenylurea,102-07-8,0.0684959169018435,0.573319392213963,2.17801340724161,92.9081223348305,TOX21_MMP_fitc|TOX21_MMP_rhodamine,FALSE
Pentaerythrityl tetrabenzoate,4196-86-5,-0.188089169057102,1.18657589371257,0.726471124798346,73.3830832388031,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
Thidiazuron,51707-55-2,-0.116223173125438,0.846747812649807,1.182518200333,72.2925648864275,APR_HepG2_MitoMembPot_1h_dn|NVS_LGIC_bGABARa5|NVS_LGIC_rGABARa6|TOX21_MMP_ratio_down|NVS_GPCR_h5HT5A,FALSE
Xanthone,90-47-1,0.166772383803142,0.934083669294675,1.24361849940477,89.441029104832,NVS_ENZ_rMAOAC,FALSE
"1H,3H-Naphtho(1,8-cd)pyran-1,3-dione",81-84-5,0.204934478477391,0.580464416636077,2.54105575208785,46.7512809288191,TOX21_MMP_ratio_down,FALSE
"1H-Benzo[de]isoquinoline-1,3(2H)-dione",81-83-4,0.0298834387960305,1.18474089873168,0.827839969677396,82.4948857888023,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
"5,5-Diphenylhydantoin",57-41-0,0.153809072740733,1.32584624376377,0.843294234256227,93.9056227134791,NVS_TR_hDAT|BD,FALSE
"Tris(2,3-epoxypropyl)isocyanurate",2451-62-9,1.0890951507339,1.66579553994536,1.65465903490041,1.60065565745055,APR_HepG2_MitoMass_24h_dn,FALSE
Chlorpheniramine maleate,113-92-8,0.160725088215862,0.848865915307595,1.11373452464414,99.1747852424719,NVS_ENZ_hES|NVS_GPCR_hDRD1|NVS_GPCR_hM2|NVS_IC_rNaCh_site2|NVS_TR_gDAT|NVS_TR_hDAT|NVS_TR_hNET,FALSE
Perhexiline maleate,6724-53-4,0.534157221823997,0.738491031551517,4.85417017782069,81.2791106268916,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
Triphenyl phosphate,115-86-6,0.381951756503361,0.974033006464334,1.32270148418975,99.9084245235167,NVS_TR_gDAT|NVS_TR_hDAT|TOX21_MMP_ratio_down|%SiNS|NSDsd|#SiNS|r|MI|LD movement pattern (pearson) 5dpf|percent affected 5dpf|d D2 distmoved 5dpf|LD movement pattern (spearman) 5dpf|LD movement pattern (cosine) 1dpf|b D1 distmoved 5dpf,FALSE
Triphenylphosphine oxide,791-28-6,0.245619784965732,1.51024197774668,0.754567265137833,100,NVS_GPCR_gOpiateK,FALSE
"2E,4E-Hexadienoic acid",110-44-1,0.891318686662972,2.03662270715449,0.83317834598171,1.8446655855007,APR_HepG2_MitoMass_72h_up,FALSE
Retinal,116-31-4,0.933999704324306,1.30807158729594,2.58427375480293,79.2770804182451,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
alpha-Tomatine,17406-45-0,-0.058400871562486,0.37479938076735,2.20345555225586,93.473199015814,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
4-Nitrobenzoic acid,62-23-7,-0.542212835047876,0.558223056792146,0.867149569107339,100,NVS_LGIC_rGABAR_NonSelective,FALSE
5-(2-Chloro-4-(trifluoromethyl)phenoxy)-2-nitrobenzoic acid,50594-66-6,0.108253725136175,1.61253561701904,0.635763550471856,20.9217232800579,NCCT_MITO_basal_resp_rate_OCR_dn|NVS_GPCR_hAdoRA2a,FALSE
Cyclanilide,113136-77-9,0.637291140039783,1.25641749167607,1.5412726447798,90.2611582233316,TOX21_MMP_rhodamine,FALSE
Iodophthalein,386-17-4,0.297404953999404,0.678270706143813,2.53136561581297,88.3107111012038,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
Perfluorodecanoic acid,335-76-2,0.449759216283075,1.39973873206897,1.00470977710499,104.522502787996,NVS_GPCR_hAdoRA2a|NVS_GPCR_hOpiate_D1,FALSE
Perfluoroheptanoic acid,375-85-9,0.575708362538586,1.02298762394451,2.13343785812888,1.34952639218743,APR_HepG2_MitoMass_72h_dn,FALSE
Rhein,478-43-3,-0.193932714829327,0.899761946541764,0.878566327714957,92.2605676467835,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
Endothal,145-73-3,0.847682158504281,1.04674355039627,1.17386986670085,8.78167654255421,APR_HepG2_MitoMass_24h_dn|APR_HepG2_MitoMass_72h_dn|NVS_LGIC_rGABAR_NonSelective,FALSE
Tamoxifen citrate,54965-24-1,0.150044758586412,0.796200788281019,1.23675686611205,100,APR_HepG2_MitoMembPot_24h_dn|NVS_GPCR_hDRD1|NVS_GPCR_hM4|NVS_GPCR_hORL1|NVS_GPCR_hOpiate_mu|NVS_IC_rCaBTZCHL|NVS_TR_hDAT|NVS_GPCR_h5HT5A|NVS_GPCR_h5HT7|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NETWORK_BURST_PERCENTAGE,FALSE
"2,4,5-Trichlorophenoxyacetic acid",93-76-5,0.917374009568473,1.37863845950196,2.06875363921264,100,TOX21_MMP_fitc,FALSE
"2,4-Dichlorophenoxybutyric acid",94-82-6,0.382872584060675,1.3371150935,1,100,NCCT_MITO_basal_resp_rate_OCR_dn|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG,FALSE
Fenarimol,60168-88-9,-0.535892869939325,0.4183496395,1,100,NVS_TR_hDAT|NVS_GPCR_h5HT6|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Malic acid,6915-15-7,-0.12278288937048,0.66905966077303,1.20509122585845,100,NVS_TR_gDAT,FALSE
"2,2'-Bisphenol F",2467-02-09,0.379963496810109,1.05204981580028,1.4211395730998,105.043477574414,TOX21_MMP_fitc|TOX21_MMP_ratio_down,FALSE
"2,3,4,5-Tetrachlorophenol",4901-51-3,0.204682551408142,0.727066417701742,1.82670746746034,95.5799963482082,TOX21_MMP_ratio_down,FALSE
"2,3,4,6-Tetrachlorophenol",58-90-2,0.858455106713031,1.20764649661379,2.73272061407502,99.5324035508741,TOX21_MMP_ratio_down,FALSE
"2,3,5,6-Tetrachlorophenol",935-95-5,0.362534410472797,0.825761605312643,2.08377217851743,91.6092158681827,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
"2,4,5-Trichlorophenol",95-95-4,0.564995714560675,1.519238224,1,100,APR_HepG2_MitoMass_24h_dn|NVS_ENZ_rMAOAC|NVS_ENZ_rMAOBC|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
"2,4-Dichlorophenol",120-83-2,0.00197490843005232,0.910794020154413,1.04998068056555,62.053826790742,NVS_ENZ_rMAOBC,FALSE
"2,4-Dinitrophenol",51-28-5,-0.506416288084059,0.0381084962962671,1.75243172911819,97.0517163303686,TOX21_MMP_rhodamine,FALSE
2-Phenylphenol,90-43-7,0.456273847778212,1.17132179508461,1.03688501675785,100,NVS_TR_hNET|TOX21_MMP_fitc|SH-S5Y5 neurite outgrowth,FALSE
"4,4'-Sulfonylbis[2-(prop-2-en-1-yl)phenol]",41481-66-7,0.272701441559844,1.09150438870044,1,99.6814862002725,APR_HepG2_MitoMass_24h_dn|NCCT_MITO_basal_resp_rate_OCR_dn|NCCT_MITO_max_resp_rate_OCR_dn|NVS_GPCR_bAdoR_NonSelective|NVS_GPCR_hAdoRA1|NVS_GPCR_hAdoRA2a|NVS_GPCR_hOpiate_mu|NVS_GPCR_rOpiate_NonSelectiveNa|NVS_IC_rCaDHPRCh_L|NVS_TR_gDAT|NVS_TR_hNET|NVS_GPCR_g5HT4|NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|AREA_UNDER_CROSS_CORRELATION,FALSE
5-Chlorosalicylanilide,4638-48-6,-0.487899271124841,0.0854100061593324,1.85942006091792,98.2976781402046,TOX21_MMP_fitc|TOX21_MMP_rhodamine,FALSE
Bithionol,97-18-7,-1.27122234675327,-0.461855686047441,1.1790791901468,94.5400230727877,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
Bithionoloxide,844-26-8,0.876883124755598,2.25425601353332,0.692798963312047,100,TOX21_MMP_fitc,FALSE
Bromoxynil,1689-84-5,0.117939404069956,0.640617738459821,1.62276391968849,48.6742586510436,APR_HepG2_MitoMembPot_24h_dn|NCCT_MITO_basal_resp_rate_OCR_up|NVS_ENZ_rCOMT|TOX21_MMP_fitc|TOX21_MMP_rhodamine|SH-S5Y5 neurite outgrowth,FALSE
Clorophene,120-32-1,-0.0195534364393248,0.627711663711892,1,100,NCCT_MITO_basal_resp_rate_OCR_dn|NCCT_MITO_max_resp_rate_OCR_dn|NVS_GPCR_hOpiate_mu|NVS_TR_gDAT|NVS_TR_hDAT|NVS_TR_hNET|TOX21_MMP_fitc|TOX21_MMP_ratio_down|TOX21_MMP_rhodamine|NVS_GPCR_h5HT6|NVS_GPCR_h5HT7|NVS_GPCR_p5HT2C|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Fluorosalan,4776-06-01,-1.37501040422798,-0.924984196418242,2.36469945075782,102.142566643798,TOX21_MMP_fitc|TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
Ioxynil,1689-83-4,0.388610638634195,0.593972816420948,4.64663220717403,103.444261894975,TOX21_MMP_rhodamine,FALSE
Pentabromophenol,608-71-9,-0.222383598969491,0.520358014172414,1.28476030114606,96.2406559897954,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
Rafoxanide,22662-39-1,1.24252701317492,1.38722866659308,6.59455152652414,100,TOX21_MMP_fitc,FALSE
Salicylanilide,87-17-2,0.230412302139191,0.638154808139749,2.34030667736667,100,TOX21_MMP_fitc|TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
Tribromsalan,1987-10-05,-0.716326551051675,-0.178726056728725,1.77500303574142,105.121197540562,TOX21_MMP_ratio_down,FALSE
"((3,4-Dihydroxyphenyl)methylene)-Propanedinitrile",118409-57-7,0.793274080263519,1.19779159686841,2.35896461900651,87.3457162415034,TOX21_MMP_rhodamine,FALSE
1-Hydroxypyrene,5315-79-7,0.0352398215251728,0.678008259486674,1.18310464423909,94.51388450377,APR_HepG2_MitoMass_72h_dn|APR_HepG2_MitoMembPot_72h_dn|NVS_ENZ_rMAOAC|NVS_ENZ_rMAOAP|TOX21_MMP_ratio_down,FALSE
"2,2',4,4'-Tetrahydroxybenzophenone",131-55-5,-0.2682112321769,0.937307847955959,0.844845060209343,73.6310733362605,APR_HepG2_MitoMass_72h_up|NCCT_MITO_basal_resp_rate_OCR_dn|NVS_ENZ_rMAOAC|NVS_ENZ_rMAOAP|NVS_GPCR_bAdoR_NonSelective|NVS_GPCR_hAdoRA1|TOX21_MMP_rhodamine,FALSE
"2,3',4,4'-Tetrahydroxybenzophenone",61445-50-9,0.231510295024113,0.863839644328806,1.50909096737105,87.3919400624271,TOX21_MMP_ratio_down,FALSE
"2,3,4,4'-Tetrahydroxybenzophenone",31127-54-5,0.875050837141117,1.77890096237384,1.05575303117166,78.6612081898452,TOX21_MMP_rhodamine,FALSE
"2,3,5-Trichlorophenol",933-78-8,0.0909439329964313,0.755276255131694,1.4588814520728,94.0488790250727,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
"2,4-Dihydroxybenzophenone",131-56-6,1.06034997397956,1.54629154539507,1.96369803608217,102.063972492803,TOX21_MMP_ratio_down,FALSE
"3,4,5-Trichlorophenol",609-19-8,0.0514341087762388,0.613183011163801,1.70263957270592,96.5111025928938,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
3-Trifluoromethyl-4-nitrophenol,88-30-2,0.310489406584335,0.629899943802963,2.98751105003831,78.1273991345545,TOX21_MMP_rhodamine,FALSE
"4,6-Dichloro-1,3-benzenediol",137-19-9,0.432128502001264,0.981862305303153,1.73653962938087,88.5082367808734,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
4-Hydroxyazobenzene,1689-82-3,0.127953314671977,0.71816052352049,1.61679236568635,97.4798918136548,TOX21_MMP_rhodamine,FALSE
4-Phenylphenol,92-69-3,0.281888497482579,1.09104461044532,1.79359511308691,63.4649872513893,NVS_ENZ_rMAOAC|NVS_TR_gDAT|NVS_TR_hDAT,FALSE
"7,4'-Dihydroxyisoflavone",486-66-8,0.972156607664237,1.53103977554833,1.93234034305832,72.6902572707531,TOX21_MMP_fitc|TOX21_MMP_ratio_down,FALSE
Apigenin,520-36-5,0.0646540513761821,0.240834893742698,5.41626715266907,91.664546775991,TOX21_MMP_rhodamine,FALSE
Benzyl 4-hydroxybenzoate,94-18-8,0.732228304770153,1.34851959790827,1.86253220386157,70.603599033724,TOX21_MMP_fitc|TOX21_MMP_ratio_down,FALSE
Bisdemethoxycurcumin,33171-05-0,-0.489982437444319,0.437680280688218,1.14864431020182,87.9429290280529,APR_HepG2_MitoMass_72h_dn|ERF_GPCR_binding_hHTR5A_up|ERF_GPCR_binding_hHTR6_up|ERF_GPCR_binding_hHTR7_up|ERF_TR_binding_hSLC6A4_dn,FALSE
Bisphenol AF,1478-61-1,0.219968449212154,1.00188742463785,1.28779045963829,100,NCCT_MITO_basal_resp_rate_OCR_dn|NCCT_MITO_max_resp_rate_OCR_dn|NVS_GPCR_gMPeripheral_NonSelective|NVS_GPCR_hAdra2C|NVS_GPCR_hAdrb1|NVS_GPCR_hDRD1|NVS_GPCR_hDRD2s|NVS_GPCR_hDRD4.4|NVS_GPCR_hOpiate_mu|NVS_LGIC_rGluNMDA_Agonist|NVS_TR_gDAT|NVS_TR_hNET|NVS_TR_rVMAT2|NVS_GPCR_g5HT4|NVS_GPCR_h5HT5A|NVS_GPCR_h5HT6|NVS_GPCR_p5HT2C|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|percent affected 4dpf|LD movement pattern (spearman) 1dpf|percent affected 5dpf|LD movement pattern (cosine) 1dpf|percent affected 1dpf|percent affected 4dpf,FALSE
Chloroxine,773-76-2,0.404561024133049,0.901385962033574,1.92068158549317,54.2074090213728,TOX21_MMP_ratio_down,FALSE
Genistein,446-72-0,-0.124916689372857,0.693122145748318,1.09948921673589,71.001661961384,APR_HepG2_MitoMembPot_24h_dn|APR_HepG2_MitoMembPot_72h_dn|NVS_ENZ_rMAOAC|TOX21_MMP_fitc|TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
Resveratrol,501-36-0,-0.163571883579058,0.506773052007666,1.02436400331506,98.0313951363784,NVS_ENZ_rMAOAC|NVS_TR_gDAT|NVS_TR_hDAT|NVS_TR_hNET,FALSE
1-Naphthol,90-15-3,0.63421879333212,1.7185070043703,0.883281403755258,89.5868018030061,NVS_ENZ_rMAOAC|TOX21_MMP_fitc,FALSE
"2,2-Bis(4-chlorophenyl)ethanol",2642-82-2,1.01903961937537,1.46635098000188,2.13328476187771,90.8180726984105,TOX21_MMP_rhodamine,FALSE
"2,3,4-Trichlorophenol",15950-66-0,0.172136927604094,0.689496252986845,1.84444826375433,98.5740775210582,TOX21_MMP_ratio_down,FALSE
2-Hydroxyanthraquinone,605-32-3,-0.513372049985477,0.580499739760493,0.872353157275341,111.932775049372,TOX21_MMP_rhodamine,FALSE
2-Naphthalenol,135-19-3,0.214291153243407,1.18156756967114,0.963876398398626,100,NVS_ENZ_rMAOAC|NVS_ENZ_rMAOAP|NVS_ENZ_rMAOBC|NVS_TR_hNET|NVS_TR_rNET|NVS_GPCR_p5HT2C,FALSE
2-[(4-Hydroxyphenyl)methyl]phenol,2467-03-0,0.519467816476514,1.43982107089374,1.03682200813595,100,TOX21_MMP_ratio_down,FALSE
"3,4-Dichlorophenol",95-77-2,0.505039004416461,0.971577050769726,2.04536911169034,96.3279214378721,TOX21_MMP_ratio_down,FALSE
3-Hydroxy-N-(3-nitrophenyl)naphthalene-2-carboxamide,135-65-9,-1.0400331896382,-0.652281381124099,2.4609621115529,88.087533125021,TOX21_MMP_ratio_down,FALSE
3-Hydroxy-N-phenylaniline,101-18-8,0.565011263398701,1.35755340941919,1.20407471703188,100,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
3-Hydroxybenzophenone,13020-57-0,0.950377442445302,1.43146205573417,1.98352323703678,85.7611697662605,TOX21_MMP_ratio_down,FALSE
3-Hydroxyfluorene,6344-67-8,-0.0959051496630492,0.711701609865445,1.15425623542694,93.8106978936891,NVS_ENZ_rMAOAC|NVS_ENZ_rMAOAP|NVS_ENZ_rMAOBC|NVS_TR_hDAT|NVS_TR_hNET|TOX21_MMP_ratio_down|NVS_GPCR_p5HT2C,FALSE
3-Phenylphenol,580-51-8,0.0928244516431544,1.1734087729269,0.890920265396156,102.06594478849,NVS_ENZ_rMAOAC|NVS_TR_hDAT,FALSE
"4,4'-Thiodiphenol",2664-63-3,0.824326555174504,1.49017600626449,1.43657734619367,103.17276091513,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
4-Anilinophenol,122-37-2,0.271076260491328,1.31759594633825,0.952034739715811,98.6272961554393,NVS_ENZ_rMAOAC|NVS_TR_gDAT|NVS_TR_hDAT|NVS_TR_hNET,FALSE
4-Benzylphenol,101-53-1,0.970776527073187,1.44283458556931,2.02683159346583,67.1312429916519,TOX21_MMP_fitc|TOX21_MMP_rhodamine,FALSE
"5-(5-Nitro-2-furyl)-1,3,4-oxadiazole-2-ol",2122-86-3,1.16980813873496,1.59680411925315,2.23478101194603,59.2730967627916,TOX21_MMP_rhodamine,FALSE
9-Phenanthrol,484-17-3,-0.225968099360165,0.723232604487509,1.2438201199516,7.0483458111788,APR_HepG2_MitoMass_24h_up|APR_HepG2_MitoMass_72h_up|APR_HepG2_MitoMembPot_24h_dn|APR_HepG2_MitoMembPot_72h_dn|NCCT_MITO_basal_resp_rate_OCR_up|NCCT_MITO_inhib_resp_rate_OCR_up|NVS_ENZ_hES|NVS_ENZ_rMAOAC|NVS_ENZ_rMAOAP|NVS_TR_hNET|TOX21_MMP_fitc|TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
Bis(4-hydroxyphenyl)methane,620-92-8,-0.0904297434563477,1.12525868545703,0.795081921047587,98.6497327898804,NVS_TR_gDAT|NVS_TR_hDAT,FALSE
Bronopol,52-51-7,0.288172055060675,1.23056486773333,1,100,APR_HepG2_MitoMembPot_24h_dn|NVS_GPCR_bAdoR_NonSelective|NVS_GPCR_rOpiate_NonSelective|NUMBER_OF_SPIKES|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Chrysin,480-40-0,0.311377089898874,0.715781020874132,2.37753462037777,106.492863742367,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
Cyclododecanol,1724-39-6,0.911425542668712,2.08477453965322,0.81326400916668,69.5253537153379,TOX21_MMP_fitc,FALSE
Danthron,117-10-2,-0.047973617297133,0.731669723139429,1.22394748976499,79.5203607459334,TOX21_MMP_rhodamine,FALSE
Dichlorophen,97-23-4,-0.210597442415506,0.169422189583484,2.52448375968028,90.3615781141949,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
Fluorescein,2321-07-05,-1.69181272280035,-1.40558511223825,3.33385904862698,100,TOX21_MMP_fitc,FALSE
3-Phenoxybenzenemethanol,13826-35-2,0.984829020053503,2.01496252901228,0.926328967207209,100,TOX21_MMP_fitc,FALSE
Aloe-emodin,481-72-1,-0.426959233175352,0.373149682867001,1.19264076465911,74.9899964594476,TOX21_MMP_rhodamine,FALSE
CP-544439,230954-09-3,1.08443542918368,2.30309655962903,0.893568555844499,1.77365439308718,NCCT_MITO_basal_resp_rate_OCR_dn|NCCT_MITO_max_resp_rate_OCR_dn,FALSE
Perfluorooctanesulfonic acid,1763-23-1,-0.0543598573262119,1.07000476502286,0.848694889959877,92.4098902957706,APR_HepG2_MitoMass_72h_dn|NVS_GPCR_hAdoRA2a|NVS_GPCR_h5HT5A,FALSE
2-Mercaptobenzothiazole,149-30-4,1.15252135844702,1.94882500765205,1.07135025026556,15.5578557154649,APR_HepG2_MitoMembPot_24h_dn|APR_HepG2_MitoMembPot_72h_dn|NVS_TR_hNET,FALSE
Thiocarbanilide,102-08-9,0.740701787471209,1.45818863571497,1.33443979960183,100.554492387415,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine,FALSE
Benzo(b)fluoranthene,205-99-2,0.814304163928565,1.27566496602021,1.22913726531112,33.4010430022566,APR_HepG2_MitoMass_24h_up|APR_HepG2_MitoMembPot_24h_dn|TOX21_MMP_fitc|TOX21_MMP_ratio_down,FALSE
Benzo(e)pyrene,192-97-2,0.144387336278563,0.979862752395938,1.14215510238935,15.2552463258368,TOX21_MMP_fitc,FALSE
Benzo(f)quinoline,1985-02-09,0.17981370685768,1.19095738875384,1.05758994094526,99.0716173979536,NVS_ENZ_rMAOAC|NVS_TR_hDAT|NVS_TR_hNET|TOX21_MMP_fitc,FALSE
"Dibenz[a,c]anthracene",215-58-7,0.603894109549658,1.39646270090442,1.93042382921512,75.2953594286247,TOX21_MMP_fitc|percent spikes in network spike|percent affected 5dpf,FALSE
Pyrene,129-00-0,0.740663870418067,1.34280264385567,2.13268400159184,100,APR_HepG2_MitoMembPot_24h_dn|percent affected 5dpf|b excitatory distmoved 1dpf,FALSE
"10,11-Dihydro-5H-dibenz[b,f]azepine",494-19-9,0.822148232565694,1.37089317187951,1.73895455078378,94.3253396367712,TOX21_MMP_ratio_down,FALSE
Acenaphthene,83-32-9,-1.05424763544668,0.341799559170524,0.683531698010382,91.0369035004837,NVS_LGIC_rGABAR_NonSelective,FALSE
Piperazine,110-85-0,-0.601044104563675,0.612619190870458,0.786249788577472,92.5376120764224,NVS_LGIC_rGABAR_NonSelective,FALSE
Bis(trichloromethyl)sulfone,3064-70-8,-0.00304725826515084,1.24394124299423,0.781624178551146,100,NVS_GPCR_hDRD1|NVS_GPCR_hOpiate_mu,FALSE
Chlorothalonil,1897-45-6,0.0211043575606751,0.893705806,1,100,APR_HepG2_MitoMass_1h_dn|APR_HepG2_MitoMembPot_1h_dn|CCTE_Simmons_MITO_basal_resp_rate_OCR_dn|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION,FALSE
Kepone,143-50-0,0.062692020560675,1.01693453,1,100,TOX21_MMP_ratio_down|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Mirex,2385-85-5,0.0447208699449233,0.291867209392068,3.99837602308549,100.009606039561,CCTE_Shafer_MEA_dev_active_electrodes_number_dn|CCTE_Shafer_MEA_dev_bursting_electrodes_number_dn|CCTE_Shafer_MEA_dev_interburst_interval_mean_dn|CCTE_Shafer_MEA_dev_network_spike_number_dn,FALSE
Pentachloropyridine,2176-62-7,1.64191523515354,1.76814033455884,7.55984755753926,2.05709029492335,APR_HepG2_MitoMass_72h_dn,FALSE
Potassium perfluorooctanesulfonate,2795-39-3,0.278571077632104,1.21478579262248,0.734772673820079,100,APR_HepG2_MitoMass_72h_dn|NVS_GPCR_hAdoRA2a|TOX21_MMP_ratio_up,FALSE
Tetraiodoethene,513-92-8,0.427261874608908,0.72841991831655,3.16857719518753,103.370261585431,TOX21_MMP_ratio_down,FALSE
1-Nitronaphthalene,86-57-7,0.0473585487722228,1.10841226275548,0.899334780948125,100,NVS_TR_rSERT,FALSE
"2,2',4,4'-Tetrabromodiphenyl ether",5436-43-1,0.145654566350549,0.444563739655729,2.30028034623428,100,CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_BPCount_loss|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteCount_loss|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteLength_loss|CCTE_Mundy_HCI_hN2_NOG_BPCount_loss|CCTE_Mundy_HCI_hN2_NOG_NeuriteLength_loss|MFR|#NS|%SiNS|NS-ISI|#SiNS|r|MI|mutual information|mean firing rate|number network spikes|bursts per minute|mean correlation|LD movement pattern (pearson) 5dpf|percent affected 5dpf,FALSE
"3,3'-Dimethoxybenzidine",119-90-4,0.787719738419905,0.941299677815207,6.213327816097,70.8770730778474,NVS_GPCR_r5HT1_NonSelective,FALSE
4-(Diethylamino)benzaldehyde,120-21-8,0.274978680578722,0.394384102919962,7.99161789078774,18.9355281037346,NVS_TR_rSERT,FALSE
6-aminopyridine-3-carboxamide,329-89-5,-0.156655389939325,0.8272134195,1,100,CCTE_Mundy_HCI_Cortical_NOG_NeuriteCount_loss|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_BPCount_loss|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteCount_loss|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteLength_loss|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteSpotCountPerNeuron_loss|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuronCount_loss|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_SynapseCount_loss|MFR|BR|ISI|%SiB|BD|IBI|#AE|#ABE|#NS|NSP|NSD|%SiNS|NS-ISI|NSDsd|#SiNS|r|MI,FALSE
Acrylamide,1979-06-01,-0.0372624624393249,0.916980047,1,100,CCTE_Mundy_HCI_hN2_NOG_NeuronCount_loss|IBI|NS-ISI,FALSE
Azinphos-methyl,86-50-0,-1.91233918043932,-0.958096671,1,100,NVS_LGIC_bGABARa1|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|AREA_UNDER_CROSS_CORRELATION,FALSE
Bensulide,741-58-2,0.160777445560675,1.115019955,1,100,CCTE_Mundy_HCI_hN2_NOG_NeuriteLength_loss|NVS_LGIC_bGABARa1|NUMBER_OF_SPIKES|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION,FALSE
Bifenazate,149877-41-8,-1.39489070941729,-0.565757737812202,2.03114552321052,94.3241041810999,NVS_ENZ_rMAOAC|NVS_ENZ_rMAOAP|NVS_ENZ_rMAOBP,FALSE
Colchicine,64-86-8,-2.47712125443933,-1.698970004,1,100,CCTE_Mundy_HCI_Cortical_NOG_BPCount_loss|CCTE_Mundy_HCI_Cortical_NOG_NeuriteCount_loss|CCTE_Mundy_HCI_Cortical_NOG_NeuriteLength_loss|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_BPCount_loss|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_CellBodySpotCount_loss|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteLength_loss|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteSpotCountPerNeuron_loss|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuronCount_loss|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_SynapseCount_loss|CCTE_Mundy_HCI_hN2_NOG_NeuriteCount_loss|CCTE_Mundy_HCI_hN2_NOG_NeuronCount_loss|CCTE_Mundy_HCI_hNP1_Casp3_7_gain|MFR|BR|ISI|%SiB|BD|IBI|#AE|#ABE|#NS|NSP|NSD|%SiNS|NS-ISI|NSDsd|#SiNS|r|MI|CNS neurite outgrowth|SH-S5Y5 neurite outgrowth,FALSE
Deltamethrin,52918-63-5,-0.216070198939325,0.533605066437458,1,100,CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteLength_loss|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteSpotCountPerNeuron_loss|MFR|BR|ISI|%SiB|BD|IBI|#AE|#ABE|#NS|NSP|NSD|%SiNS|NS-ISI|NSDsd|#SiNS|r|MI|percent affected 4dpf|percent affected 5dpf|mutual information|percent spikes in network spike|number network spikes|number actively bursting electrodes|bursts per minute|percent affected 2dpf|a background distmoved 1dpf|LD movement pattern (pearson) 1dpf|percent affected 4dpf|percent affected 2dpf|mean correlation,FALSE
Dexamethasone,1950-02-02,0.873160363055261,1.36357410790156,1.94579071134801,51.1917838300183,CCTE_Mundy_HCI_Cortical_NOG_NeuriteLength_loss,FALSE
Flufenacet,142459-58-3,-0.426087295439325,0.528155214,1,100,NVS_LGIC_bGABARa1|NVS_TR_rSERT|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION,FALSE
Heptachlor,76-44-8,0.403310135102652,0.882224490345645,3.81950212283422,99.9151444342355,CCTE_Mundy_HCI_Cortical_NOG_BPCount_loss|CCTE_Mundy_HCI_Cortical_NOG_NeuriteCount_loss|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_BPCount_loss|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_CellBodySpotCount_loss|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteCount_loss|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteLength_loss|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteSpotCountPerNeuron_loss|CCTE_Mundy_HCI_hN2_NOG_BPCount_loss|CCTE_Mundy_HCI_hN2_NOG_NeuriteCount_loss|CCTE_Mundy_HCI_hN2_NOG_NeuriteLength_loss|CCTE_Mundy_HCI_hN2_NOG_NeuronCount_loss|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|SYNCHRONY_INDEX,FALSE
Tetrac,67-30-1,-0.338501405166706,1.31255619207716,0.577958340782452,100,NVS_GPCR_h5HT7,FALSE
Lindane,58-89-9,0.228742457560675,0.911690159,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|AREA_UNDER_CROSS_CORRELATION|MFR|BR|BD|IBI|#NS|NSDsd|#SiNS|LD movement pattern (pearson) 5dpf|b D1 distmoved 5dpf|percent scrunching Tail 12d|mean firing rate|number network spikes|percent affected 4dpf|a L1 distmoved 5dpf|LD movement pattern (spearman) 1dpf|LD movement pattern (spearman) 5dpf|e L3 distmoved 5dpf,FALSE
Endrin,72-20-8,-0.480994301439325,0.473248208,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|AREA_UNDER_CROSS_CORRELATION,FALSE
Tefluthrin,79538-32-2,-1.28925080543932,-0.335008296,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Isoxaben,82558-50-7,0.781109615560675,1.735352125,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|INTER_BURST_INTERVAL_AVG_(SEC)|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION,FALSE
Flusilazole,85509-19-9,-0.158467666939325,0.7957748425,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX|MFR|BR|BD|#AE|#ABE|NSD|%SiNS|NSDsd|MI,FALSE
"Methyl (RS)-2-[4-(2,4-dichlorophenoxy)phenoxy]propionate",51338-27-3,0.348797323560675,1.303039833,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Fenpropathrin,39515-41-8,-0.848906938439325,0.105335571,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Cycloate,1134-23-2,-0.592445068439325,0.361797441,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Imazapyr,81334-34-1,-2.53180457043933,-1.577562061,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|BURST_DURATION_AVG_ (SEC)|INTER_BURST_INTERVAL_AVG_(SEC)|NETWORK_BURST_PERCENTAGE|SYNCHRONY_INDEX,FALSE
Cypermethrin,52315-07-8,-0.422197044439325,0.532045465,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|SYNCHRONY_INDEX|MFR|BR|ISI|%SiB|BD|IBI|#AE|#ABE|#NS|NSP|NSD|%SiNS|NS-ISI|NSDsd|#SiNS|r|MI,FALSE
Trifloxystrobin,141517-21-7,-1.10945888943932,-0.15521638,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX|SH-S5Y5 neurite outgrowth,FALSE
Buprofezin,69327-76-0,0.380002720060675,1.3342452295,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Fenamidone,161326-34-7,0.388672017560675,1.342914527,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Amitraz,33089-61-1,-1.53485184343932,-0.580609334,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION,FALSE
Imazethapyr,81335-77-5,-1.90743113843932,-0.953188629,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|AREA_UNDER_CROSS_CORRELATION,FALSE
Folpet,133-07-3,-0.624252674439325,0.329989835,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_PERCENTAGE_AVG_(SEC),FALSE
Pyraclostrobin,175013-18-0,-1.65765889843932,-0.703416389,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX|SH-S5Y5 neurite outgrowth,FALSE
Ethalfluralin,55283-68-6,0.478054155560675,1.432296665,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|AREA_UNDER_CROSS_CORRELATION,FALSE
Carbaryl,63-25-2,0.135753007560675,1.045620975,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_PERCENTAGE_STD_(SEC)|AREA_UNDER_CROSS_CORRELATION|SYNCHRONY_INDEX|MFR|BR|%SiB|BD|#AE|#ABE|#NS|NSP|NSD|%SiNS|NSDsd|#SiNS|MI|number network spikes|percent affected 4dpf|SH-S5Y5 neurite outgrowth,FALSE
"2,2-Bis(4-hydroxyphenyl)-1,1,1-trichloroethane",2971-36-0,-0.367699562439325,0.586542947,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Lactofen,77501-63-4,-0.0243422159393248,0.9299002935,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|ISI|NS-ISI,FALSE
"Fenpyroximate (Z,E)",111812-58-9,-0.450205087439325,0.504037422,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Trifluralin,1582-09-8,-0.0421259094393249,0.9121166,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION,FALSE
Oxadiazon,19666-30-9,-1.84011317643932,-0.885870667,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_PERCENTAGE_AVG_(SEC)|NETWORK_BURST_PERCENTAGE,FALSE
Clodinafop-propargyl,105512-06-9,-2.11491231943933,-1.16066981,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|AREA_UNDER_CROSS_CORRELATION,FALSE
Endosulfan,115-29-7,-0.963733971439325,-0.009491462,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|AREA_UNDER_CROSS_CORRELATION,FALSE
Pyriproxyfen,95737-68-1,0.0870586320606751,1.0413011415,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
2-tert-Butylphenol,88-18-6,0.425680658560675,1.379923168,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Hydroquinone,123-31-9,-1.28179092343933,-0.327548414,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|AREA_UNDER_CROSS_CORRELATION,FALSE
Fipronil,120068-37-3,0.0442903400606752,0.9985328495,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX|MFR|%SiNS|NS-ISI|NSDsd|SH-S5Y5 neurite outgrowth,FALSE
Diclosulam,145701-21-9,-2.24049309343933,-1.286250584,1,100,NUMBER_OF_SPIKES|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NETWORK_BURST_PERCENTAGE|SYNCHRONY_INDEX,FALSE
Propargite,2312-35-8,0.242510894560675,1.196753404,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Pyridaben,96489-71-3,-0.583527103439325,0.370715406,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Emamectin benzoate,155569-91-8,-2.44423893593933,-1.4899964265,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX|MFR|BR|ISI|%SiB|BD|IBI|#AE|#ABE|#NS|NSP|NSD|%SiNS|NS-ISI|NSDsd|#SiNS|r|MI,FALSE
Tebupirimfos,96182-53-5,0.294506857060675,1.2487493665,1,100,NUMBER_OF_SPIKES|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
2-(Butan-2-yl)phenol,89-72-5,-0.278491967939325,0.6757505415,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION,FALSE
5-Heptyldihydro-2(3H)-furanone,104-67-6,0.359462092560675,1.313704602,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|AREA_UNDER_CROSS_CORRELATION,FALSE
Sodium dehydroacetate,4418-26-2,-2.40695637293933,-1.4527138635,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_SPIKES_PER_BURST_AVG|AREA_UNDER_CROSS_CORRELATION,FALSE
1-Decanol,112-30-1,0.320142899060675,1.2743854085,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
4-(Butan-2-yl)phenol,99-71-8,0.401348750560675,1.35559126,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
4-(2-Methylbutan-2-yl)phenol,80-46-6,-0.0692137604393249,0.885028749,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
"2,4-Di-tert-pentylphenol",120-95-6,0.153901565560675,1.108144075,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Octylbicycloheptenedicarboximide,113-48-4,0.600209581560675,1.554452091,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Cyazofamid,120116-88-3,-0.402093285439325,0.552149224,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION,FALSE
Tri-allate,2303-17-5,0.223676880560675,1.17791939,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
1-Dodecanol,112-53-8,0.354158287060675,1.3084007965,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Sodium benzoate,532-32-1,-0.520301817439325,0.433940692,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|INTER_BURST_INTERVAL_AVG_(SEC)|AREA_UNDER_CROSS_CORRELATION,FALSE
(E)-Anethole,4180-23-8,-0.560338213439325,0.393904296,1,100,NUMBER_OF_SPIKES|NUMBER_OF_SPIKES_PER_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION,FALSE
Dicloran,99-30-9,0.462080559560675,1.416323069,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|SYNCHRONY_INDEX,FALSE
"2,5-Di-tert-butylbenzene-1,4-diol",88-58-4,0.367144346560675,1.321386856,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION,FALSE
Ethion,563-12-2,0.148514704560675,1.102757214,1,100,NUMBER_OF_SPIKES|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Amiodarone hydrochloride,19774-82-4,0.172060719560675,1.126303229,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|AREA_UNDER_CROSS_CORRELATION,FALSE
Tributyltin methacrylate,2155-70-6,-2.18008173743932,-1.225839228,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
4-Cyclohexylcyclohexanol,2433-14-9,0.332915039560675,1.287157549,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION,FALSE
Resmethrin,10453-86-8,0.176759312560675,1.131001822,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
EPN,2104-64-5,0.418235395560675,1.372477905,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION,FALSE
Zamifenacin,127308-82-1,-2.07794842143933,-1.123705912,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|INTER_BURST_INTERVAL_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG,FALSE
Enadoline,124378-77-4,-0.0361272924393249,0.918115217,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
PD 0343701,676116-04-4,0.259494076560675,1.213736586,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
CP-728663,368832-42-2,-0.466168254439325,0.488074255,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION,FALSE
UK-333747,197077-55-7,0.320364282560675,1.274606792,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
UK-373911,291305-06-1,0.568439630560675,1.52268214,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
SB236057A,180084-01-9,-0.217550866439325,0.736691643,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Troglitazone,97322-87-7,-0.426376819439325,0.52786569,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
MK-274,NOCAS_47328,-0.898875503439325,0.055367006,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
PharmaGSID_47330,NOCAS_47330,-0.610384771439325,0.343857738,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
HMR1426,262376-75-0,0.552244980060675,1.5064874895,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
SSR146977,264618-44-2,-0.475545953939325,0.4786965555,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
SSR504734,742693-38-5,-0.192350395439325,0.761892114,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
SSR 103800,1075752-90-7,-0.189082907439325,0.765159602,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|INTER_BURST_INTERVAL_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION,FALSE
SAR115740,NOCAS_47366,-0.388638914439325,0.565603595,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION,FALSE
SSR69071,344930-95-6,-2.83617207693933,-1.8819295675,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|INTER_BURST_INTERVAL_AVG_(SEC),FALSE
AVE5638,725228-45-5,0.0376509175606752,0.991893427,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
SAR 150640,433212-21-6,-1.58455515593933,-0.6303126465,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_PERCENTAGE_AVG_(SEC),FALSE
Haloperidol,52-86-8,-0.809671091439325,0.144571418,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|MFR|BR|ISI|%SiB|BD|IBI|#AE|#ABE|#NS|NSP|NSD|%SiNS|NS-ISI|NSDsd|#SiNS|r|MI,FALSE
Nitrofen,1836-75-5,0.117473525560675,1.071716035,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
6-Propyl-2-thiouracil,51-52-5,-1.99863532743933,-1.044392818,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|AREA_UNDER_CROSS_CORRELATION,FALSE
Phenolphthalein,1977-09-08,0.345045047560675,1.299287557,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Mercuric chloride,7487-94-7,0.450241787560675,1.404484297,1,100,NUMBER_OF_SPIKES|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
"1,2-Diphenylhydrazine",122-66-7,0.183075626560675,1.137318136,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Azobenzene,103-33-3,0.0383121905606751,0.9925547,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|AREA_UNDER_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
"7,12-Dimethylbenz(a)anthracene",57-97-6,0.329696152060675,1.2839386615,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Diethylstilbestrol,56-53-1,0.0778825665606751,0.82421029,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX|MFR|BR|ISI|%SiB|BD|IBI|#AE|#ABE|#NS|NSP|NSD|%SiNS|NSDsd|#SiNS|r|MI|number network spikes|percent affected 4dpf|mean firing rate|bursts per minute|b excitatory distmoved 1dpf|percent affected 5dpf|mutual information|LD movement pattern (pearson) 1dpf|LD movement pattern (spearman) 1dpf|percent affected 4dpf|LD movement pattern (cosine) 1dpf|percent affected 1dpf|a background distmoved 1dpf,FALSE
Tributyltin chloride,1461-22-9,-1.32548902093932,-0.3712465115,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Dipentyl phthalate,131-18-0,6.34756067507958e-06,0.954248857,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Triethylene glycol bis(2-ethylhexanoate),94-28-0,-0.0366673299393249,0.9175751795,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|AREA_UNDER_CROSS_CORRELATION,FALSE
"2,2,4-Trimethyl-1,3-pentanediol diisobutyrate",6846-50-0,-2.24857771393933,-1.2943352045,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_SPIKES_PER_BURST_AVG|AREA_UNDER_CROSS_CORRELATION,FALSE
"2,4-Bis(1-methyl-1-phenylethyl)phenol",2772-45-4,0.0569606615606752,1.011203171,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
6-Methylquinoline,91-62-3,0.246306942560675,1.200549452,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|AREA_UNDER_CROSS_CORRELATION,FALSE
"4-Nonylphenol, branched",84852-15-3,0.304103855560675,1.258346365,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Phenylmercuric acetate,62-38-4,-0.906925577439325,0.047316932,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Didecyldimethylammonium chloride,7173-51-5,-0.126888056939325,0.8273544525,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Diisobutyl phthalate,84-69-5,0.101382901060675,1.0556254105,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Bis(2-ethylhexyl) decanedioate,122-62-3,-2.43007702643933,-1.475834517,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS,FALSE
Fabesetron hydrochloride,129299-90-7,-0.0161655244393249,0.938076985,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Methadone hydrochloride,1095-90-5,-0.594113202439325,0.360129307,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION,FALSE
Mepanipyrim,110235-47-7,-0.154879554439325,0.799362955,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
4-Hydroxytamoxifen,68392-35-8,0.438843233560675,1.393085743,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
PharmaGSID_48509,NOCAS_48509,0.301799957560675,1.256042467,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
PharmaGSID_48511,1062243-51-9,0.285835533060675,1.2400780425,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Niclosamide,50-65-7,-1.46219284893932,-0.5079503395,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
HMR1171 trifluoroacetate (1:1),NOCAS_48522,0.0417170695606751,0.995959579,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Abamectin,71751-41-2,-3.38295482193933,-2.4287123125,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Methylene bis(thiocyanate),6317-18-6,0.297010407560675,1.251252917,1,100,NUMBER_OF_SPIKES|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Benzyl butyl phthalate,85-68-7,-0.0914244999393249,0.8628180095,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Raloxifene hydrochloride,82640-04-8,0.591905700560675,1.54614821,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
5alpha-Dihydrotestosterone,521-18-6,0.194016290560675,1.1482588,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION,FALSE
SSR 241586 HCl,NOCAS_47353,0.249207069560675,1.203449579,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Clomiphene citrate (1:1),50-41-9,0.0858604765606751,1.040102986,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|AREA_UNDER_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Mifepristone,84371-65-3,0.079902292560675,1.034144802,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Triclosan,3380-34-5,0.0708434815606752,1.025085991,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Cyclohexylphenylketone,712-50-5,0.534830098560675,1.489072608,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION,FALSE
UK-337312,203942-49-8,-0.483217233439325,0.471025276,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Hexythiazox,78587-05-0,0.424065327560675,1.378307837,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Perfluoroundecanoic acid,2058-94-8,1.11291376056068,2.06715627,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION,FALSE
Reserpine,50-55-5,-0.888177067439325,0.066065442,1,100,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION,FALSE
Fenthion,55-38-9,0.416493535560675,1.370736045,1,100,MEAN_FIRING_RATE_HZ|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Esfenvalerate,66230-04-4,-1.08166345393932,-0.1274209445,1,100,NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Sethoxydim,74051-80-2,0.430811158560675,1.385053668,1,100,NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
S-Bioallethrin,28434-00-6,0.387502703560675,1.341745213,1,100,NUMBER_OF_BURSTS|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Diallyl phthalate,131-17-9,0.463730345560675,1.417972855,1,100,NUMBER_OF_BURSTS|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|AREA_UNDER_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
alpha-Isomethylionone,127-51-5,1.14766476056068,2.10190727,1,100,NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|SYNCHRONY_INDEX,FALSE
Dinoseb,88-85-7,0.644156619560675,1.598399129,1,100,NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|BURST_PERCENTAGE_AVG_(SEC),FALSE
Elzasonan,361343-19-3,0.477688792060675,1.4319313015,1,100,NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|SYNCHRONY_INDEX,FALSE
Volinanserin,139290-65-6,0.0539480355606751,1.008190545,1,100,NUMBER_OF_BURSTS|INTER_BURST_INTERVAL_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION,FALSE
SR144190,181640-09-5,-0.0330874164393249,0.921155093,1,100,NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Spirodiclofen,148477-71-8,-2.29549877593933,-1.3412562665,1,100,BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NETWORK_BURST_PERCENTAGE|SYNCHRONY_INDEX,FALSE
Bifenthrin,82657-04-3,-1.00324664443932,-0.049004135,1,100,BURST_DURATION_AVG_ (SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX|SH-S5Y5 neurite outgrowth,FALSE
Chlorpyrifos oxon,5598-15-2,-0.109890697939325,0.8443518115,1,100,BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|MFR|BR|%SiB|BD|#AE|#ABE|#NS|NSP|NSD|%SiNS|NSDsd|#SiNS|r|MI|SH-S5Y5 neurite outgrowth,FALSE
Prallethrin,23031-36-9,0.282602256560675,1.236844766,1,100,BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Ziram,137-30-4,0.409790404060675,1.3640329135,1,100,BURST_DURATION_AVG_ (SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
SAR102779,NOCAS_47387,-0.203672753939325,0.7505697555,1,100,BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Phenolphthalin,81-90-3,-1.86750946743933,-0.913266958,1,100,NUMBER_OF_SPIKES_PER_BURST_AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG,FALSE
Dieldrin,60-57-1,-0.0655015484393249,0.461990390780664,1,100,NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX|MFR|BR|ISI|%SiB|BD|IBI|#AE|#ABE|#NS|NSP|NSD|%SiNS|NS-ISI|NSDsd|#SiNS|r|MI|percent spikes in burst|LD movement pattern (spearman) 4dpf|LD movement pattern (pearson) 4dpf|LD movement pattern (spearman) 5dpf|LD movement pattern (pearson) 5dpf|e L3 distmoved 5dpf|c L2 distmoved 4dpf|a L1 distmoved 5dpf|c L2 distmoved 5dpf|b D1 distmoved 5dpf|LD movement pattern (cosine) 4dpf|LD movement pattern (pearson) 5dpf|total outgrowth|SH-S5Y5 neurite outgrowth,FALSE
Chlorpropham,101-21-3,0.335311309060675,1.2895538185,1,100,NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Butralin,33629-47-9,0.185388834560675,1.139631344,1,100,NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|AREA_UNDER_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Biphenyl,92-52-4,-1.13644337693933,-0.1822008675,1,100,NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION,FALSE
Clotrimazole,23593-75-1,-0.0724922104393249,0.881750299,1,100,NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
CP-122721,145742-28-5,-0.343711874439325,0.610530635,1,100,NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION,FALSE
UK-416244,402910-27-4,0.421476913060675,1.3757194225,1,100,NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
"1,2-Benzisothiazolin-3-one",2634-33-5,0.484387040060675,1.4386295495,1,100,NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NETWORK_BURST_PERCENTAGE|SYNCHRONY_INDEX|SH-S5Y5 neurite outgrowth,FALSE
Pentamidine isethionate,140-64-7,0.485325453060675,1.4395679625,1,100,NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Gentian Violet,548-62-9,-0.734753557439325,0.219488952,1,100,NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Tetramethrin,7696-12-0,0.124378241560675,1.078620751,1,100,INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NETWORK_BURST_PERCENTAGE|SYNCHRONY_INDEX,FALSE
Clofentezine,74115-24-5,0.764156732560675,1.718399242,1,100,INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NETWORK_BURST_PERCENTAGE,FALSE
4-Octylphenol,1806-26-4,0.0801154940606751,1.0343580035,1,100,INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Darbufelone mesylate,139340-56-0,0.345179930560675,1.29942244,1,100,INTER_BURST_INTERVAL_AVG_(SEC)|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE,FALSE
"3,4-Diaminotoluene",496-72-0,0.0211448245606751,0.975387334,1,100,INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|SYNCHRONY_INDEX,FALSE
Allethrin,584-79-2,-0.0638856804393249,0.890356829,1,100,INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|SYNCHRONY_INDEX,FALSE
Heptachlor epoxide B,1024-57-3,-0.245821609439325,0.7084209,1,100,BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX|MFR|BR|ISI|%SiB|BD|IBI|#AE|#ABE|#NS|NSP|NSD|%SiNS|NS-ISI|NSDsd|#SiNS|r|MI,FALSE
Chlorpyrifos-methyl,5598-13-0,-2.74410353543933,-1.789861026,1,100,BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|AREA_UNDER_CROSS_CORRELATION,FALSE
Permethrin,52645-53-1,0.232713825560675,1.123198075,1,100,BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|SYNCHRONY_INDEX|MFR|BR|ISI|%SiB|BD|IBI|#AE|#ABE|#NS|NSP|NSD|%SiNS|NS-ISI|NSDsd|#SiNS|r|MI|LD movement pattern (spearman) 4dpf|c L2 distmoved 4dpf|b D1 distmoved 5dpf|percent affected 5dpf,FALSE
Dicofol,115-32-2,0.254569990560675,1.2088125,1,100,BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
tert-Butylhydroquinone,1948-33-0,0.626738863560675,1.580981373,1,100,BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION,FALSE
Eugenol,97-53-0,-1.53863138043933,-0.584388871,1,100,BURST_PERCENTAGE_AVG_(SEC)|NETWORK_BURST_PERCENTAGE|SYNCHRONY_INDEX,FALSE
Etoxazole,153233-91-1,0.246561057560675,1.200803567,1,100,BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX,FALSE
Dimethyl sulfate,77-78-1,-0.174373495439325,0.779869014,1,100,NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NETWORK_BURST_PERCENTAGE,FALSE
5-Fluorouracil,51-21-8,-0.538723766939325,0.1673072855,1,100,MFR|BR|ISI|%SiB|BD|IBI|#AE|#ABE|#NS|NSP|NSD|%SiNS|NS-ISI|NSDsd|#SiNS|r|MI|percent spikes in network spike|mean correlation|mutual information|number network spikes|number actively bursting electrodes|number active electrodes|mean firing rate,FALSE
"",56-35-9,-2.26413688893932,-1.397940009,1,100,MFR|BR|ISI|%SiB|BD|IBI|#AE|#ABE|#NS|NSP|NSD|%SiNS|NS-ISI|NSDsd|#SiNS|r|MI|bursts per minute|mean firing rate|LD movement pattern (pearson) 5dpf|d D2 distmoved 5dpf|PNS neurite outgrowth|total branches|percent affected 2dpf,FALSE
"",133052-90-1,-0.486635034439325,0.274984558851224,1,100,MFR|BR|ISI|%SiB|BD|IBI|#AE|#ABE|#NS|NSP|NSD|%SiNS|NS-ISI|NSDsd|#SiNS|r|MI|mutual information|number network spikes|bursts per minute|mean firing rate|percent spikes in network spike,FALSE
"",7790-78-5,-1.47712125443932,-0.522878745,1,100,MFR|BR|ISI|%SiB|BD|IBI|#AE|#ABE|#NS|NSP|NSD|%SiNS|NS-ISI|NSDsd|#SiNS|r|MI,FALSE
"",62571-86-2,-0.726485092939325,0.2277574165,1,100,BD|MI,FALSE
"",438-41-5,0.197109063060675,1.1513515725,1,100,MFR|BR|ISI|%SiB|BD|IBI|#AE|#ABE|#NS|NSP|NSD|%SiNS|NSDsd|#SiNS|r|MI,FALSE
"",50-53-3,-0.256141963439325,0.698100546,1,100,MFR|BR|ISI|%SiB|BD|IBI|#AE|#ABE|#NS|NSP|NSD|%SiNS|NS-ISI|NSDsd|#SiNS|r|MI,FALSE
"",486-56-6,0.0161043665606752,0.970346876,1,100,IBI,FALSE
"",50-18-0,0.243313703560675,1.197556213,1,100,BD|NS-ISI|MI,FALSE
"",147-94-4,-1.43572856943933,-0.48148606,1,100,MFR|BR|ISI|%SiB|BD|IBI|#AE|#ABE|#NS|NSP|NSD|%SiNS|NS-ISI|NSDsd|#SiNS|r|MI,FALSE
"",117-81-7,-0.0703982239393249,0.85635052,1,100,MFR|BR|ISI|%SiB|BD|#AE|#ABE|#NS|NSP|NSD|%SiNS|NSDsd|#SiNS|r|MI|mutual information|number network spikes|SH-S5Y5 neurite outgrowth,FALSE
"",439-14-5,-0.434149093439325,0.351980134821983,1,100,MFR|BR|ISI|BD|NSD|%SiNS|NSDsd|MI|bursts per minute|mean firing rate|a background distmoved 1dpf|mutual information,FALSE
"",14277-97-5,-0.966526605439325,-0.0128400362310531,1,100,MFR|BR|ISI|%SiB|BD|IBI|#AE|#ABE|#NS|NSP|NSD|%SiNS|NS-ISI|NSDsd|#SiNS|r|MI|mean firing rate|bursts per minute|number active electrodes,FALSE
Fluoxetine,54910-89-3,-0.583174647439325,0.371067862,1,100,MFR|BR|ISI|%SiB|BD|IBI|#AE|#ABE|#NS|NSP|NSD|%SiNS|NS-ISI|NSDsd|#SiNS|r|MI,FALSE
"",70-30-4,-0.568625203939325,0.00992628102571232,1,100,MFR|BR|ISI|%SiB|BD|IBI|#AE|#ABE|#NS|NSP|NSD|%SiNS|NS-ISI|NSDsd|#SiNS|r|MI|mutual information|bursts per minute|number actively bursting electrodes|percent spikes in network spike|number network spikes|percent affected 5dpf|percent affected 4dpf|percent affected 3dpf|percent affected 2dpf|mean correlation|percent affected 1dpf|number active electrodes|percent spikes in burst|mean firing rate|SH-S5Y5 neurite outgrowth,FALSE
Hydroxyurea,127-07-1,-0.106669850439325,0.847572659,1,100,BD|#SiNS|MI,FALSE
"",54-85-3,-0.125630418939325,0.8286120905,1,100,BR|BD|IBI|#SiNS|r|MI,FALSE
"",33795-24-3,0.205021214560675,1.159263724,1,100,#NS|%SiNS,FALSE
"",6080-56-4,0.148534105560675,1.102776615,1,100,MFR|%SiB|BD|IBI|#AE|#ABE|#NS|NSP|NSD|%SiNS|NS-ISI|NSDsd|#SiNS|r|MI|percent affected 4dpf|percent aggregates,FALSE
"",53179-11-6,-0.890384445123543,0.0193795244951757,1,100,MFR|BR|ISI|%SiB|BD|IBI|#AE|#ABE|#NS|NSP|NSD|%SiNS|NS-ISI|NSDsd|#SiNS|r|MI|mean firing rate|bursts per minute|mutual information|number active electrodes|number actively bursting electrodes|number network spikes,FALSE
Maneb,12427-38-2,-2.47712125443933,-1.522878745,1,100,NS-ISI,FALSE
"",1959-05-02,-2.47712125443933,-1.522878745,1,100,MFR|BR|ISI|%SiB|BD|IBI|#AE|#ABE|#NS|NSP|NSD|%SiNS|NS-ISI|NSDsd|#SiNS|r|MI,FALSE
5-Chloro-2-methyl-3(2H)-isothiazolone,26172-55-4,-0.280766916939325,0.6734755925,1,100,MFR|BR|ISI|%SiB|BD|IBI|#AE|#ABE|#NS|NSD|%SiNS|NS-ISI|NSDsd|#SiNS|r|MI,FALSE
"",22967-92-6,-1.47712125443932,-0.546304967044905,1,100,MFR|BR|ISI|%SiB|BD|IBI|#AE|#ABE|#NS|NSP|NSD|%SiNS|NS-ISI|NSDsd|#SiNS|r|MI|bursts per minute|number network spikes|mean firing rate|mutual information|percent spikes in network spike|percent spikes in burst|mean correlation,FALSE
"",73573-88-3,-0.963582422439325,-0.0929965946625602,1,100,MFR|BR|ISI|%SiB|BD|IBI|#AE|#ABE|#NS|NSP|NSD|%SiNS|NS-ISI|NSDsd|#SiNS|r|MI|number network spikes|bursts per minute|percent spikes in network spike|mean correlation|mutual information|number actively bursting electrodes|number active electrodes|percent spikes in burst|mean firing rate,FALSE
"",465-65-6,0.0702431585606752,1.024485668,1,100,#NS,FALSE
Nicotine,1954-11-05,0.155654504060675,1.1098970135,1,100,#SiNS|r,FALSE
Paraquat,4685-14-7,-0.840414828439325,0.113827681,1,100,MFR|BR|ISI|%SiB|BD|IBI|#AE|#ABE|#NS|NSP|NSD|%SiNS|NS-ISI|NSDsd|#SiNS|r|MI|SH-S5Y5 neurite outgrowth,FALSE
"",7784-46-5,-0.813135442939325,0.1411070665,1,100,MFR|BR|ISI|%SiB|BD|IBI|#AE|#ABE|#NS|NSP|NSD|%SiNS|NS-ISI|NSDsd|#SiNS|r|MI|mean firing rate,FALSE
"",13721-39-6,0.0771659545606752,1.031408464,1,100,MFR|BR|%SiB|#AE|#ABE|NSP|NSD|%SiNS|NS-ISI|NSDsd|#SiNS|r|MI,FALSE
D-Glucitol,50-70-4,0.336684893560675,1.290927403,1,100,BD|#SiNS,FALSE
Spiroxamine,118134-30-8,-1.67548890843932,-0.721246399,1,100,MFR|BR|ISI|%SiB|BD|IBI|#AE|#ABE|#NS|NSP|NSD|%SiNS|NS-ISI|NSDsd|#SiNS|r|MI,FALSE
all-trans-Retinoic acid,302-79-4,-0.0826695734393249,0.871572936,1,100,MFR|BR|ISI|%SiB|BD|IBI|#AE|#ABE|#NS|NSP|NSD|%SiNS|NS-ISI|NSDsd|#SiNS|r|MI,FALSE
Tris(2-chloroethyl) phosphate,115-96-8,0.177218803060675,1.1314613125,1,100,IBI|NSDsd,FALSE
Thiouracil,141-90-2,0.370022337560675,1.324264847,1,100,MFR|BR|%SiB|BD|IBI|#AE|#ABE|#NS|NSP|NSD|%SiNS|NS-ISI|NSDsd|#SiNS|r|MI,FALSE
"",2767-54-6,-1.80811447343932,-0.853871964,1,100,MFR|BR|ISI|%SiB|BD|IBI|#AE|#ABE|#NS|NSP|NSD|%SiNS|NS-ISI|NSDsd|#SiNS|r|MI,FALSE
"",56-24-6,-1.57403126743932,-0.619788758,1,100,MFR|BR|ISI|%SiB|BD|IBI|#AE|#ABE|#NS|NSP|NSD|%SiNS|NS-ISI|NSDsd|#SiNS|r|MI,FALSE
Valproic acid,99-66-1,1.88612709456068,2.840369604,1,100,%SiNS|NSDsd|#SiNS,FALSE
"",732,1.91026857156068,2.864511081,1,100,732,FALSE
"2,3,7,8-Tetrachlorodibenzo-p-dioxin",1746-01-6,-2.69682908431569,-2.53888156750743,5.52182350673528,100.000115147955,percent affected 4dpf|percent affected 5dpf|percent affected 2dpf|percent affected 3dpf,FALSE
Valinomycin,2001-95-8,-1.29622324151648,-0.73928091709308,2.4292750559462,99.7391526946039,percent affected 4dpf|percent affected 2dpf|percent affected 1dpf|percent affected 2dpf|percent affected 3dpf|percent affected 4dpf|percent affected 5dpf|CNS neurite outgrowth|a background distmoved 1dpf|b excitatory distmoved 1dpf|NCC migration|LD movement pattern (spearman) 1dpf|LD movement pattern (pearson) 1dpf|total branches|total outgrowth|LD movement pattern (cosine) 1dpf,FALSE
Methyl mercuric (II) chloride,115-09-3,-0.122281954051376,0.102639533663094,3.37444231226119,95.3941870540601,CNS neurite outgrowth|total branches|total processes,FALSE
Berberine chloride,633-65-8,-1.15775099703208,-0.729019220653686,4.11972191050543,100.000039862795,number network spikes|number actively bursting electrodes|mean firing rate|number active electrodes|percent affected 2dpf|percent affected 4dpf|mutual information|bursts per minute|percent spikes in burst,FALSE
Benzo(k)fluoranthene,207-08-9,-0.475482726846906,0.0973878995179072,1.68546725999392,89.6964100014859,percent affected 4dpf|percent affected 5dpf,FALSE
"Phenol, isopropylated, phosphate (3:1)",68937-41-7,0.716596646464074,0.899209048249295,3.36996980161792,99.8040852600556,percent affected 4dpf|b excitatory distmoved 1dpf|percent affected 5dpf|LD movement pattern (spearman) 1dpf|LD movement pattern (pearson) 1dpf|LD movement pattern (cosine) 1dpf|percent affected 4dpf|percent affected 1dpf|percent affected 2dpf,FALSE
"Dibenz(a,h)anthracene",53-70-3,-0.523851334195766,0.00186048259995543,1.8151437326548,100.328802083954,percent affected 4dpf,FALSE
Auramine O,2465-27-2,0.3239510269969,0.4324523784428,8.74420259058829,100.000535200469,percent spikes in network spike|percent spikes in burst|number actively bursting electrodes|bursts per minute|number network spikes|mean correlation|number active electrodes|percent affected 5dpf|LD movement pattern (cosine) 1dpf|percent affected 1dpf|mean firing rate,FALSE
6-Hydroxydopamine hydrochloride,28094-15-7,0.15985134953759,0.431953483359532,3.50692769672935,90.4941686866421,mutual information,FALSE
Benz(a)anthracene,56-55-3,0.798304201999196,1.02094951931764,6.0782437738253,103.41807120749,percent affected 4dpf|percent affected 5dpf,FALSE
tert-Butylphenyl diphenyl phosphate,56803-37-3,0.715838891383147,1.04759959566369,4.40305060391012,100.032881700941,percent affected 4dpf|b excitatory distmoved 1dpf|percent affected 5dpf|b D1 distmoved 5dpf|f D3 distmoved 5dpf|d D2 distmoved 5dpf,FALSE
Firemaster 550,860302-33-6,0.88162896986291,1.25459632298339,2.61871031397024,97.8206186128654,percent affected 2dpf|percent affected 4dpf|LD movement pattern (spearman) 1dpf|percent affected 2dpf|LD movement pattern (cosine) 1dpf|LD movement pattern (pearson) 1dpf,FALSE
"4-H-Cyclopenta(d,e,f)phenanthrene",203-64-5,0.858975534485547,1.21171916752185,3.07050856507828,104.630868643163,percent affected 4dpf|percent affected 2dpf,FALSE
Tricresyl phosphate,1330-78-5,0.687065645351123,1.00550690713887,2.79041891931986,98.471645030218,percent affected 5dpf|LD movement pattern (pearson) 1dpf|a background distmoved 1dpf|b excitatory distmoved 1dpf,FALSE
Phenanthrene,1985-01-08,0.980510049860256,1.31558644201756,2.89777010701979,104.896021781163,percent affected 4dpf|percent affected 2dpf,FALSE
Parathion,56-38-2,0.558377006370611,0.905194753801572,2.78478126215946,99.8069956190423,LD movement pattern (pearson) 1dpf|b excitatory distmoved 1dpf,FALSE
Acenaphthylene,208-96-8,1.00528972027393,1.186659915635,5.26129724643906,97.195664203045,percent affected 4dpf,FALSE
"Bis(2-ethylhexyl) 3,4,5,6- tetrabromophthalate (TBPH)",26040-51-7,1.01191779779819,1.32165548453265,4.52933391200932,99.4638250079269,percent affected 5dpf|percent affected 1dpf,FALSE
2-Ethylhexyl diphenyl phosphate,1241-94-7,1.01880570947394,1.29187032463519,3.68357688245479,101.206402471256,b excitatory distmoved 1dpf|percent affected 5dpf,FALSE
Fluorene,86-73-7,1.28182570296783,1.53859776078577,3.83593387945512,96.1160167695327,percent affected 4dpf|percent affected 2dpf,FALSE
Isodecyl diphenyl phosphate,29761-21-5,1.51863578848969,1.7225218563692,4.68029416920806,65.5122996406101,percent affected 4dpf|percent affected 2dpf,FALSE
Estradiol,50-28-2,0.782510405807995,0.89133759334412,8.7684201994338,86.4606070338569,b excitatory distmoved 1dpf,FALSE
Verapamil,52-53-9,-3.65321421110311,-2.69897170166378,1,100,SH-S5Y5 neurite outgrowth,FALSE
Thiamethoxam,153719-23-4,-2.16042083610311,-1.20617832666378,1,100,SH-S5Y5 neurite outgrowth,FALSE
Sulfamethoxazole,723-46-6,-1.62991313410311,-0.675670624663781,1,100,SH-S5Y5 neurite outgrowth,FALSE
Roxithromycin,80214-83-1,-3.46476186110311,-2.51051935166378,1,100,SH-S5Y5 neurite outgrowth,FALSE
Paraoxon-ethyl,311-45-5,-2.73582863310311,-1.78158612366378,1,100,SH-S5Y5 neurite outgrowth,FALSE
Naphthalene-2-sulfonic acid,120-18-3,-1.86883843810311,-0.91459592866378,1,100,SH-S5Y5 neurite outgrowth,FALSE
N-Methyl-2-pyrrolidone,872-50-4,-1.23850399210311,-0.28426148266378,1,100,SH-S5Y5 neurite outgrowth,FALSE
Mebendazole,31431-39-7,-5.72763415410311,-4.77339164466378,1,100,SH-S5Y5 neurite outgrowth,FALSE
Ifosfamide,3778-73-2,-1.30985990110311,-0.355617391663781,1,100,SH-S5Y5 neurite outgrowth,FALSE
alpha-Endosulfan,959-98-8,-3.13480390910311,-2.18056139966378,1,100,SH-S5Y5 neurite outgrowth,FALSE
Diazoxon,962-58-3,-2.33050667110311,-1.37626416166378,1,100,SH-S5Y5 neurite outgrowth,FALSE
Deethylatrazine,6190-65-4,-2.35047775210311,-1.39623524266378,1,100,SH-S5Y5 neurite outgrowth,FALSE
Clarithromycin,81103-11-9,-2.88022295610311,-1.92598044666378,1,100,SH-S5Y5 neurite outgrowth,FALSE
Benzothiazole,95-16-9,-1.87222256810311,-0.917980058663781,1,100,SH-S5Y5 neurite outgrowth,FALSE
Ampyrone,1983-07-08,-1.54750291710311,-0.59326040766378,1,100,SH-S5Y5 neurite outgrowth,FALSE
3-Nitroaniline,1999-09-02,-2.33706218410311,-1.38281967466378,1,100,SH-S5Y5 neurite outgrowth,FALSE
2-Butoxyethanol,111-76-2,-1.06505282910311,-0.110810319663781,1,100,SH-S5Y5 neurite outgrowth,FALSE
2-Allylphenol,1745-81-9,-2.10284139010311,-1.14859888066378,1,100,SH-S5Y5 neurite outgrowth,FALSE
3-Hydroxycarbofuran,16655-82-6,-3.98031674810311,-3.02607423866378,1,100,SH-S5Y5 neurite outgrowth,FALSE
Citalopram,59729-33-8,-3.54217408410311,-2.58793157466378,1,100,SH-S5Y5 neurite outgrowth,FALSE
Sertraline,79617-96-2,-4.17723433510311,-3.22299182566378,1,100,SH-S5Y5 neurite outgrowth,FALSE
Fipronil sulfone,120068-36-2,-3.55836084510311,-2.60411833566378,1,100,SH-S5Y5 neurite outgrowth,FALSE
Diquat,2764-72-9,-4.39908308510311,-3.44484057566378,1,100,SH-S5Y5 neurite outgrowth,FALSE
Narciclasine,29477-83-6,-7.16262538210311,-6.20838287266378,1,100,SH-S5Y5 neurite outgrowth,FALSE
2(4-morpholinyl)benzothiazole,4225-26-7,-2.68883207010311,-1.73458956066378,1,100,SH-S5Y5 neurite outgrowth,FALSE
Cycloheximide,66-81-9,-6.00960612410311,-5.05536361466378,1,100,SH-S5Y5 neurite outgrowth,FALSE
1-Benzyl-3-methylimidazolium chloride,36443-80-8,0.962239793764079,2.5242593798453,0.610903037287337,95.7677392783332,TOX21_RT_HEK293_GLO_40hr_viability,TRUE
1-Benzylquinolinium chloride,15619-48-4,1.11321676556191,2.0135408480854,2.29535635486231,2.79545930946863,ACEA_AR_agonist_AUC_viability|APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_24h_dn|APR_HepG2_MicrotubuleCSK_72h_dn|APR_HepG2_NuclearSize_72h_dn|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
1-Decyl-3-methylimidazolium bromide,188589-32-4,-0.74555432948818,0.228442912081721,2.32954929287296,48.8879460437136,TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_PGC_ERR_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_VDR_BLA_Agonist_viability,TRUE
1-Decyl-3-methylimidazolium chloride,171058-18-7,-1.04435452721327,-0.465750954726143,1.69606207259026,43.1773443081473,TOX21_CAR_Agonist_viabillity|TOX21_PGC_ERR_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
1-Hexadecyl-3-methylimidazolium chloride,61546-01-8,0.510216455702377,1.27413729398315,0.999503117795507,100,TOX21_AP1_BLA_Agonist_viability|TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_CASP3_CHO_viability|TOX21_ERR_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_PXR_viability|TOX21_RAR_LUC_Agonist_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RXR_BLA_Agonist_viability|TOX21_VDR_BLA_Agonist_viability,TRUE
1-Hexyl-3-methylimidazolium bromide,85100-78-3,0.251073752774469,1.33081684266307,1.01489948737857,44.8767149028089,TOX21_AR_BLA_Antagonist_viability|TOX21_CAR_Agonist_viabillity|TOX21_CAR_Antagonist_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
1-Hexylpyridinium bromide,74440-81-6,0.367606081118059,0.720829087850703,2.5653826989521,25.1307197425375,TOX21_CAR_Agonist_viabillity|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
1-Hexylpyridinium chloride,6220-15-1,1.16883108797343,1.48132816732625,3.06815848968192,32.5140386142093,TOX21_CAR_Agonist_viabillity|TOX21_CAR_Antagonist_viability,TRUE
1-Methyl-3-octylimidazolium chloride,64697-40-1,-0.224050343558984,0.539697912701416,1.24942021355526,56.6373311855453,TOX21_AR_BLA_Antagonist_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_VDR_BLA_Agonist_viability,TRUE
1-Methyl-3-tetradecylimidazolium chloride,171058-21-2,0.179080578946477,1.20013075958817,1.12090300764945,100,TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_Aromatase_Inhibition_viability|TOX21_CASP3_CHO_viability|TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2_viability|TOX21_ESRE_BLA_viability|TOX21_GR_BLA_Antagonist_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_FLO_24hr_viability|TOX21_RXR_BLA_Agonist_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_VDR_BLA_Agonist_viability|TOX21_VDR_BLA_antagonist_viability|TOX21_p53_BLA_p3_viability,TRUE
Benzethonium chloride,121-54-0,0.274183967051357,0.691245879561251,2.21579327495321,0.825110303245026,BSK_3C_Proliferation_down|BSK_3C_Vis_down|BSK_4H_SRB_down|BSK_BE3C_SRB_down|BSK_CASM3C_Proliferation_down|BSK_CASM3C_SRB_down|BSK_KF3CT_SRB_down|BSK_SAg_Proliferation_down|BSK_SAg_SRB_down|BSK_hDFCGF_Proliferation_down|BSK_hDFCGF_SRB_down|TOX21_ERR_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_ESRE_BLA_viability|TOX21_RT_HEK293_FLO_32hr_viability|TOX21_RT_HEK293_FLO_40hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability,TRUE
Benzyldimethyldodecylammonium chloride,139-07-1,0.59621461342814,1.14695321744337,1.37247966115602,93.9828892733908,ATG_XTT_Cytotoxicity_up|TOX21_ARE_BLA_agonist_viability|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_CASP3_CHO_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_ESRE_BLA_viability|TOX21_HSE_BLA_agonist_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_PR_BLA_Agonist_viability|TOX21_RT_HEK293_FLO_32hr_viability|TOX21_RT_HEK293_FLO_40hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_FLO_40hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability|TOX21_VDR_BLA_antagonist_viability,TRUE
Benzyldodecyldimethylammonium bromide,7281-04-01,-0.21692565704645,0.900443367087036,1.12367470371998,85.1632170451726,TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability|TOX21_RXR_BLA_Agonist_viability,TRUE
Benzylhexadecyldimethylammonium chloride,122-18-9,0.464287479457097,1.12093473645593,1.67959977878182,93.8597276560102,ATG_XTT_Cytotoxicity_up|BSK_SAg_PBMCCytotoxicity_down|TOX21_ARE_BLA_agonist_viability|TOX21_CASP3_CHO_viability|TOX21_HDAC_Inhibition_viability|TOX21_HRE_BLA_Agonist_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_PR_BLA_Antagonist_viability|TOX21_RT_HEK293_FLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_VDR_BLA_Agonist_viability|TOX21_VDR_BLA_antagonist_viability|TOX21_p53_BLA_p3_viability,TRUE
Betamethasone,378-44-9,-1.60840221886019,-0.3772228751529,0.806521032944697,47.1580654287854,TOX21_HRE_BLA_Agonist_viability|TOX21_RT_HEPG2_GLO_00hr_ctrl_viability,TRUE
Bethanechol chloride,590-63-6,0.294361769559286,0.41947698198756,8.04030790181652,-293.118566176309,TOX21_RT_HEPG2_FLO_08hr_viability|TOX21_RT_HEPG2_FLO_16hr_ctrl_viability,TRUE
Cetylpyridinium bromide,140-72-7,0.29268954886398,0.91146227059975,1.46173601405204,79.8440034369464,TOX21_AhR_LUC_Agonist_viability|TOX21_ERa_BLA_Antagonist_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_ESRE_BLA_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_PR_BLA_Agonist_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_TR_LUC_GH3_Antagonist_viability,TRUE
Cetylpyridinium chloride,123-03-5,0.57896196652862,1.24570903373524,1.23861661932733,100,TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_CAR_Agonist_viabillity|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_PGC_ERR_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_FLO_24hr_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_RXR_BLA_Agonist_viability|TOX21_VDR_BLA_Agonist_viability,TRUE
Colchicine,64-86-8,-2.23469560349371,-1.60712498120566,1.6680423035127,36.6505400422205,STM_H9_Viability_norm|TOX21_CAR_Agonist_viabillity|TOX21_CAR_Antagonist_viability|TOX21_CASP3_CHO_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability|NCC cell viability|SH-S5Y5 viability,TRUE
Dequalinium dichloride,522-51-0,-0.569365086377093,0.936591507391669,0.633645427356751,38.5785221116829,TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2_viability,TRUE
Dexamethasone,1950-02-02,1.02691193947174,1.37335120278231,2.75442944982799,63.1265582220127,TOX21_RT_HEPG2_GLO_00hr_ctrl_viability,TRUE
Didodecyldimethylammonium bromide,3282-73-3,1.01507128946124,1.35774236950276,3.19439063533087,98.7945617266092,ATG_XTT_Cytotoxicity_up|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_CAR_Antagonist_viability|TOX21_CASP3_CHO_viability|TOX21_CASP3_HEPG2_viability|TOX21_ESRE_BLA_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_HRE_BLA_Agonist_viability|TOX21_NFkB_BLA_agonist_viability|TOX21_RAR_LUC_Agonist_viability|TOX21_RAR_LUC_Antagonist_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_SBE_BLA_Agonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_p53_BLA_p2_viability|TOX21_p53_BLA_p5_viability,TRUE
Dioctyldimethylammonium chloride,5538-94-3,0.466708357301344,0.694085041693952,4.19674740173293,38.9308647111595,TOX21_ERa_BLA_Antagonist_viability,TRUE
Dodecyltrimethylammonium bromide,1119-94-4,1.09445859567188,1.39749695151138,2.55999341436056,44.2653701008641,TOX21_CAR_Agonist_viabillity|TOX21_CAR_Antagonist_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_HSE_BLA_agonist_viability|TOX21_PXR_viability|TOX21_TR_LUC_GH3_Antagonist_viability,TRUE
Dodecyltrimethylammonium chloride,112-00-5,0.459243843220907,1.10873020262243,1.6862333613187,38.5181488588683,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|BSK_CASM3C_Proliferation_down|BSK_SAg_Proliferation_down|BSK_hDFCGF_Proliferation_down|NCCT_MITO_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_CAR_Agonist_viabillity|TOX21_CAR_Antagonist_viability|TOX21_ESRE_BLA_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability,TRUE
Domiphen bromide,538-71-6,0.668514938835913,1.03089166842685,2.35743621390805,100,TOX21_CASP3_CHO_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_PR_BLA_Agonist_viability|TOX21_PXR_viability|TOX21_RT_HEK293_FLO_24hr_viability|TOX21_RT_HEK293_FLO_32hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_VDR_BLA_antagonist_viability,TRUE
Estrone,53-16-7,0.16111650133941,0.679597648965008,1.84045748588798,37.5959953026244,BSK_hDFCGF_Proliferation_down|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Ethylhexadecyldimethylammonium bromide,124-03-8,0.299670897416382,0.993311291086249,1.11387050101647,78.3677514780244,ATG_XTT_Cytotoxicity_up|BSK_SAg_PBMCCytotoxicity_down|TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_ERR_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_FLO_24hr_viability|TOX21_RT_HEPG2_FLO_40hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_RXR_BLA_Agonist_viability|TOX21_VDR_BLA_antagonist_viability,TRUE
Etoposide,33419-42-0,-0.358460376416554,-0.0952179911456208,3.63021472903767,59.3634865465993,TOX21_AR_BLA_Antagonist_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Hexadecyl trimethyl ammonium chloride,112-02-7,0.123269914026512,0.966932194527607,1.26718144390697,71.7777564127976,TOX21_ERa_BLA_Antagonist_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_RT_HEK293_FLO_16hr_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_VDR_BLA_antagonist_viability,TRUE
Hexadecyltrimethylammonium bromide,57-09-0,0.840893407138386,1.41830026433884,2.87608748288007,100,TOX21_ARE_BLA_agonist_viability|TOX21_AR_BLA_Antagonist_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEPG2_FLO_32hr_ctrl_viability|TOX21_RT_HEPG2_FLO_40hr_ctrl_viability|TOX21_VDR_BLA_Agonist_viability,TRUE
Lynestrenol,52-76-6,0.277605058760668,0.768918087293264,2.39465218887893,24.5304864495011,TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Medroxyprogesterone acetate,71-58-9,-0.105249053965177,0.882387365383852,0.875396601092805,72.6700058119995,TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_00hr_ctrl_viability,TRUE
Methylene blue,61-73-4,0.142830362082098,0.827349061952693,1.22195770977142,72.5524477051495,ACEA_AR_antagonist_AUC_viability|ACEA_ER_AUC_viability|NCCT_HEK293T_CellTiterGLO|TOX21_ARE_BLA_agonist_viability|TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_CAR_Agonist_viabillity|TOX21_CASP3_CHO_viability|TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_HDAC_Inhibition_viability|TOX21_PGC_ERR_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability|TOX21_p53_BLA_p1_viability|TOX21_p53_BLA_p4_viability,TRUE
Miripirium chloride,2748-88-1,0.397995198358743,1.02634026922508,1.64265670535534,42.6847411927885,TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_Aromatase_Inhibition_viability|TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2_viability|TOX21_TR_LUC_GH3_Antagonist_viability,TRUE
"Myristyltrimethylammonium chlorideN,N,N-Trimethyltetradecan-1-aminium chloride",4574-04-03,0.581924836317904,1.05312982484842,1.99261337083499,100,ACEA_AR_agonist_AUC_viability|ACEA_AR_antagonist_AUC_viability|ATG_XTT_Cytotoxicity_up|TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_ERR_viability|TOX21_FXR_BLA_agonist_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_PGC_ERR_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_VDR_BLA_Agonist_viability|TOX21_VDR_BLA_antagonist_viability,TRUE
"N,N,N-Trimethyloctadecan-1-aminium chloride",112-03-8,0.169159351516899,1.18786085560728,1.76239671502801,85.6520786447352,BSK_BE3C_SRB_down|BSK_CASM3C_SRB_down|BSK_KF3CT_SRB_down|BSK_LPS_SRB_down|BSK_SAg_SRB_down|TOX21_CASP3_CHO_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_GR_BLA_Antagonist_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RXR_BLA_Agonist_viability,TRUE
"N,N-Dimethyl-N-benzyl-N-octadecylammonium chloride",122-19-0,0.295566107224494,1.2366069059821,1.06916105828823,100,TOX21_ARE_BLA_agonist_viability|TOX21_CASP3_CHO_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_HRE_BLA_Agonist_viability|TOX21_HSE_BLA_agonist_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_PR_BLA_Agonist_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_FLO_24hr_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_VDR_BLA_Agonist_viability|TOX21_p53_BLA_p1_viability|TOX21_p53_BLA_p3_viability|TOX21_p53_BLA_p4_viability,TRUE
Nitroblue tetrazolium dichloride,298-83-9,0.754587550317921,0.896630351108121,6.71799277492961,103.855345212566,TOX21_AR_BLA_Antagonist_viability,TRUE
Rhodamine B,81-88-9,0.381304457240677,0.877063782782527,1.93662274863446,73.8078137110408,ACEA_AR_antagonist_AUC_viability|NCCT_HTTr_Viability_MCF7_DMEM_6hr|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_AhR_LUC_Agonist_viability|TOX21_RAR_LUC_Antagonist_viability|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_RT_HEK293_FLO_00hr_viability|TOX21_RT_HEK293_FLO_08hr_viability|TOX21_RT_HEK293_FLO_16hr_viability|TOX21_RT_HEK293_FLO_24hr_viability|TOX21_RT_HEK293_FLO_32hr_viability|TOX21_RT_HEK293_FLO_40hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_FLO_00hr_ctrl_viability|TOX21_RT_HEPG2_FLO_08hr_viability|TOX21_RT_HEPG2_FLO_16hr_ctrl_viability|TOX21_RT_HEPG2_FLO_24hr_viability|TOX21_RT_HEPG2_FLO_32hr_ctrl_viability|TOX21_RT_HEPG2_FLO_40hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability,TRUE
Rotenone,83-79-4,-1.43899385680792,-0.383509545844198,0.822945242612366,57.5613415649176,APR_HepG2_CellLoss_24h_dn|APR_HepG2_MicrotubuleCSK_1h_dn|NCCT_HEK293T_CellTiterGLO|NCCT_MITO_viability|TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_CAR_Agonist_viabillity|TOX21_ERR_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_RAR_LUC_Agonist_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_FLO_32hr_ctrl_viability|TOX21_RT_HEPG2_FLO_40hr_ctrl_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_TR_LUC_GH3_Antagonist_viability|cell viability|percent mortality Tail 7d|percent mortality 1dpf|percent mortality 2dpf|percent mortality 1dpf|SH-S5Y5 viability,TRUE
Stanozolol,10418-03-8,0.331730811955116,0.987682229678449,1.20682200153124,68.9298070717317,TOX21_ERb_BLA_Antagonist_viability|TOX21_HRE_BLA_Agonist_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RXR_BLA_Agonist_viability,TRUE
Tetra-N-octylammonium bromide,14866-33-2,-0.0135798104238014,0.870609849392616,1.23435223038987,100,TOX21_ARE_BLA_agonist_viability|TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_Aromatase_Inhibition_viability|TOX21_CAR_Agonist_viabillity|TOX21_ERR_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_FXR_BLA_agonist_viability|TOX21_FXR_BLA_antagonist_viability|TOX21_GR_BLA_Antagonist_viability|TOX21_HRE_BLA_Agonist_viability|TOX21_PGC_ERR_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PXR_viability|TOX21_RAR_LUC_Antagonist_viability|TOX21_RT_HEK293_FLO_08hr_viability|TOX21_RT_HEK293_FLO_16hr_viability|TOX21_RT_HEK293_FLO_24hr_viability|TOX21_RT_HEK293_FLO_32hr_viability|TOX21_RT_HEK293_FLO_40hr_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_FLO_08hr_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_SBE_BLA_Antagonist_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_p53_BLA_p1_viability|TOX21_p53_BLA_p3_viability,TRUE
Tetrabutylammonium bromide,1643-19-2,0.767202665443461,0.926495768394095,7.00714723702861,22.9291218343001,TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Tetrabutylphosphonium bromide,3115-68-2,0.500525357463556,1.28674444108199,1.23223689291173,54.3945790526514,TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability,TRUE
Tetrabutylphosphonium chloride,2304-30-5,-0.0907163737326403,0.744104583463157,1.15126262887635,55.7824466582301,TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Tetradecylpyridinium bromide,1155-74-4,0.223990783680508,1.1809872265625,0.88729558279767,90.0590243760778,ATG_XTT_Cytotoxicity_up|TOX21_ARE_BLA_agonist_viability|TOX21_CASP3_CHO_viability|TOX21_CASP3_HEPG2_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_PXR_viability|TOX21_RT_HEK293_FLO_32hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability,TRUE
Tetradonium bromide,1119-97-7,0.660030574574656,1.29738563052444,1.7599822802281,87.9044883576199,ACEA_ER_AUC_viability|ATG_XTT_Cytotoxicity_up|TOX21_AP1_BLA_Agonist_viability|TOX21_AR_BLA_Antagonist_viability|TOX21_CAR_Antagonist_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_FXR_BLA_agonist_viability|TOX21_FXR_BLA_antagonist_viability|TOX21_HSE_BLA_agonist_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_VDR_BLA_Agonist_viability,TRUE
Tetraoctylphosphonium bromide,23906-97-0,0.312457141904041,0.944108381055077,2.04175118299666,100,TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_CASP3_CHO_viability|TOX21_CASP3_HEPG2_viability|TOX21_ELG1_LUC_Agonist_viability|TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_ESRE_BLA_viability|TOX21_FXR_BLA_antagonist_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_HDAC_Inhibition_viability|TOX21_HSE_BLA_agonist_viability|TOX21_MMP_viability|TOX21_NFkB_BLA_agonist_viability|TOX21_PGC_ERR_viability|TOX21_PR_BLA_Antagonist_viability|TOX21_PXR_viability|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_RT_HEK293_FLO_24hr_viability|TOX21_RT_HEK293_FLO_32hr_viability|TOX21_RT_HEK293_FLO_40hr_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_FLO_08hr_viability|TOX21_RT_HEPG2_FLO_16hr_ctrl_viability|TOX21_RT_HEPG2_FLO_24hr_viability|TOX21_RT_HEPG2_GLO_00hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability|TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability|TOX21_p53_BLA_p2_viability,TRUE
Tributyltetradecylphosphonium chloride,81741-28-8,0.261764365690585,0.86503994341289,2.42362981896316,97.6251479130286,ACEA_ER_AUC_viability|ATG_XTT_Cytotoxicity_up|NCCT_HEK293T_CellTiterGLO|TOX21_AP1_BLA_Agonist_viability|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_CAR_Antagonist_viability|TOX21_ELG1_LUC_Agonist_viability|TOX21_ERR_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_ESRE_BLA_viability|TOX21_FXR_BLA_antagonist_viability|TOX21_HRE_BLA_Agonist_viability|TOX21_NFkB_BLA_agonist_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_PXR_viability|TOX21_RT_HEK293_FLO_16hr_viability|TOX21_RT_HEK293_FLO_24hr_viability|TOX21_RT_HEK293_FLO_32hr_viability|TOX21_RT_HEK293_FLO_40hr_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability|TOX21_VDR_BLA_Agonist_viability|TOX21_VDR_BLA_antagonist_viability|TOX21_p53_BLA_p1_viability,TRUE
Trihexyltetradecylphosphonium bromide,654057-97-3,0.416586789250184,1.06002315464184,1.52368385705132,97.8768248235308,TOX21_AP1_BLA_Agonist_viability|TOX21_ARE_BLA_agonist_viability|TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_CAR_Agonist_viabillity|TOX21_CAR_Antagonist_viability|TOX21_CASP3_HEPG2_viability|TOX21_ELG1_LUC_Agonist_viability|TOX21_ERa_BLA_Antagonist_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_ESRE_BLA_viability|TOX21_FXR_BLA_antagonist_viability|TOX21_NFkB_BLA_agonist_viability|TOX21_PR_BLA_Agonist_viability|TOX21_RAR_LUC_Agonist_viability|TOX21_RAR_LUC_Antagonist_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_FLO_24hr_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_SBE_BLA_Agonist_viability|TOX21_SBE_BLA_Antagonist_viability|TOX21_VDR_BLA_antagonist_viability|TOX21_p53_BLA_p3_viability,TRUE
Trihexyltetradecylphosphonium chloride,258864-54-9,0.371795194533079,1.13929521098047,1.45308848809007,98.4873108689193,TOX21_ARE_BLA_agonist_viability|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_AhR_LUC_Agonist_viability|TOX21_CASP3_HEPG2_viability|TOX21_ERR_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_ESRE_BLA_viability|TOX21_FXR_BLA_antagonist_viability|TOX21_GR_BLA_Antagonist_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_HSE_BLA_agonist_viability|TOX21_NFkB_BLA_agonist_viability|TOX21_PGC_ERR_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_RAR_LUC_Agonist_viability|TOX21_RAR_LUC_Antagonist_viability|TOX21_RT_HEK293_FLO_16hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_VDR_BLA_Agonist_viability|TOX21_VDR_BLA_antagonist_viability|TOX21_p53_BLA_p1_viability|TOX21_p53_BLA_p3_viability,TRUE
1-Acetyl-2-phenylhydrazine,114-83-0,0.43336078724032,0.817177892172612,2.4861906808652,26.1135171030623,TOX21_CASP3_CHO_viability|TOX21_ERR_viability|TOX21_TR_LUC_GH3_Antagonist_viability,TRUE
"2,2,2-Trichloro-1-phenylethyl acetate",90-17-5,0.844349673425383,0.970668035759058,7.55719751033349,18.806179011372,TOX21_RT_HEPG2_FLO_32hr_ctrl_viability|TOX21_RT_HEPG2_FLO_40hr_ctrl_viability,TRUE
Cyproterone acetate,427-51-0,0.866986126817422,1.39814524878814,1.30639246081098,39.1495485142743,BSK_hDFCGF_Proliferation_down|NCCT_MITO_viability|TOX21_MMP_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability,TRUE
Ketoconazole,65277-42-1,0.731436227488099,1.29857157735871,1.23598933506124,90.6270509111186,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|NCCT_HEK293T_CellTiterGLO|TOX21_ERR_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_00hr_ctrl_viability|TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_VDR_BLA_antagonist_viability,TRUE
Melengestrol acetate,2919-66-6,0.356017951050618,1.64037980312027,1.09131483481647,92.5751481502685,TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEPG2_GLO_00hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability,TRUE
N-Acetyl-m-toluidine,537-92-8,1.04367849235494,1.23877554084513,3.44413184727216,11.8821334902291,TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
"1-(4-Chlorophenyl)-4,4-dimethylpent-1-en-3-one",1577-03-3,-1.46827416683845,-1.03219485786042,2.18823156658277,88.1731246509711,TOX21_RT_HEK293_FLO_24hr_viability,TRUE
"2,4,6-Tris(tert-butyl)phenol",732-26-3,0.457473654608234,0.653237499321987,4.87445733830279,-2.58830839889774,TOX21_RT_HEPG2_FLO_32hr_ctrl_viability,TRUE
"2,6-Di-tert-butyl-4-nitrophenol",728-40-5,0.545295648777048,1.04638026827744,1.90149394514502,49.7873416798386,ACEA_ER_AUC_viability|BSK_3C_Proliferation_down|BSK_3C_SRB_down|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_CASP3_CHO_viability|TOX21_ERR_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability|TOX21_PGC_ERR_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_PXR_viability|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability|TOX21_p53_BLA_p3_viability,TRUE
2-Acetoxy-5-nitrobenzyl chloride,5174-32-3,0.961845087649007,1.53552162167624,1.2287095017262,71.3615396081571,TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_AhR_LUC_Agonist_viability|TOX21_Aromatase_Inhibition_viability|TOX21_CASP3_CHO_viability|TOX21_CASP3_HEPG2_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability,TRUE
4-tert-Butylcatechol,98-29-3,0.456072046940227,0.743989597968856,3.27847218441185,1.3381673003372,ACEA_ER_AUC_viability|BSK_3C_Proliferation_down|BSK_CASM3C_Proliferation_down|BSK_SAg_Proliferation_down|BSK_hDFCGF_SRB_down|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability,TRUE
5-Nitro-2-furanmethanediol diacetate,92-55-7,1.09809470194778,1.36679442495018,3.55133417622023,103.105040775144,TOX21_Aromatase_Inhibition_viability,TRUE
Adefovir dipivoxil,142340-99-6,-0.38268058167037,0.248281078329815,1.68784386783816,51.0756053004129,TOX21_CAR_Agonist_viabillity|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RXR_BLA_Agonist_viability,TRUE
Bitertanol,55179-31-2,0.352782835045664,0.494534111594161,4.26069215331018,0.028417365408279,BSK_3C_Proliferation_down|BSK_4H_SRB_down|BSK_CASM3C_Proliferation_down|BSK_CASM3C_SRB_down|TOX21_SSH_3T3_GLI3_Antagonist_viability,TRUE
Buturon,3766-60-7,0.948246039923689,2.59733843066307,0.580070974175488,96.0215772879944,TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability,TRUE
Fluocinonide,356-12-7,-0.451566454170026,0.432319902145582,1.07959864141018,67.1001083928861,TOX21_RT_HEPG2_GLO_00hr_ctrl_viability,TRUE
Paclobutrazol,76738-62-0,0.71711559763755,0.895486889745407,2.98848474926446,11.9730260859696,ACEA_AR_antagonist_AUC_viability|APR_HepG2_CellLoss_72h_dn|BSK_SAg_Proliferation_down|CEETOX_H295R_MTT_cell_viability_up,TRUE
Pindone,83-26-1,1.23713748952422,1.5387026096066,3.00994467826215,47.5119358125251,TOX21_ERR_viability|TOX21_PGC_ERR_viability|TOX21_RORg_LUC_CHO_Antagonist_viability,TRUE
Tebuconazole,107534-96-3,1.54452208745525,1.83699142437526,3.26270958688682,0.740703457595059,APR_HepG2_CellLoss_24h_dn,TRUE
Triadimenol,55219-65-3,0.777918159151042,1.49589829519055,1.32906533417912,1.67742686389475,APR_HepG2_CellLoss_72h_dn,TRUE
"2,2',6,6'-Tetrachlorobisphenol A",79-95-8,0.684225685793372,1.09188175171748,3.14950566200083,0.587459847696405,BSK_3C_Proliferation_down|BSK_4H_SRB_down|BSK_CASM3C_SRB_down|BSK_SAg_PBMCCytotoxicity_down|BSK_SAg_SRB_down|BSK_hDFCGF_Proliferation_down|BSK_hDFCGF_SRB_down|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
"2,4-Bis(1-methyl-1-phenylethyl)phenol",2772-45-4,0.801999648942134,1.33573304982493,3.03854145764778,89.7339744578658,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|BSK_3C_SRB_down|BSK_4H_SRB_down|BSK_LPS_SRB_down|BSK_SAg_PBMCCytotoxicity_down|BSK_SAg_SRB_down|TOX21_AP1_BLA_Agonist_viability|TOX21_ARE_BLA_agonist_viability|TOX21_Aromatase_Inhibition_viability|TOX21_CASP3_CHO_viability|TOX21_ESRE_BLA_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_NFkB_BLA_agonist_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_PXR_viability|TOX21_RAR_LUC_Agonist_viability|TOX21_RAR_LUC_Antagonist_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_p53_BLA_p2_viability|TOX21_p53_BLA_p4_viability,TRUE
"2,6-Di-tert-butylphenol",128-39-2,1.48018460378871,2.07498199012807,1.61990566414018,65.0123561688639,APR_HepG2_CellLoss_24h_dn|NCCT_HEK293T_CellTiterGLO,TRUE
2-Acrylamido-2-methyl-1-propanesulfonic acid,15214-89-8,0.759146610094754,0.870740255349995,8.83311150870756,46.9093642391729,TOX21_RT_HEPG2_FLO_00hr_ctrl_viability|TOX21_RT_HEPG2_FLO_24hr_viability|TOX21_RT_HEPG2_FLO_32hr_ctrl_viability,TRUE
2-Chloro-2-nitropropane,594-71-8,-0.568584479802317,0.879718584484107,0.65886935750528,62.7428119486738,TOX21_RT_HEPG2_GLO_00hr_ctrl_viability,TRUE
"3,3',5,5'-Tetrabromobisphenol A",79-94-7,0.706567185837989,1.06260241748312,2.63785930405568,87.1113244337334,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|CEETOX_H295R_MTT_cell_viability_up|NCCT_HEK293T_CellTiterGLO|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_p53_BLA_p2_viability|TOX21_p53_BLA_p4_viability|percent mortality 4dpf|percent mortality 3dpf|percent mortality 2dpf|percent mortality 5dpf|percent mortality 1dpf|SH-S5Y5 viability,TRUE
"4,4'-(Isopropylidenebis(4,1-phenyleneoxy))dianiline",13080-86-9,0.836674238301476,1.00607215432185,6.83205705525527,26.2016144290553,TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
"4-(1,1,3,3-Tetramethylbutyl)phenol",140-66-9,1.18454954436868,1.38250037429866,4.75565875887277,5.4792853342896,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|APR_HepG2_NuclearSize_24h_dn|ATG_XTT_Cytotoxicity_up|BSK_3C_Proliferation_down|BSK_CASM3C_Proliferation_down|BSK_LPS_SRB_down|BSK_SAg_PBMCCytotoxicity_down|BSK_SAg_SRB_down|BSK_hDFCGF_Proliferation_down|BSK_hDFCGF_SRB_down|TOX21_AP1_BLA_Agonist_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEPG2_FLO_24hr_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RXR_BLA_Agonist_viability,TRUE
4-Cumylphenol,599-64-4,0.553283771159026,1.27707393364369,2.22971874115815,39.2187882992058,ACEA_AR_agonist_AUC_viability|APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|NCCT_HEK293T_CellTiterGLO|TOX21_MMP_viability|TOX21_RT_HEK293_FLO_08hr_viability|TOX21_RT_HEK293_FLO_24hr_viability|TOX21_RT_HEK293_GLO_24hr_viability,TRUE
BisOPP-A,24038-68-4,1.28661879861637,1.42268446307627,5.70373107717313,90.9277625820653,TOX21_AP1_BLA_Agonist_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_PXR_viability|TOX21_SBE_BLA_Agonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability,TRUE
Bisphenol A diglycidyl ether,1675-54-3,0.912636913323773,1.72734671034058,1.8820745398549,74.4729460334411,ATG_XTT_Cytotoxicity_up|TOX21_p53_BLA_p5_viability,TRUE
CP-457677,214535-77-0,0.655224048641919,1.22320637567448,2.05937821844491,38.2442250808928,TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Clofoctol,37693-01-9,0.908899859188758,1.20653739435623,4.26322071850039,93.9428974555463,TOX21_AP1_BLA_Agonist_viability|TOX21_ARE_BLA_agonist_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_NFkB_BLA_agonist_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_VDR_BLA_antagonist_viability|TOX21_p53_BLA_p4_viability|TOX21_p53_BLA_p5_viability,TRUE
Dicumyl peroxide,80-43-3,1.27972754053237,1.46398684838524,5.17880220304153,24.7127230515458,APR_HepG2_CellLoss_24h_dn|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability,TRUE
Finasteride,98319-26-7,0.116679980519279,1.90988779761418,0.532142733453646,28.7693238863873,TOX21_RT_HEPG2_GLO_00hr_ctrl_viability,TRUE
Halofenozide,112226-61-6,0.116855249878371,0.833095200623051,1.20924847525791,37.6451017836893,ACEA_AR_antagonist_AUC_viability|TOX21_Aromatase_Inhibition_viability|TOX21_CAR_Antagonist_viability|TOX21_CASP3_HEPG2_viability|TOX21_ERR_viability|TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability|TOX21_PGC_ERR_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Hydroxyflutamide,52806-53-8,1.01190342561112,1.26943647938983,4.30731136683263,42.9600781513,TOX21_CASP3_CHO_viability|TOX21_RT_HEK293_GLO_32hr_viability,TRUE
Neopentyl glycol dibenzoate,4196-89-8,1.07547185527229,1.30357418810883,2.13925545310096,0.376867544265746,BSK_3C_Proliferation_down|BSK_4H_SRB_down|BSK_LPS_SRB_down|BSK_hDFCGF_SRB_down,TRUE
Octrizole,3147-75-9,0.128007433215939,0.599947963543884,2.02195498821904,2.92548915874269,TOX21_p53_BLA_p3_viability,TRUE
Propyzamide,23950-58-5,2.01121618617715,3.57414705944199,0.610546842321944,7.74770256752196,APR_HepG2_CellLoss_72h_dn,TRUE
Tetrabromobisphenol A bis(2-hydroxyethyl) ether,4162-45-2,0.507493920876156,1.03011473109613,2.28431000713098,2.7839024798068,ATG_XTT_Cytotoxicity_up|BSK_3C_Proliferation_down|BSK_3C_SRB_down|BSK_KF3CT_SRB_down|BSK_hDFCGF_SRB_down|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability,TRUE
tert-Butyl perbenzoate,614-45-9,0.838662560317464,1.18364571034252,2.76605541276441,33.1807347592522,TOX21_RT_HEK293_GLO_08hr_viability,TRUE
"2,2,4-Trimethyl-1,3-pentanediol",144-19-4,-0.399857336487335,-0.10081999064522,2.69514383518712,64.1043006358954,TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability,TRUE
Esfenvalerate,66230-04-4,0.519275939290903,0.929493749358622,2.57769834911636,0.328352568941857,ACEA_AR_agonist_AUC_viability|ACEA_AR_antagonist_AUC_viability|BSK_3C_Proliferation_down|BSK_3C_SRB_down|BSK_CASM3C_Proliferation_down|BSK_SAg_Proliferation_down,TRUE
Farnesyl acetate,29548-30-9,-0.894980666330437,0.524348046733681,0.672319597747909,-0.0101724977517056,BSK_hDFCGF_SRB_down,TRUE
Flucythrinate,70124-77-5,0.445545063051865,0.842817803121908,2.40198335599639,11.1258095459387,TOX21_RT_HEPG2_GLO_16hr_ctrl_viability,TRUE
Flutamide,13311-84-7,0.740906682019915,1.43244405346605,1.52730461499392,19.4169631597152,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_24h_up|APR_HepG2_MicrotubuleCSK_72h_up|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Gossypol,303-45-7,0.513539122420294,1.07568449374943,1.72861707190669,100,TOX21_ELG1_LUC_Agonist_viability|TOX21_ERR_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_ESRE_BLA_viability|TOX21_GR_BLA_Antagonist_viability|TOX21_HRE_BLA_Agonist_viability|TOX21_HSE_BLA_agonist_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_VDR_BLA_antagonist_viability|TOX21_p53_BLA_p1_viability|TOX21_p53_BLA_p3_viability,TRUE
Isopropamide,7492-32-2,0.557366219314857,0.808016013742359,3.80707477386474,13.1120939282949,TOX21_RT_HEPG2_GLO_40hr_viability,TRUE
Nerolidol,7212-44-4,0.232325272964155,0.343584516902134,8.5767481034768,8.77092205584933,TOX21_RT_HEPG2_FLO_08hr_viability,TRUE
Riboprine,7724-76-7,0.171173274445381,0.807393719310695,1.71636666215583,59.7449413028282,TOX21_ARE_BLA_agonist_viability|TOX21_CAR_Agonist_viabillity|TOX21_CAR_Antagonist_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_NFkB_BLA_agonist_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_PXR_viability|TOX21_RORg_LUC_CHO_Antagonist_viability,TRUE
S-Bioallethrin,28434-00-6,0.750408713284697,1.4454843926773,1.14729591596256,93.370130948472,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_TR_LUC_GH3_Antagonist_viability,TRUE
"2,4,7,9-Tetramethyl-5-decyne-4,7-diol",126-86-3,-4.0956936002373,-3.04094527808126,0.904711094954605,100,TOX21_PR_BLA_Antagonist_viability|TOX21_PR_BLA_Antagonist_viability,TRUE
"2,6,8-Trimethyl-4-nonanone",123-18-2,0.552269284983346,1.25241080889294,1.36292803219387,57.1279540904438,TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
2-(Propan-2-yl)-9H-thioxanthen-9-one,5495-84-1,1.10290123879836,1.39072915398528,3.34647597044065,39.8021078061625,TOX21_AR_BLA_Antagonist_viability|TOX21_HDAC_Inhibition_viability|TOX21_MMP_viability|TOX21_RT_HEPG2_FLO_40hr_ctrl_viability|TOX21_AR_BLA_Antagonist_viability|TOX21_HDAC_Inhibition_viability|TOX21_MMP_viability|TOX21_RT_HEPG2_FLO_40hr_ctrl_viability,TRUE
"3,7-Dimethyloctan-1-ol",106-21-8,0.368323598610292,0.912738166815714,1.22810606319446,0.0189392443793295,BSK_3C_Proliferation_down|BSK_3C_SRB_down|BSK_BE3C_SRB_down|BSK_3C_Proliferation_down|BSK_3C_SRB_down|BSK_BE3C_SRB_down,TRUE
"4,4'-(4-Methylpentane-2,2-diyl)diphenol",6807-17-6,-0.395312306062985,0.0240938300976096,5.39064148771421,18.892025057889,TOX21_MMP_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability|TOX21_MMP_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability,TRUE
4-Isopropylphenol,99-89-8,-0.530050399291589,0.323968344286266,1.11735546393465,30.6017715242361,ACEA_AR_antagonist_AUC_viability|ACEA_AR_antagonist_AUC_viability,TRUE
CP-863187,668981-02-0,-0.0969904796819272,1.38421176606662,0.607947413295537,100,TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Ipconazole,125225-28-7,1.1242385386251,1.44766252140136,3.12178474117608,93.6320006662133,ACEA_ER_AUC_viability|ATG_XTT_Cytotoxicity_up|TOX21_CASP3_CHO_viability|TOX21_ERR_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_FLO_24hr_viability|TOX21_RT_HEPG2_FLO_32hr_ctrl_viability|TOX21_TR_LUC_GH3_Antagonist_viability|ACEA_ER_AUC_viability|ATG_XTT_Cytotoxicity_up|TOX21_CASP3_CHO_viability|TOX21_ERR_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_FLO_24hr_viability|TOX21_RT_HEPG2_FLO_32hr_ctrl_viability|TOX21_TR_LUC_GH3_Antagonist_viability,TRUE
Menthyl anthranilate,134-09-8,1.31114945731827,1.42555984150482,5.76639061425976,100,TOX21_PPARd_BLA_Agonist_viability|TOX21_RT_HEK293_FLO_40hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RXR_BLA_Agonist_viability|TOX21_VDR_BLA_Agonist_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_RT_HEK293_FLO_40hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RXR_BLA_Agonist_viability|TOX21_VDR_BLA_Agonist_viability,TRUE
"N-(1,3-Dimethylbutyl)-N'-phenyl-p-phenylenediamine",793-24-8,1.25095440589482,1.44519462598631,3.13626588947432,96.5569405883756,TOX21_AR_BLA_Antagonist_viability|TOX21_Aromatase_Inhibition_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_VDR_BLA_Agonist_viability|TOX21_AR_BLA_Antagonist_viability|TOX21_Aromatase_Inhibition_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_VDR_BLA_Agonist_viability,TRUE
Propofol,2078-54-8,-1.80677733841594,-1.6836510936422,7.7501146176663,-5.57313194548527,TOX21_RT_HEK293_FLO_40hr_viability|TOX21_RT_HEK293_FLO_40hr_viability,TRUE
2-(4-Tert-Butylbenzyl)propionaldehyde,80-54-6,5.89295479190054,6.71911439848695,1.15503409006177,-239.634899552788,TOX21_RT_HEK293_FLO_40hr_viability,TRUE
"2-Methyl-2,4-pentanediol",107-41-5,1.15980251696988,1.25534654844091,9.81108704113266,0.358304015972478,APR_HepG2_CellLoss_72h_dn|BSK_3C_Proliferation_down|BSK_hDFCGF_Proliferation_down,TRUE
"4,4',4''-Ethane-1,1,1-triyltriphenol",27955-94-8,0.143240956014584,0.505690812075221,5.29747971857458,52.8687858112839,ACEA_AR_antagonist_AUC_viability|TOX21_AR_BLA_Antagonist_viability,TRUE
"4,4'-(1-Phenylethylidene)bisphenol",1571-75-1,1.34725108611456,1.47690286557426,7.3600417473325,88.0211349475,ATG_XTT_Cytotoxicity_up,TRUE
"4,4-Bis(4-hydroxyphenyl)valeric acid",126-00-1,-0.0949076770615109,0.0190963595550865,8.37025194685431,29.9442970744019,ACEA_AR_antagonist_AUC_viability,TRUE
Acetamide,60-35-5,1.60955072864392,2.09128545205232,1.98084643491714,1.50177383867543,APR_HepG2_CellLoss_72h_dn,TRUE
Acetic acid,64-19-7,2.319956427528,3.36723498143188,0.911163993459289,27.1792299759677,APR_HepG2_CellLoss_24h_dn,TRUE
Chlorfenethol,1980-06-08,0.77988692494413,0.966264695343858,5.1267301281053,21.324727561394,TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Citronellyl formate,105-85-1,0.827262729123911,1.05400197874634,4.20854576800603,12.4759057906016,TOX21_p53_BLA_p3_viability,TRUE
Myralact,15518-87-3,0.617062795403284,0.950980343956464,2.85771895958727,38.9493982850871,TOX21_RT_HEPG2_GLO_16hr_ctrl_viability,TRUE
Tripropylene glycol diacrylate,42978-66-5,0.643711699669475,0.940899291169789,2.61616039703478,0.76982510210614,BSK_3C_Proliferation_down|BSK_3C_SRB_down|BSK_3C_Vis_down|BSK_4H_SRB_down|BSK_CASM3C_Proliferation_down|BSK_CASM3C_SRB_down|BSK_LPS_SRB_down|BSK_SAg_Proliferation_down|BSK_SAg_SRB_down|BSK_hDFCGF_Proliferation_down|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_SSH_3T3_GLI3_Agonist_viability,TRUE
(+)-2-Methylbutyl-4-methoxybenzyladine-4'-aminocyannate,24140-30-5,0.310725230904436,1.47202563899258,0.918036808466517,53.7562058074289,TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RXR_BLA_Agonist_viability,TRUE
Azithromycin,83905-01-5,-0.0904834778538275,1.08159804336855,0.814143463710731,29.4101683760422,TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2_viability,TRUE
But-2-en-1-ol,6117-91-5,0.632499605140295,1.9332235219865,0.733624174262147,39.4938073751213,ACEA_ER_AUC_viability,TRUE
Cyfluthrin,68359-37-5,0.537726860492201,1.06054820894339,1.47693527782526,0.415414990756526,ACEA_AR_antagonist_AUC_viability|BSK_3C_Proliferation_down|BSK_3C_SRB_down|BSK_SAg_SRB_down|BSK_hDFCGF_Proliferation_down|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability,TRUE
Fenpropathrin,39515-41-8,0.547941803966653,0.945217306805586,2.37405046932515,0.352799743282829,APR_HepG2_CellLoss_72h_dn|BSK_3C_Proliferation_down|BSK_3C_SRB_down|BSK_CASM3C_Proliferation_down|BSK_SAg_SRB_down|BSK_hDFCGF_Proliferation_down|TOX21_RT_HEK293_GLO_16hr_viability,TRUE
Haloxyfop,69806-34-4,0.606452585941047,1.14508414948736,1.87130625933687,56.3623046916417,TOX21_ERb_BLA_Agonist_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_HRE_BLA_Agonist_viability,TRUE
Metconazole,125116-23-6,-0.0318279015477648,0.707247421642735,1.29113025357141,37.2736707629283,TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Tamoxifen,10540-29-1,1.05708743258755,1.22131652137481,7.7787883264712,44.9753185384931,APR_HepG2_CellLoss_72h_dn|BSK_3C_Proliferation_down|BSK_LPS_SRB_down|BSK_SAg_PBMCCytotoxicity_down|BSK_SAg_Proliferation_down|BSK_SAg_SRB_down|TOX21_H2AX_HTRF_CHO_viability|TOX21_NFkB_BLA_agonist_viability|TOX21_PGC_ERR_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_RT_HEK293_FLO_40hr_viability|TOX21_RT_HEPG2_FLO_24hr_viability|TOX21_RXR_BLA_Agonist_viability,TRUE
Triticonazole,131983-72-7,0.995777758204891,1.51898486983087,1.82383414258978,18.8239546774185,ACEA_AR_antagonist_AUC_viability|APR_HepG2_CellLoss_72h_dn,TRUE
meso-Hexestrol,84-16-2,0.764710049160008,1.26584578530358,2.18137762039974,18.5219517673741,BSK_3C_Proliferation_down|BSK_hDFCGF_Proliferation_down|NCCT_HEK293T_CellTiterGLO|TOX21_MMP_viability|TOX21_RT_HEK293_GLO_08hr_viability,TRUE
trans-Hex-3-en-1-ol,928-97-2,0.748395830560587,1.80103667876292,0.906522401319451,70.676223186902,TOX21_PR_BLA_Agonist_viability,TRUE
"2,3-Dimethylphenol",526-75-0,-0.824702374174862,0.0420769111161064,5.13429765602526,18.5647472552701,ACEA_AR_antagonist_AUC_viability|TOX21_RT_HEK293_FLO_08hr_viability,TRUE
2-Amino-m-cresol,2835-97-4,2.29242210598767,2.41982399137361,7.4900187430402,-9856.25456769835,TOX21_RT_HEK293_GLO_40hr_viability,TRUE
3-Chloro-4-methylaniline,95-74-9,0.548510284700389,1.36608283905856,1.16716553699439,32.2707653484511,NCCT_HEK293T_CellTiterGLO,TRUE
"3-Methyl-4,6-di-tert-butylphenol",497-39-2,0.784895616081735,1.25661384718494,2.0233427866491,99.9172942927199,ACEA_ER_AUC_viability|ATG_XTT_Cytotoxicity_up|BSK_3C_Vis_down|BSK_SAg_Proliferation_down|TOX21_ARE_BLA_agonist_viability|TOX21_AR_BLA_Antagonist_viability|TOX21_CASP3_CHO_viability|TOX21_FXR_BLA_antagonist_viability|TOX21_NFkB_BLA_agonist_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_RT_HEK293_FLO_24hr_viability|TOX21_RT_HEK293_FLO_32hr_viability|TOX21_RT_HEK293_FLO_40hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEPG2_FLO_16hr_ctrl_viability|TOX21_RT_HEPG2_FLO_24hr_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RXR_BLA_Agonist_viability|TOX21_VDR_BLA_Agonist_viability|TOX21_p53_BLA_p5_viability,TRUE
"5,5-Dimethyl-3-(alpha,alpha,alpha-trifluoro-4-nitro-m-tolyl)hydantoin",63612-50-0,0.765772683633598,1.21052532505329,2.01435362015263,12.2008271714936,APR_HepG2_CellLoss_72h_dn|BSK_CASM3C_Proliferation_down|NCCT_MITO_viability|TOX21_CASP3_CHO_viability,TRUE
Clomazone,81777-89-1,-0.769738097733066,0.106771456628578,1.09731501291771,72.70161795557,ACEA_AR_antagonist_AUC_viability|SH-S5Y5 viability,TRUE
Docebenone,80809-81-0,-0.711087675503629,-0.223405735555012,1.97961035275574,81.2359408566258,TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
FR167356,174185-16-1,0.695607373818322,1.16543456473294,2.02764452632956,24.1414907811227,BSK_4H_SRB_down|BSK_CASM3C_Proliferation_down|BSK_SAg_PBMCCytotoxicity_down|BSK_hDFCGF_Proliferation_down|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_PXR_viability|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEPG2_FLO_40hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability|TOX21_TR_LUC_GH3_Antagonist_viability,TRUE
Famoxadone,131807-57-3,0.712406521167654,1.32336713863141,1.5096900587213,57.6817805936746,ACEA_AR_agonist_AUC_viability|ACEA_AR_antagonist_AUC_viability|APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_24h_up|NCCT_HEK293T_CellTiterGLO|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_CASP3_CHO_viability|TOX21_CASP3_HEPG2_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_GR_BLA_Antagonist_viability|TOX21_PXR_viability|TOX21_SBE_BLA_Antagonist_viability|TOX21_TRB_BLA_Antagonist_Followup_viability|TOX21_p53_BLA_p4_viability,TRUE
Fenhexamid,126833-17-8,1.30198999900659,1.63133200193426,4.40277552876878,1.20644326426567,APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_24h_up|APR_HepG2_MicrotubuleCSK_72h_up|TOX21_SSH_3T3_GLI3_Antagonist_viability,TRUE
Flunisolide,3385-03-03,-0.139300049548197,0.550820482853679,1.382718618903,44.2092087964713,TOX21_RT_HEPG2_GLO_00hr_ctrl_viability,TRUE
Halcinonide,3093-35-4,-0.291522224086171,0.704491071432592,0.958062019586112,71.2549651123612,TOX21_RT_HEPG2_GLO_00hr_ctrl_viability,TRUE
Haloxon,321-55-1,0.00778478769878754,1.70834307820928,0.567863173939185,42.5413550438141,TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Methodichlorophen,7761-45-7,-0.212756465313501,0.0387458249120339,4.13907226296001,45.0985678150952,TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_SBE_BLA_Agonist_viability,TRUE
Rimonabant,168273-06-1,-0.529608050561104,-0.433809085237375,9.96088534165996,10.5290446281401,TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Terbacil,5902-51-2,-0.0518101278968568,0.842131382979012,1.06745519458468,0.138399842182667,BSK_SAg_PBMCCytotoxicity_up,TRUE
Vinclozolin,50471-44-8,1.15243211527749,1.5790834145249,1.68162210019863,60.112644533875,TOX21_ERb_BLA_Agonist_viability|TOX21_PR_BLA_Agonist_viability|TOX21_RXR_BLA_Agonist_viability,TRUE
"{4-[({2-[3-Fluoro-4-(trifluoromethyl)phenyl]-4-methyl-1,3-thiazol-5-yl}methyl)sulfanyl]-2-methylphenoxy}acetic acid",317318-84-6,0.738500521770227,1.32722767915489,2.11963497109933,80.0906199828817,TOX21_ERb_BLA_Agonist_viability|TOX21_FXR_BLA_agonist_viability|TOX21_HRE_BLA_Agonist_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_PR_BLA_Agonist_viability|TOX21_RXR_BLA_Agonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability|TOX21_p53_BLA_p3_viability|TOX21_p53_BLA_p4_viability,TRUE
"1,3-Dimethyl-4-nitrobenzene",89-87-2,0.763456114774011,1.23672572927798,2.01627672725084,40.0495442616417,TOX21_RT_HEPG2_FLO_08hr_viability,TRUE
1-Methyl phenanthrene,832-69-9,0.685285924733326,0.948245568640204,3.62885534548888,0.192818601296109,BSK_3C_Proliferation_down,TRUE
"2,4-Dimethylphenol",105-67-9,0.314583607489413,1.21975218819479,1.05421523656478,0.271823906391427,BSK_hDFCGF_Proliferation_down,TRUE
2-Chloro-N-(2-methyl-4-bromophenyl)acetamide,96686-51-0,0.981534666687387,1.36792280448318,2.69975228067158,94.2285421903619,TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_ERR_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_FXR_BLA_agonist_viability|TOX21_HSE_BLA_agonist_viability|TOX21_PGC_ERR_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_PR_BLA_Antagonist_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability|TOX21_VDR_BLA_antagonist_viability,TRUE
"2-Methyl-1,3-benzenediol",608-25-3,-0.409050830234595,0.341686779163422,1.29503266067637,0.0700288889227574,BSK_SAg_PBMCCytotoxicity_down|BSK_SAg_Proliferation_down,TRUE
"2-Methyl-4,6-dinitrophenol",534-52-1,0.940400634695045,1.52218398021529,2.00909559467448,80.6905600499936,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_72h_up|BSK_SAg_PBMCCytotoxicity_up|TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_AhR_LUC_Agonist_viability|TOX21_CAR_Agonist_viabillity|TOX21_CAR_Antagonist_viability|TOX21_CASP3_HEPG2_viability|TOX21_ELG1_LUC_Agonist_viability|TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability|TOX21_MMP_viability|TOX21_PXR_viability|TOX21_SSH_3T3_GLI3_Agonist_viability,TRUE
2-Methyl-4-nitroaniline,99-52-5,1.20934305152722,2.09519810691164,1.07719937210859,68.8684014566932,TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_CAR_Antagonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability,TRUE
"3,3'-Dimethylbenzidine",119-93-7,0.158718139262155,0.681575246990499,1.83052059072069,16.6765354554359,ACEA_AR_antagonist_AUC_viability|BSK_SAg_Proliferation_down,TRUE
"3,3'-Dimethylbisphenol A",79-97-0,0.0497748662655661,0.882470953258626,5.70998589726622,0.0710725081419996,BSK_3C_Proliferation_down|BSK_3C_SRB_down|BSK_4H_SRB_down|BSK_CASM3C_SRB_down|BSK_hDFCGF_Proliferation_down,TRUE
"3,5-Dimethylpyridine",591-22-0,-0.0440395975586261,0.990550681654321,0.92233856108261,34.2658938715395,ACEA_ER_AUC_viability,TRUE
"4,4'-Diamino-3,3'-dimethyldiphenylmethane",838-88-0,1.02198539712723,2.08604523575018,0.967440861789747,61.4369694074813,ACEA_AR_antagonist_AUC_viability|APR_HepG2_CellLoss_72h_dn|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
"4,4'-Propane-2,2-diylbis(2,6-dimethylphenol)",5613-46-7,0.871820627627921,1.34330936636417,2.02539888469999,92.7216573031146,TOX21_AR_BLA_Antagonist_viability|TOX21_RT_HEK293_GLO_16hr_viability,TRUE
4-Chloro-2-methylaniline,95-69-2,-0.434992833831502,0.672537947258317,0.907799622357487,16.06889150446,ACEA_ER_AUC_viability|BSK_3C_Proliferation_down,TRUE
"4-Methyl-2,6-dinitrophenol",609-93-8,0.867247358880031,1.6477285631271,1.15045060292524,60.1992097662207,TOX21_AR_BLA_Antagonist_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability,TRUE
4-Methyl-2-tert-butylphenol,2409-55-4,0.834672288848143,1.02621249997573,5.51650444190566,0.68332252932388,BSK_3C_Proliferation_down|BSK_3C_SRB_down|BSK_3C_Vis_down|BSK_CASM3C_Proliferation_down|BSK_CASM3C_SRB_down|BSK_LPS_SRB_down|BSK_SAg_Proliferation_down|BSK_SAg_SRB_down|BSK_hDFCGF_Proliferation_down|BSK_hDFCGF_SRB_down|TOX21_p53_BLA_p3_viability,TRUE
6-Methyl-2-thiouracil,1956-04-02,-0.540605367859909,1.2573316574958,0.530743010451402,48.97949171967,ACEA_AR_antagonist_AUC_viability,TRUE
"6-tert-Butyl-2,4-xylenol",1879-09-0,0.841469960601352,1.00104341678076,5.97995764637979,0.394910053120591,BSK_3C_Vis_down|BSK_BE3C_SRB_down|BSK_CASM3C_Proliferation_down|BSK_CASM3C_SRB_down|BSK_LPS_SRB_down|BSK_hDFCGF_Proliferation_down|TOX21_RT_HEK293_FLO_16hr_viability,TRUE
Butylated hydroxytoluene,128-37-0,1.22680047948905,1.38926751567923,5.87345305125361,52.7910018091249,TOX21_RT_HEK293_FLO_40hr_viability,TRUE
Carboxin,5234-68-4,0.269289302830876,1.25068769078991,0.978091814421303,23.8730486238084,TOX21_CASP3_CHO_viability|TOX21_H2AX_HTRF_CHO_viability,TRUE
Geliomycin,20004-62-0,-0.48874733462541,0.345506504014208,1.68123637904639,45.0578585811385,TOX21_ELG1_LUC_Agonist_viability|TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2_viability|TOX21_GR_BLA_Antagonist_viability|TOX21_p53_BLA_p1_viability|TOX21_p53_BLA_p3_viability,TRUE
Isophorone,78-59-1,-2.58219834363183,-2.46199113224655,7.93831333779812,3.02657327745567,TOX21_RT_HEPG2_FLO_32hr_ctrl_viability,TRUE
MCPA,94-74-6,0.179250591610321,0.74641679852706,1.68247419857194,13.7424593001661,ACEA_AR_antagonist_AUC_viability,TRUE
Methylhydroquinone,95-71-6,1.19400057537956,1.45447426156661,4.74722413224497,96.6667770495913,TOX21_RXR_BLA_Agonist_viability|TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability,TRUE
Tiliquinol,5541-67-3,0.329573318525561,0.815026674149185,2.2292265818357,49.4737700238917,TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_CAR_Agonist_viabillity|TOX21_CAR_Antagonist_viability|TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PR_BLA_Antagonist_viability|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_VDR_BLA_Agonist_viability,TRUE
Tri-o-cresyl phosphate,78-30-8,0.689078754516358,0.98202505490143,3.25459959999051,0.651152044099365,BSK_3C_Proliferation_down|BSK_3C_Vis_down|BSK_4H_SRB_down|BSK_BE3C_SRB_down|BSK_CASM3C_Proliferation_down|BSK_LPS_SRB_down|BSK_SAg_PBMCCytotoxicity_down|BSK_SAg_SRB_down|BSK_hDFCGF_SRB_down|TOX21_MMP_viability|TOX21_PXR_viability,TRUE
o-Aminoazotoluene,97-56-3,0.656922164133042,1.43712091746933,1.40119207804056,49.4179563333886,APR_HepG2_CellLoss_24h_dn|APR_HepG2_NuclearSize_72h_dn|ATG_FoxA2_CIS_up|BSK_3C_Proliferation_down|BSK_3C_SRB_down|BSK_4H_SRB_down|BSK_LPS_SRB_down|BSK_SAg_SRB_down|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_AhR_LUC_Agonist_viability|TOX21_CAR_Antagonist_viability|TOX21_CASP3_CHO_viability|TOX21_CASP3_HEPG2_viability|TOX21_ELG1_LUC_Agonist_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2_viability|TOX21_MMP_viability|TOX21_RT_HEPG2_FLO_32hr_ctrl_viability|TOX21_RT_HEPG2_FLO_40hr_ctrl_viability|TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability|TOX21_TR_LUC_GH3_Antagonist_viability,TRUE
(E)-beta-Nitrostyrene,5153-67-3,0.720730101889389,1.11161349877054,3.15973819365477,83.2953820818845,TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_Aromatase_Inhibition_viability|TOX21_CASP3_CHO_viability|TOX21_FXR_BLA_antagonist_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability,TRUE
"1,2-Dinitrobenzene",528-29-0,1.36607377683827,1.85712850353649,1.85115545641153,5.2708882703628,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_24h_dn|TOX21_SSH_3T3_GLI3_Agonist_viability,TRUE
"1,4-Dinitrobenzene",100-25-4,0.949133995698428,1.30684792884915,1.58740981506046,16.429913749323,BSK_3C_Proliferation_down|BSK_SAg_Proliferation_down|BSK_hDFCGF_Proliferation_down|TOX21_CASP3_CHO_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_PXR_viability,TRUE
"1-Butyl-2,3-dimethylimidazolium iodide",108203-70-9,0.539252484536962,0.768005623325251,4.17149471475656,11.3881283026888,TOX21_RT_HEPG2_GLO_40hr_viability,TRUE
"1-Chloro-2,4-dinitrobenzene",97-00-7,0.839526457389618,1.06147078491579,5.1173695908092,96.2096177839551,ACEA_ER_AUC_viability|TOX21_ARE_BLA_agonist_viability|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_AhR_LUC_Agonist_viability|TOX21_CASP3_CHO_viability|TOX21_CASP3_HEPG2_viability|TOX21_ERR_viability|TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability|TOX21_ESRE_BLA_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_PXR_viability|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability|TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability|TOX21_VDR_BLA_antagonist_viability,TRUE
1-Dodecyl-3-methylimidazolium iodide,81995-09-7,-0.489087983115771,0.873186973242626,2.01511060380336,65.5869018042414,TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_CAR_Antagonist_viability|TOX21_ESRE_BLA_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_p53_BLA_p4_viability,TRUE
"1-Fluoro-2,4-dinitrobenzene",70-34-8,0.691411909138214,1.38099293802517,1.69595884046094,75.4215370545658,TOX21_ARE_BLA_agonist_viability|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_CASP3_HEPG2_viability|TOX21_ELG1_LUC_Agonist_viability|TOX21_ERR_viability|TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability|TOX21_ESRE_BLA_viability|TOX21_MMP_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_SSH_3T3_GLI3_Agonist_viability,TRUE
"2,3,4-Trichloronitrobenzene",17700-09-3,-1.24101753949325,0.200671812035912,0.661891903708096,4.92048707339487,TOX21_RT_HEK293_FLO_40hr_viability,TRUE
"2,4-Dichloro-1,3-dinitro-5-(trifluoromethyl)benzene",29091-09-6,0.752379763315924,1.06074454346728,2.20803678385261,97.0843194428536,ATG_XTT_Cytotoxicity_up|TOX21_AR_BLA_Antagonist_viability|TOX21_Aromatase_Inhibition_viability|TOX21_CASP3_CHO_viability|TOX21_ESRE_BLA_viability|TOX21_FXR_BLA_antagonist_viability|TOX21_HRE_BLA_Agonist_viability|TOX21_PGC_ERR_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PXR_viability|TOX21_RT_HEPG2_FLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_RXR_BLA_Agonist_viability,TRUE
4-Chloro-3-nitrobenzaldehyde,16588-34-4,-0.866639505954418,-0.624872458870885,5.63776813475809,6.2522784830326,TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_FLO_24hr_viability,TRUE
4-Nitrochalcone,1222-98-6,0.488923416830507,0.608126503180098,8.21984578906974,-12.2071752339819,TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEPG2_GLO_40hr_viability,TRUE
4-Nitropyridine-1-oxide,1124-33-0,0.993082657134293,1.55344115522348,1.77231732829577,58.3145653266965,TOX21_CASP3_CHO_viability|TOX21_ERb_BLA_Agonist_viability,TRUE
"5-Bromo-5-nitro-1,3-dioxane",30007-47-7,1.03630666873963,1.37155591506481,2.90894240719149,105.845011256567,TOX21_CASP3_CHO_viability|TOX21_TR_LUC_GH3_Antagonist_viability,TRUE
Ammonium carbamate,1111-78-0,0.886113516703212,1.08953869782364,5.71944364959657,0.326382216053875,APR_HepG2_NuclearSize_24h_dn|APR_HepG2_NuclearSize_72h_dn,TRUE
Ammonium dodecyl sulfate,2235-54-3,1.25472809324393,1.43761356695102,5.21770532178843,66.3277998835711,TOX21_RXR_BLA_Agonist_viability,TRUE
Fluazinam,79622-59-6,0.237028764881396,0.782251031774369,1.4892970764189,89.5352788505742,ACEA_ER_AUC_viability|APR_HepG2_CellLoss_24h_dn|APR_HepG2_MicrotubuleCSK_24h_up|APR_HepG2_MicrotubuleCSK_72h_dn|ATG_XTT_Cytotoxicity_up|BSK_SAg_PBMCCytotoxicity_down|TOX21_AP1_BLA_Agonist_viability|TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_Aromatase_Inhibition_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_FXR_BLA_antagonist_viability|TOX21_GR_BLA_Antagonist_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_HDAC_Inhibition_viability|TOX21_HRE_BLA_Agonist_viability|TOX21_HSE_BLA_agonist_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_PR_BLA_Antagonist_viability|TOX21_RT_HEK293_FLO_24hr_viability|TOX21_RT_HEK293_FLO_32hr_viability|TOX21_RT_HEK293_FLO_40hr_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_FLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability|TOX21_RXR_BLA_Agonist_viability|TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_VDR_BLA_Agonist_viability,TRUE
Pyrrolnitrin,1018-71-9,0.522545904033158,1.02823211183013,1.88702498649604,40.3936890542465,TOX21_MMP_viability,TRUE
Stilonium iodide,77257-42-2,0.533250950650008,1.20657556262983,2.02631827704506,42.6872941281217,TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability,TRUE
1-Amino-2-methylanthraquinone,82-28-0,0.156985583814123,1.05322923494389,1.13073581584504,80.7800111308572,BSK_3C_Vis_down|BSK_hDFCGF_Proliferation_down|TOX21_CAR_Antagonist_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
"2,3,6-Trimethylphenol",2416-94-6,-0.11101566900957,0.210816944190418,5.16621558479942,1.77623710911939,APR_HepG2_CellLoss_72h_dn|TOX21_RT_HEK293_FLO_00hr_viability,TRUE
"2,4-Dichloro-3,5-dimethylphenol",133-53-9,0.394046692928723,1.57118695581759,0.810644695048897,46.2598645515394,TOX21_SSH_3T3_GLI3_Antagonist_viability,TRUE
2-(2H-Benzotriazol-2-yl)-4-methylphenol,2440-22-4,0.965150407972371,1.47217603506829,1.88203999648877,71.1124300272513,ACEA_AR_antagonist_AUC_viability|NCCT_HEK293T_CellTiterGLO|TOX21_H2AX_HTRF_CHO_viability,TRUE
2-Dodecylisoquinolinium tosylate,5412-37-3,0.448841841368113,0.744558777582772,3.22687811409844,68.7559390346817,TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_ERa_BLA_Antagonist_viability|TOX21_TR_LUC_GH3_Antagonist_viability,TRUE
2-Methylphenanthrene,2531-84-2,0.171993520874382,0.914473511956357,1.28520973076831,28.9193563754584,TOX21_RT_HEK293_GLO_32hr_viability,TRUE
"3,4-Dinitrotoluene",610-39-9,0.884561947232712,1.47329748722969,5.6398724624467,18.2232635982689,BSK_hDFCGF_Proliferation_down|TOX21_PR_BLA_Antagonist_viability|TOX21_RT_HEK293_FLO_24hr_viability|TOX21_RT_HEPG2_FLO_00hr_ctrl_viability,TRUE
"4,4'-Thiobis(6-tert-butyl-m-cresol)",96-69-5,0.965464091000927,1.2838198999997,3.23097989922398,99.4153595238046,TOX21_AP1_BLA_Agonist_viability|TOX21_ARE_BLA_agonist_viability|TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_CASP3_CHO_viability|TOX21_ERR_viability|TOX21_ERa_BLA_Antagonist_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_GR_BLA_Antagonist_viability|TOX21_HSE_BLA_agonist_viability|TOX21_NFkB_BLA_agonist_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_PXR_viability|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_SBE_BLA_Agonist_viability|TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_VDR_BLA_Agonist_viability|TOX21_VDR_BLA_antagonist_viability|TOX21_p53_BLA_p2_viability|TOX21_p53_BLA_p3_viability|TOX21_p53_BLA_p4_viability|TOX21_p53_BLA_p5_viability,TRUE
4-Methylbenzophenone,134-84-9,-0.296905663686899,0.568165723214513,1.23176043610704,-0.0117300697123965,BSK_4H_SRB_down|BSK_hDFCGF_Proliferation_down,TRUE
4-Methylcatechol,452-86-8,1.29740719335647,1.65706564926096,2.65319080859515,100,TOX21_SSH_3T3_GLI3_Agonist_viability,TRUE
"5,7-Dichloro-8-hydroxy-2-methylquinoline",72-80-0,0.613303117262617,1.05167190353669,2.358674144885,30.3462066661203,TOX21_p53_BLA_p3_viability|TOX21_p53_BLA_p4_viability,TRUE
C.I. Solvent Orange 7,3118-97-6,0.217185520890744,0.851040778412887,1.52577587814203,35.8548771567374,BSK_SAg_Proliferation_down|TOX21_CASP3_CHO_viability|TOX21_PXR_viability,TRUE
Celecoxib,169590-42-5,1.14035352447197,1.73979149470398,1.86360405962021,7.17647135059582,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|TOX21_CASP3_CHO_viability,TRUE
Clofilium tosylate,92953-10-1,0.0811200976417354,0.665893335762146,1.63181631311732,42.5662444372875,TOX21_TR_RXR_BLA_Antagonist_Followup_viability,TRUE
Diiodomethyl 4-methylphenyl sulfone,20018-09-1,0.700418412141339,1.10703301007216,3.681014632396,89.7681330946918,ACEA_ER_AUC_viability|ATG_XTT_Cytotoxicity_up|BSK_CASM3C_SRB_down|BSK_SAg_PBMCCytotoxicity_down|BSK_hDFCGF_SRB_down|TOX21_CASP3_CHO_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_HRE_BLA_Agonist_viability|TOX21_PXR_viability|TOX21_RAR_LUC_Antagonist_viability|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_00hr_ctrl_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RXR_BLA_Agonist_viability|TOX21_SSH_3T3_GLI3_Agonist_viability,TRUE
Emodin,518-82-1,0.423026821155092,1.0281169192724,1.57702549158941,16.4998028686307,TOX21_SSH_3T3_GLI3_Antagonist_viability,TRUE
Pyrimethanil,53112-28-0,1.11118558746156,1.63593694422773,1.81846601659102,1.39063798472669,APR_HepG2_CellLoss_72h_dn,TRUE
Triethylene glycol bis(3-tert-butyl-4-hydroxy-5-methylphenyl)propionate,36443-68-2,0.119257979773985,0.281635566704185,5.87668857186254,0.374086674055276,BSK_LPS_SRB_down|BSK_SAg_Proliferation_down|BSK_SAg_SRB_down|BSK_hDFCGF_Proliferation_down|TOX21_RT_HEK293_GLO_08hr_viability,TRUE
m-Cresol,108-39-4,-0.698696431213985,-0.598979416257529,9.56950536331256,1.83452261253871,TOX21_RT_HEK293_FLO_08hr_viability,TRUE
"2,3-Dinitrotoluene",602-01-7,1.50120621523516,1.8790852567536,2.52525915595863,3.13267464896919,APR_HepG2_CellLoss_72h_dn,TRUE
2-tert-Butyl-6-methylphenol,2219-82-1,-0.878783251671892,-0.781272566243986,9.78603016943041,2.15566804162564,TOX21_RT_HEPG2_GLO_08hr_ctrl_viability,TRUE
Allyl Ionone,79-78-7,-2.66715304370186,-1.03123461957906,0.583306902941082,-5.56586465684974,TOX21_RT_HEK293_FLO_40hr_viability,TRUE
Bexarotene,153559-49-0,0.893074752577445,1.36404256677001,2.99915938694939,83.4760780712303,ATG_XTT_Cytotoxicity_up|TOX21_ERb_BLA_Antagonist_viability|TOX21_HSE_BLA_agonist_viability|TOX21_PR_BLA_Antagonist_viability|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_TR_LUC_GH3_Antagonist_viability,TRUE
Cyprodinil,121552-61-2,1.29349169411529,1.5835991198715,2.00549914281594,1.79072663049007,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_24h_up|APR_HepG2_MicrotubuleCSK_72h_up|BSK_SAg_PBMCCytotoxicity_up|TOX21_RT_HEK293_GLO_08hr_viability,TRUE
Parthenolide,20554-84-1,0.752249144821766,1.06398463184325,3.06106474613066,97.1453587498193,TOX21_TR_LUC_GH3_Antagonist_viability,TRUE
Benoxacor,98730-04-2,0.497106200236564,0.88620594013403,2.67851106829948,0.9060383922585,ACEA_AR_agonist_AUC_viability|ACEA_ER_AUC_viability|BSK_3C_Proliferation_down|BSK_3C_Vis_down|BSK_CASM3C_Proliferation_down|BSK_CASM3C_SRB_down|BSK_SAg_SRB_down|BSK_hDFCGF_Proliferation_down|BSK_hDFCGF_SRB_down|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_Aromatase_Inhibition_viability|TOX21_CASP3_CHO_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability,TRUE
Chlormidazole,3689-76-7,-0.0143289959653927,0.750624362340082,1.26947399749334,58.680707685613,TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_AhR_LUC_Agonist_viability|TOX21_CAR_Antagonist_viability|TOX21_CASP3_CHO_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_TRB_BLA_Antagonist_Followup_viability,TRUE
Difenoconazole,119446-68-3,0.653212811330873,1.35585993224796,1.45112322195848,44.5373168804199,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_72h_up|CEETOX_H295R_MTT_cell_viability_up|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_ERR_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_MMP_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Mecloqualone,340-57-8,0.510203147135469,1.31190293624487,1.30708592712454,60.8057092698089,TOX21_AhR_LUC_Agonist_viability|TOX21_Aromatase_Inhibition_viability|TOX21_CAR_Agonist_viabillity|TOX21_CASP3_CHO_viability|TOX21_PGC_ERR_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability,TRUE
Memantine,19982-08-2,0.724753959591823,1.42534042424879,1.36206243993959,48.3042979094934,TOX21_SSH_3T3_GLI3_Agonist_viability,TRUE
Procymidone,32809-16-8,0.936354682456999,1.29184091145322,2.68433045109457,0.169935031247419,BSK_CASM3C_Proliferation_down,TRUE
Siduron,1982-49-6,1.33018323862993,1.46121995858217,7.28225271349204,44.812716101466,TOX21_RT_HEK293_GLO_24hr_viability,TRUE
"2,4-Di-tert-pentylphenol",120-95-6,0.951374387408938,1.33180329466223,4.90528047936216,62.1195162810871,TOX21_Aromatase_Inhibition_viability|TOX21_ERR_viability|TOX21_ESRE_BLA_viability|TOX21_RT_HEPG2_FLO_16hr_ctrl_viability|TOX21_TR_LUC_GH3_Antagonist_viability,TRUE
"2,6-Di(butan-2-yl)phenol",5510-99-6,0.531007042471169,0.715740745747781,5.72480801682143,19.1787526650301,TOX21_CASP3_CHO_viability|TOX21_RT_HEK293_FLO_40hr_viability,TRUE
2-(Butan-2-yl)phenol,89-72-5,-0.205490687109421,0.060455521566365,5.5860241549597,39.544844397722,TOX21_RT_HEK293_FLO_40hr_viability|TOX21_RT_HEPG2_FLO_24hr_viability,TRUE
4-(2-Methylbutan-2-yl)cyclohexanol,5349-51-9,0.580217408013011,1.42779489792036,1.12584692349916,42.6397183429991,ACEA_AR_antagonist_AUC_viability,TRUE
Binapacryl,485-31-4,0.666241862632789,0.980912996512737,2.28416326943216,0.541938959258728,BSK_3C_Proliferation_down|BSK_3C_SRB_down|BSK_3C_Vis_down|BSK_BE3C_SRB_down|BSK_CASM3C_Proliferation_down|BSK_CASM3C_SRB_down|BSK_KF3CT_SRB_down|BSK_LPS_SRB_down|BSK_SAg_PBMCCytotoxicity_down|BSK_SAg_Proliferation_down|BSK_SAg_SRB_down|TOX21_ARE_BLA_agonist_viability|TOX21_CASP3_CHO_viability|TOX21_ERR_viability|TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability|TOX21_H2AX_HTRF_CHO_viability,TRUE
Eprinomectin B1a,133305-88-1,0.728704634148216,1.15162576068325,3.47296167839138,93.8379000575989,TOX21_ELG1_LUC_Agonist_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_p53_BLA_p1_viability,TRUE
Iopanoic acid,96-83-3,-0.504214977851155,-0.307649027453848,4.85456666075979,27.0174884890059,ACEA_AR_agonist_AUC_viability,TRUE
Isoxaben,82558-50-7,1.01966281059229,1.29091955013497,3.5178573297316,23.3505051146371,ACEA_AR_agonist_AUC_viability|APR_HepG2_CellLoss_72h_dn|TOX21_RT_HEK293_FLO_08hr_viability,TRUE
"N,N'-Bis(1-methylpropyl)-1,4-benzenediamine",101-96-2,0.614157296566457,1.02358182817454,2.69317017427847,87.6019478772662,TOX21_Aromatase_Inhibition_viability|TOX21_CAR_Agonist_viabillity|TOX21_CAR_Antagonist_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_FXR_BLA_antagonist_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_HDAC_Inhibition_viability|TOX21_HRE_BLA_Agonist_viability|TOX21_NFkB_BLA_agonist_viability|TOX21_PGC_ERR_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_RAR_LUC_Agonist_viability|TOX21_RAR_LUC_Antagonist_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability|TOX21_RXR_BLA_Agonist_viability|TOX21_SBE_BLA_Agonist_viability|TOX21_SBE_BLA_Antagonist_viability|TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_VDR_BLA_antagonist_viability|TOX21_p53_BLA_p1_viability|TOX21_p53_BLA_p2_viability|TOX21_p53_BLA_p3_viability|TOX21_p53_BLA_p4_viability,TRUE
Propanil,709-98-8,0.446088765198814,1.17859546248217,4.06859277613185,24.5301640431651,ACEA_AR_antagonist_AUC_viability|APR_HepG2_CellLoss_72h_dn|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Simvastatin,79902-63-9,0.609841236510101,1.34798717180525,1.74528041733739,16.4622614985727,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_72h_up|ATG_XTT_Cytotoxicity_up|TOX21_CASP3_CHO_viability|TOX21_RT_HEPG2_FLO_08hr_viability|TOX21_RT_HEPG2_FLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability,TRUE
"2,2'-Methylenebis(ethyl-6-tert-butylphenol)",88-24-4,0.73130832529566,1.28929785276385,1.8057475234303,98.1894410054272,ATG_XTT_Cytotoxicity_up|NCCT_HEK293T_CellTiterGLO|TOX21_ARE_BLA_agonist_viability|TOX21_ERR_viability|TOX21_FXR_BLA_antagonist_viability|TOX21_GR_BLA_Antagonist_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_HRE_BLA_Agonist_viability|TOX21_HSE_BLA_agonist_viability|TOX21_NFkB_BLA_agonist_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_VDR_BLA_antagonist_viability|TOX21_p53_BLA_p2_viability,TRUE
2-Ethylphenol,90-00-6,0.463435027630815,0.581237579651375,8.10035515421411,6.34752323374972,TOX21_RT_HEK293_FLO_40hr_viability,TRUE
2-tert-Butyl-4-ethylphenol,96-70-8,1.16804821111947,1.4682839624876,2.67577198740505,5.41934268156839,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_24h_dn|NCCT_HEK293T_CellTiterGLO|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability,TRUE
"4,4'-Methylenebis(2,6-diethylaniline)",13680-35-8,0.683759105215064,0.794275300709636,1.98736188108896,33.491665638379,ACEA_AR_agonist_AUC_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_00hr_viability|TOX21_RT_HEPG2_FLO_32hr_ctrl_viability,TRUE
Alachlor,15972-60-8,1.45055966999703,1.9264466739816,1.61183572920968,16.5594202864153,APR_HepG2_CellLoss_24h_dn|APR_HepG2_MicrotubuleCSK_24h_up|BSK_hDFCGF_Proliferation_down|TOX21_SSH_3T3_GLI3_Antagonist_viability,TRUE
Enefexine,67765-04-2,0.484751927939273,0.731278548523165,3.87074834830909,32.308021967138,TOX21_PR_BLA_Agonist_viability,TRUE
Metolachlor,51218-45-2,1.82638546468455,2.62117891421783,1.20275148713235,41.1159967034605,APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_72h_up,TRUE
Metolachlor ESA,171118-09-5,1.30092354841066,1.44330590583727,6.70197155522723,22.1603657241983,TOX21_RT_HEPG2_GLO_00hr_ctrl_viability,TRUE
Pyrimethamine,58-14-0,0.511967007485644,1.22440607074486,1.66623155135593,43.794093235399,APR_HepG2_CellLoss_72h_dn|BSK_hDFCGF_Proliferation_down|TOX21_AR_BLA_Antagonist_viability|TOX21_ERa_BLA_Antagonist_viability|TOX21_PGC_ERR_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_VDR_BLA_Agonist_viability|TOX21_p53_BLA_p1_viability|TOX21_p53_BLA_p3_viability,TRUE
Tebufenozide,112410-23-8,-0.243893807390616,1.10063267551217,0.803281142677597,39.9228456887599,APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_72h_up|TOX21_CAR_Agonist_viabillity|TOX21_CASP3_HEPG2_viability|TOX21_ERR_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability|TOX21_PGC_ERR_viability,TRUE
Trimethylolpropane triacrylate,15625-89-5,0.790840382276207,1.19611112309318,1.96051643715927,78.9331412438931,TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_ERR_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_FXR_BLA_antagonist_viability|TOX21_HSE_BLA_agonist_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_PR_BLA_Agonist_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability,TRUE
2-(1-Methylbutyl)phenol,87-26-3,39.4690587340054,39.7503967659535,3.39180061377435,-4490.0866684501,TOX21_SSH_3T3_GLI3_Antagonist_viability,TRUE
"4,4'-Butane-1,1-diylbis(2-tert-butyl-5-methylphenol)",85-60-9,0.781716513194364,1.14293361246403,3.36488002321668,95.6764349179818,TOX21_AP1_BLA_Agonist_viability|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_Aromatase_Inhibition_viability|TOX21_CASP3_CHO_viability|TOX21_ERR_viability|TOX21_ESRE_BLA_viability|TOX21_HRE_BLA_Agonist_viability|TOX21_NFkB_BLA_agonist_viability|TOX21_PGC_ERR_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PXR_viability|TOX21_RT_HEPG2_FLO_24hr_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_RXR_BLA_Agonist_viability|TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_VDR_BLA_Agonist_viability|TOX21_VDR_BLA_antagonist_viability|TOX21_p53_BLA_p4_viability,TRUE
Diofenolan,63837-33-2,0.232391186284993,1.79063765767849,0.61238226876007,100,TOX21_RT_HEK293_GLO_32hr_viability,TRUE
Etaconazole,60207-93-4,0.962790110418376,1.24722751101777,5.61990653147477,26.824293213439,TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_32hr_viability,TRUE
Penconazole,66246-88-6,0.108300362484673,1.12149930358584,0.941811593685871,30.6949768655466,TOX21_ERb_BLA_Antagonist_viability,TRUE
Propiconazole,60207-90-1,0.866725331668999,1.62730542285131,1.35165944336192,3.18049702661658,APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_72h_up|TOX21_RT_HEPG2_FLO_24hr_viability|SH-S5Y5 viability,TRUE
Telmisartan,144701-48-4,0.770317193231712,1.96232986433249,0.800530508252163,73.3100984625511,TOX21_SSH_3T3_GLI3_Antagonist_viability,TRUE
2-Ethylhexyl diphenyl phosphate,1241-94-7,0.633874642470891,0.957955803133076,3.48977226870256,0.630048911235486,ACEA_AR_agonist_AUC_viability|ATG_FoxO_CIS_up|BSK_3C_Proliferation_down|BSK_3C_SRB_down|BSK_3C_Vis_down|BSK_4H_SRB_down|BSK_CASM3C_SRB_down|BSK_LPS_SRB_down|BSK_hDFCGF_SRB_down|STM_H9_Viability_norm|percent mortality 4dpf|percent mortality 5dpf,TRUE
2-Ethylhexyl p-hydroxybenzoate,5153-25-3,1.24123393883451,1.40339809620279,5.88442307428169,63.8237415164237,ACEA_AR_antagonist_AUC_viability|NCCT_HEK293T_CellTiterGLO|TOX21_AP1_BLA_Agonist_viability|TOX21_HSE_BLA_agonist_viability|TOX21_RT_HEK293_FLO_32hr_viability,TRUE
2-Ethylhexyl thioglycolate,7659-86-1,1.09422803743907,1.36654574738064,3.50420918196405,54.1892814213002,TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
"2-Ethylhexyl-2-cyano-3,3-diphenylacrylate",6197-30-4,0.796638256526839,1.17867085509406,2.49780388641736,31.9692411082126,TOX21_MMP_viability,TRUE
3-((2-Ethylhexyl)oxy)propionitrile,10213-75-9,0.530599381840164,2.3990876322623,0.510702975640194,0.756376820799681,BSK_hDFCGF_Proliferation_down,TRUE
4-Butylaniline,104-13-2,-0.100500204858045,0.0154470744018783,1.2128941136024,8.98887129653267,NCCT_HEK293T_CellTiterGLO|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
4-Butylphenol,1638-22-8,0.260788800981553,1.26932339370289,0.916800900907904,68.968936263303,ACEA_AR_agonist_AUC_viability|ACEA_AR_antagonist_AUC_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Betamethasone valerate,2152-44-5,1.94550174079919,2.20642473820546,4.63104052930705,-4816.05489622034,TOX21_ERb_BLA_Antagonist_viability|TOX21_p53_BLA_p4_viability,TRUE
Bis(2-ethylhexyl) nonanedioate,103-24-2,0.657558833174847,1.08735281932584,1.55271810853231,44.694330490635,TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_CAR_Agonist_viabillity|TOX21_ERR_viability|TOX21_PGC_ERR_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability,TRUE
Bis(2-ethylhexyl) phosphate,298-07-7,0.82776172753484,1.2324483210299,3.25630403264946,35.482314187553,TOX21_ERR_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_ESRE_BLA_viability|TOX21_RXR_BLA_Agonist_viability|TOX21_p53_BLA_p2_viability,TRUE
Bupirimate,41483-43-6,0.416000034055184,1.24979587982158,1.28374154941201,73.8044123817688,TOX21_PGC_ERR_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_SSH_3T3_GLI3_Agonist_viability,TRUE
Ethirimol,23947-60-6,0.643973106473298,0.908994657813298,3.61486634024703,23.9770646453357,TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability,TRUE
Hexaconazole,79983-71-4,1.05968270517627,1.31043471414284,5.9785291696146,9.49674517065945,APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_24h_up|NCCT_MITO_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
"Hexanoic acid, 2-ethyl-, diester with tetraethylene glycol",18268-70-7,0.934699637292281,1.23816796805408,3.14489112569237,39.8317848276207,TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability,TRUE
Myclobutanil,88671-89-0,1.07070460015466,1.36752387732124,6.15942712492933,0.640289738345347,APR_HepG2_CellLoss_72h_dn|TOX21_RT_HEK293_FLO_32hr_viability|TOX21_RT_HEPG2_FLO_24hr_viability,TRUE
N-Arachidonylglycine,179113-91-8,0.76278477295049,1.04368984408807,3.39702841808777,33.0767040149767,TOX21_ERb_BLA_Agonist_viability,TRUE
Parbendazole,14255-87-9,-1.2824733637164,-1.14144310576959,5.5841980872016,35.7681568625818,TOX21_PGC_ERR_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_TR_LUC_GH3_Antagonist_viability,TRUE
"(9Z,12R)-12-Hydroxyoctadec-9-enoic acid",141-22-0,1.11126855802601,1.93594895460688,1.15710584778735,64.5779508028266,TOX21_VDR_BLA_Agonist_viability,TRUE
12-Hydroxyoctadecanoic acid,106-14-9,0.82503578054524,1.05745347508731,4.10572229158133,39.9941000555054,TOX21_PPARd_BLA_Agonist_viability,TRUE
2-(Phenylmethylene)octanal,101-86-0,1.28222826821227,1.40150953992051,7.99993574660562,1.01400376044533,APR_HepG2_CellLoss_72h_dn,TRUE
4-Hexylaniline,33228-45-4,-0.149267418302517,1.29112547152256,0.671170562048512,61.3708782844938,NCCT_HEK293T_CellTiterGLO|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RXR_BLA_Agonist_viability,TRUE
4-Hexylresorcinol,136-77-6,0.816551211914065,1.29745100317598,1.98428555549031,24.65271528615,TOX21_MMP_viability,TRUE
4-Pentylaniline,33228-44-3,0.517708066177133,0.972315442394672,2.20967351164308,0.31979122547428,BSK_3C_Proliferation_down|BSK_3C_SRB_down|BSK_4H_SRB_down|BSK_LPS_SRB_down|BSK_hDFCGF_Proliferation_down,TRUE
4-Pentylphenol,14938-35-3,0.72030331491011,0.970780523340956,3.74318920145776,0.831232854968244,BSK_3C_Proliferation_down|BSK_3C_SRB_down|BSK_3C_Vis_down|BSK_4H_SRB_down|BSK_CASM3C_Proliferation_down|BSK_CASM3C_SRB_down|BSK_LPS_SRB_down|BSK_SAg_Proliferation_down|BSK_SAg_SRB_down|BSK_hDFCGF_Proliferation_down|BSK_hDFCGF_SRB_down|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|SH-S5Y5 viability,TRUE
Cloquintocet-mexyl,99607-70-2,0.969840572692381,1.44606069547107,2.00378451853614,45.0231592027207,TOX21_RXR_BLA_Agonist_viability,TRUE
Dihydrojasmone lactone,7011-83-8,0.16678589724605,0.295460371249579,7.44893757463072,33.5271002529691,ACEA_AR_agonist_AUC_viability|ACEA_AR_antagonist_AUC_viability,TRUE
Methyl 12-hydroxyoctadecanoate,141-23-1,-0.221323467442525,0.6075193030716,1.15129496617002,0.299378099921409,BSK_hDFCGF_Proliferation_down,TRUE
"N-(1-Methylheptyl)-N'-phenyl-1,4-benzenediamine",15233-47-3,0.32103932420201,1.39626802677747,1.40260349098241,84.9943696471153,TOX21_PPARd_BLA_Agonist_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_VDR_BLA_Agonist_viability|TOX21_VDR_BLA_antagonist_viability,TRUE
Olivetol,500-66-3,1.34670548396068,1.45292825556744,8.9834081243146,85.7115346903237,TOX21_RT_HEPG2_FLO_16hr_ctrl_viability,TRUE
alpha-Amylcinnamyl alcohol,101-85-9,0.703745626599992,1.01855318010783,4.76361994981391,16.9975613959816,TOX21_AR_BLA_Antagonist_viability|TOX21_RT_HEK293_FLO_32hr_viability,TRUE
gamma-Decanolactone,706-14-9,0.0032638651026482,0.833446718127541,1.14943654396426,42.6134903348636,ACEA_AR_antagonist_AUC_viability,TRUE
"(9Z)-N,N-Bis(2-hydroxyethyl)octadec-9-enamide",93-83-4,-0.137117176111063,0.332706367060135,4.96592841894574,19.142632482626,TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2_viability|TOX21_RT_HEK293_FLO_40hr_viability,TRUE
(Z)-N-[(4-Hydroxy-3-methoxyphenyl)methyl]octadec-9-enamide,58493-49-5,0.0532254003799212,0.396560143564621,2.74759847593894,73.9323273430322,TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
"1,2-Epoxydodecane",2855-19-8,0.439323441613822,1.03586621560712,4.33513690242086,0.0779025680980686,BSK_3C_SRB_down|BSK_CASM3C_SRB_down|BSK_KF3CT_SRB_down|BSK_SAg_Proliferation_down|BSK_SAg_SRB_down|BSK_hDFCGF_Proliferation_down|BSK_hDFCGF_SRB_down,TRUE
1-Monolaurin,142-18-7,0.689402973518791,0.886451893856066,4.84266804307282,28.1298620132445,ACEA_AR_antagonist_AUC_viability,TRUE
4-Heptylphenol,1987-50-4,0.523090644404405,1.26105707249092,2.06336192532295,83.9118286305402,ACEA_AR_agonist_AUC_viability|NCCT_HEK293T_CellTiterGLO|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEPG2_FLO_32hr_ctrl_viability|TOX21_RT_HEPG2_FLO_40hr_ctrl_viability,TRUE
4-Nonylphenol,104-40-5,0.0667644584249874,0.773146774544606,2.14805214810985,10.337190791513,BSK_3C_SRB_down|BSK_CASM3C_Proliferation_down|BSK_KF3CT_SRB_down|BSK_SAg_PBMCCytotoxicity_down|BSK_SAg_Proliferation_down|NCCT_HEK293T_CellTiterGLO|TOX21_RT_HEK293_FLO_24hr_viability|TOX21_RT_HEK293_FLO_32hr_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
N-[3-(Dimethylamino)propyl]dodecanamide,3179-80-4,1.16071443781829,1.36750008733785,4.04604653581006,92.0497435626522,ATG_XTT_Cytotoxicity_up|TOX21_ARE_BLA_agonist_viability|TOX21_CASP3_CHO_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_PR_BLA_Agonist_viability|TOX21_RT_HEPG2_FLO_40hr_ctrl_viability|TOX21_RXR_BLA_Agonist_viability|TOX21_VDR_BLA_antagonist_viability,TRUE
Oleyl sarcosine,110-25-8,1.22966285762848,1.3614140371793,7.24276255205147,46.6402069203443,TOX21_RXR_BLA_Agonist_viability,TRUE
Orlistat,96829-58-2,0.339979411684741,0.621518672818419,3.38937633634777,39.5246711081678,TOX21_RT_HEK293_GLO_32hr_viability,TRUE
2-Bromohexadecanoic acid,18263-25-7,-0.187590381424984,-0.0917404171808585,9.95558545028675,22.6342541153339,TOX21_RT_HEPG2_GLO_32hr_ctrl_viability,TRUE
Ascorbyl palmitate,137-66-6,0.930215973312212,1.59762460370698,3.30254157252998,65.5939195317665,TOX21_RT_HEK293_GLO_00hr_viability|TOX21_RXR_BLA_Agonist_viability,TRUE
Dodecanoic acid,143-07-7,0.984322264837768,1.25602240326376,3.51211639039798,21.640168769106,TOX21_ERb_BLA_Antagonist_viability,TRUE
1-Decyl-3-methylimidazolium trifluoromethanesulfonate,412009-62-2,-0.864885171409611,0.139314960924278,1.34042116321761,49.5213113081911,TOX21_CAR_Agonist_viabillity|TOX21_CAR_Antagonist_viability|TOX21_ERR_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_VDR_BLA_Agonist_viability,TRUE
1-Dodecyl-3-methylimidazolium trifluoromethanesulfonate,404001-52-1,-0.411975141259685,0.704184496204108,1.31025910625196,77.1126680020518,TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_CASP3_CHO_viability|TOX21_ESRE_BLA_viability|TOX21_GR_BLA_Antagonist_viability|TOX21_HSE_BLA_agonist_viability|TOX21_PGC_ERR_viability|TOX21_PR_BLA_Antagonist_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_SBE_BLA_Antagonist_viability,TRUE
1-Methyl-3-hexylimidazolium trifluoromethylsulfonate,460345-16-8,0.597233552535736,1.72968001207392,1.271155448929,71.7331483275614,TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_CAR_Agonist_viabillity|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
1-Methyl-3-octylimidazolium trifluoromethanesulfonate,403842-84-2,0.0661172474361081,0.473930332904297,2.63702175104939,50.2416747054977,TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_CAR_Antagonist_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
1-Nitropyrene,5522-43-0,0.393120195916819,0.954565062675199,1.59511454244833,23.0433464400219,TOX21_CAR_Antagonist_viability|TOX21_ERR_viability|TOX21_PXR_viability|TOX21_RT_HEK293_FLO_08hr_viability,TRUE
"2,4-Dinitrophenyl thiocyanate",1594-56-5,0.921304466830698,1.27470805703533,3.57057177021215,92.7141558738662,TOX21_ARE_BLA_agonist_viability|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_FXR_BLA_antagonist_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_NFkB_BLA_agonist_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_PR_BLA_Antagonist_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability,TRUE
4-Nitro-N-phenylaniline,836-30-6,1.03968772143748,1.70956579367491,1.49206764652386,87.3653064830892,TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_AhR_LUC_Agonist_viability|TOX21_Aromatase_Inhibition_viability|TOX21_ERR_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_p53_BLA_p2_viability,TRUE
5-Nitroacenaphthene,602-87-9,0.904837703047427,1.21728282744646,3.05411233820573,0.277903524584875,BSK_hDFCGF_Proliferation_down,TRUE
Brolamfetamine hydrobromide,53581-53-6,0.660963567995253,1.66745905304133,4.09116722879033,55.9410816714513,TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_TR_LUC_GH3_Antagonist_viability,TRUE
Methyltrioctylammonium trifluoromethanesulfonate,121107-18-4,-0.0302771987386048,0.842970233389422,1.61929892693953,100,TOX21_ARE_BLA_agonist_viability|TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_PGC_ERR_viability|TOX21_PXR_viability|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_RT_HEK293_FLO_16hr_viability|TOX21_RT_HEK293_FLO_24hr_viability|TOX21_RT_HEK293_FLO_32hr_viability|TOX21_RT_HEK293_FLO_40hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_FLO_16hr_ctrl_viability|TOX21_RT_HEPG2_FLO_24hr_viability|TOX21_RT_HEPG2_FLO_32hr_ctrl_viability|TOX21_RT_HEPG2_FLO_40hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability|TOX21_SBE_BLA_Antagonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability|TOX21_VDR_BLA_Agonist_viability|TOX21_p53_BLA_p1_viability,TRUE
Pentabromoethane,75-95-6,1.17469757677231,1.37506178883406,4.76253967522536,43.9192582320395,TOX21_HRE_BLA_Agonist_viability,TRUE
Tibrofan,15686-72-3,0.656644538637074,1.35973723449567,1.35720725739305,100,TOX21_TR_LUC_GH3_Antagonist_viability,TRUE
1-Decanol,112-30-1,0.765143146177757,0.88116549246805,8.22464413063816,15.6025135779071,TOX21_RT_HEK293_FLO_08hr_viability,TRUE
1-Dodecyl-2-pyrrolidinone,2687-96-9,1.31200323888852,1.65800624910396,2.44074021195278,5.48944646964864,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|NCCT_HEK293T_CellTiterGLO|TOX21_PPARd_BLA_Agonist_viability|TOX21_RT_HEPG2_FLO_24hr_viability,TRUE
1-Tetradecanol,112-72-1,1.63251318673898,1.7593581381602,5.77696921630104,1.79587929611366,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_24h_up,TRUE
1-Undecanol,112-42-5,0.363826632371486,1.59711122997094,0.773752356693599,48.633379547073,TOX21_RT_HEK293_FLO_32hr_viability|TOX21_RT_HEK293_FLO_40hr_viability,TRUE
"2,2'-(Tetradecylimino)diethanol",18924-66-8,1.30748768968183,1.45668826706564,4.69308178104063,90.9899176753584,ATG_XTT_Cytotoxicity_up|TOX21_Aromatase_Inhibition_viability|TOX21_CASP3_CHO_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_RT_HEK293_GLO_00hr_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability,TRUE
3-Thiatetradecanoic acid,116296-31-2,1.13935804340021,1.36482422658969,4.71120403567528,63.2790437511432,TOX21_ERb_BLA_Agonist_viability|TOX21_VDR_BLA_antagonist_viability,TRUE
Decyl beta-D-glucopyranoside,58846-77-8,0.0148585022786263,1.53265080933585,0.628704273306971,27.3369535046532,TOX21_RT_HEK293_GLO_32hr_viability,TRUE
Dodecylparaben,2664-60-0,1.21860771893684,1.5377318206009,4.30432883002773,80.8831650320009,TOX21_PPARd_BLA_Agonist_viability|TOX21_VDR_BLA_Agonist_viability,TRUE
Hexadecylamine,143-27-1,0.426715906797861,0.715875664866063,4.01745765148318,31.6211874231807,TOX21_RT_HEK293_FLO_00hr_viability|TOX21_RT_HEK293_FLO_16hr_viability,TRUE
Laurocapram,59227-89-3,0.850838727447716,1.19653063042491,4.16513324029293,39.4509146855727,ACEA_AR_agonist_AUC_viability|ATG_XTT_Cytotoxicity_up|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_VDR_BLA_Agonist_viability,TRUE
Lauryl gallate,1166-52-5,0.33202208548538,0.859236469222028,1.67973816041575,100,ACEA_AR_agonist_AUC_viability|ACEA_AR_antagonist_AUC_viability|ACEA_ER_AUC_viability|NCCT_HEK293T_CellTiterGLO|TOX21_PPARd_BLA_Agonist_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEPG2_FLO_08hr_viability|TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_VDR_BLA_Agonist_viability|TOX21_VDR_BLA_antagonist_viability|TOX21_p53_BLA_p4_viability,TRUE
Lauryldiethanolamine,1541-67-9,0.953264273065536,1.30425222860219,2.44380323301017,100,TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_FLO_24hr_viability|TOX21_RXR_BLA_Agonist_viability,TRUE
Polyoxyethylene (9) lauryl ether,3055-99-0,0.490417991126601,0.809986275889626,2.98603633382124,34.0241002656934,TOX21_AhR_LUC_Agonist_viability,TRUE
"1-O-Hexyl-2,3,5-trimethylhydroquinone",148081-72-5,0.554771300243242,1.22988229347886,2.79016112833882,45.3530632954156,TOX21_Aromatase_Inhibition_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_FLO_08hr_viability|TOX21_RT_HEPG2_FLO_16hr_ctrl_viability|TOX21_RT_HEPG2_FLO_24hr_viability|TOX21_RT_HEPG2_FLO_32hr_ctrl_viability|TOX21_RT_HEPG2_FLO_40hr_ctrl_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability|TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_VDR_BLA_Agonist_viability|TOX21_VDR_BLA_antagonist_viability,TRUE
2-[4-(Dibutylamino)-2-hydroxybenzoyl]benzoic acid,54574-82-2,0.952218444635201,1.27889493698602,5.24988716273469,49.9969665511282,TOX21_ERb_BLA_Antagonist_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_PR_BLA_Agonist_viability|TOX21_p53_BLA_p1_viability,TRUE
3-(Octyloxy)propan-1-amine,15930-66-2,0.88602939226093,1.39385475994815,1.87907609614938,39.637369122397,TOX21_PPARd_BLA_antagonist_viability|TOX21_PR_BLA_Agonist_viability|TOX21_VDR_BLA_Agonist_viability,TRUE
4-(Hexyloxy)phenol,18979-55-0,0.26700587972369,1.03953716221274,1.80284391066313,70.9830024378714,ACEA_AR_agonist_AUC_viability|ACEA_AR_antagonist_AUC_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_FLO_16hr_ctrl_viability|TOX21_RT_HEPG2_FLO_24hr_viability|TOX21_RT_HEPG2_FLO_32hr_ctrl_viability|TOX21_RT_HEPG2_FLO_40hr_ctrl_viability|TOX21_TR_LUC_GH3_Antagonist_viability,TRUE
4-Hexyloxyaniline,39905-57-2,0.832340831007402,0.939781683586271,8.88156121749731,21.8323640371335,TOX21_RT_HEK293_GLO_08hr_viability,TRUE
Butyryl-n-trihexylcitrate,82469-79-2,0.232879837923821,0.890931346696617,1.45010306445296,0.217680126807472,BSK_SAg_Proliferation_down,TRUE
Carmofur,61422-45-5,0.384966782366861,0.649833260651736,3.60273038558318,20.8250693406523,TOX21_ERb_BLA_Agonist_viability,TRUE
Di-n-octyl phthalate,117-84-0,0.256531985356938,0.67150014257698,2.29955598480615,0.147545587391084,BSK_SAg_PBMCCytotoxicity_up,TRUE
Diheptyl phthalate,3648-21-3,-0.761171236956819,0.130352299958854,1.07035032719454,0.092814916521273,BSK_SAg_PBMCCytotoxicity_up,TRUE
Dihexyl phthalate,84-75-3,1.62976833653341,1.77760560224113,6.00156190129373,0.478002202330928,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_72h_up|BSK_hDFCGF_Proliferation_down,TRUE
Flumiclorac-pentyl,87546-18-7,2.57318507877203,3.22965959493804,1.45358652307231,52.6047184941326,APR_HepG2_CellLoss_72h_dn,TRUE
Heptyl p-hydroxybenzoate,1085-12-7,0.796465096351589,1.43927284534052,1.36261442698721,43.6926201581568,ACEA_AR_antagonist_AUC_viability|TOX21_RT_HEK293_FLO_32hr_viability|TOX21_RT_HEK293_FLO_40hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_FLO_16hr_ctrl_viability|TOX21_RT_HEPG2_FLO_24hr_viability,TRUE
Hexylparaben,1083-27-8,0.142478079048554,0.96030737720744,1.38851635644189,31.6897739678478,TOX21_MMP_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_FLO_08hr_viability|TOX21_RT_HEPG2_FLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_p53_BLA_p2_viability,TRUE
Neticonazole,130726-68-0,-0.198041451476351,0.0523952412134785,5.89890896511667,46.5180852949836,TOX21_PR_BLA_Agonist_viability|TOX21_RT_HEK293_GLO_24hr_viability,TRUE
Nonylparaben,38713-56-3,1.30528412696815,1.43700202008333,7.77876989729483,67.4895094176675,TOX21_AP1_BLA_Agonist_viability|TOX21_PGC_ERR_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PPARd_BLA_antagonist_viability,TRUE
Octhilinone,26530-20-1,0.689006105332988,0.989142005068022,2.46204701115822,89.4912998222191,ACEA_ER_AUC_viability|APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_24h_dn|BSK_BE3C_SRB_down|TOX21_ARE_BLA_agonist_viability|TOX21_AR_BLA_Antagonist_viability|TOX21_Aromatase_Inhibition_viability|TOX21_CAR_Agonist_viabillity|TOX21_CAR_Antagonist_viability|TOX21_CASP3_CHO_viability|TOX21_ERR_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_FXR_BLA_agonist_viability|TOX21_FXR_BLA_antagonist_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_PXR_viability|TOX21_RAR_LUC_Agonist_viability|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_RXR_BLA_Agonist_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_VDR_BLA_Agonist_viability|TOX21_VDR_BLA_antagonist_viability,TRUE
Octyl gallate,1034-01-1,0.574525405901542,1.15888512433027,1.76575151482449,74.1102691109352,ACEA_AR_agonist_AUC_viability|ACEA_AR_antagonist_AUC_viability|APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|BSK_SAg_Proliferation_down|NCCT_HEK293T_CellTiterGLO|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability|TOX21_VDR_BLA_antagonist_viability,TRUE
Octylparaben,1219-38-1,0.749069897971733,1.3630574125017,4.75954682218812,53.0860364398995,TOX21_ESRE_BLA_viability|TOX21_NFkB_BLA_agonist_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Pebulate,1114-71-2,-0.118727858833761,0.952966584258077,0.890405390818614,41.49992057318,TOX21_RT_HEK293_GLO_32hr_viability,TRUE
Pentylparaben,6521-29-5,0.762959732727026,2.01756558229637,0.760591471629818,57.1398570396612,TOX21_MMP_viability,TRUE
"3,6,9,12-Tetraoxahexadecan-1-ol",1559-34-8,0.689698690276141,2.0511872565425,0.700881765064077,66.9485306529588,TOX21_PR_BLA_Antagonist_viability,TRUE
3-Iodo-2-propynyl-N-butylcarbamate,55406-53-6,0.453548490779091,0.719548685033169,2.77408614651099,82.2658285830037,ACEA_ER_AUC_viability|APR_HepG2_CellLoss_24h_dn|APR_HepG2_MicrotubuleCSK_72h_dn|BSK_3C_Proliferation_down|BSK_3C_Vis_down|BSK_CASM3C_Proliferation_down|BSK_SAg_PBMCCytotoxicity_down|TOX21_ARE_BLA_agonist_viability|TOX21_Aromatase_Inhibition_viability|TOX21_CAR_Agonist_viabillity|TOX21_CASP3_CHO_viability|TOX21_RAR_LUC_Agonist_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEPG2_GLO_00hr_ctrl_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_p53_BLA_p4_viability|CNS cell viability|cell viability|percent mortality 1dpf,TRUE
Acetyl tributyl citrate,77-90-7,0.951910172735056,1.62736347786256,2.32674299524504,1.50352572667687,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_72h_up,TRUE
Alpidem,82626-01-5,0.170634890105853,0.562343798046957,2.43610913810207,61.2560727436491,TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability,TRUE
Butyl 4-aminobenzoate,94-25-7,-3.51603249179958,-3.2451617198717,3.522869974666,22.5674489457374,TOX21_ERR_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Butylparaben,94-26-8,0.715957532896395,0.892525398782255,5.40439510129312,15.4294919387007,TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Cyhalofop-butyl,122008-85-9,1.18991221043361,1.51657223127214,3.98024089704552,33.1246631861981,APR_HepG2_CellLoss_72h_dn|TOX21_RT_HEK293_GLO_08hr_viability,TRUE
Dibutyl butylphosphonate,78-46-6,1.15001361182426,1.28095249752153,7.28769383027702,21.6245542274543,TOX21_RT_HEPG2_GLO_00hr_ctrl_viability,TRUE
Dibutyl phthalate,84-74-2,-0.164281425592215,1.18015641042607,0.709770644558344,0.206369650254734,BSK_LPS_SRB_down,TRUE
Fluazifop-butyl,69806-50-4,-1.31157835657887,0.193642025482339,0.633955346879245,-6.0159499783578,TOX21_RT_HEK293_GLO_08hr_viability,TRUE
Isopropalin,33820-53-0,0.968790480654794,1.52622155997687,2.49935656324046,3.43412237087087,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_72h_up|BSK_hDFCGF_Proliferation_down|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
N-Butylbenzenesulfonamide,3622-84-2,-0.00455074660967703,0.868764659610502,1.0926665241936,67.3626112496854,TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Oryzalin,19044-88-3,1.09464514055992,1.56821739551165,3.08824474648549,46.8536948241566,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|APR_HepG2_NuclearSize_24h_dn|BSK_hDFCGF_Proliferation_down|NCCT_HEK293T_CellTiterGLO|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEPG2_FLO_40hr_ctrl_viability,TRUE
Prochloraz,67747-09-5,0.395923680715378,1.12149517640635,2.1856602770285,27.9870742168692,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|NCCT_MITO_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Profluralin,26399-36-0,0.43444546413906,0.941353867836795,1.88247522131894,29.6134362077953,TOX21_RT_HEK293_GLO_08hr_viability,TRUE
Propyl gallate,121-79-9,0.160167572991873,0.821842326054398,1.32306502338919,0.552710621716382,APR_HepG2_CellLoss_72h_dn|BSK_3C_Proliferation_down|BSK_CASM3C_Proliferation_down|BSK_hDFCGF_Proliferation_down,TRUE
Tributyl phosphate,126-73-8,0.583441778776367,1.51987371988512,1.01901960788467,52.5526701754373,NCCT_MITO_viability,TRUE
Triclopyr butotyl,64700-56-7,1.22473080428953,1.39079358186803,5.74627573592302,35.980475737262,TOX21_RT_HEK293_FLO_08hr_viability,TRUE
3-Amino-9-ethylcarbazole,132-32-1,0.780175136998434,1.00646534160631,2.52495015251744,9.47412426588892,BSK_3C_Proliferation_down|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_ERb_BLA_Agonist_viability,TRUE
4-(Diethylamino)salicylaldehyde,17754-90-4,0.726931564484429,1.97739338242415,0.763112072475388,49.5674273701363,TOX21_RXR_BLA_Agonist_viability,TRUE
7-Diethylamino-4-methylcoumarin,91-44-1,-1.17045186478286,-0.207083461034211,0.990615991962574,76.4684006877392,ACEA_ER_AUC_viability|SH-S5Y5 viability,TRUE
Albendazole,54965-21-8,-0.517623273362605,-0.316084109097157,4.73477456809579,26.6278588573974,TOX21_CASP3_CHO_viability|TOX21_ERR_viability|TOX21_RT_HEK293_GLO_32hr_viability,TRUE
Albendazole oxide,54029-12-8,0.355267478528475,0.466571786116329,8.57327564511483,24.9929311632941,TOX21_RT_HEK293_GLO_40hr_viability,TRUE
C.I. Solvent Yellow 56,2481-94-9,0.485241244430465,1.49823724192858,1.3293134504673,51.0273735265787,BSK_3C_Proliferation_down|BSK_SAg_PBMCCytotoxicity_down|BSK_SAg_Proliferation_down|BSK_SAg_SRB_down|BSK_hDFCGF_Proliferation_down|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_CAR_Antagonist_viability|TOX21_CASP3_CHO_viability|TOX21_ERR_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_RXR_BLA_Agonist_viability|TOX21_SSH_3T3_GLI3_Agonist_viability,TRUE
Dinitramine,29091-05-2,0.360436600245383,1.11830462840974,1.28174835720598,84.7560196737637,TOX21_ERb_BLA_Antagonist_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability,TRUE
Entacapone,130929-57-6,0.590824401386506,1.26336055402644,1.32536620820805,43.0738762017405,TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_CAR_Agonist_viabillity|TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability,TRUE
"N,N-Diethyl-p-phenylenediamine",93-05-0,0.562967934597498,1.35169692684329,1.54808360615748,89.5046455966534,TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_CAR_Antagonist_viability|TOX21_CASP3_CHO_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_MMP_viability|TOX21_PR_BLA_Antagonist_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RXR_BLA_Agonist_viability|TOX21_SBE_BLA_Antagonist_viability|TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_VDR_BLA_Agonist_viability,TRUE
"N-Ethyl-N-(3-methylphenyl)ethane-1,2-diamine",19248-13-6,1.34124828317232,1.43906862232962,9.75505214620917,23.1256162066643,TOX21_RT_HEPG2_FLO_24hr_viability,TRUE
N-Ethyl-N-phenyl benzylamine,92-59-1,0.664148485660322,1.44367639223206,1.22412873406413,36.9713175945861,TOX21_PGC_ERR_viability,TRUE
Oxibendazole,20559-55-1,-1.05635048533186,-0.730429501377978,3.20640697919767,31.1027810670691,TOX21_PGC_ERR_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability,TRUE
Pirimiphos-methyl,29232-93-7,0.743134377313796,1.56719311533005,1.15797875250551,27.4919139473466,NCCT_MITO_viability,TRUE
Tetraethylthiuram disulfide,97-77-8,0.17121626480808,0.606929725581573,2.65071462815463,35.4327144498105,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_72h_dn|BSK_3C_Proliferation_down|BSK_CASM3C_Proliferation_down|BSK_KF3CT_SRB_down|BSK_SAg_Proliferation_down|BSK_hDFCGF_SRB_down|TOX21_CAR_Agonist_viabillity|TOX21_CASP3_CHO_viability|TOX21_PGC_ERR_viability|TOX21_RT_HEK293_FLO_32hr_viability|TOX21_RT_HEK293_FLO_40hr_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEPG2_GLO_40hr_viability|TOX21_VDR_BLA_Agonist_viability|cell viability,TRUE
Thiobencarb,28249-77-6,1.64424307570798,1.80794286116121,5.82922272498641,0.541237130035595,APR_HepG2_CellLoss_72h_dn,TRUE
Tiamulin,55297-95-5,0.769988046372643,1.14250576046499,2.56160304152078,78.4985456711066,TOX21_TR_LUC_GH3_Antagonist_viability,TRUE
Triflumizole,68694-11-1,1.03489148939818,1.51684670907021,1.95777583395437,100,ACEA_AR_agonist_AUC_viability|ACEA_ER_AUC_viability|NCCT_HEK293T_CellTiterGLO|NCCT_MITO_viability|TOX21_CASP3_CHO_viability|TOX21_ERR_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability,TRUE
Acetyltriethyl citrate,77-89-4,1.14086482707029,1.64794732556213,1.88182891793232,1.35571751715635,APR_HepG2_CellLoss_72h_dn,TRUE
Ametryn,834-12-8,0.543779227221276,1.94980557447267,0.678680389812574,67.2630280350638,TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Benzocaine,1994-09-07,0.624253617518392,1.4106941618309,1.28950346651001,42.2087134902433,ACEA_ER_AUC_viability|NCCT_HEK293T_CellTiterGLO,TRUE
Clofibrate,637-07-0,-2.52372193926012,-0.971346649850475,0.614698337411836,0.853613238071829,TOX21_RT_HEK293_FLO_40hr_viability,TRUE
Cyanazine,21725-46-2,0.754547167330353,0.871375969979971,8.26962491210966,13.8364692757586,ACEA_AR_antagonist_AUC_viability|TOX21_RT_HEK293_FLO_00hr_viability,TRUE
Ethyl 4-iodobenzoate,51934-41-9,4.76288990751271,4.90281556259614,6.81963939257843,-667.844997292752,TOX21_RT_HEK293_FLO_40hr_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_32hr_viability,TRUE
Fenchlorazole-ethyl,103112-35-2,0.792235144765925,1.23613550334729,2.149677266513,59.3120584362743,TOX21_ARE_BLA_agonist_viability,TRUE
Fenoxaprop-P-ethyl,71283-80-2,-0.17317399602144,1.32134411458176,0.756971085331797,74.7237625561052,ACEA_AR_agonist_AUC_viability|ACEA_AR_antagonist_AUC_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability,TRUE
Mefenpyr-diethyl,135590-91-9,0.729691129544943,1.00438698165042,3.47381477414119,0.0976126869101686,BSK_4H_SRB_down,TRUE
N-Ethylperfluorooctanesulfonamide,4151-50-2,1.09654550749978,1.76177820517336,1.13792817361427,2.59231152419261,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_24h_up|APR_HepG2_MicrotubuleCSK_72h_up|TOX21_ARE_BLA_agonist_viability,TRUE
Pyrazophos,13457-18-6,0.587831617808744,0.835489402322368,3.85306890842686,33.6359864724909,TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
"2,4,5-Triethoxyacetophenone",63213-29-6,0.734824936916011,1.5041403945766,1.01287857520623,52.4563786017871,TOX21_CAR_Antagonist_viability|TOX21_CASP3_HEPG2_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability|TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability|TOX21_TR_LUC_GH3_Antagonist_viability,TRUE
2-Ethoxyaniline,94-70-2,0.0284682034519213,0.767609906980815,1.29101430061851,29.7041293922585,TOX21_RT_HEK293_GLO_40hr_viability,TRUE
4-Ethoxyphenol,622-62-8,0.933979231188118,1.06001123955983,7.57230374382112,36.6947245581625,TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_24hr_viability,TRUE
"6-Ethoxy-2,3,4-trimethyl-1,2,3,4-tetrahydroquinoline",16489-90-0,-0.386632292707335,1.33508057271668,0.554240215428904,37.4734135124942,TOX21_RT_HEK293_FLO_40hr_viability,TRUE
Acetochlor,34256-82-1,0.247589120161484,1.25035377834432,2.62170552355246,0.875251466636181,APR_HepG2_MicrotubuleCSK_24h_dn|BSK_hDFCGF_Proliferation_down|TOX21_SSH_3T3_GLI3_Antagonist_viability,TRUE
Benazolin-ethyl,25059-80-7,-0.0782701007779827,0.820482411020871,0.892482012805967,25.5523098935175,TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability,TRUE
Benfuracarb,82560-54-1,0.908497257826705,1.3855773656718,2.72671338145777,1.63497279824884,BSK_SAg_Proliferation_down|BSK_hDFCGF_Proliferation_down,TRUE
Chlorfenvinphos,470-90-6,0.938832772279837,1.23677722634065,5.75543011131751,0.175914118254567,BSK_3C_Proliferation_down|BSK_CASM3C_Proliferation_down|BSK_CASM3C_SRB_down|BSK_SAg_SRB_down|BSK_hDFCGF_SRB_down|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Cloforex,14261-75-7,0.679890102513792,1.06715835330327,5.66713232149018,12.3786458886436,TOX21_RT_HEK293_FLO_32hr_viability|TOX21_RT_HEK293_FLO_40hr_viability,TRUE
Ethoxyquin,91-53-2,1.41699399515995,2.18007523944914,1.84354616213817,9.79301248023517,APR_HepG2_CellLoss_72h_dn|BSK_SAg_PBMCCytotoxicity_down,TRUE
"Ethyl 4-(5-chloro-2,3-dihydro-2-oxo-1h-benzimidazol-2-yl)piperidine-1-carboxylate",53786-46-2,-0.299081558684795,0.00265779804941513,4.6153875947792,13.1681145536998,TOX21_CAR_Antagonist_viability|TOX21_RT_HEK293_GLO_08hr_viability,TRUE
Ethyl 4-nitrophenyl ethylphosphonate,546-71-4,0.820826507715436,1.26271196188179,2.15947934117804,18.1633754267047,TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability,TRUE
Ethyl 4-oxo-1-piperidinecarboxylate,29976-53-2,-0.709890174367893,-0.560262315412051,6.37743877442596,3.20095821800016,TOX21_RT_HEPG2_FLO_40hr_ctrl_viability,TRUE
Etofenprox,80844-07-1,1.4267110957248,1.84022204832632,2.30765957572808,1.19648859671914,APR_HepG2_CellLoss_72h_dn,TRUE
Fenamiphos,22224-92-6,1.40275189572587,1.97977811561564,1.65372469490488,1.49928864963159,APR_HepG2_CellLoss_72h_dn,TRUE
Fenoxycarb,72490-01-8,1.20513523632442,1.9408290778023,1.4038106767769,2.02038748608646,ACEA_AR_antagonist_AUC_viability|APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_72h_up|TOX21_RT_HEK293_GLO_24hr_viability,TRUE
Oxyfluorfen,42874-03-3,0.404378118614691,1.01686545447269,1.54719829178781,0.643746979049158,ACEA_AR_agonist_AUC_viability|ACEA_AR_antagonist_AUC_viability|APR_HepG2_CellLoss_72h_dn|BSK_BE3C_SRB_down|BSK_SAg_SRB_down|BSK_hDFCGF_Proliferation_down|TOX21_RT_HEK293_GLO_08hr_viability,TRUE
Thiophanate,23564-06-9,1.33417334161032,1.4577309135321,7.72305974127923,27.8412811361971,TOX21_RT_HEK293_GLO_16hr_viability,TRUE
Tralkoxydim,87820-88-0,0.533486467117969,0.83060714904277,3.21163273878335,7.19019961558235,TOX21_RT_HEK293_GLO_24hr_viability,TRUE
"(+)-2,5-Dimethoxy-4-ethylamphetamine hydrochloride",50505-91-4,0.704955833046009,1.75520238114557,1.28648847660086,57.9491008492679,TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_TR_LUC_GH3_Antagonist_viability,TRUE
"(-)-2,5-Dimethoxy-4-ethylamphetamine hydrochloride",42011-76-7,0.938242724897602,1.48513851780169,1.74483424780464,31.9133686321664,TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability,TRUE
2-Chloropropyldimethylamine hydrochloride,4584-49-0,1.20160977298017,1.4728689839397,3.75711640105283,1.4349762960407,BSK_SAg_PBMCCytotoxicity_down|BSK_SAg_Proliferation_down,TRUE
"3,3'-Dichlorobenzidine dihydrochloride",612-83-9,-0.13286985865702,0.768086485675653,1.14335241707792,27.515283124723,BSK_3C_Proliferation_down|BSK_3C_Vis_down|BSK_4H_SRB_down|BSK_LPS_SRB_down|BSK_hDFCGF_Proliferation_down|TOX21_CASP3_HEPG2_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_PGC_ERR_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_FLO_32hr_ctrl_viability|TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_TR_LUC_GH3_Antagonist_viability,TRUE
"3,3'-Dimethylbenzidine dihydrochloride",612-82-8,-0.009274506276572,1.51063032079622,0.627830435460301,100,ACEA_AR_antagonist_AUC_viability,TRUE
4-Chloro-2-methylaniline hydrochloride,3165-93-3,0.438251980070481,0.938651112228614,4.59813700801005,59.5405700413449,TOX21_RT_HEK293_FLO_32hr_viability|TOX21_RT_HEPG2_FLO_40hr_ctrl_viability,TRUE
Azinphos-ethyl,2642-71-9,0.614708747934473,1.229389931973,1.73181830842152,26.0194909893635,BSK_4H_SRB_down|BSK_CASM3C_Proliferation_down|TOX21_ERR_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability,TRUE
Benzidine dihydrochloride,531-85-1,0.616764976880764,1.10977781344571,1.9355327867079,31.1196519405789,TOX21_ERb_BLA_Agonist_viability,TRUE
Chlorpyrifos,2921-88-2,0.290020884596344,1.74942261818555,0.653858692556499,100,NCCT_HEK293T_CellTiterGLO,TRUE
Clonidine hydrochloride,4205-91-8,1.38676899094005,1.54311664279874,6.10333764591374,31.1164385601182,TOX21_PR_BLA_Antagonist_viability,TRUE
Coumaphos,56-72-4,0.300627095225656,1.21388122458826,1.15494359773573,69.6100347679586,TOX21_MMP_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability,TRUE
Cycloguanil hydrochloride,152-53-4,0.218580615885801,0.871040790401368,1.71198117574977,74.9540292772038,TOX21_p53_BLA_p2_viability|TOX21_p53_BLA_p4_viability,TRUE
Decominol hydrochloride,60812-23-9,0.607257472795217,0.853884691529325,3.86916948720127,100,TOX21_RT_HEPG2_FLO_32hr_ctrl_viability,TRUE
Diphenoxylate hydrochloride,3810-80-8,0.244491431469318,0.707351434042639,3.0964098780396,23.1493400597035,TOX21_ERb_BLA_Antagonist_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_p53_BLA_p4_viability,TRUE
Disulfoton,298-04-4,1.23494291509217,1.42521783106144,5.01507255740124,0.143313076638881,STM_H9_Viability_norm,TRUE
Dodecylamine hydrochloride,929-73-7,1.06835697677729,1.5209536208041,4.30537767016303,98.8725996341343,TOX21_ARE_BLA_agonist_viability|TOX21_ESRE_BLA_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_PR_BLA_Antagonist_viability|TOX21_PXR_viability|TOX21_RT_HEPG2_FLO_32hr_ctrl_viability|TOX21_RT_HEPG2_FLO_40hr_ctrl_viability|TOX21_VDR_BLA_Agonist_viability,TRUE
Dyclonine hydrochloride,536-43-6,0.468503300044539,0.770025022414264,4.43845818888921,39.0466406679278,TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_FLO_40hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability|TOX21_RXR_BLA_Agonist_viability,TRUE
EPN,2104-64-5,0.47854585236911,1.43431605536416,0.867346283466267,1.26739076610892,ACEA_AR_antagonist_AUC_viability|APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|BSK_hDFCGF_Proliferation_down|TOX21_RT_HEPG2_GLO_00hr_ctrl_viability,TRUE
Ethyl dichlorophosphate,1498-51-7,-0.264426028431044,1.05719694849809,0.722023244220953,29.1713077784576,TOX21_RT_HEK293_GLO_32hr_viability,TRUE
Irinotecan hydrochloride,100286-90-6,0.147131196834901,0.407121639334602,4.08624639855316,57.8069720003814,TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Isofenphos,25311-71-1,0.403967991575938,1.14296495361853,1.42668416058625,67.2374398937994,TOX21_HRE_BLA_Agonist_viability|TOX21_RXR_BLA_Agonist_viability,TRUE
Isoproterenol hydrochloride,51-30-9,1.64322559966244,1.77872932385985,7.04218659000956,0.931614920736807,APR_HepG2_CellLoss_72h_dn,TRUE
Mabuterol hydrochloride,54240-36-7,0.356488203592649,1.70279322902331,0.724479486121811,72.4935460842877,TOX21_AhR_LUC_Agonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability,TRUE
Molinate,2212-67-1,0.693478033100278,1.06033407291154,3.21554729166051,41.5457272464491,TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability,TRUE
N-(1-Naphthyl)ethylenediamine dihydrochloride,1465-25-4,0.906874988746566,1.36425117228416,2.1042367030911,49.4859636381513,TOX21_ERb_BLA_Antagonist_viability|TOX21_RT_HEK293_GLO_00hr_viability,TRUE
Oxybutynin hydrochloride,1508-65-2,0.194894310529348,1.0779295551912,1.11769230542553,74.5379317178646,TOX21_Aromatase_Inhibition_viability|TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2_viability,TRUE
Phosalone,2310-17-0,0.0194271013085288,1.09711920065418,1.36479590151592,32.4593159262821,APR_HepG2_CellLoss_72h_dn|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Pioglitazone hydrochloride,112529-15-4,1.30404170601799,1.45035404107186,1.9425758040022,7.54162231690385,APR_HepG2_CellLoss_72h_dn|BSK_SAg_Proliferation_down|TOX21_RT_HEK293_GLO_08hr_viability,TRUE
Pirimiphos-ethyl,23505-41-1,1.21174441837898,1.37564680563813,5.82201714933248,44.9195219861913,TOX21_RXR_BLA_Agonist_viability,TRUE
Proguanil hydrochloride,637-32-1,0.129538200907871,0.888105439464354,1.35639757125055,44.6746552777281,TOX21_CASP3_CHO_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_RT_HEPG2_FLO_16hr_ctrl_viability,TRUE
Quinalphos,13593-03-8,-0.204671465745518,0.249531075313443,5.32734329628324,1.22537866087282,TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_32hr_viability,TRUE
SB243213A,200940-23-4,0.59761609399546,1.03065213481219,1.24132784574355,38.2258649245736,ACEA_AR_agonist_AUC_viability|ACEA_AR_antagonist_AUC_viability|ACEA_ER_AUC_viability|APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_24h_up|BSK_3C_Proliferation_down|TOX21_CASP3_CHO_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability,TRUE
Triazophos,24017-47-8,0.321958254263343,1.25710446891313,1.02042065132744,32.5865283719226,TOX21_ERb_BLA_Agonist_viability,TRUE
-Methyl-2H-isothiazol-3-one hydrochloride,26172-54-3,1.01362781371135,1.41485836399457,2.37828976075161,87.459931203073,TOX21_CASP3_CHO_viability,TRUE
"1-(2-Chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane",53-19-0,-2.3720392007714,-2.03638088736734,2.84289848138103,13.4015970851355,TOX21_RT_HEK293_FLO_24hr_viability,TRUE
1-Phenylcyclohexylamine hydrochloride,1934-71-0,0.904168376669056,1.63071479082801,1.36837931090462,79.9621904354578,TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability,TRUE
"2'-Deoxy-2',2'-difluorocytidine monohydrochloride",122111-03-9,-0.363361086143586,-0.0889462636149963,3.47737232503142,70.7449832423195,TOX21_RT_HEK293_GLO_40hr_viability,TRUE
"2,2'-Dichlorobiphenyl",13029-08-8,0.64542934432845,1.18144931139047,1.90649338322106,71.4880424165625,TOX21_RT_HEK293_FLO_16hr_viability|TOX21_RT_HEK293_FLO_24hr_viability|TOX21_RT_HEK293_FLO_40hr_viability|TOX21_RT_HEPG2_FLO_32hr_ctrl_viability,TRUE
"4-Bromo-2,5-dimethoxyamphetamine hydrochloride",29705-96-2,0.72705521627072,1.43660016016636,3.07634188296412,39.2188245917837,TOX21_PXR_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
4-Chloroaniline hydrochloride,20265-96-7,0.099802389418101,0.873655677259104,1.23310519504491,46.4182166879856,ACEA_ER_AUC_viability,TRUE
Aldrin,309-00-2,0.912229630719137,1.18575856459422,5.48255155647089,1.67777370397923,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|BSK_3C_Proliferation_down|BSK_hDFCGF_Proliferation_down|BSK_hDFCGF_SRB_down|TOX21_PPARd_BLA_Agonist_viability,TRUE
C.I. Basic Orange 2,532-82-1,0.783899987212268,1.69638008018698,1.13483000395804,62.8638530349297,TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_AhR_LUC_Agonist_viability|TOX21_CAR_Agonist_viabillity|TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_PXR_viability|TOX21_RT_HEPG2_GLO_00hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability,TRUE
C.I. Basic Red 9 monohydrochloride,569-61-9,0.255755847664598,0.998941698558819,1.22004587413588,69.1171789789905,TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_Aromatase_Inhibition_viability|TOX21_CAR_Agonist_viabillity|TOX21_CAR_Antagonist_viability|TOX21_ELG1_LUC_Agonist_viability|TOX21_ERR_viability|TOX21_ERa_BLA_Antagonist_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_MMP_viability|TOX21_PGC_ERR_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_PXR_viability|TOX21_RAR_LUC_Agonist_viability|TOX21_RAR_LUC_Antagonist_viability|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_VDR_BLA_Agonist_viability,TRUE
Captafol,2425-06-01,0.0830668869892644,0.633433307171868,1.82381476882522,90.2408928696938,TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_CASP3_CHO_viability|TOX21_FXR_BLA_agonist_viability|TOX21_GR_BLA_Antagonist_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_00hr_ctrl_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_SBE_BLA_Antagonist_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_VDR_BLA_Agonist_viability|TOX21_p53_BLA_p2_viability|TOX21_p53_BLA_p4_viability|TOX21_p53_BLA_p5_viability,TRUE
Captan,133-06-2,0.502114244750351,1.05988113768189,1.45565346258424,78.867356918519,TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_CAR_Agonist_viabillity|TOX21_CASP3_CHO_viability|TOX21_FXR_BLA_agonist_viability|TOX21_HRE_BLA_Agonist_viability|TOX21_PGC_ERR_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_RAR_LUC_Agonist_viability|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_00hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability|TOX21_SBE_BLA_Antagonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability,TRUE
Clomipramine hydrochloride,17321-77-6,0.887147155633284,1.36981492324084,1.88519001939449,99.6115066719061,ATG_XTT_Cytotoxicity_up|TOX21_ERb_BLA_Agonist_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_VDR_BLA_antagonist_viability,TRUE
Dexchlorpheniramine hydrochloride,5502-69-2,0.694592079664718,1.36166453126334,1.43049305536829,31.6336442534497,TOX21_PXR_viability,TRUE
Diphenhydramine hydrochloride,147-24-0,1.15637693927324,2.3594870728301,1.51497934699838,37.5585575830242,APR_HepG2_CellLoss_72h_dn|TOX21_CAR_Agonist_viabillity|TOX21_PXR_viability,TRUE
Donepezil hydrochloride,120011-70-3,0.666728072020428,1.79835437519348,0.843248788724382,76.7746560720088,TOX21_RT_HEPG2_FLO_32hr_ctrl_viability,TRUE
Fluoxetine hydrochloride,56296-78-7,0.548091263683955,1.25487418267802,1.73293339273626,97.9812869559134,TOX21_ARE_BLA_agonist_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_VDR_BLA_antagonist_viability,TRUE
Isodrin,465-73-6,0.641518906162202,0.964391338348938,1.87945024351744,0.360106095034936,BSK_3C_SRB_down|BSK_3C_Vis_down|BSK_CASM3C_Proliferation_down|BSK_LPS_SRB_down|BSK_SAg_PBMCCytotoxicity_down|BSK_SAg_Proliferation_down|BSK_SAg_SRB_down|BSK_hDFCGF_Proliferation_down,TRUE
"L-3,4-Dihydroxyphenylalanine methyl ester hydrochloride",1421-65-4,0.689696981472413,1.55458279544654,1.10331617656509,86.342947769446,TOX21_Aromatase_Inhibition_viability,TRUE
MON-4660,71526-07-3,0.277289223026959,1.05726918642217,1.22341925975323,100,ACEA_ER_AUC_viability,TRUE
Maprotiline hydrochloride,10347-81-6,0.722808766463301,1.2573240564111,1.78524829389354,93.9789918596925,TOX21_ARE_BLA_agonist_viability|TOX21_CAR_Antagonist_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_FXR_BLA_antagonist_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_PR_BLA_Antagonist_viability|TOX21_RT_HEPG2_FLO_40hr_ctrl_viability|TOX21_VDR_BLA_antagonist_viability,TRUE
Naftifine hydrochloride,65473-14-5,0.23399451547915,0.753439760806591,1.83704157083544,30.2591072060611,TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RXR_BLA_Agonist_viability,TRUE
Procyclidine hydrochloride,1508-76-5,0.0141260674856244,0.650812688094617,1.50579798364288,26.7300060944307,TOX21_CAR_Agonist_viabillity|TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability,TRUE
"R-(-)-2,5-Dimethoxy-4-bromoamphetamine hydrochloride",50505-92-5,0.670234927940465,1.17951935898681,1.99804793350502,30.4570909344868,TOX21_ERb_BLA_Agonist_viability|TOX21_PR_BLA_Agonist_viability|TOX21_PXR_viability|TOX21_TR_LUC_GH3_Antagonist_viability,TRUE
"S-(+)-2,5-Dimethoxy-4-bromoamphetamine hydrochloride",50505-93-6,0.524912287693044,1.23152103246001,1.35045386362154,19.6257944480758,TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability,TRUE
Sertraline hydrochloride,79559-97-0,0.359115052313113,1.06632654173656,2.54406024432751,52.1216597496915,TOX21_ARE_BLA_agonist_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PR_BLA_Antagonist_viability|TOX21_RT_HEK293_FLO_08hr_viability|TOX21_RT_HEPG2_FLO_32hr_ctrl_viability,TRUE
Thioridazine hydrochloride,130-61-0,1.14377048003467,1.33763076096268,3.72323702595904,96.8099340940991,TOX21_ARE_BLA_agonist_viability|TOX21_AR_BLA_Antagonist_viability|TOX21_ERR_viability|TOX21_FXR_BLA_agonist_viability|TOX21_HRE_BLA_Agonist_viability|TOX21_PGC_ERR_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_PR_BLA_Antagonist_viability|TOX21_RT_HEK293_GLO_00hr_viability|TOX21_RT_HEPG2_FLO_24hr_viability|TOX21_RT_HEPG2_FLO_32hr_ctrl_viability|TOX21_RXR_BLA_Agonist_viability,TRUE
Trihexyphenidyl hydrochloride,52-49-3,0.31300270374609,1.04146989031576,1.33075211362736,29.754156314307,TOX21_PXR_viability|TOX21_SSH_3T3_GLI3_Agonist_viability,TRUE
"o,p'-DDE",3424-82-6,0.848531654207807,0.966615258278253,7.61893602097957,0.671009260548552,BSK_3C_Proliferation_down|BSK_3C_Vis_down|BSK_LPS_SRB_down|BSK_SAg_Proliferation_down|TOX21_RT_HEPG2_FLO_40hr_ctrl_viability,TRUE
"p,p'-DDD",72-54-8,0.63125305932122,0.866446503419601,4.20371096287379,4.48795257454248,ACEA_AR_agonist_AUC_viability|ACEA_AR_antagonist_AUC_viability|APR_HepG2_CellLoss_72h_dn|BSK_SAg_Proliferation_down|BSK_hDFCGF_Proliferation_down|BSK_hDFCGF_SRB_down|TOX21_AP1_BLA_Agonist_viability|TOX21_RT_HEPG2_FLO_24hr_viability,TRUE
"p,p'-DDE",72-55-9,0.731178010284281,0.943422549367039,2.85957732956513,1.35062893905765,APR_HepG2_CellLoss_24h_dn|BSK_hDFCGF_Proliferation_down|BSK_hDFCGF_SRB_down,TRUE
p-Anisidinium chloride,20265-97-8,-0.157685465531808,0.743900762088261,1.6646687052135,45.0716294398263,ACEA_ER_AUC_viability|NCCT_HEK293T_CellTiterGLO,TRUE
"2,4-Dichlorophenyl benzenesulfonate",97-16-5,0.836733339030689,1.12090522025539,5.26568013470573,33.648794033168,TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
4-Chlorobenzotrichloride,5216-25-1,1.17615335403663,1.34759614390283,5.56595299332243,41.9032696379251,TOX21_RT_HEPG2_FLO_40hr_ctrl_viability,TRUE
4-Chlorobiphenyl,2051-62-9,0.334868465682221,0.674491855741762,2.81794038606381,21.7646045940898,BSK_3C_SRB_down|TOX21_RT_HEK293_FLO_32hr_viability,TRUE
Azaconazole,60207-31-0,0.998421509755205,1.35887157182234,2.64736397593291,27.7682116200265,TOX21_RT_HEK293_GLO_32hr_viability,TRUE
Bromuconazole,116255-48-2,-0.226651464184131,-0.0505375603915492,5.42780173450645,1.97106975217869,TOX21_RT_HEPG2_FLO_32hr_ctrl_viability|TOX21_RT_HEPG2_FLO_40hr_ctrl_viability,TRUE
DDT,50-29-3,-1.20972639054093,-0.633372039291144,2.90404296249493,100,TOX21_RXR_BLA_Agonist_viability|SH-S5Y5 viability,TRUE
Endosulfan sulfate,1031-07-8,0.639728080821386,0.900984569238828,4.14998468515532,13.8277177037916,BSK_3C_Proliferation_down|BSK_4H_SRB_down|BSK_CASM3C_Proliferation_down|TOX21_PR_BLA_Followup_Antagonist_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Fenbuconazole,114369-43-6,1.2083949156193,1.62883197955224,1.94356467720925,34.479794393564,APR_HepG2_CellLoss_24h_dn|APR_HepG2_MicrotubuleCSK_24h_up|BSK_SAg_Proliferation_down|TOX21_AR_BLA_Antagonist_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_RT_HEPG2_GLO_00hr_ctrl_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability,TRUE
Imazalil,35554-44-0,0.577734203766206,1.4539514089727,1.13385842227314,44.006729017343,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_72h_up|NCCT_MITO_viability|TOX21_PR_BLA_Antagonist_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Isoconazole,27523-40-6,0.718442951623692,1.18173827580251,3.10139780345781,59.1903662082185,TOX21_CASP3_CHO_viability|TOX21_ERb_BLA_Antagonist_viability,TRUE
Robenidine,25875-51-8,0.912301905113541,1.17018346502313,3.85146688446949,89.820895396829,TOX21_AP1_BLA_Agonist_viability|TOX21_ARE_BLA_agonist_viability|TOX21_NFkB_BLA_agonist_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_VDR_BLA_Agonist_viability,TRUE
Thiacloprid,111988-49-9,1.53411090151123,1.98418971609181,2.12016757626898,1.04949552985861,APR_HepG2_CellLoss_72h_dn,TRUE
Tioconazole,65899-73-2,6.6011914232053,8.28912366855052,0.573813458328182,-124.760561158396,TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability,TRUE
"1,2-Bis(chloromethyl)benzene",612-12-4,1.29809484102234,1.45358807608747,6.13687475882575,39.8453608700805,TOX21_RORg_LUC_CHO_Antagonist_viability,TRUE
"1-(2,6-Dichlorophenyl)-2-indolinone",15362-40-0,0.898273112499175,1.35634356567527,2.0831784779458,34.5949826365278,TOX21_ERb_BLA_Agonist_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_RXR_BLA_Agonist_viability,TRUE
"2-Chloro-N,N-bis(2-chloroethyl)ethanamine",555-77-1,-0.0872407981295254,0.19713926319135,3.35551833348338,60.7408542282845,TOX21_HRE_BLA_Agonist_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
2-Chloro-N-phenylacetamide,587-65-5,0.966350269825991,1.41091083179453,2.9121435498376,83.1796793330537,ACEA_ER_AUC_viability|TOX21_CASP3_CHO_viability|TOX21_ERR_viability|TOX21_HSE_BLA_agonist_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_VDR_BLA_Agonist_viability,TRUE
Amoxapine,14028-44-5,0.12772170227481,1.02960727277384,1.08428871364387,70.4647459939393,TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_TR_LUC_GH3_Antagonist_viability,TRUE
Carbonyl cyanide chlorophenylhydrazone,555-60-2,-0.0258710411695742,0.990188186019732,0.912685079781899,95.6529730699912,TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_CAR_Agonist_viabillity|TOX21_CASP3_HEPG2_viability|TOX21_ELG1_LUC_Agonist_viability|TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability|TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2_viability|TOX21_FXR_BLA_antagonist_viability|TOX21_PGC_ERR_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_PXR_viability|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_RT_HEPG2_FLO_24hr_viability|TOX21_RT_HEPG2_FLO_32hr_ctrl_viability|TOX21_RT_HEPG2_FLO_40hr_ctrl_viability|TOX21_RT_HEPG2_GLO_00hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability|TOX21_SBE_BLA_Antagonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_VDR_BLA_Agonist_viability|TOX21_p53_BLA_p2_viability,TRUE
Chlorfenson,80-33-1,1.31170053799579,2.68605736195442,0.694319330180039,60.6550216950654,TOX21_H2AX_HTRF_CHO_viability,TRUE
Cypromid,2759-71-9,0.299882197756075,0.44747192907368,6.46550746397017,30.0180848673105,TOX21_RT_HEK293_GLO_32hr_viability,TRUE
Domperidone,57808-66-9,0.196386819688021,0.414299548158949,3.66003050270398,36.8240548742465,TOX21_ERb_BLA_Agonist_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability,TRUE
Forchlorfenuron,68157-60-8,1.22686989822653,1.45761075871788,3.09540549167171,2.09734166922541,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_24h_up|APR_HepG2_MicrotubuleCSK_72h_up|TOX21_CAR_Antagonist_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Heptachlor,76-44-8,1.29539719480554,1.49540947718679,6.8836926432885,1.1647000353774,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_72h_dn|BSK_SAg_Proliferation_down|BSK_hDFCGF_SRB_down,TRUE
Ticlatone,70-10-0,0.504611332367496,1.0991548462786,1.60500028528104,112.192466478473,TOX21_CASP3_CHO_viability,TRUE
Triclocarban,101-20-2,0.371888818364188,0.698299671718798,2.8101853983769,33.5866798797799,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_72h_up|BSK_CASM3C_Proliferation_down|BSK_CASM3C_SRB_down|NCCT_HEK293T_CellTiterGLO|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_CAR_Antagonist_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_HRE_BLA_Agonist_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_RAR_LUC_Agonist_viability|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEPG2_FLO_40hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability,TRUE
"Tris(1,3-dichloro-2-propyl) phosphate",13674-87-8,1.39346240262975,1.81608826258576,2.25819571768339,5.02110259793947,APR_HepG2_CellLoss_72h_dn|APR_HepG2_NuclearSize_24h_dn,TRUE
"1,2,5,6,9,10-Hexabromocyclododecane",3194-55-6,0.760607249877125,1.24665575240058,3.75186935155964,63.5014596375104,TOX21_CASP3_CHO_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_PR_BLA_Agonist_viability|TOX21_PR_BLA_Antagonist_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RXR_BLA_Agonist_viability|TOX21_p53_BLA_p2_viability|TOX21_p53_BLA_p3_viability,TRUE
"1,2-Dibromo-2,4-dicyanobutane",35691-65-7,0.529725618325329,0.909506939454529,2.55669617627976,12.0064386516488,ACEA_AR_antagonist_AUC_viability|ACEA_ER_AUC_viability|BSK_3C_Vis_down|BSK_BE3C_SRB_down|BSK_CASM3C_SRB_down|BSK_hDFCGF_SRB_down|TOX21_AR_BLA_Antagonist_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEPG2_FLO_32hr_ctrl_viability|TOX21_RT_HEPG2_FLO_40hr_ctrl_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability|TOX21_TR_LUC_GH3_Antagonist_viability,TRUE
"2,2',4,4',5-Pentabromodiphenyl ether",60348-60-9,1.20173222996787,1.33515638568725,7.15194714401132,56.4233917088393,TOX21_RXR_BLA_Agonist_viability,TRUE
"2,2',4,4'-Tetrabromodiphenyl ether",5436-43-1,1.31538366136094,1.45139148741718,7.0160853026554,41.7821783806882,TOX21_RXR_BLA_Agonist_viability,TRUE
9-Bromophenanthrene,573-17-1,0.973725300717687,1.34529114007252,4.88969296755741,40.7212824610411,TOX21_ERb_BLA_Agonist_viability|TOX21_RT_HEK293_FLO_40hr_viability,TRUE
"2-Chloro-N,N-dimethyl-3-oxobutanamide",5810-11-07,0.559918476265212,1.74130482108056,0.81143116681324,1.32278747902399,BSK_SAg_PBMCCytotoxicity_down|BSK_SAg_Proliferation_down,TRUE
3'-Methyl-4-(dimethylamino)azobenzene,55-80-1,0.541763392964664,1.22064325853447,1.23506866254452,37.0890570387314,TOX21_ERR_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability|TOX21_MMP_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability,TRUE
3-Dimethylaminophenol,99-07-0,-1.74652505390583,-0.185158470089812,0.611158532102778,11.0284211505525,TOX21_RT_HEPG2_FLO_24hr_viability,TRUE
7-(Dimethylamino)-4-methylcoumarin,1987-01-04,0.327212611557278,0.451010077978361,6.35779294592933,10.6911400854116,TOX21_PR_BLA_Agonist_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability,TRUE
Amitraz,33089-61-1,1.36337285093689,1.64997749243026,4.18878390786339,97.8076819620131,TOX21_HRE_BLA_Agonist_viability|TOX21_PXR_viability,TRUE
Bencyclane,2179-37-5,-0.00685480320573528,0.919194157562355,1.03044498710722,36.710936173409,TOX21_RXR_BLA_Agonist_viability,TRUE
Chloroxuron,1982-47-4,0.390435666756077,1.06929503318402,1.62634107006098,27.0622350787213,TOX21_H2AX_HTRF_CHO_viability|TOX21_RT_HEK293_GLO_08hr_viability,TRUE
Clomipramine,303-49-1,0.800625027823162,1.22311801124141,1.95345124862321,56.6159997740749,TOX21_ERb_BLA_Agonist_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_RXR_BLA_Agonist_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_VDR_BLA_Agonist_viability,TRUE
"N,N-Dimethyl-4-nitrosoaniline",138-89-6,1.07597000272592,1.44685433741886,2.87904205460371,82.8464161010044,TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_CAR_Agonist_viabillity|TOX21_CAR_Antagonist_viability|TOX21_CASP3_CHO_viability|TOX21_GR_BLA_Antagonist_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_RAR_LUC_Agonist_viability|TOX21_RT_HEPG2_GLO_00hr_ctrl_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability,TRUE
"N,N-Dimethyl-p-phenylenediamine",99-98-9,1.14928382466225,1.43466318220526,2.69819404174432,54.9010608483542,TOX21_AR_BLA_Antagonist_viability|TOX21_HDAC_Inhibition_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RXR_BLA_Agonist_viability,TRUE
"N,N-Dimethylacrylamide",2680-03-07,1.31334053252362,1.45374650497089,6.79630996322246,20.941240165967,TOX21_RT_HEPG2_GLO_00hr_ctrl_viability,TRUE
Tetramethylthiuram monosulfide,97-74-5,-0.190062103018601,0.136425191073127,2.26612419491044,72.0210953284774,BSK_3C_Proliferation_down|BSK_3C_SRB_down|BSK_CASM3C_Proliferation_down|BSK_hDFCGF_Proliferation_down|BSK_hDFCGF_SRB_down|TOX21_ARE_BLA_agonist_viability|TOX21_AR_BLA_Antagonist_viability|TOX21_Aromatase_Inhibition_viability|TOX21_CAR_Antagonist_viability|TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_FXR_BLA_agonist_viability|TOX21_FXR_BLA_antagonist_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_PGC_ERR_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PR_BLA_Agonist_viability|TOX21_PR_BLA_Antagonist_viability|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_RT_HEK293_FLO_24hr_viability|TOX21_RT_HEK293_FLO_32hr_viability|TOX21_RT_HEK293_FLO_40hr_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_FLO_24hr_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability,TRUE
Thiram,137-26-8,-1.00373201387531,-0.509208910494116,2.17001522590068,70.2143096886397,APR_HepG2_MicrotubuleCSK_72h_dn|BSK_3C_Proliferation_down|BSK_BE3C_SRB_down|BSK_CASM3C_Proliferation_down|BSK_KF3CT_SRB_down|BSK_SAg_PBMCCytotoxicity_down|STM_H9_Viability_norm|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_CAR_Agonist_viabillity|TOX21_CASP3_CHO_viability|TOX21_CASP3_HEPG2_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_NFkB_BLA_agonist_viability|TOX21_PGC_ERR_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PXR_viability|TOX21_RT_HEK293_FLO_08hr_viability|TOX21_RT_HEK293_FLO_32hr_viability|TOX21_RT_HEK293_FLO_40hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEPG2_FLO_16hr_ctrl_viability|TOX21_RT_HEPG2_FLO_40hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability|TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_VDR_BLA_Agonist_viability,TRUE
1-Methyl-3-phenyl-5-(3-(trifluoromethyl)phenyl)-4-pyridone,59756-60-4,0.848485493407303,1.91784064524687,1.08438151533379,55.9105199204494,APR_HepG2_CellLoss_72h_dn|TOX21_Aromatase_Inhibition_viability|TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability,TRUE
Acetamiprid,135410-20-7,-0.572949185692318,0.0700712828834294,1.93798527922368,50.0526504616661,BSK_4H_SRB_down|SH-S5Y5 viability,TRUE
Butafenacil,134605-64-4,0.996516322790556,1.49749565090325,2.1472871707009,11.0353399380144,APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_72h_up|TOX21_RT_HEK293_GLO_00hr_viability|TOX21_SSH_3T3_GLI3_Agonist_viability,TRUE
Dichlofluanid,1085-98-9,0.14432100556878,0.761491160009873,1.39517838465411,88.0217068611992,TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_CAR_Antagonist_viability|TOX21_ERR_viability|TOX21_HRE_BLA_Agonist_viability|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_RT_HEK293_FLO_32hr_viability|TOX21_RT_HEK293_FLO_40hr_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_00hr_ctrl_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability,TRUE
Meloxicam,71125-38-7,1.09058294381567,1.66577571156743,2.17810572131044,36.9468580626873,TOX21_CASP3_HEPG2_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability,TRUE
Tolylfluanid,731-27-1,0.444594485041089,0.937424652395427,2.08798318810571,86.7263240564692,ATG_XTT_Cytotoxicity_up|TOX21_ARE_BLA_agonist_viability|TOX21_AR_BLA_Antagonist_viability|TOX21_Aromatase_Inhibition_viability|TOX21_FXR_BLA_antagonist_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_00hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_TR_LUC_GH3_Antagonist_viability,TRUE
"1,1,3-Trimethyl-2-thiourea",2489-77-2,0.590320801339244,1.00309527689345,4.82633116152045,56.1079364628405,TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Aldoxycarb,1646-88-4,0.292600084640911,0.769081433617368,2.00268596344675,31.9850097846869,ACEA_AR_antagonist_AUC_viability,TRUE
Carbaryl,63-25-2,0.604679749811005,1.27707786518996,1,93.8302134165319,TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|SH-S5Y5 viability,TRUE
Methiocarb,2032-65-7,0.677039865571385,1.26708950312611,1,0.737056113806351,BSK_3C_Proliferation_down|BSK_3C_SRB_down|BSK_CASM3C_Proliferation_down|BSK_CASM3C_SRB_down|SH-S5Y5 viability,TRUE
N-Methyl-4-nitroaniline,100-15-2,1.12048840636623,1.592408372817,2.15591540938397,57.7500056526747,TOX21_CAR_Antagonist_viability|TOX21_CASP3_CHO_viability|TOX21_CASP3_HEPG2_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_PGC_ERR_viability|TOX21_SSH_3T3_GLI3_Agonist_viability,TRUE
Olanzapine,132539-06-1,0.293248223272005,1.10674578585316,1.29224727323008,70.0821412032814,TOX21_AhR_LUC_Agonist_viability|TOX21_Aromatase_Inhibition_viability|TOX21_CAR_Agonist_viabillity|TOX21_CASP3_CHO_viability|TOX21_ERR_viability|TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability|TOX21_PXR_viability|TOX21_TR_LUC_GH3_Antagonist_viability,TRUE
Oxamyl,23135-22-0,2.02605912553385,2.65704304618129,1.52779131385143,26.9804557133798,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn,TRUE
Azoxystrobin,131860-33-8,0.251948938390343,0.930778957761782,1.25449298453634,1.99697852272714,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|BSK_3C_SRB_down|BSK_CASM3C_Proliferation_down|BSK_LPS_SRB_down|BSK_SAg_PBMCCytotoxicity_up|TOX21_CAR_Agonist_viabillity|TOX21_CASP3_CHO_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_PXR_viability|SH-S5Y5 viability,TRUE
CP-607366,289716-94-5,1.12831213454822,1.64419329564115,1.7041777306984,52.9127116254424,APR_HepG2_NuclearSize_24h_dn|TOX21_AR_BLA_Antagonist_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_RT_HEK293_GLO_00hr_viability|TOX21_RT_HEK293_GLO_24hr_viability,TRUE
Dimethyl isophthalate,1459-93-4,0.458561013517332,0.732085134948781,4.14040698468665,46.7853930940833,TOX21_RT_HEK293_FLO_24hr_viability|TOX21_RT_HEPG2_FLO_00hr_ctrl_viability,TRUE
Dimethyl terephthalate,120-61-6,1.26498383832937,1.57355985940481,4.77877502302675,-176.341093947645,TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_32hr_viability,TRUE
Doramectin,117704-25-3,0.613048309084639,0.769849111294543,5.44566025393281,98.7485830823759,TOX21_p53_BLA_p1_viability|TOX21_p53_BLA_p2_viability|TOX21_p53_BLA_p4_viability|TOX21_p53_BLA_p5_viability,TRUE
Fluoxastrobin,361377-29-9,-0.0423996276050105,0.986597233714264,0.996686728101972,38.9442451684304,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_72h_up|BSK_CASM3C_Proliferation_down|NCCT_MITO_viability|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_CAR_Agonist_viabillity|TOX21_CASP3_CHO_viability|TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability|TOX21_PXR_viability,TRUE
Fluoxetine,54910-89-3,0.577317064531445,1.14384313901468,1.85015537824438,77.455798162984,TOX21_ERb_BLA_Agonist_viability|TOX21_PR_BLA_Agonist_viability,TRUE
Haloxyfop-methyl,69806-40-2,-4.25917834388282,-2.78201853677162,0.645998154597424,-8.20014729122679,TOX21_RT_HEK293_GLO_08hr_viability,TRUE
Maprotiline,10262-69-8,0.51881841236737,1.45993417957302,1.01394806323631,41.9518649006334,TOX21_PR_BLA_Agonist_viability,TRUE
Methyl 3-methylorsellinate,4707-47-5,-0.207621071962527,0.829987084601109,0.919655944686863,50.594803304085,ACEA_AR_antagonist_AUC_viability,TRUE
Methylparaben,99-76-3,0.350568373460246,1.08654479376453,1.2965666876186,41.7284515726495,ACEA_AR_antagonist_AUC_viability,TRUE
Picoxystrobin,117428-22-5,-0.0223012805988341,0.7486740107687,1.1120750621068,49.3902973862042,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|BSK_hDFCGF_SRB_down|TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_CAR_Antagonist_viability|TOX21_CASP3_CHO_viability|TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Rifabutin,72559-06-9,0.900977678959393,1.49757397485505,1.52018460681924,84.3614828140394,TOX21_AhR_LUC_Agonist_viability|TOX21_Aromatase_Inhibition_viability|TOX21_CAR_Agonist_viabillity|TOX21_CASP3_HEPG2_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability|TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2_viability|TOX21_PGC_ERR_viability|TOX21_PXR_viability|TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability|TOX21_p53_BLA_p3_viability,TRUE
Rifampicin,13292-46-1,0.502209486417425,1.27374545958788,1.18475497751697,83.3506644931485,APR_HepG2_CellLoss_72h_dn|BSK_CASM3C_Proliferation_down|TOX21_AhR_LUC_Agonist_viability|TOX21_CASP3_CHO_viability|TOX21_CASP3_HEPG2_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_PGC_ERR_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability,TRUE
Thiazopyr,117718-60-2,1.28243908123818,1.78950820320262,1.8295236759746,1.20931945176713,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_72h_up|BSK_SAg_PBMCCytotoxicity_up,TRUE
2-Methoxy-3-aminodibenzofuran,5834-17-3,-1.56820014532292,0.123289812996072,0.56414317137753,18.5449893439227,TOX21_RT_HEK293_GLO_16hr_viability,TRUE
Carbendazim,10605-21-7,0.484927277932425,0.872244729886006,2.35998960500079,0.513063484546253,ACEA_AR_antagonist_AUC_viability|ACEA_ER_AUC_viability|APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|APR_HepG2_NuclearSize_72h_up|BSK_3C_Proliferation_down|BSK_3C_SRB_down|BSK_4H_SRB_down|BSK_CASM3C_Proliferation_down|BSK_LPS_SRB_down|BSK_SAg_SRB_down|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_32hr_viability,TRUE
Cyclobendazole,31431-43-3,-0.670283879363101,0.262981781689985,1.35105325292239,32.1825509383463,TOX21_CASP3_CHO_viability|TOX21_PGC_ERR_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Fenbendazole,43210-67-9,-0.684255028559888,0.0867346928898545,0.960195179363987,64.8095296549718,TOX21_Aromatase_Inhibition_viability|TOX21_CAR_Antagonist_viability|TOX21_CASP3_CHO_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_FLO_32hr_ctrl_viability|TOX21_RT_HEPG2_FLO_40hr_ctrl_viability|TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_TR_LUC_GH3_Antagonist_viability,TRUE
Fluthiacet-methyl,117337-19-6,2.30678305156973,2.94760517347776,1.49643050034666,15.6165526480819,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn,TRUE
Hydrotropic aldehyde dimethyl acetal,90-87-9,0.646342891472258,1.30336807110678,1.45236824861132,31.45251680104,ACEA_ER_AUC_viability,TRUE
"Methyl 3,3-dimethylpent-4-enoate",63721-05-1,-0.19827560434369,0.0523319755757279,4.41331643169914,69.1860786993422,TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
"Methyl 3-amino-5,6-dichloropyrazine-2-carboxylate",1458-18-0,-0.333745215142663,0.788498512805501,1.09807425337065,84.2355128922939,TOX21_CASP3_CHO_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability,TRUE
Methyl carbamate,598-55-0,0.881619459291527,1.35046170735039,2.67820550910106,51.504838145126,TOX21_PR_BLA_Agonist_viability|TOX21_PR_BLA_Antagonist_viability,TRUE
Mycophenolate mofetil,128794-94-5,-0.65764077998368,-0.013761237309656,1.87037042294835,42.1053895951557,TOX21_CASP3_CHO_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PR_BLA_Agonist_viability|TOX21_PR_BLA_Antagonist_viability|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_p53_BLA_p4_viability,TRUE
Thiophanate-methyl,23564-05-8,0.666446484713311,1.35122456854114,1.34562770193332,1.20065773963113,ACEA_AR_agonist_AUC_viability|ACEA_AR_antagonist_AUC_viability|APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_24h_up|BSK_SAg_PBMCCytotoxicity_up,TRUE
Zafirlukast,107753-78-6,0.705613718537898,1.01245733554686,4.65589137906249,71.2759562804783,TOX21_ERb_BLA_Antagonist_viability|TOX21_p53_BLA_p4_viability,TRUE
2-Methoxy-4-nitroaniline,97-52-9,0.0553078930093905,1.08862040000617,1.2064256154444,45.0753122314176,ACEA_AR_agonist_AUC_viability|ACEA_AR_antagonist_AUC_viability|NCCT_HEK293T_CellTiterGLO|TOX21_CAR_Agonist_viabillity,TRUE
"4'-Chloro-2',5'-dimethoxyacetoacetanilide",4433-79-8,0.205258743238582,1.27640031515098,0.845944566902169,76.9436950885644,TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_p53_BLA_p4_viability,TRUE
Desmethoxyyangonin,15345-89-8,-1.54998839530084,-0.279067226270433,0.76089075560904,20.7631819781813,TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Dimethomorph,110488-70-5,0.450339313366456,1.39914210429198,1.42580910048106,1.50179513743099,APR_HepG2_CellLoss_72h_dn|BSK_SAg_PBMCCytotoxicity_up|BSK_SAg_Proliferation_down|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability,TRUE
Epirizole,18694-40-1,0.82448967266577,1.05874178462306,4.07357057089547,61.8780467157675,TOX21_PR_BLA_Agonist_viability,TRUE
Griseofulvin,126-07-8,0.979847899395551,1.34378506544639,4.64799893222802,40.0270453666375,BSK_3C_Proliferation_down|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEPG2_FLO_32hr_ctrl_viability,TRUE
Teniposide,29767-20-2,-0.718674337385031,0.0639884796648009,1.21922555748368,48.4712118868288,TOX21_AR_BLA_Antagonist_viability,TRUE
"1-(4-tert-Butylphenyl)-3-(4-methoxyphenyl)propane-1,3-dione",70356-09-1,3.85899893007056,4.03966393078661,5.28183381206824,100,TOX21_RT_HEK293_GLO_32hr_viability,TRUE
"2,2'-Dihydroxy-4,4'-dimethoxybenzophenone",131-54-4,-0.250994571227897,0.704991595502835,0.751400527648348,26.4774968909164,TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
"2,2'-Dihydroxy-4-methoxybenzophenone",131-53-3,0.20921168509019,0.650489291372776,2.17604280694441,26.4610559747028,TOX21_RT_HEK293_GLO_24hr_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability,TRUE
"2,4-Dimethoxyaniline",2735-04-08,1.29770950663186,1.52582722879978,4.18311431646202,36.0480702412522,TOX21_ERb_BLA_Antagonist_viability,TRUE
2-Hydroxy-4-methoxybenzophenone,131-57-7,-0.169025625292915,1.63215791338183,0.529786381537456,0.197945975684609,BSK_3C_SRB_down,TRUE
3-Hydroxy-2-naphthoic o-anisidide,135-62-6,0.728546631148159,0.834695145354896,1.22804656707152,8.71350134417754,TOX21_AR_BLA_Antagonist_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability|TOX21_TR_RXR_BLA_Antagonist_Followup_viability,TRUE
"4,4'-Dimethoxyazoxybenzene",1562-94-3,0.614187253530752,2.41505770749624,0.529878485894473,79.189691496812,TOX21_RT_HEK293_GLO_40hr_viability,TRUE
"4,4'-Dimethoxydiphenylamine",101-70-2,0.133810489866625,1.20815205920976,0.894819525604261,67.8363013943623,TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_32hr_viability,TRUE
4-Methoxy-2-methyl-N-phenylaniline,41317-15-1,11.8186762866266,11.9814751643998,5.86148088053225,-14667.0603837125,TOX21_RT_HEK293_FLO_32hr_viability,TRUE
4-Methoxyaniline,104-94-9,0.879622289824857,1.0604013446167,5.27850148645864,22.3462243401883,TOX21_ERR_viability,TRUE
6-Methoxy-2-benzothiazolamine,1747-60-0,-0.451451290202622,0.323458323820267,1.23142427474276,56.5999662804029,TOX21_RT_HEK293_GLO_32hr_viability,TRUE
Biochanin A,491-80-5,0.13192850695807,0.828149394127541,1.37060310459638,33.2947113317999,ACEA_AR_antagonist_AUC_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_MMP_viability,TRUE
C.I. Solvent Red 80,6358-53-8,0.494832289208661,1.00011230616106,2.01412231996251,1.54047758474193,BSK_3C_Proliferation_down|BSK_3C_Vis_down|BSK_hDFCGF_Proliferation_down|BSK_hDFCGF_SRB_down|TOX21_CAR_Agonist_viabillity|TOX21_CAR_Antagonist_viability|TOX21_CASP3_CHO_viability|TOX21_HRE_BLA_Agonist_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_24hr_viability,TRUE
Chlorotrianisene,569-57-3,0.806554669825931,1.58550439023991,1.27698258332482,53.6627136890334,TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability,TRUE
Difpas-pyrazole,151506-44-4,1.08961734144963,1.88168306677921,1.21456227367344,22.0805134333621,APR_HepG2_CellLoss_72h_dn|TOX21_RT_HEK293_GLO_32hr_viability,TRUE
Formononetin,485-72-3,-0.406719178288865,1.01559743340717,0.670907237947141,30.7644799788201,TOX21_RORg_LUC_CHO_Antagonist_viability,TRUE
Frentizole,26130-02-9,0.0933687766072012,0.569379795766502,2.0046647473091,41.5022093775756,TOX21_ERb_BLA_Antagonist_viability|TOX21_HRE_BLA_Agonist_viability|TOX21_MMP_viability|TOX21_RT_HEK293_FLO_08hr_viability|TOX21_RT_HEK293_FLO_24hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Methoxychlor,72-43-5,0.346525173645613,0.998017415475119,1.5632585712694,0.491228792638332,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_72h_up|BSK_KF3CT_SRB_down|BSK_SAg_Proliferation_down|BSK_hDFCGF_Proliferation_down|BSK_hDFCGF_SRB_down,TRUE
Methoxyfenozide,161050-58-4,0.168586258303151,0.810363061451703,1.48687597426055,4.94798169833441,TOX21_ERR_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability,TRUE
Tepoxalin,103475-41-8,-3.08064455735572,-2.89403399037419,5.11355023927329,-16.8280399527349,TOX21_RT_HEPG2_FLO_40hr_ctrl_viability,TRUE
Azamethiphos,35575-96-3,1.00858602290748,1.4901588695708,2.16133862830913,2.5894050691402,ACEA_AR_antagonist_AUC_viability|APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_24h_up|APR_HepG2_MicrotubuleCSK_72h_up|BSK_hDFCGF_Proliferation_down|TOX21_ARE_BLA_agonist_viability|TOX21_CAR_Agonist_viabillity|TOX21_CAR_Antagonist_viability|TOX21_RT_HEK293_GLO_16hr_viability,TRUE
Brucine,357-57-3,0.928882380858259,1.3704024679117,2.07524074897937,30.8376162390171,TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Chlorbromuron,13360-45-7,0.555636511556712,1.48727626500768,3.78215857542179,56.8551230489847,TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_24hr_viability,TRUE
Di(2-methoxyethyl) phthalate,117-82-8,-2.46627770512106,-1.80830953125166,1.45028672713391,6.04316138382985,TOX21_RT_HEPG2_FLO_08hr_viability,TRUE
Ethylene glycol dimethyl ether,110-71-4,-0.425470962236257,-0.138695051926364,3.53796217822594,66.7259323764882,TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Famphur,52-85-7,0.845767992127227,1.92451211434529,0.884586520367092,0.423589571130598,BSK_hDFCGF_Proliferation_down,TRUE
Fluvoxamine,54739-18-3,0.399207295369056,0.650735980670631,3.74254938471792,23.3769462893542,TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability,TRUE
Linuron,330-55-2,-0.29557506916401,0.882817876640237,0.809782944506732,100,ACEA_AR_antagonist_AUC_viability,TRUE
Prazosin,19216-56-9,0.766090167483108,0.949574436246136,5.2006775069733,91.0545283227509,TOX21_TR_LUC_GH3_Antagonist_viability,TRUE
Tetrachlorovinphos,961-11-5,2.88599928748336,3.08531719756491,4.78754021175969,-2087.09299051659,TOX21_RT_HEPG2_FLO_40hr_ctrl_viability,TRUE
Tolclofos-methyl,57018-04-9,1.01570432285453,1.34380137482111,2.82490313979314,0.446742985739598,BSK_3C_Proliferation_down|BSK_4H_SRB_down|BSK_CASM3C_Proliferation_down|BSK_SAg_Proliferation_down|BSK_SAg_SRB_down,TRUE
Z-Tetrachlorvinphos,22248-79-9,0.337415937186192,2.13266384244397,0.531538015805292,52.2491941469512,TOX21_RT_HEPG2_GLO_08hr_ctrl_viability,TRUE
1-Decyl-3-methylimidazolium hexafluorophosphate,362043-46-7,-0.826068250766831,0.423622582876847,1.12192078978341,51.9435590954642,TOX21_AR_BLA_Antagonist_viability|TOX21_ERR_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_PGC_ERR_viability|TOX21_RT_HEK293_FLO_32hr_viability|TOX21_RT_HEK293_FLO_40hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_TRB_BLA_Antagonist_Followup_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_TR_RXR_BLA_Antagonist_Followup_viability,TRUE
1-Dodecyl-3-methylimidazolium hexafluorophosphate,219947-93-0,0.291598334457263,1.19712415998609,1.03163159104573,98.6175166636068,TOX21_CAR_Agonist_viabillity|TOX21_ESRE_BLA_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_HSE_BLA_agonist_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_PR_BLA_Antagonist_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_FLO_40hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability,TRUE
1-Dodecyl-3-methylimidazolium tetrafluoroborate,244193-59-7,-0.240989308385254,0.793081296671892,1.2379432166333,75.7120894403469,TOX21_ARE_BLA_agonist_viability|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_CAR_Antagonist_viability|TOX21_ERR_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_GR_BLA_Antagonist_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_PGC_ERR_viability|TOX21_PR_BLA_Antagonist_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_FLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability,TRUE
1-Ethyl-3-methylimidazolium hexafluorophosphate,155371-19-0,-1.280888825861,0.174886319868983,0.643418578781972,55.4597848310808,TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability,TRUE
1-Hexadecyl-3-methylimidazolium tetrafluoroborate,244193-64-4,0.241955607685545,1.22538640045948,0.915020063553919,100,TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_CASP3_CHO_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_GR_BLA_Antagonist_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_FLO_40hr_ctrl_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_VDR_BLA_Agonist_viability,TRUE
1-Hexyl-3-methylimidazolium hexafluorophosphate,304680-35-1,0.0893079109170394,1.32298174218921,0.809731102171647,67.1691308366564,TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_CAR_Agonist_viabillity|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
1-Hexyl-3-methylimidazolium tetrafluoroborate,244193-50-8,0.738345347771155,1.12115338039118,2.13677432328639,27.6033189826052,TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_CAR_Antagonist_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability,TRUE
1-Hexylpyridinium hexafluorophosphate,797789-00-5,-0.0797500962167386,1.42986715382559,0.708865047355425,53.7628162308825,TOX21_CAR_Agonist_viabillity|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability,TRUE
1-Methyl-3-octadecylimidazolium hexafluorophosphate,219947-96-3,0.338051514660099,1.09920851952817,1.27937130658417,97.0383749767771,TOX21_ARE_BLA_agonist_viability|TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_CAR_Agonist_viabillity|TOX21_CAR_Antagonist_viability|TOX21_ERR_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_ESRE_BLA_viability|TOX21_GR_BLA_Antagonist_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_PXR_viability|TOX21_RT_HEK293_FLO_16hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_FLO_24hr_viability|TOX21_RXR_BLA_Agonist_viability|TOX21_VDR_BLA_Agonist_viability,TRUE
1-Methyl-3-octylimidazolium tetrafluoroborate,244193-52-0,0.133224099873105,0.516037555174444,2.49325766830442,41.3168046472654,TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_CAR_Agonist_viabillity|TOX21_CAR_Antagonist_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_RT_HEK293_FLO_40hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_VDR_BLA_Agonist_viability,TRUE
3-Methyl-4-(methylthio)phenol,3120-74-9,1.12920749233948,1.30554963539372,6.00454155096494,94.9764627371418,ACEA_ER_AUC_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability,TRUE
4-Chlorophenyl methyl sulfone,98-57-7,-3.25307311635556,-3.09363693442716,5.98510637860037,100,TOX21_RT_HEPG2_FLO_16hr_ctrl_viability,TRUE
Aziprotryne,4658-28-0,2.09492266085106,2.22519224332573,7.32513677646026,-6813.6189751173,TOX21_RT_HEK293_GLO_24hr_viability,TRUE
Benztropine methylsulfonate,132-17-2,0.327430530182547,1.24902007488396,1.03543113626413,100,TOX21_TR_LUC_GH3_Antagonist_viability,TRUE
Bromocriptine mesylate,22260-51-1,0.314437114073826,0.930321124052903,1.31490926156971,47.0890753406147,ACEA_AR_agonist_AUC_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability,TRUE
Cybutryne,28159-98-0,0.605094104014219,1.06104376968868,2.09286809768302,24.4326596194474,TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Difenzoquat metilsulfate,43222-48-6,0.625902053642839,1.35408875674301,1.16875555151617,46.4750463472632,TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_CAR_Agonist_viabillity|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Doxazosin mesylate,77883-43-3,0.262937438534816,0.46283215364127,4.77372555313001,22.2684222267973,TOX21_RT_HEPG2_GLO_00hr_ctrl_viability,TRUE
Fenamidone,161326-34-7,0.703790626396914,1.33263827537351,1.9845228228911,1.39739584012872,APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_24h_up|APR_HepG2_MicrotubuleCSK_72h_up|BSK_3C_SRB_down|BSK_LPS_SRB_down|BSK_SAg_PBMCCytotoxicity_up|STM_H9_Viability_norm|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_CAR_Agonist_viabillity|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability,TRUE
Metribuzin,21087-64-9,0.356849614509923,1.38585222871496,0.927347021539429,38.3612228677653,ACEA_AR_agonist_AUC_viability,TRUE
Pentachlorothioanisole,1825-19-0,0.750462254689257,0.89990068124013,6.38552299742311,16.7052469445753,TOX21_RT_HEK293_FLO_32hr_viability,TRUE
PharmaGSID_48506,588941-45-1,0.808200686828997,1.66087631814375,1.1900072954787,20.0522451784033,BSK_4H_SRB_down|BSK_SAg_Proliferation_down|TOX21_Aromatase_Inhibition_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability,TRUE
Saquinavir mesylate,149845-06-7,0.888931207305751,1.40244812102062,1.74681449641198,99.0841678158595,TOX21_AhR_LUC_Agonist_viability|TOX21_Aromatase_Inhibition_viability|TOX21_CAR_Agonist_viabillity|TOX21_CAR_Antagonist_viability|TOX21_CASP3_HEPG2_viability|TOX21_ERR_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_PGC_ERR_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability|TOX21_TR_LUC_GH3_Antagonist_viability,TRUE
Thiodicarb,59669-26-0,0.821551713438808,0.975812298586598,5.31208291768848,0.983001690671321,APR_HepG2_CellLoss_24h_dn|BSK_3C_Vis_down|BSK_KF3CT_SRB_down|BSK_SAg_PBMCCytotoxicity_down|BSK_SAg_Proliferation_down|BSK_hDFCGF_SRB_down|TOX21_TR_LUC_GH3_Antagonist_viability,TRUE
Thioridazine,50-52-2,0.545519086289036,1.09963861649996,1.96920463775109,97.3024700495002,TOX21_ERb_BLA_Agonist_viability|TOX21_FXR_BLA_agonist_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PPARd_BLA_antagonist_viability,TRUE
Trihexyltetradecylphosphonium hexafluorophosphate,374683-44-0,0.343086617035523,1.03122828209062,1.40577500252288,92.9656055276971,TOX21_AP1_BLA_Agonist_viability|TOX21_ARE_BLA_agonist_viability|TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_Aromatase_Inhibition_viability|TOX21_CASP3_CHO_viability|TOX21_CASP3_HEPG2_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability|TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_ESRE_BLA_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_HRE_BLA_Agonist_viability|TOX21_HSE_BLA_agonist_viability|TOX21_PR_BLA_Agonist_viability|TOX21_PR_BLA_Antagonist_viability|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_RT_HEK293_FLO_16hr_viability|TOX21_RT_HEK293_FLO_32hr_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_VDR_BLA_Agonist_viability,TRUE
Cloflucarban,369-77-7,0.442166166640136,1.04735590635731,1.87641161500291,68.2132361799226,TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_CAR_Agonist_viabillity|TOX21_CAR_Antagonist_viability|TOX21_CASP3_CHO_viability|TOX21_ELG1_LUC_Agonist_viability|TOX21_ERa_BLA_Antagonist_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_MMP_viability|TOX21_PGC_ERR_viability|TOX21_PXR_viability|TOX21_RT_HEK293_FLO_40hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RXR_BLA_Agonist_viability|TOX21_SBE_BLA_Agonist_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_VDR_BLA_Agonist_viability|TOX21_VDR_BLA_antagonist_viability,TRUE
Efavirenz,154598-52-4,-2.64213126045302,-1.1196964856676,0.626787121027118,29.7198817845728,TOX21_PR_BLA_Followup_Agonist_viability,TRUE
Fludioxonil,131341-86-1,0.559656699286534,1.06811917051061,1.9358191160429,2.182638053025,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_72h_up|BSK_3C_Proliferation_down|BSK_3C_SRB_down|BSK_3C_Vis_down|BSK_LPS_SRB_down|BSK_hDFCGF_Proliferation_down|BSK_hDFCGF_SRB_down|TOX21_CASP3_CHO_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_p53_BLA_p4_viability,TRUE
Fluopicolide,239110-15-7,0.794479293855441,1.11331098995303,3.66130731920107,29.5950087510113,TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_CASP3_CHO_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RXR_BLA_Agonist_viability|TOX21_SSH_3T3_GLI3_Agonist_viability,TRUE
Flurochloridone,61213-25-0,0.30488270555763,0.409357937301201,6.74883423678352,16.7285797370321,TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Lufenuron,103055-07-8,-0.00524473485276555,0.759002688300449,2.01161629207465,37.1098088785532,ACEA_AR_antagonist_AUC_viability|TOX21_MMP_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Tetraconazole,112281-77-3,0.864560262456156,1.37259415523959,1.53842639575334,2.75396472709654,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_24h_up|APR_HepG2_MicrotubuleCSK_72h_up|NCCT_MITO_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEPG2_FLO_16hr_ctrl_viability,TRUE
Tralopyril,122454-29-9,-0.55553153776968,0.192144620011252,1.25041088314235,43.0785618013274,ACEA_ER_AUC_viability|BSK_3C_Vis_down|BSK_CASM3C_Proliferation_down|BSK_SAg_Proliferation_down|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_CAR_Agonist_viabillity|TOX21_CASP3_CHO_viability|TOX21_ERR_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_SBE_BLA_Agonist_viability|TOX21_SBE_BLA_Antagonist_viability,TRUE
Triflumuron,64628-44-0,0.727817090561171,1.43098152112705,1.00367237554727,50.8696377940755,TOX21_PR_BLA_Agonist_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
"1,2-Diphenoxyethane",104-66-5,0.544496357333446,2.11600797805641,0.607213142337649,113.048779552942,ACEA_AR_antagonist_AUC_viability,TRUE
"1,4-Butanediol diglycidyl ether",2425-79-8,-0.190366129407458,-0.0608775012975504,7.36931515429586,-5.70970457678803,TOX21_RT_HEK293_GLO_40hr_viability,TRUE
17-Methyltestosterone,58-18-4,0.0865000878159611,1.08444374166287,0.95620880573856,81.9038773303577,TOX21_RT_HEPG2_GLO_00hr_ctrl_viability,TRUE
4-(3-Phenylpropyl)pyridine,2057-49-0,0.706723365056007,1.08695204166752,2.51370649298673,28.9152826647718,TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEPG2_FLO_16hr_ctrl_viability|TOX21_RT_HEPG2_FLO_24hr_viability,TRUE
4-(Diglycidylamino)phenyl glycidyl ether,5026-74-4,0.881992046115898,1.24047363506971,2.80014387649783,64.2440900883796,TOX21_PXR_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Cantharidin,56-25-7,0.105799078519007,0.398660327370049,2.44800863972125,70.7279782633718,TOX21_AhR_LUC_Agonist_viability|TOX21_Aromatase_Inhibition_viability|TOX21_ELG1_LUC_Agonist_viability|TOX21_TR_LUC_GH3_Antagonist_viability,TRUE
Clodinafop-propargyl,105512-06-9,0.0359900921269316,1.07760177133064,0.741199227507639,53.0890776043239,ACEA_AR_agonist_AUC_viability|ACEA_AR_antagonist_AUC_viability|TOX21_RT_HEK293_FLO_08hr_viability,TRUE
Diphenylmethane,101-81-5,-0.0387832204753054,0.800811053754179,1.13655194982726,43.7529388813056,ACEA_AR_antagonist_AUC_viability,TRUE
Mometasone furoate,83919-23-7,0.534502630703533,1.26654593947863,1.57584035391798,39.2380934718809,TOX21_CASP3_CHO_viability|TOX21_ERR_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RXR_BLA_Agonist_viability,TRUE
N-Benzyladenine,1214-39-7,1.14031648575827,1.25981406875553,7.77035545905665,20.0478946046052,TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Rutin,153-18-4,0.956396354800159,1.9408172577828,0.975741333193811,65.7146251438842,TOX21_PGC_ERR_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability,TRUE
"Tris(2,3-dibromopropyl) phosphate",126-72-7,0.577839184560568,1.61759767144502,1.26639473308649,53.4330865657224,TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_RT_HEK293_GLO_24hr_viability,TRUE
Valerenic acid,3569-10-06,-1.78943282124699,-1.16033894924332,3.37471779218064,10.1426404513607,TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_24hr_viability,TRUE
2-(Thiocyanomethylthio)benzothiazole,21564-17-0,0.696910718793556,1.04997374353829,2.51064589459822,41.2792976700768,ACEA_AR_antagonist_AUC_viability|APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_24h_up|BSK_CASM3C_SRB_down|BSK_SAg_PBMCCytotoxicity_down|BSK_SAg_SRB_down|NCCT_HEK293T_CellTiterGLO|TOX21_ARE_BLA_agonist_viability|TOX21_Aromatase_Inhibition_viability|TOX21_ESRE_BLA_viability|TOX21_HRE_BLA_Agonist_viability|TOX21_RT_HEK293_FLO_32hr_viability|TOX21_RT_HEK293_FLO_40hr_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_VDR_BLA_Agonist_viability,TRUE
2-Iodoethylbenzene,17376-04-4,0.685492338509893,1.0033365531856,3.00231142005976,50.2717384261348,TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability,TRUE
5-Fluorouracil,51-21-8,0.0436384684798236,0.57275897854827,1.7521184722307,52.04669675922,TOX21_CASP3_CHO_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_p53_BLA_p2_viability|TOX21_p53_BLA_p3_viability|TOX21_p53_BLA_p4_viability|cell viability,TRUE
Benodanil,15310-01-7,0.828412826531655,2.04437616771224,1.08062968583898,33.2239163421705,APR_HepG2_CellLoss_72h_dn|TOX21_PXR_viability,TRUE
C.I. 1040,212631-79-3,-2.22029808484283,-0.827285763173017,0.779462087875501,39.5081465942043,TOX21_CASP3_CHO_viability|TOX21_RT_HEPG2_FLO_24hr_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_SSH_3T3_GLI3_Agonist_viability,TRUE
Chlorfluazuron,71422-67-8,0.0689842241973617,1.36464908470196,1.38558764443248,43.8067982135628,TOX21_AR_BLA_Antagonist_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability,TRUE
Diflubenzuron,35367-38-5,0.304110568792521,1.00470773631892,4.73355291158663,48.1636133016508,TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Diphenylamine,122-39-4,-0.802994721130816,-0.140109045319101,4.30185298189687,-6.64570304116466,TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability,TRUE
Droperidol,548-73-2,0.272311349451563,0.394146449254277,7.83224629835338,22.0677696489019,TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Flufenoxuron,101463-69-8,0.718522412919615,1.26444763605842,2.64456607549321,32.9127320405088,TOX21_AR_BLA_Antagonist_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability,TRUE
Letrozole,112809-51-5,0.435943084369333,0.728901276270849,3.25726515188253,32.6541975151772,ACEA_AR_agonist_AUC_viability,TRUE
Methylene bis(thiocyanate),6317-18-6,0.785624664767389,1.10873797427217,3.41707043208229,100,ACEA_ER_AUC_viability|APR_HepG2_CellLoss_24h_dn|BSK_4H_SRB_down|NCCT_HEK293T_CellTiterGLO|TOX21_ARE_BLA_agonist_viability|TOX21_AR_BLA_Antagonist_viability|TOX21_CASP3_CHO_viability|TOX21_HSE_BLA_agonist_viability|TOX21_RAR_LUC_Agonist_viability|TOX21_RT_HEK293_FLO_32hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_FLO_24hr_viability|TOX21_RT_HEPG2_FLO_32hr_ctrl_viability,TRUE
"N,N'-Diphenyl-p-phenylenediamine",74-31-7,0.534924230811063,1.24681475653073,1.34265825927112,35.6268721963498,TOX21_Aromatase_Inhibition_viability|TOX21_CASP3_CHO_viability|TOX21_ERR_viability|TOX21_MMP_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability|TOX21_TR_LUC_GH3_Antagonist_viability,TRUE
N-Phenyl-1-naphthylamine,90-30-2,-0.390608832283998,0.309604195994678,1.36278885267977,42.8848877779892,ACEA_AR_antagonist_AUC_viability,TRUE
N-Phenyl-2-naphthylamine,135-88-6,-0.0227061437931912,0.67275355782458,1.88840015703335,0.0149651132150963,BSK_3C_Proliferation_down|BSK_4H_SRB_down|BSK_BE3C_SRB_down|BSK_CASM3C_Proliferation_down|BSK_KF3CT_SRB_down|BSK_hDFCGF_SRB_down,TRUE
Phenyl 11-iodo-10-undecynoate,2020-25-9,0.277410365254671,0.484170572954658,4.96878989282996,78.8696306794932,TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability,TRUE
"1,3-Diiminobenz(f)isoindoline",65558-69-2,0.964911115757468,1.42680829475466,2.16204575260356,95.151330849245,TOX21_CAR_Antagonist_viability|TOX21_HRE_BLA_Agonist_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability|TOX21_p53_BLA_p2_viability|TOX21_p53_BLA_p5_viability,TRUE
"1,3-Diphenylguanidine",102-06-7,0.874231558342734,1.32782800017592,2.10545169229274,1.89380555953354,APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_72h_up|ATG_FoxA2_CIS_up|TOX21_PXR_viability,TRUE
Carbazole,86-74-8,0.540083928646646,0.863153843682372,4.31384445603193,7.46521442269606,ACEA_ER_AUC_viability|BSK_3C_Proliferation_down,TRUE
Guanabenz,5051-62-7,0.0720470390464603,1.17580767470919,1.09906143030525,61.8167823434548,TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2_viability|TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability,TRUE
Indole,120-72-9,0.0468828457413416,0.238269095898611,4.98595123032708,100,TOX21_RT_HEPG2_FLO_32hr_ctrl_viability,TRUE
Phenothiazine,92-84-2,0.410187070117793,1.32663083712952,0.881567916481002,31.5932801458314,ACEA_AR_antagonist_AUC_viability|APR_HepG2_CellLoss_72h_dn|NCCT_HEK293T_CellTiterGLO,TRUE
Phthalamide,88-96-0,1.22453887294758,1.6632259200126,2.175223808917,-9.98962017849437,TOX21_RT_HEK293_GLO_32hr_viability,TRUE
2-Benzimidazolylurea,24370-25-0,6.91073521860112,7.67130645496475,1.28578309098508,-210.767784945664,TOX21_RT_HEK293_FLO_08hr_viability|TOX21_RT_HEK293_FLO_16hr_viability,TRUE
6-aminopyridine-3-carboxamide,329-89-5,-0.14075846012181,0.0644040859500597,4.65115357412775,79.0521260855382,TOX21_RORg_LUC_CHO_Antagonist_viability,TRUE
CJ-013790,179465-71-5,0.93911377859051,1.55485449865085,0.916013709272437,2.41395015594083,APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_24h_dn|BSK_3C_Proliferation_down|BSK_3C_SRB_down|BSK_hDFCGF_Proliferation_down|TOX21_PGC_ERR_viability|TOX21_RT_HEK293_GLO_08hr_viability,TRUE
"1,3-Propanediol, bis(4-aminobenzoate)",57609-64-0,0.450794097117612,1.24030141105109,1.2086556927321,27.2371296736079,TOX21_ERb_BLA_Antagonist_viability,TRUE
"1-Amino-4-bromo-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid",116-81-4,0.42202835551738,1.49898316317741,0.938243124172608,81.823042319792,TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_ELG1_LUC_Agonist_viability,TRUE
"2-Amino-4,6-dinitrophenol",96-91-3,0.860216194743343,1.5978663787497,1.11170801626933,85.1428252197413,TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_AhR_LUC_Agonist_viability|TOX21_ELG1_LUC_Agonist_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_MMP_viability|TOX21_PXR_viability,TRUE
2-Amino-4-chloro-5-nitrophenol,6358-07-02,0.640815794629345,1.29628523665899,1.45581540229326,40.2843162719529,TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
2-Amino-4-chlorophenol,95-85-2,0.51034350231826,1.60022510082593,1.18541147641629,53.5901385594007,TOX21_ELG1_LUC_Agonist_viability|TOX21_RT_HEK293_GLO_08hr_viability,TRUE
2-Amino-4-nitrophenol,99-57-0,1.04461352438545,1.62349259592864,2.1597062084228,55.2996987151071,TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_CAR_Antagonist_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_08hr_viability,TRUE
2-Amino-5-nitrophenol,121-88-0,0.305541399440088,0.926542652106086,1.53661929882219,0.3560744728955,BSK_hDFCGF_Proliferation_down,TRUE
2-Biphenylamine,90-41-5,-2.68816849195947,-2.52391991912491,5.80974612425085,-7.1145714593702,TOX21_RT_HEK293_FLO_40hr_viability,TRUE
"2-Bromo-4,6-dinitroaniline",1817-73-8,0.868534270427787,1.37254759996176,1.89328823966155,20.2013888730043,TOX21_SSH_3T3_GLI3_Antagonist_viability,TRUE
"3,3'-Dichlorobenzidine",91-94-1,0.59160053627395,0.850590051634553,1.6916577071015,30.8361767024683,TOX21_CAR_Antagonist_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability,TRUE
"3,4-Dichloroaniline",95-76-1,0.0773995019354769,0.610075746453,5.10954235570872,26.5812234842468,ACEA_AR_agonist_AUC_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
3-(Trifluoromethyl)aniline,98-16-8,0.919613664013643,1.13740028668139,4.38154785519186,17.6914859247994,TOX21_RT_HEK293_FLO_24hr_viability,TRUE
"4,4'-Diaminoazobenzene",538-41-0,0.773520156007659,1.56854318953969,1.20027026789391,52.8903061825729,TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability,TRUE
4-Aminoazobenzene,1960-09-03,0.625202460031725,0.950737757563264,1.63039521329323,1.36989730731186,ACEA_ER_AUC_viability|APR_HepG2_CellLoss_72h_dn|BSK_3C_Proliferation_down|BSK_4H_SRB_down|BSK_hDFCGF_Proliferation_down|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_PGC_ERR_viability,TRUE
4-Biphenylamine,92-67-1,0.134273212427708,0.943412982519904,1.30349972544956,72.4522486352047,TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
"4-Chloro-1,2-diaminobenzene",95-83-0,0.588974901272308,1.29093336676908,1.35940024423527,-68.8586240418913,TOX21_RT_HEPG2_FLO_40hr_ctrl_viability,TRUE
"4-Chloro-1,3-diaminobenzene",5131-60-2,0.255265732816967,1.23520540025325,0.973776795806025,37.9590359244197,TOX21_VDR_BLA_Agonist_viability,TRUE
4-Chloro-3-nitroaniline,635-22-3,0.648228550598078,1.04489000322458,2.40568500700227,19.7336863735008,TOX21_ERR_viability,TRUE
"4-Nitro-1,2-phenylenediamine",99-56-9,0.872133167741015,1.52128543236992,1.13909918741606,100,TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_Aromatase_Inhibition_viability|TOX21_CASP3_CHO_viability|TOX21_PXR_viability|TOX21_SSH_3T3_GLI3_Agonist_viability,TRUE
"4-Nitro-1,3-benzenediamine",5131-58-8,0.866621222193215,1.8700308706042,0.958007465073196,87.2866134759337,TOX21_Aromatase_Inhibition_viability|TOX21_PXR_viability,TRUE
4-Nitroaniline,100-01-6,0.566537443304398,1.2844999408868,1.39753274921993,66.0793401434609,ACEA_AR_antagonist_AUC_viability|TOX21_ERR_viability,TRUE
6-Amino-4-chloro-1-phenol-2-sulfonic acid,88-23-3,1.16420945693718,1.43160622196262,3.56863894500937,-2257.90839258734,TOX21_RT_HEK293_FLO_16hr_viability,TRUE
Cinnamyl anthranilate,87-29-6,0.0337331562507336,1.60440670970445,0.601583421006267,52.3345885734478,TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Formamide,1975-12-07,-0.455767626861283,0.241456761494879,1.36863042282433,-0.00301735689866895,BSK_hDFCGF_Proliferation_down,TRUE
Naphthalen-2-yl 2-aminobenzoate,63449-68-3,0.0940136296318382,0.290545409457051,4.89626369734828,22.3752112821473,ACEA_ER_AUC_viability|TOX21_RT_HEPG2_FLO_40hr_ctrl_viability,TRUE
"1,3-Phenylenedi(4-aminophenyl ether)",2479-46-1,0.522071505688702,1.17745716986386,1.50484926414273,29.3509837089992,TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
"1,4-Diaminoanthraquinone",128-95-0,0.47998529800645,1.27907429036949,1.00616356826909,75.1865989123662,ACEA_AR_agonist_AUC_viability|ACEA_AR_antagonist_AUC_viability|TOX21_AhR_LUC_Agonist_viability|TOX21_CAR_Agonist_viabillity|TOX21_CAR_Antagonist_viability|TOX21_ELG1_LUC_Agonist_viability|TOX21_ERR_viability|TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability|TOX21_p53_BLA_p4_viability,TRUE
"1,5-Naphthalenediamine",2243-62-1,1.3712672075273,3.21609160111417,0.619132114960597,3.24729410465449,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|BSK_hDFCGF_Proliferation_down,TRUE
1-Naphthylamine,134-32-7,0.271277972605072,0.787115134978417,1.84989097150134,0.215252019357857,BSK_3C_Proliferation_down,TRUE
2-Amino-5-chlorobenzophenone,719-59-5,1.08239180812485,1.52067993277355,2.17720366072929,23.1255809646651,TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_32hr_viability,TRUE
2-Amino-5-nitrothiazole,121-66-4,0.992371134556738,1.49828017404057,1.52319037493335,40.9901881163619,TOX21_AhR_LUC_Agonist_viability|TOX21_Aromatase_Inhibition_viability|TOX21_CAR_Agonist_viabillity,TRUE
2-Aminoanthraquinone,117-79-3,0.766350127909926,1.33101717585466,1.49382162220776,39.6973600939534,ACEA_AR_antagonist_AUC_viability|TOX21_CASP3_HEPG2_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_24hr_viability,TRUE
2-Aminodiphenylamine,534-85-0,0.521447148142676,1.46219087206345,1.16285668046076,34.4928377091915,TOX21_CASP3_HEPG2_viability|TOX21_ERR_viability|TOX21_PGC_ERR_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_TR_LUC_GH3_Antagonist_viability,TRUE
2-Aminofluorene,153-78-6,0.873297668460882,1.88602191563958,0.969718822489725,64.5404650760141,TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
3-Aminofluoranthene,2693-46-1,0.498501273368011,0.983622199852062,1.67582867580818,87.2768066774075,TOX21_ERb_BLA_Antagonist_viability|TOX21_RT_HEK293_FLO_00hr_viability|TOX21_RT_HEK293_FLO_24hr_viability|TOX21_RT_HEK293_FLO_40hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability,TRUE
4-Aminophenol,123-30-8,1.11915416135215,1.57661989250036,2.1175286826789,92.7747970067341,TOX21_CAR_Agonist_viabillity|TOX21_CAR_Antagonist_viability|TOX21_CASP3_CHO_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_PGC_ERR_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_p53_BLA_p5_viability,TRUE
4-Chloro-4'-aminodiphenyl ether,101-79-1,0.563522982511138,1.43058960621678,1.10133597515674,68.2549772593384,TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_24hr_viability,TRUE
4-Chloroaniline,106-47-8,-0.0352969135629892,0.791486352668552,1.01436919967373,59.8198854677512,ACEA_AR_agonist_AUC_viability|ACEA_AR_antagonist_AUC_viability|ACEA_ER_AUC_viability|BSK_hDFCGF_Proliferation_down,TRUE
6-Amino-4-hydroxynaphthalene-2-sulfonic acid,90-51-7,0.813142507670298,1.49816411546171,1.39301081686448,22.4336804484862,TOX21_SSH_3T3_GLI3_Antagonist_viability,TRUE
"N-Phenyl-1,4-benzenediamine",101-54-2,0.600925524677416,1.32332354705936,1.35021214439297,44.4805304531499,TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability|TOX21_PGC_ERR_viability|TOX21_TR_LUC_GH3_Antagonist_viability,TRUE
Phenethyl anthranilate,133-18-6,0.786723004663799,0.952980795959051,4.98820302380891,15.4152427848835,ATG_FoxA2_CIS_up|TOX21_AR_BLA_Antagonist_viability|TOX21_RT_HEK293_FLO_16hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEPG2_FLO_00hr_ctrl_viability|TOX21_RT_HEPG2_FLO_40hr_ctrl_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability,TRUE
"4,4'-Diaminodicyclohexylmethane",1761-71-3,0.710078506033417,1.199931368343,1.94801864572195,32.2773327245916,TOX21_PR_BLA_Agonist_viability,TRUE
"1,10-Phenanthroline hydrochloride hydrate",18851-33-7,0.200169852337045,0.903352747017449,1.74079461116444,52.3551102972862,TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_CASP3_CHO_viability|TOX21_ELG1_LUC_Agonist_viability|TOX21_ERR_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_FXR_BLA_antagonist_viability|TOX21_PGC_ERR_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability|TOX21_VDR_BLA_antagonist_viability,TRUE
6-Mercaptopurine monohydrate,6112-76-1,-0.147181592444057,0.506061248787507,1.2989527758795,46.0449900769819,TOX21_CAR_Antagonist_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_PXR_viability|TOX21_RXR_BLA_Agonist_viability|TOX21_VDR_BLA_Agonist_viability|TOX21_VDR_BLA_antagonist_viability|TOX21_p53_BLA_p2_viability|TOX21_p53_BLA_p3_viability|TOX21_p53_BLA_p4_viability,TRUE
"9-Aminoacridine, monohydrochloride, monohydrate",52417-22-8,0.149748280054234,1.07442098932267,1.97014870269593,43.2737328605538,TOX21_ARE_BLA_agonist_viability|TOX21_AR_BLA_Antagonist_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability,TRUE
Benzyldimethyltetradecylammonium chloride dihydrate,147228-81-7,0.268271403001378,0.867396997967665,1.294318061488,83.5030850381137,TOX21_ERb_BLA_Agonist_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_FXR_BLA_agonist_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PR_BLA_Antagonist_viability|TOX21_RT_HEK293_FLO_32hr_viability|TOX21_RT_HEK293_FLO_40hr_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_FLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability|TOX21_SBE_BLA_Antagonist_viability|TOX21_VDR_BLA_antagonist_viability,TRUE
Cyclobutyl phenyl ketone,5407-98-7,0.373105077503334,0.943315286675782,1.86895387387114,58.4902399977156,ACEA_AR_antagonist_AUC_viability|TOX21_RT_HEK293_FLO_16hr_viability|TOX21_RT_HEK293_FLO_24hr_viability|TOX21_RT_HEK293_FLO_32hr_viability|TOX21_RT_HEK293_FLO_40hr_viability|TOX21_RT_HEPG2_FLO_00hr_ctrl_viability|TOX21_RT_HEPG2_FLO_16hr_ctrl_viability|TOX21_RT_HEPG2_FLO_24hr_viability|TOX21_RT_HEPG2_FLO_32hr_ctrl_viability|TOX21_RT_HEPG2_FLO_40hr_ctrl_viability,TRUE
Econazole nitrate,24169-02-6,0.756151565464342,1.22543254850306,1.13677235191693,63.9627482664333,TOX21_AP1_BLA_Agonist_viability|TOX21_AR_BLA_Antagonist_viability|TOX21_Aromatase_Inhibition_viability|TOX21_CAR_Agonist_viabillity|TOX21_CAR_Antagonist_viability|TOX21_ERR_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_FXR_BLA_antagonist_viability|TOX21_HRE_BLA_Agonist_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Oxiconazole nitrate,64211-46-7,-0.406225626254707,1.10893772600198,2.93031410574481,41.1691968801894,TOX21_PR_BLA_Antagonist_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Perfluorooctanesulfonamide,754-91-6,0.781977640524819,0.967929774659766,1.98100372442022,3.39054261224301,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|BSK_hDFCGF_Proliferation_down|TOX21_MMP_viability|TOX21_PR_BLA_Antagonist_viability,TRUE
Piperine,94-62-2,0.95626737693893,1.38878704787075,2.21081430858558,32.2390276427724,TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability,TRUE
Praziquantel,55268-74-1,1.18097524627829,2.42241193046645,0.768659829045853,91.37813905411,TOX21_SSH_3T3_GLI3_Antagonist_viability,TRUE
Thiocarbazide,2231-57-4,1.19373062734303,1.42054677235085,4.20711898355576,28.6092543259053,TOX21_PPARd_BLA_Agonist_viability,TRUE
Thiosemicarbazide,79-19-6,0.843663639921297,1.44988039981835,2.05656933735582,57.0766120512665,TOX21_CAR_Antagonist_viability|TOX21_CASP3_CHO_viability|TOX21_ERR_viability|TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability|TOX21_FXR_BLA_antagonist_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_PR_BLA_Agonist_viability|TOX21_PR_BLA_Antagonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability|TOX21_VDR_BLA_Agonist_viability,TRUE
"2,2'-Dibenzoylaminodiphenyl disulfide",135-57-9,0.740200754663688,1.06473900994726,3.72549891917771,65.2988474696264,BSK_SAg_PBMCCytotoxicity_down|BSK_SAg_Proliferation_down|TOX21_ERb_BLA_Agonist_viability|TOX21_FXR_BLA_antagonist_viability|TOX21_PGC_ERR_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_RXR_BLA_Agonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability|TOX21_VDR_BLA_Agonist_viability,TRUE
"5,6-Benzoflavone",6051-87-2,0.585577598713512,1.33682605126315,1.11649901128329,71.7606795184524,TOX21_ERa_BLA_Antagonist_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_FXR_BLA_antagonist_viability|TOX21_HDAC_Inhibition_viability|TOX21_MMP_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PR_BLA_Agonist_viability|TOX21_RAR_LUC_Antagonist_viability|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_RT_HEK293_FLO_08hr_viability|TOX21_RT_HEPG2_FLO_16hr_ctrl_viability|TOX21_RT_HEPG2_FLO_24hr_viability|TOX21_RXR_BLA_Agonist_viability|TOX21_SBE_BLA_Agonist_viability|TOX21_p53_BLA_p5_viability,TRUE
"9,10-Dihydrobenzo[a]pyren-7(8H)-one",3331-46-2,0.63077538070752,1.01976610163158,4.90577167575266,54.9617048853347,TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Acenaphthenequinone,82-86-0,0.454172350253603,0.782882573202604,2.77606736260868,13.5220068229101,TOX21_CASP3_CHO_viability|TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_p53_BLA_p4_viability,TRUE
"Bis(2,3-epoxypropyl) cyclohexane-1,2-dicarboxylate",5493-45-8,0.715869880868429,1.27984391544944,1.97463258691944,22.1103562642443,TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Bismaleimide,13676-54-5,0.514227685473296,0.998711782089236,2.20351074735563,98.136179010324,BSK_3C_Proliferation_down|BSK_4H_SRB_down|BSK_BE3C_SRB_down|BSK_CASM3C_Proliferation_down|BSK_CASM3C_SRB_down|BSK_LPS_SRB_down|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_AhR_LUC_Agonist_viability|TOX21_Aromatase_Inhibition_viability|TOX21_CASP3_CHO_viability|TOX21_ELG1_LUC_Agonist_viability|TOX21_FXR_BLA_antagonist_viability|TOX21_HRE_BLA_Agonist_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_RT_HEK293_FLO_32hr_viability|TOX21_RT_HEK293_FLO_40hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEPG2_FLO_16hr_ctrl_viability|TOX21_RT_HEPG2_FLO_24hr_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability|TOX21_VDR_BLA_Agonist_viability|TOX21_VDR_BLA_antagonist_viability|TOX21_p53_BLA_p1_viability,TRUE
Buspirone,36505-84-7,-1.36035743120545,-0.937557306094579,4.15280193090836,72.9861492596021,TOX21_PPARd_BLA_Agonist_viability|TOX21_RT_HEK293_FLO_00hr_viability,TRUE
Dibenzosuberone,1210-35-1,-3.88154064647201,-2.11255113554354,0.539428020089551,8.83624664781035,TOX21_RT_HEK293_FLO_08hr_viability,TRUE
Dicyclohexyl phthalate,84-61-7,0.745167297909792,0.940346837486631,4.1610510358412,0.733161026390417,BSK_3C_Proliferation_down|BSK_3C_SRB_down|BSK_3C_Vis_down|BSK_4H_SRB_down|BSK_LPS_SRB_down|BSK_SAg_PBMCCytotoxicity_down|BSK_SAg_Proliferation_down|BSK_SAg_SRB_down|BSK_hDFCGF_SRB_down|TOX21_PXR_viability,TRUE
Diphenyl isophthalate,744-45-6,1.54801509547588,1.8257596398389,3.43568408023199,0.73178711493158,APR_HepG2_CellLoss_72h_dn,TRUE
Diphenyl phthalate,84-62-8,0.833364831785526,1.0509803783662,5.04635945722054,0.1263866321948,BSK_3C_SRB_down|BSK_SAg_Proliferation_down,TRUE
Diphenylcarbonate,102-09-0,0.395685038449582,0.969044529940447,1.66430053675065,12.5115261897184,TOX21_RT_HEPG2_GLO_40hr_viability,TRUE
Diphenylcyclopropenone,886-38-4,0.664036829579429,0.915022177616789,3.80198492422468,50.4503496294023,TOX21_FXR_BLA_agonist_viability|TOX21_FXR_BLA_antagonist_viability|TOX21_HRE_BLA_Agonist_viability|TOX21_PGC_ERR_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_VDR_BLA_Agonist_viability|TOX21_p53_BLA_p4_viability,TRUE
Diphenylurea,102-07-8,0.679793965223377,1.20019751973826,1.83365870805565,33.804875310422,TOX21_RT_HEK293_GLO_08hr_viability,TRUE
Flavone,525-82-6,-0.0440243886217474,1.27217402035525,0.729750983389202,99.067178605749,TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
"Pentane-1,5-diyl dibenzoate",6624-73-3,1.64141316711584,1.7768718947698,7.04452585644383,0.686940849353485,APR_HepG2_CellLoss_72h_dn,TRUE
Thidiazuron,51707-55-2,1.13960497895958,1.94068025242911,2.46130007643493,2.10744787988037,APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_24h_up|APR_HepG2_MicrotubuleCSK_72h_up|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability,TRUE
"1,1'-Disulfanediyldiazepan-2-one",23847-08-7,1.21066928243558,1.43397061907209,6.33153869770018,66.509754184228,TOX21_CASP3_CHO_viability|TOX21_RT_HEK293_FLO_32hr_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability,TRUE
"1,4-Dioxacyclohexadecane-5,16-dione",54982-83-1,-0.575314324150031,-0.169104453003198,3.57940124327511,29.5443845159438,TOX21_RT_HEK293_FLO_24hr_viability|TOX21_RT_HEPG2_FLO_16hr_ctrl_viability,TRUE
1-Phenyl-3-pyrazolidinone,92-43-3,0.762637050293742,1.43839825712379,1.41210016170595,43.618319191011,TOX21_ERb_BLA_Antagonist_viability,TRUE
"3,3-Diphenylacrylaldehyde",1210-39-5,0.450386293306166,1.49766398758679,3.25685427379616,39.1887338798315,TOX21_AR_BLA_Antagonist_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_MMP_viability,TRUE
Caprolactam,105-60-2,0.646899137559316,2.3414135746208,0.56314195364043,79.0925732767126,TOX21_CAR_Antagonist_viability|TOX21_PR_BLA_Antagonist_viability,TRUE
N-(Cyclohexylthio)phthalimide,17796-82-6,1.03910753065448,1.4355052173911,2.41322764153657,91.5929032349273,TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_TR_LUC_GH3_Antagonist_viability,TRUE
"Tris(2,3-epoxypropyl)isocyanurate",2451-62-9,-0.0910345666122984,0.532145221599938,1.49804394299554,63.5246271827645,ACEA_AR_agonist_AUC_viability|ACEA_AR_antagonist_AUC_viability|APR_HepG2_MicrotubuleCSK_24h_up|BSK_SAg_Proliferation_down|STM_H9_Viability_norm|TOX21_CAR_Agonist_viabillity|TOX21_CAR_Antagonist_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
"cis-1,2,3,6-Tetrahydrophthalimide",1469-48-3,0.636688867942414,1.38672276802521,1.27226583936271,68.7305721049145,TOX21_PR_BLA_Antagonist_viability,TRUE
4-Nitrosodiphenylamine,156-10-5,0.771374287558704,1.3261932765918,3.47572619530765,93.2306896063131,TOX21_AR_BLA_Antagonist_viability|TOX21_Aromatase_Inhibition_viability|TOX21_PGC_ERR_viability|TOX21_RT_HEK293_FLO_32hr_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEPG2_GLO_00hr_ctrl_viability|TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_p53_BLA_p2_viability,TRUE
Chlorpheniramine maleate,113-92-8,0.908698292049053,1.95784969531746,0.9095374666293,73.8240633759371,TOX21_PXR_viability,TRUE
N-Nitrosodiphenylamine,86-30-6,0.382011129420048,1.1969552450236,1.17092999528269,35.4529090148241,ACEA_AR_antagonist_AUC_viability,TRUE
N-Nitrosomorpholine,59-89-2,-0.380315164226621,0.444111055136885,1.22267156899649,61.3045706653283,TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Perhexiline maleate,6724-53-4,0.374511189390992,0.548725501950137,5.68710397086376,60.241787973748,TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability,TRUE
Trimipramine hydrogen maleate,521-78-8,1.20823377222279,1.56142149635171,2.70179976326415,98.0481418048422,TOX21_RT_HEK293_GLO_24hr_viability,TRUE
Triphenyl phosphate,115-86-6,1.17649028240423,1.74506497489804,2.48869716175085,3.10882548734634,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_24h_up|APR_HepG2_MicrotubuleCSK_72h_up|TOX21_MMP_viability|percent mortality 4dpf,TRUE
"(2,4,6-Trioxo-1,3,5-triazinane-1,3,5-triyl)triethane-2,1-diyl trisprop-2-enoate",40220-08-4,0.744722184053771,1.33142490388692,2.40604818112099,83.1895776784274,ATG_XTT_Cytotoxicity_up|TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_AhR_LUC_Agonist_viability|TOX21_CAR_Agonist_viabillity|TOX21_CASP3_CHO_viability|TOX21_ELG1_LUC_Agonist_viability|TOX21_ERR_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_FXR_BLA_antagonist_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability,TRUE
"1,4-Butanediol diacrylate",1070-70-8,0.502133017918288,1.19706971258508,4.23568684875621,58.0116781097155,TOX21_Aromatase_Inhibition_viability|TOX21_HSE_BLA_agonist_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability,TRUE
"1,6-Hexanediol diacrylate",13048-33-4,0.784124802317098,1.53443829277759,1.19860906762561,0.876392347100112,BSK_4H_SRB_down|BSK_CASM3C_Proliferation_down|BSK_CASM3C_SRB_down|BSK_LPS_SRB_down|BSK_SAg_Proliferation_down|TOX21_CASP3_CHO_viability|TOX21_PGC_ERR_viability|TOX21_RT_HEK293_GLO_08hr_viability,TRUE
2-Phenoxyethyl acrylate,48145-04-6,-0.0317358350941098,0.728699951656826,1.25486270644423,13.1845918150627,TOX21_RT_HEPG2_GLO_08hr_ctrl_viability,TRUE
"2E,4E-Hexadienoic acid",110-44-1,1.90398395887858,2.43840961083369,2.21765353535444,3.94584345463339,APR_HepG2_CellLoss_72h_dn|APR_HepG2_NuclearSize_72h_up,TRUE
Diethylene glycol diacrylate,4074-88-8,1.30789128175757,1.50123422939343,6.39697043805282,27.8077467744938,TOX21_CASP3_CHO_viability|TOX21_ERR_viability|TOX21_PGC_ERR_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability,TRUE
Ethylene acrylate,2274-11-05,-0.142562730190771,0.836609054671284,0.974540447541345,12.1700953556813,TOX21_RT_HEPG2_GLO_08hr_ctrl_viability,TRUE
Omoconazole,74512-12-2,0.879065369038974,1.13004020128677,3.99734209562268,74.7594397054253,TOX21_PR_BLA_Agonist_viability|TOX21_PR_BLA_Antagonist_viability,TRUE
Retinal,116-31-4,1.12142433934272,1.35233151359146,4.52400161222608,89.7662494460107,TOX21_ERR_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_FXR_BLA_agonist_viability|TOX21_GR_BLA_Antagonist_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RXR_BLA_Agonist_viability|TOX21_VDR_BLA_antagonist_viability,TRUE
Tricyclodecanedimethanol diacrylate,42594-17-2,-0.290188097842494,0.793601068742282,0.946311383596391,32.7039180460436,TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability,TRUE
all-trans-Retinoic acid,302-79-4,1.11029310231031,1.64190195321774,1.79500869447618,100,TOX21_ESRE_BLA_viability,TRUE
alpha-Tomatine,17406-45-0,0.134423543723555,0.67544229292135,1.80329650797833,99.1695055117005,TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_ELG1_LUC_Agonist_viability|TOX21_MMP_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_p53_BLA_p2_viability|TOX21_p53_BLA_p3_viability|TOX21_p53_BLA_p4_viability|TOX21_p53_BLA_p5_viability,TRUE
8-Quinolinol salicylic acid (1:1),2439-07-08,0.913682237082397,1.1548614334324,3.95657056612183,63.1209495852624,TOX21_AR_BLA_Antagonist_viability,TRUE
9-Anthracenecarboxylic acid,723-62-6,1.58948530458813,1.7180929950155,7.41979353076249,-12795.2492793956,TOX21_RT_HEK293_FLO_40hr_viability,TRUE
Alizarin Yellow R,2243-76-7,0.947818560254066,1.75076147334166,0.997550794537725,92.4155369508059,TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_GR_BLA_Antagonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability|TOX21_p53_BLA_p4_viability,TRUE
Ataluren,775304-57-9,0.127721414649796,1.41129786020577,0.743424758800398,100,TOX21_FXR_BLA_antagonist_viability,TRUE
Cyclanilide,113136-77-9,0.737178816047144,1.45264681494773,2.87911772644088,48.3923823704794,BSK_SAg_Proliferation_down|NCCT_MITO_viability,TRUE
Gallic acid,149-91-7,1.24901045153655,1.50642974446065,3.70695800846876,76.7327267783538,TOX21_SSH_3T3_GLI3_Antagonist_viability,TRUE
Perfluorodecanoic acid,335-76-2,1.68987923588512,1.82454710301519,7.08589606247817,1.48421511845259,APR_HepG2_CellLoss_72h_dn,TRUE
Perfluoroheptanoic acid,375-85-9,0.75064923394418,1.06832837097761,3.00379344501593,1.08293554680625,APR_HepG2_CellLoss_72h_dn,TRUE
Perfluorooctanoic acid,335-67-1,0.941869854927506,1.37838825819333,2.22249303144195,48.543726627529,TOX21_ERb_BLA_Agonist_viability|TOX21_HRE_BLA_Agonist_viability,TRUE
Phenolphthalin,81-90-3,1.56586695017176,3.18540594474324,0.589206257236064,3.92343618920747,APR_HepG2_CellLoss_72h_dn,TRUE
Salmeterol xinafoate,94749-08-3,0.26741633829276,1.25149766140397,1.33636163029005,88.8346861576808,TOX21_AhR_LUC_Agonist_viability|TOX21_Aromatase_Inhibition_viability|TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2_viability|TOX21_TR_LUC_GH3_Antagonist_viability,TRUE
Terephthalic acid,100-21-0,1.10432141096416,1.23075138484072,7.88058666686077,23.4113531098506,TOX21_RT_HEPG2_FLO_16hr_ctrl_viability|TOX21_RT_HEPG2_FLO_24hr_viability,TRUE
(+)-Pentazocine succinate,124819-26-7,1.54122850012194,3.04482947255629,0.634638130018227,112.791077599782,TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2_viability,TRUE
(-)-Pentazocine succinate,124819-25-6,0.499510744003771,1.27636085378196,1.22993668460429,23.7409380431786,TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability,TRUE
Endothal,145-73-3,0.811032876731167,1.33142970282018,1.61772322767556,21.6849848302789,APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_24h_up|APR_HepG2_NuclearSize_72h_dn|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability,TRUE
Pyrazolone T,118-47-8,0.391121599734317,0.87981804085985,1.9526283171647,36.4230858107327,ACEA_AR_agonist_AUC_viability,TRUE
Sildenafil citrate,171599-83-0,0.51260227024467,1.15108040197149,1.49455785879227,28.4508061884349,TOX21_SSH_3T3_GLI3_Antagonist_viability,TRUE
Tamoxifen citrate,54965-24-1,0.909388089721939,1.15982317615498,3.86261193435019,92.2768242201804,APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_24h_dn|BSK_CASM3C_Proliferation_down|BSK_LPS_SRB_down|BSK_SAg_SRB_down|BSK_hDFCGF_Proliferation_down|NCCT_HEK293T_CellTiterGLO|TOX21_AP1_BLA_Agonist_viability|TOX21_AR_BLA_Antagonist_viability|TOX21_Aromatase_Inhibition_viability|TOX21_CASP3_CHO_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_NFkB_BLA_agonist_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_RT_HEK293_GLO_00hr_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability|TOX21_VDR_BLA_Agonist_viability,TRUE
Tetrac,67-30-1,0.685791769378163,0.863425491709675,7.62874721352012,0.432836108740906,BSK_BE3C_SRB_down|BSK_KF3CT_SRB_down|BSK_hDFCGF_Proliferation_down|TOX21_HRE_BLA_Agonist_viability,TRUE
Tiratricol,51-24-1,-0.555974554885533,0.578111250489669,2.24031468371797,22.8190470948234,TOX21_RT_HEPG2_GLO_00hr_ctrl_viability|TOX21_p53_BLA_p2_viability|TOX21_p53_BLA_p3_viability,TRUE
"2-(1-Chlorocyclopropyl)-1-(2-chlorophenyl)-3-(1H-1,2,4-triazol-1-yl)-2-propanol",120983-64-4,0.811148926327255,1.25811912057797,2.08954481690938,21.6607519263056,BSK_3C_Proliferation_down|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability,TRUE
2-Hydroxy-3-phenoxypropyl prop-2-enoate,16969-10-1,-0.850348242844186,0.68733559447334,0.620571333508969,13.4118676560055,TOX21_RT_HEPG2_GLO_08hr_ctrl_viability,TRUE
4-Chlorophenoxyacetic acid,122-88-3,-1.05032919303885,-0.91650520525756,7.13057894373035,16.9410195817181,ACEA_AR_antagonist_AUC_viability,TRUE
Decanedioic acid,111-20-6,-1.00655935758107,0.423815306732995,0.667127664692614,46.9301085833279,ACEA_AR_antagonist_AUC_viability,TRUE
Fenarimol,60168-88-9,0.525030173291178,0.920832412104286,2.53214532865397,82.7702861975303,APR_HepG2_MicrotubuleCSK_24h_up|BSK_SAg_Proliferation_down|TOX21_RT_HEK293_FLO_24hr_viability|TOX21_RT_HEK293_FLO_32hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_FLO_40hr_ctrl_viability,TRUE
Hexanedioic acid,124-04-9,0.241428147758293,0.775284864380917,1.79759615326472,39.4532942079795,ACEA_AR_agonist_AUC_viability|ACEA_AR_antagonist_AUC_viability,TRUE
Parinol,17781-31-6,-0.555552775258735,0.0881688429319579,3.15238016808919,42.7287566192789,TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability,TRUE
Pentetic acid,67-43-6,-0.233119868502365,0.114423406096762,2.76439058685283,11.9195657512811,TOX21_CAR_Agonist_viabillity|TOX21_RT_HEPG2_FLO_16hr_ctrl_viability,TRUE
Prothioconazole,178928-70-6,0.763565917076513,1.13640895850971,3.45726345782415,0.172943698099169,BSK_3C_Proliferation_down|BSK_3C_SRB_down|BSK_4H_SRB_down|BSK_CASM3C_SRB_down|BSK_SAg_Proliferation_down|BSK_hDFCGF_Proliferation_down,TRUE
Tridecanedioic acid,505-52-2,1.20901534673303,1.38346012677613,5.96568546148678,-4.43347590530371,TOX21_RT_HEK293_FLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Trimethylenediaminetetraacetic acid,1939-36-2,-0.0194460013188449,0.504094422559668,1.86523015512221,28.6349577791411,TOX21_ERb_BLA_Agonist_viability|TOX21_PXR_viability,TRUE
"2,2'-Bisphenol F",2467-02-09,0.610563468539914,1.45478808967983,1.10819364302773,42.8145998445672,ACEA_AR_antagonist_AUC_viability|TOX21_MMP_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
"2,3,4,5-Tetrachlorophenol",4901-51-3,0.663479065413169,1.35699096524846,1.60027424951169,53.515502500522,TOX21_GR_BLA_Antagonist_viability|TOX21_PXR_viability|TOX21_VDR_BLA_Agonist_viability|TOX21_p53_BLA_p3_viability,TRUE
"2,3,4,6-Tetrachlorophenol",58-90-2,0.798615315965395,1.08184357313789,2.92359182108154,0.52237687660058,BSK_3C_Proliferation_down|BSK_3C_SRB_down|BSK_3C_Vis_down|BSK_4H_SRB_down|BSK_LPS_SRB_down|BSK_SAg_Proliferation_down|BSK_SAg_SRB_down|BSK_hDFCGF_Proliferation_down,TRUE
"2,3,5,6-Tetrachlorophenol",935-95-5,1.14625038431611,1.34101061680509,4.89957573599294,41.5190296969604,TOX21_AR_BLA_Antagonist_viability,TRUE
"2,4,5-Trichlorophenol",95-95-4,0.97387582812265,1.3052674041997,3.07285128448776,1.58978474162692,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_24h_up|BSK_SAg_PBMCCytotoxicity_up,TRUE
"2,4,6-Tribromophenol",118-79-6,0.851776762251255,1.2207888497338,2.58593835218055,40.5984768054694,TOX21_RXR_BLA_Agonist_viability,TRUE
"2,4-Dinitrophenol",51-28-5,0.688382590503984,1.60896421083011,0.775791781407328,60.6418194881971,NCCT_MITO_viability|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_CAR_Antagonist_viability|TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2_viability|TOX21_MMP_viability|TOX21_RXR_BLA_Agonist_viability|TOX21_SSH_3T3_GLI3_Agonist_viability,TRUE
"2,6-Diiodo-4-nitrophenol",305-85-1,0.475853518193468,0.747313163262884,2.66537128400378,61.4555839098725,TOX21_ELG1_LUC_Agonist_viability|TOX21_p53_BLA_p1_viability|TOX21_p53_BLA_p3_viability,TRUE
"4,4'-Sulfonylbis[2-(prop-2-en-1-yl)phenol]",41481-66-7,1.01481547669476,1.71346545417318,1.89517754789136,11.353239880547,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|BSK_hDFCGF_Proliferation_down|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability,TRUE
4-Chloro-2-cyclopentylphenol,13347-42-7,-2.4572957387605,-2.21441149399766,8.40192942167995,3.85953359386513,TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
5-Chlorosalicylanilide,4638-48-6,0.805177701031982,1.28285989351521,1.95633070334876,45.3143372470817,TOX21_AR_BLA_Antagonist_viability|TOX21_AhR_LUC_Agonist_viability|TOX21_Aromatase_Inhibition_viability|TOX21_CASP3_CHO_viability|TOX21_CASP3_HEPG2_viability|TOX21_ERR_viability|TOX21_FXR_BLA_antagonist_viability|TOX21_GR_BLA_Antagonist_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_HSE_BLA_agonist_viability|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_SBE_BLA_Antagonist_viability|TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_VDR_BLA_antagonist_viability,TRUE
Atovaquone,95233-18-4,0.895508458528156,1.20786468672303,3.05498153487756,50.3126072413941,TOX21_CASP3_CHO_viability,TRUE
BPS-MPE4,63134-33-8,1.212827313376,1.78498853753981,2.25573149852481,84.4850242023852,TOX21_H2AX_HTRF_CHO_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_FLO_24hr_viability|TOX21_RT_HEPG2_FLO_32hr_ctrl_viability,TRUE
Bithionol,97-18-7,0.857517647411604,1.29433921316045,2.26365152767617,56.3127857533534,ATG_XTT_Cytotoxicity_up|TOX21_ARE_BLA_agonist_viability|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_Aromatase_Inhibition_viability|TOX21_CASP3_CHO_viability|TOX21_CASP3_HEPG2_viability|TOX21_ERR_viability|TOX21_HRE_BLA_Agonist_viability|TOX21_PGC_ERR_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_VDR_BLA_Agonist_viability|TOX21_p53_BLA_p2_viability|TOX21_p53_BLA_p4_viability,TRUE
Clorophene,120-32-1,0.713690181342622,1.14449192942839,2.52459192464166,40.4425173305534,ACEA_AR_antagonist_AUC_viability|ACEA_ER_AUC_viability|APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|BSK_hDFCGF_Proliferation_down|NCCT_HEK293T_CellTiterGLO|TOX21_MMP_viability|TOX21_RT_HEK293_FLO_24hr_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_p53_BLA_p4_viability,TRUE
Dinex,131-89-5,0.503957372612437,1.10052340889266,1.59955889441734,68.8329612963772,TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_Aromatase_Inhibition_viability|TOX21_CAR_Agonist_viabillity|TOX21_CASP3_HEPG2_viability|TOX21_ERR_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_PXR_viability|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability,TRUE
Fluorosalan,4776-06-01,0.249901004806194,0.720111035709477,1.62814913606375,48.0955764879878,TOX21_ARE_BLA_agonist_viability|TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_Aromatase_Inhibition_viability|TOX21_CAR_Agonist_viabillity|TOX21_ELG1_LUC_Agonist_viability|TOX21_ERR_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_FXR_BLA_antagonist_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_PR_BLA_Antagonist_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_FLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability|TOX21_RXR_BLA_Agonist_viability|TOX21_SBE_BLA_Agonist_viability|TOX21_VDR_BLA_Agonist_viability|TOX21_VDR_BLA_antagonist_viability|TOX21_p53_BLA_p2_viability|TOX21_p53_BLA_p3_viability|TOX21_p53_BLA_p4_viability,TRUE
Ioxynil,1689-83-4,0.570478086199781,0.796882003967237,4.21486035189946,23.5102067202271,TOX21_MMP_viability|TOX21_PR_BLA_Followup_Agonist_viability,TRUE
Pentabromophenol,608-71-9,-0.625057492999631,-0.523581450819015,9.40362364291745,18.4783423525765,TOX21_PR_BLA_Agonist_viability,TRUE
Phenyl salicylate,118-55-8,2.72991206554017,2.87920679316418,6.39166918099419,-12652.2048937299,TOX21_RT_HEPG2_FLO_40hr_ctrl_viability,TRUE
Rafoxanide,22662-39-1,0.225195727312646,0.611919989719495,2.40021020257998,44.2491491640183,TOX21_ERa_BLA_Antagonist_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_p53_BLA_p2_viability|TOX21_p53_BLA_p3_viability|TOX21_p53_BLA_p4_viability,TRUE
Salicylanilide,87-17-2,0.589845770707933,1.37431855806695,1.28036892844635,38.544355563868,TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability,TRUE
Tribromsalan,1987-10-05,0.740351586349066,1.06918329757054,2.80456749315339,51.9022220661534,TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_Aromatase_Inhibition_viability|TOX21_CAR_Agonist_viabillity|TOX21_CASP3_CHO_viability|TOX21_ERR_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_FXR_BLA_agonist_viability|TOX21_FXR_BLA_antagonist_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_PGC_ERR_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_FLO_40hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability|TOX21_VDR_BLA_Agonist_viability|TOX21_p53_BLA_p3_viability|TOX21_p53_BLA_p4_viability,TRUE
"1,1-Bis(3-cyclohexyl-4-hydroxyphenyl)cyclohexane",4221-68-5,1.18946508649764,1.30448755472265,6.5123095615659,90.7567319240144,TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_PXR_viability|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEPG2_GLO_00hr_ctrl_viability|TOX21_RXR_BLA_Agonist_viability|TOX21_SSH_3T3_GLI3_Agonist_viability,TRUE
"1,8-Dihydroxy-4,5-dinitroanthraquinone",81-55-0,0.462284010478782,1.0509172112436,1.62335530384129,100,TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_AhR_LUC_Agonist_viability|TOX21_Aromatase_Inhibition_viability|TOX21_CAR_Agonist_viabillity|TOX21_CASP3_CHO_viability|TOX21_CASP3_HEPG2_viability|TOX21_ERR_viability|TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability|TOX21_ESRE_BLA_viability|TOX21_FXR_BLA_antagonist_viability|TOX21_GR_BLA_Antagonist_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_HRE_BLA_Agonist_viability|TOX21_NFkB_BLA_agonist_viability|TOX21_PGC_ERR_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_RAR_LUC_Antagonist_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_VDR_BLA_Agonist_viability|TOX21_p53_BLA_p2_viability|TOX21_p53_BLA_p3_viability|TOX21_p53_BLA_p4_viability|TOX21_p53_BLA_p5_viability,TRUE
"1,?2-?Benzenediol",120-80-9,0.505929557330714,0.994003090545311,2.38255260537957,0.41637596520784,ACEA_AR_agonist_AUC_viability|APR_HepG2_CellLoss_72h_dn|BSK_3C_Proliferation_down|BSK_3C_SRB_down|BSK_4H_SRB_down|BSK_CASM3C_Proliferation_down|BSK_LPS_SRB_down|BSK_SAg_SRB_down|BSK_hDFCGF_Proliferation_down|TOX21_CASP3_CHO_viability|TOX21_ERR_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_p53_BLA_p1_viability,TRUE
1-Hydroxypyrene,5315-79-7,0.626099629138626,0.961510785607838,2.92684732609317,2.86495394932541,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|APR_HepG2_NuclearSize_72h_dn|BSK_SAg_PBMCCytotoxicity_down|BSK_SAg_Proliferation_down|NCCT_HEK293T_CellTiterGLO|TOX21_RT_HEK293_GLO_08hr_viability,TRUE
"2,2',4,4'-Tetrahydroxybenzophenone",131-55-5,0.937399064239207,1.32562224528415,2.45797406242174,0.213987951002956,BSK_SAg_Proliferation_down,TRUE
"2,3',4,4'-Tetrahydroxybenzophenone",61445-50-9,-0.912222916906252,-0.814721639538659,9.78697443974716,9.71036135518691,TOX21_RT_HEK293_GLO_32hr_viability,TRUE
"2,3,4,4'-Tetrahydroxybenzophenone",31127-54-5,1.13797135336415,1.7324181392898,2.74824631684062,64.0956499826744,TOX21_AhR_LUC_Agonist_viability|TOX21_SSH_3T3_GLI3_Agonist_viability,TRUE
"2,3,4-Trihydroxbenzophenone",1143-72-2,1.24594708387465,1.58583804790937,2.80749596315201,27.1314235650792,TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability,TRUE
"2,3,5-Trichlorophenol",933-78-8,1.48850506629176,1.6333059216007,6.59003365279448,32.554091896542,TOX21_H2AX_HTRF_CHO_viability,TRUE
"2,4,4'-Trihydroxybenzophenone",1470-79-7,0.714878521453924,1.59999438955713,1.07809897418771,42.210288995704,TOX21_RT_HEK293_GLO_32hr_viability,TRUE
"2,4,6-Triiodophenol",609-23-4,0.769134624368589,0.955624987389341,3.15170596604754,0.730964927905419,BSK_3C_Proliferation_down|BSK_3C_SRB_down|BSK_3C_Vis_down|BSK_LPS_SRB_down|BSK_SAg_Proliferation_down|BSK_hDFCGF_Proliferation_down,TRUE
"2,5-Dichlorophenol",583-78-8,-2.43945642656091,-1.5044133286339,1.32454074612581,1.83523681019953,TOX21_RT_HEPG2_FLO_32hr_ctrl_viability|TOX21_RT_HEPG2_FLO_40hr_ctrl_viability,TRUE
"3,4,5-Trichlorophenol",609-19-8,0.847102207327078,1.00979171930631,5.35193940983206,26.893458592768,TOX21_PXR_viability|TOX21_RT_HEK293_FLO_32hr_viability|TOX21_RT_HEK293_FLO_40hr_viability|TOX21_p53_BLA_p2_viability,TRUE
3-Trifluoromethyl-4-nitrophenol,88-30-2,1.08417104598806,1.39134848226663,2.31309417116619,76.747530152399,ACEA_AR_antagonist_AUC_viability|TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_CASP3_CHO_viability|TOX21_PXR_viability|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_p53_BLA_p4_viability,TRUE
4-Hydroxyazobenzene,1689-82-3,0.500130161162338,1.42328097329678,1.81325858413225,41.6512879048979,TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability|TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2_viability|TOX21_PGC_ERR_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability,TRUE
4-Nitrophenol,100-02-7,1.22424170333126,1.85912271458395,1.28860837919968,74.147832393541,TOX21_ERR_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_PGC_ERR_viability|TOX21_SSH_3T3_GLI3_Agonist_viability,TRUE
4-Phenylphenol,92-69-3,-0.88969634360766,-0.471715935336107,3.39036419043669,-9.72617139252351,ACEA_AR_antagonist_AUC_viability|TOX21_PXR_viability|TOX21_RT_HEK293_FLO_24hr_viability|TOX21_RT_HEK293_FLO_40hr_viability,TRUE
"7,4'-Dihydroxyisoflavone",486-66-8,0.977565370701859,1.41261926381698,2.58098689479439,26.9067892664917,BSK_SAg_Proliferation_down|TOX21_MMP_viability|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Apigenin,520-36-5,0.928800021439923,1.44461794251454,2.74118120065817,64.2869017290795,ACEA_AR_antagonist_AUC_viability|TOX21_CASP3_CHO_viability|TOX21_CASP3_HEPG2_viability|TOX21_HSE_BLA_agonist_viability|TOX21_MMP_viability|TOX21_PXR_viability,TRUE
Benzyl 4-hydroxybenzoate,94-18-8,-1.72980147204688,-0.753858808162469,0.977764928977781,3.36542916065404,TOX21_RT_HEK293_GLO_24hr_viability,TRUE
Bisdemethoxycurcumin,33171-05-0,1.55803428639464,1.68989886076337,7.23653425499279,0.327298866876586,APR_HepG2_NuclearSize_72h_dn,TRUE
Bisphenol AF,1478-61-1,0.973799400635878,1.36454225496145,3.80685341775192,4.25799315488506,ACEA_AR_agonist_AUC_viability|APR_HepG2_CellLoss_72h_dn|ATG_XTT_Cytotoxicity_up|BSK_3C_Proliferation_down|BSK_3C_SRB_down|BSK_SAg_Proliferation_down|NCCT_HEK293T_CellTiterGLO|TOX21_PR_BLA_Agonist_viability|TOX21_RT_HEK293_GLO_08hr_viability|percent mortality 1dpf,TRUE
Broxyquinoline,521-74-4,0.072708995376713,0.236724118938277,6.8035103135714,27.6063672596798,TOX21_PR_BLA_Antagonist_viability|TOX21_p53_BLA_p4_viability,TRUE
Chloroxine,773-76-2,0.57853812547501,0.847150169053614,2.34273407066641,40.4692252336381,TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_ERR_viability|TOX21_PGC_ERR_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_RT_HEK293_FLO_24hr_viability|TOX21_p53_BLA_p4_viability,TRUE
Clioquinol,130-26-7,0.47466528692201,1.22443398912172,2.2003966993609,58.5089583826663,TOX21_AR_BLA_Antagonist_viability|TOX21_CASP3_CHO_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_PPARg_BLA_antagonist_viability,TRUE
Genistein,446-72-0,0.413781235882038,1.17714774847493,1.669456318802,0.402442774541225,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|BSK_3C_Proliferation_down|BSK_4H_SRB_down|BSK_CASM3C_Proliferation_down|BSK_LPS_SRB_down|BSK_hDFCGF_Proliferation_down|BSK_hDFCGF_SRB_down|TOX21_RT_HEK293_GLO_16hr_viability,TRUE
Iodoquinol,83-73-8,0.780480933141798,0.932356000133981,6.28307547998278,17.1882791566728,TOX21_p53_BLA_p4_viability,TRUE
Nitroxoline,4008-48-4,0.280232850462306,0.657983503212656,2.29855330539307,42.6818121486781,TOX21_AR_BLA_Antagonist_viability|TOX21_CASP3_CHO_viability|TOX21_ERR_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PXR_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability|TOX21_RXR_BLA_Agonist_viability,TRUE
Phenylparaben,17696-62-7,1.07872828622964,1.55972405426027,1.98388961579917,17.0994139322855,TOX21_RT_HEPG2_FLO_08hr_viability,TRUE
Quinalizarin,81-61-8,0.842120601794881,0.998097757567507,6.11783504265432,0.222657766369395,BSK_3C_SRB_down,TRUE
Resveratrol,501-36-0,0.80599654582421,1.15139929584206,2.14490646170752,31.8594606970847,BSK_CASM3C_Proliferation_down|BSK_SAg_Proliferation_down|BSK_hDFCGF_Proliferation_down|TOX21_ERR_viability|TOX21_PGC_ERR_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Triclosan,3380-34-5,1.2270500054498,1.44645476237706,4.56487665823278,74.4581388929109,TOX21_AP1_BLA_Agonist_viability|TOX21_PGC_ERR_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability,TRUE
1-Naphthol,90-15-3,0.890478539859412,1.86628282948587,2.20594152155147,0.639443240706538,BSK_SAg_Proliferation_down|BSK_hDFCGF_Proliferation_down,TRUE
"2,2'-Dihydroxybenzophenone",835-11-0,-4.55816112798097,-2.74405066420502,0.52601124820874,17.375218536166,TOX21_RT_HEK293_FLO_40hr_viability,TRUE
"2,2-Bis(4-chlorophenyl)ethanol",2642-82-2,0.837651231713436,0.946181069945073,5.97327782011363,2.38134476548387,TOX21_AR_BLA_Antagonist_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability,TRUE
"2,3-Dihydroxynaphthalene",92-44-4,3.36685359793009,3.52630391410088,5.98457583751203,-2845.71732665117,TOX21_RT_HEK293_FLO_24hr_viability|TOX21_RT_HEK293_FLO_32hr_viability|TOX21_RT_HEK293_FLO_40hr_viability,TRUE
2-Hydroxyanthraquinone,605-32-3,1.17479166049645,1.9285960798726,1.26590198320813,87.1729685281282,TOX21_PXR_viability,TRUE
2-Hydroxybenzophenone,117-99-7,-2.28043160758865,-1.43653478417673,4.65762516010996,5.96899139405131,TOX21_RT_HEK293_FLO_24hr_viability|TOX21_RT_HEK293_FLO_40hr_viability,TRUE
2-Hydroxyfluorene,2443-58-5,0.510647990398852,1.67876162493941,0.855501234263918,73.9941202013387,TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_VDR_BLA_Agonist_viability,TRUE
2-Naphthalenol,135-19-3,1.11593010465826,2.04096363899505,4.75708066351207,12.5812854990906,BSK_3C_Proliferation_down|CEETOX_H295R_MTT_cell_viability_up,TRUE
2-[(4-Hydroxyphenyl)methyl]phenol,2467-03-0,0.741635173880207,1.22880079855859,2.00129747370096,52.5565359665089,TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
"3,5,6-Trichloro-2-pyridinol",6515-38-4,1.23988709852627,2.03033062104652,1.20722414979988,69.5457905274218,TOX21_ERb_BLA_Antagonist_viability,TRUE
3-Chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone,77439-76-0,-0.525343459961541,0.0531899177449979,1.82334294995302,42.0086731543958,TOX21_AR_BLA_Antagonist_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability,TRUE
3-Hydroxy-N-(3-nitrophenyl)naphthalene-2-carboxamide,135-65-9,0.322858797275381,0.814770379952406,2.07251187886269,45.8833534027562,TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_CASP3_HEPG2_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_PR_BLA_Antagonist_viability|TOX21_PXR_viability|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability|TOX21_SBE_BLA_Agonist_viability|TOX21_SBE_BLA_Antagonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_VDR_BLA_Agonist_viability,TRUE
3-Hydroxy-N-phenylaniline,101-18-8,0.306771078670211,1.64588214001138,0.72330292419531,100,TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
3-Hydroxybenzophenone,13020-57-0,1.16552305522528,1.39352513502864,5.78416838080987,26.2907634316551,TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability,TRUE
3-Hydroxyfluorene,6344-67-8,1.91446915540736,3.04653616343233,0.842920518551386,12.040741653176,APR_HepG2_CellLoss_72h_dn,TRUE
3-Phenylphenol,580-51-8,0.0381090116613147,0.530407823881992,1.94238278927932,-0.00541068416285166,BSK_SAg_PBMCCytotoxicity_down|BSK_SAg_SRB_down|BSK_hDFCGF_Proliferation_down|BSK_hDFCGF_SRB_down,TRUE
"4,4'-Thiodiphenol",2664-63-3,0.0776355778206139,1.12930882636068,0.90735645388338,38.9155094226163,TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
4-Anilinophenol,122-37-2,0.282192549279818,1.16854219277121,1.90064108522388,26.0034566693814,ACEA_ER_AUC_viability|BSK_3C_Proliferation_down|BSK_CASM3C_Proliferation_down|BSK_SAg_SRB_down|BSK_hDFCGF_Proliferation_down|TOX21_ERR_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability,TRUE
"5-(5-Nitro-2-furyl)-1,3,4-oxadiazole-2-ol",2122-86-3,0.866186679510487,1.94276610513015,0.886365173558908,64.1157977529785,TOX21_SSH_3T3_GLI3_Antagonist_viability,TRUE
8-Hydroxyquinoline,148-24-3,0.110763733575378,0.562288700130925,1.9674255266013,63.0096718684563,ACEA_AR_antagonist_AUC_viability|APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|BSK_SAg_Proliferation_down|NCCT_HEK293T_CellTiterGLO|TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_CAR_Antagonist_viability|TOX21_CASP3_CHO_viability|TOX21_ERR_viability|TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PXR_viability|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_RT_HEK293_FLO_32hr_viability|TOX21_RT_HEK293_FLO_40hr_viability|TOX21_RT_HEPG2_FLO_24hr_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability,TRUE
9-Phenanthrol,484-17-3,0.731341468708819,0.915221907152065,4.21224823245753,92.0827794629708,ACEA_AR_agonist_AUC_viability|APR_HepG2_CellLoss_24h_dn|APR_HepG2_MicrotubuleCSK_24h_dn|APR_HepG2_MicrotubuleCSK_72h_dn|BSK_CASM3C_Proliferation_down|BSK_LPS_SRB_down|BSK_SAg_SRB_down|NCCT_HEK293T_CellTiterGLO|NCCT_MITO_viability|TOX21_ARE_BLA_agonist_viability|TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_AhR_LUC_Agonist_viability|TOX21_Aromatase_Inhibition_viability|TOX21_CASP3_CHO_viability|TOX21_CASP3_HEPG2_viability|TOX21_ERR_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_HDAC_Inhibition_viability|TOX21_HRE_BLA_Agonist_viability|TOX21_NFkB_BLA_agonist_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_PR_BLA_Antagonist_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability|TOX21_VDR_BLA_Agonist_viability|TOX21_p53_BLA_p4_viability,TRUE
Alizarin,72-48-0,0.877868167576386,1.73038040812384,1.22507136904817,69.3304449710403,TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability,TRUE
Bis(4-hydroxyphenyl)methane,620-92-8,0.512916684943544,1.48733590491441,0.897642025439073,47.4606821744016,TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability,TRUE
Bronopol,52-51-7,1.02796661274765,1.5542791504042,1.81307196991388,8.90030282188105,APR_HepG2_CellLoss_72h_dn|BSK_4H_SRB_down|BSK_SAg_Proliferation_down|TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_TR_LUC_GH3_Antagonist_viability,TRUE
C.I. Solvent Yellow 14,842-07-9,0.491990970453041,1.43481763399224,1.03225051804641,69.3383148475352,ATG_FoxA2_CIS_up|BSK_SAg_Proliferation_down|NCCT_HEK293T_CellTiterGLO|TOX21_Aromatase_Inhibition_viability|TOX21_CAR_Agonist_viabillity|TOX21_ERR_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_PGC_ERR_viability|TOX21_PXR_viability,TRUE
Chrysin,480-40-0,0.975161395671051,1.43597990232745,1.99031410742833,22.9278922618583,TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_ERR_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability,TRUE
Cloxyquin,130-16-5,0.545960576517854,1.19095877875894,3.6551076267432,38.1732185291791,TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_PR_BLA_Antagonist_viability|TOX21_PXR_viability,TRUE
Cyclododecanol,1724-39-6,0.580432483876134,1.08008525594244,2.65161315534427,73.2950892441782,TOX21_RT_HEPG2_FLO_00hr_ctrl_viability|TOX21_RT_HEPG2_FLO_16hr_ctrl_viability,TRUE
Dichlorophen,97-23-4,1.03248557090191,1.37739087693195,3.21803470340484,83.475099778879,ACEA_AR_antagonist_AUC_viability|ACEA_ER_AUC_viability|ATG_XTT_Cytotoxicity_up|TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_CASP3_CHO_viability|TOX21_ERR_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_PGC_ERR_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEPG2_GLO_40hr_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_VDR_BLA_Agonist_viability|TOX21_VDR_BLA_antagonist_viability,TRUE
Fluorescein,2321-07-05,0.622559062011236,0.896686419349494,3.60733445298981,24.2752573345578,BSK_3C_Proliferation_down|NCCT_HTTr_Apoptosis_MCF7_DMEM_6hr|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability,TRUE
4-Hydroxybutyl prop-2-enoate,2478-10-06,0.535360576709901,0.891623324502253,2.67847962031525,15.8209883448302,TOX21_RT_HEPG2_GLO_08hr_ctrl_viability,TRUE
Aloe-emodin,481-72-1,0.496560582269677,0.920843543599219,1.76745970155011,22.6647588672174,TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_RORg_LUC_CHO_Antagonist_viability,TRUE
C.I. Disperse Blue 27,15791-78-3,0.788278557894506,1.49915459781517,1.66834398534536,1.07105565754805,BSK_3C_Proliferation_down|BSK_CASM3C_Proliferation_down|BSK_hDFCGF_Proliferation_down|BSK_hDFCGF_SRB_down|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_PXR_viability,TRUE
SB281832,219790-72-4,0.415329514456665,1.42290472161671,0.947068271091102,50.4550062435768,ACEA_AR_antagonist_AUC_viability,TRUE
Salmeterol,89365-50-4,0.259211341025301,1.06628000542293,1.28643321815927,77.6922611509302,TOX21_AhR_LUC_Agonist_viability|TOX21_Aromatase_Inhibition_viability|TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2_viability|TOX21_TR_LUC_GH3_Antagonist_viability,TRUE
Tricyclodecanedimethanol,26896-48-0,1.02483251585118,1.57887601254161,1.72232417696349,42.4487505184651,TOX21_HRE_BLA_Agonist_viability,TRUE
1-(2-Hydroxyethyl)pyrrolidin-2-one,3445-11-02,0.975125477290394,1.27310683656684,3.20235638818623,51.1537643778269,TOX21_PR_BLA_Antagonist_viability,TRUE
1-Hydroxybenzotriazole,2592-95-2,-1.74412503510513,0.0874823824778466,0.570599772736228,42.4812581641442,TOX21_AR_BLA_Antagonist_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_ERb_BLA_Antagonist_viability,TRUE
CP-544439,230954-09-3,1.21083353957254,1.84067499552048,1.51505192366729,1.24617594868259,APR_HepG2_CellLoss_72h_dn,TRUE
Perfluorooctanesulfonic acid,1763-23-1,0.714072755006957,0.912064332661673,3.00647233757286,1.20406825879348,APR_HepG2_NuclearSize_72h_dn|BSK_hDFCGF_Proliferation_down|TOX21_ERb_BLA_Antagonist_viability,TRUE
Tris(2-hydroxyethyl) isocyanurate,839-90-7,0.73703157809641,0.997536899530841,4.00274748495855,40.1721137953136,TOX21_RT_HEK293_FLO_16hr_viability|TOX21_RT_HEK293_FLO_32hr_viability|TOX21_RT_HEPG2_FLO_24hr_viability,TRUE
2-Mercaptobenzimidazole,583-39-1,1.10726728826887,1.37406432908617,3.57666076998502,61.4205485912193,TOX21_PR_BLA_Antagonist_viability,TRUE
6-Mercaptopurine,50-44-2,-0.3373433410637,0.669403081007962,0.983512364138489,39.4055560400978,TOX21_CAR_Agonist_viabillity|TOX21_ERR_viability|TOX21_PGC_ERR_viability|TOX21_PR_BLA_Agonist_viability|TOX21_PXR_viability|TOX21_SBE_BLA_Agonist_viability|TOX21_SBE_BLA_Antagonist_viability|TOX21_VDR_BLA_antagonist_viability|TOX21_p53_BLA_p2_viability|TOX21_p53_BLA_p4_viability,TRUE
Dicyclopentamethylenethiuram disulfide,94-37-1,0.679677965906798,0.792012926368585,8.49461739708303,72.1953355329524,TOX21_AR_BLA_Antagonist_viability,TRUE
Ensulizole,27503-81-7,0.318909523497506,1.26665964996315,1.1187578190733,55.1876284821101,TOX21_AP1_BLA_Agonist_viability|TOX21_AR_BLA_Antagonist_viability|TOX21_GR_BLA_Antagonist_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_HDAC_Inhibition_viability|TOX21_HRE_BLA_Agonist_viability|TOX21_SBE_BLA_Agonist_viability|TOX21_SBE_BLA_Antagonist_viability|TOX21_VDR_BLA_Agonist_viability|TOX21_p53_BLA_p5_viability,TRUE
Imazalil sulfate,58594-72-2,0.0596683627255517,0.582297038757439,1.82585180109999,19.9206884845121,TOX21_RT_HEK293_GLO_40hr_viability,TRUE
"N,N'-Dicyclohexylthiourea",1212-29-9,0.899590880491224,1.26392093298284,5.76278174978624,38.4759194835075,TOX21_CASP3_CHO_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability,TRUE
Naphthalene-2-sulfonic acid,120-18-3,-0.460158792156415,0.540146858845937,0.955978100751559,75.6999305269541,TOX21_HRE_BLA_Agonist_viability|SH-S5Y5 viability,TRUE
"1,1':3',1''-Terphenyl",1992-06-08,0.80247447341557,0.943378885110789,4.21880661563123,0.703379490913231,BSK_3C_Proliferation_down|BSK_3C_SRB_down|BSK_3C_Vis_down|BSK_SAg_PBMCCytotoxicity_down|BSK_SAg_Proliferation_down|BSK_SAg_SRB_down|BSK_hDFCGF_Proliferation_down,TRUE
"1,10-Phenanthroline",66-71-7,0.0482804548284357,0.565729573757112,2.34088635659616,77.1715448173918,ACEA_AR_agonist_AUC_viability|ACEA_AR_antagonist_AUC_viability|TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_CAR_Agonist_viabillity|TOX21_FXR_BLA_antagonist_viability|TOX21_PGC_ERR_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability|TOX21_VDR_BLA_Agonist_viability|TOX21_VDR_BLA_antagonist_viability,TRUE
Benzo(b)fluoranthene,205-99-2,-0.045899400945264,0.128500690621244,5.47157114923544,84.8916803007232,TOX21_RT_HEPG2_FLO_40hr_ctrl_viability,TRUE
Benzo(e)pyrene,192-97-2,1.07148383677656,1.28544941888683,4.4597944212707,24.3498414692442,TOX21_RT_HEK293_GLO_08hr_viability,TRUE
Benzo(f)quinoline,1985-02-09,1.2110500917208,2.51200258524378,0.733495276876125,0.649210823053385,BSK_4H_SRB_down,TRUE
"Dibenz(a,h)anthracene",53-70-3,0.448565314899803,0.552744784935322,9.15960226246098,39.7061093757067,TOX21_RT_HEPG2_FLO_40hr_ctrl_viability,TRUE
"Dibenz[a,c]anthracene",215-58-7,0.488580056235625,0.953396979673233,2.17504343350685,41.6023457537623,TOX21_PXR_viability|NCC cell viability,TRUE
Fluoranthene,206-44-0,0.322833399424424,0.881683832640598,1.70750965324958,40.7388888854601,ACEA_AR_antagonist_AUC_viability,TRUE
Pyrene,129-00-0,0.773847770453592,1.22385955526829,2.12048337763478,47.9031843984713,ACEA_AR_antagonist_AUC_viability,TRUE
Triphenylphosphine,603-35-0,0.839639363581221,1.30114824896272,2.06765793609913,32.6256085913432,TOX21_RT_HEK293_GLO_40hr_viability,TRUE
"10,11-Dihydro-5H-dibenz[b,f]azepine",494-19-9,-0.947422800918087,-0.841882904550384,9.04153350799891,-2.2516404820632,TOX21_RT_HEPG2_FLO_40hr_ctrl_viability,TRUE
"2-(Morpholin-4-yldithio)-1,3-benzothiazole",95-32-9,1.15306976221042,1.36846662544608,4.43015972983466,82.8914455371281,TOX21_Aromatase_Inhibition_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_RAR_LUC_Agonist_viability,TRUE
"5,6,7,8-Tetrahydroquinoxaline",34413-35-9,0.597446243821113,0.895050738145348,3.21297847938053,33.3312373938716,TOX21_RT_HEPG2_FLO_00hr_ctrl_viability|TOX21_RT_HEPG2_FLO_24hr_viability,TRUE
(2-Nitro-1-propenyl)benzene,705-60-2,0.837387683183993,1.25026428180878,3.70144033585432,85.8487041189607,ACEA_ER_AUC_viability|ATG_XTT_Cytotoxicity_up|TOX21_ARE_BLA_agonist_viability|TOX21_CASP3_CHO_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability,TRUE
3-Methylbut-3-en-1-ol,763-32-6,1.49450903011614,2.22619514410374,1.30416922119626,86.2779031485983,TOX21_RT_HEPG2_GLO_00hr_ctrl_viability,TRUE
6:2 Fluorotelomer methacrylate,2144-53-8,0.729396410375288,0.954277318903675,4.64671013429629,0.921744315624281,BSK_3C_Proliferation_down|BSK_CASM3C_Proliferation_down|BSK_SAg_Proliferation_down|BSK_hDFCGF_Proliferation_down,TRUE
Benzyl methacrylate,2495-37-6,1.04257286786796,1.53876702996387,1.92312320928691,60.0660934737074,TOX21_PR_BLA_Agonist_viability,TRUE
Bisphenol A glycidyl methacrylate,1565-94-2,0.686899463221839,1.20134963962082,2.64722028221337,51.6689744926773,TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PR_BLA_Antagonist_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability,TRUE
Chloranocryl,2164-09-02,0.461101001005019,1.25760274656345,1.20183016660745,42.5435727911631,TOX21_AR_BLA_Antagonist_viability|TOX21_RT_HEK293_GLO_08hr_viability,TRUE
Di(ethylene glycol) dimethacrylate,2358-84-1,0.607265096997363,1.27525200337167,1.42853475170458,35.9041723979157,ACEA_ER_AUC_viability,TRUE
Mepanipyrim,110235-47-7,1.3153474586123,1.87238277853888,1.71307361544886,1.7983617300689,APR_HepG2_CellLoss_72h_dn,TRUE
Methyl trans-styryl ketone,1896-62-4,1.05703921089284,2.3248227879597,0.771076972079145,1.65474188411461,BSK_3C_Proliferation_down|BSK_SAg_Proliferation_down,TRUE
"2,3,4,5-Tetrachloro-6-(trichloromethyl)pyridine",1134-04-9,1.01322468673166,1.36539980270725,2.43885541288242,49.419192724884,TOX21_Aromatase_Inhibition_viability|TOX21_CASP3_CHO_viability|TOX21_HRE_BLA_Agonist_viability|TOX21_PGC_ERR_viability|TOX21_RORg_LUC_CHO_Antagonist_viability,TRUE
"3,4,5,6-Tetrachloropyridine-2-carbonitrile",17824-83-8,0.469056187274751,0.985779226098304,2.21197779498731,88.7027062750916,ATG_XTT_Cytotoxicity_up|TOX21_ARE_BLA_agonist_viability|TOX21_AR_BLA_Antagonist_viability|TOX21_CAR_Antagonist_viability|TOX21_CASP3_CHO_viability|TOX21_ELG1_LUC_Agonist_viability|TOX21_FXR_BLA_agonist_viability|TOX21_FXR_BLA_antagonist_viability|TOX21_GR_BLA_Antagonist_viability|TOX21_PGC_ERR_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_RT_HEK293_FLO_24hr_viability|TOX21_RT_HEK293_FLO_32hr_viability|TOX21_RT_HEK293_FLO_40hr_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability|TOX21_RXR_BLA_Agonist_viability|TOX21_SHH_3T3_GLI3_Agonist_viability|TOX21_VDR_BLA_Agonist_viability|TOX21_p53_BLA_p2_viability,TRUE
Bis(trichloromethyl)sulfone,3064-70-8,0.697146606114923,1.15628690137226,2.50365377869813,90.124882956989,ATG_XTT_Cytotoxicity_up|BSK_CASM3C_SRB_down|BSK_SAg_PBMCCytotoxicity_down|BSK_SAg_Proliferation_down|TOX21_CAR_Agonist_viabillity|TOX21_CAR_Antagonist_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_PGC_ERR_viability|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_RT_HEK293_FLO_40hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_40hr_viability|TOX21_RXR_BLA_Agonist_viability|TOX21_SHH_3T3_GLI3_Agonist_viability,TRUE
Chloranil,118-75-2,0.445392285276299,0.908161869486339,2.23630739570719,81.1358869098843,TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_RT_HEK293_FLO_40hr_viability|TOX21_RT_HEPG2_GLO_00hr_ctrl_viability|TOX21_SHH_3T3_GLI3_Agonist_viability|TOX21_TR_LUC_GH3_Antagonist_viability,TRUE
Chlorothalonil,1897-45-6,0.088437192740348,0.693395833130142,1.84173752776135,94.1612912464124,ACEA_ER_AUC_viability|APR_HepG2_CellLoss_24h_dn|APR_HepG2_MicrotubuleCSK_24h_up|CCTE_Simmons_MITO_viability|TOX21_AP1_BLA_Agonist_viability|TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_CASP3_CHO_viability|TOX21_CASP3_HEPG2_viability|TOX21_ERR_viability|TOX21_FXR_BLA_antagonist_viability|TOX21_HRE_BLA_Agonist_viability|TOX21_PGC_ERR_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_PXR_viability|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_RT_HEK293_FLO_16hr_viability|TOX21_RT_HEK293_FLO_24hr_viability|TOX21_RT_HEK293_FLO_32hr_viability|TOX21_RT_HEK293_FLO_40hr_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEPG2_FLO_08hr_viability|TOX21_RT_HEPG2_FLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability|TOX21_SHH_3T3_GLI3_Agonist_viability|TOX21_SHH_3T3_GLI3_Antagonist_viability|TOX21_VDR_BLA_antagonist_viability,TRUE
"Hexachloro-1,3-butadiene",87-68-3,0.247664679706545,1.02210892225497,3.41888470652512,0.101539886367869,BSK_3C_Proliferation_down|BSK_SAg_Proliferation_down|BSK_hDFCGF_Proliferation_down,TRUE
Hexachlorocyclopentadiene,77-47-4,0.641078690995487,0.976497185360732,2.48562147903544,53.058687420071,ATG_XTT_Cytotoxicity_up|BSK_CASM3C_SRB_down|BSK_SAg_PBMCCytotoxicity_down|BSK_SAg_Proliferation_down|TOX21_ARE_BLA_agonist_viability|TOX21_ELG1_LUC_Agonist_viability|TOX21_RT_HEK293_FLO_32hr_viability|TOX21_p53_BLA_p3_viability,TRUE
Kepone,143-50-0,0.441456296555171,1.10622434086738,1.43545183557465,89.5724102899636,TOX21_TR_LUC_GH3_Antagonist_viability,TRUE
Mirex,2385-85-5,0.181198335666906,0.363310149598052,6.57548663995659,87.259172494974,CCTE_Shafer_MEA_dev_AB_dn|CCTE_Shafer_MEA_dev_LDH_dn,TRUE
Pentachloronitrobenzene,82-68-8,1.40359916061166,1.55542914131436,6.2849412548356,78.7210469805603,TOX21_SHH_3T3_GLI3_Agonist_viability,TRUE
Pentachloropyridine,2176-62-7,1.12171885984215,1.94054942200919,1.18282995844602,5.03833671622516,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn,TRUE
Potassium perfluorooctanesulfonate,2795-39-3,0.799958921615228,1.28843152464768,2.35071397605614,44.3744521524198,TOX21_PPARd_BLA_Agonist_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_RT_HEK293_FLO_16hr_viability|TOX21_VDR_BLA_Agonist_viability,TRUE
Tetraiodoethene,513-92-8,0.54095090142323,1.05526080008666,2.22465627420288,90.0298209032452,TOX21_AP1_BLA_Agonist_viability|TOX21_ARE_BLA_agonist_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_FXR_BLA_agonist_viability|TOX21_FXR_BLA_antagonist_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_HRE_BLA_Agonist_viability|TOX21_PGC_ERR_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_RAR_LUC_Agonist_viability|TOX21_RAR_LUC_Antagonist_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEPG2_FLO_24hr_viability|TOX21_RT_HEPG2_FLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability|TOX21_SHH_3T3_GLI3_Antagonist_viability|TOX21_VDR_BLA_antagonist_viability,TRUE
"2,3,7,8-Tetrachlorodibenzo-p-dioxin",1746-01-6,-2.6743623548615,-1.82534736673466,1.44774929806195,99.3303053850092,percent mortality 5dpf|percent mortality 4dpf|percent mortality 4dpf|percent mortality 5dpf,TRUE
"",56-35-9,-1.25168914761762,-0.60870272096701,8.9105376939809,99.6678114427877,cell viability|PNS cell viability|cell viability,TRUE
"",22967-92-6,-1.37919542135162,-0.745394515134982,1.50558716480149,102.695327246321,cell viability,TRUE
Valinomycin,2001-95-8,-0.668619621349064,-0.541894124881728,7.75420280625884,100.000421421189,percent mortality 2dpf|percent mortality 4dpf|percent mortality 5dpf|percent mortality 2dpf|percent mortality 3dpf|CNS cell viability|NCC cell viability,TRUE
"",73573-88-3,-1.25407965040919,-0.509396414045191,1.28140726532065,93.7323569217656,cell viability,TRUE
Methyl mercuric (II) chloride,115-09-3,-0.508811432308803,0.158750882470165,3.3216375298146,98.434184668061,CNS cell viability|percent mortality Full 7d|PNS cell viability|percent mortality 2dpf|cell viability,TRUE
"",70-30-4,-0.228118085671431,0.0489443219343003,4.66368163557004,100.000250559654,percent mortality Tail 7d|percent mortality Tail 12d|cell viability|percent mortality 1dpf|percent mortality 1dpf|SH-S5Y5 viability,TRUE
Deltamethrin,52918-63-5,-0.880177183354047,-0.606977889837642,3.49284398637007,99.6644296487966,percent mortality 4dpf,TRUE
"",7784-46-5,-0.224344432750836,0.0386558699260687,3.6282943393096,99.8346302402715,cell viability,TRUE
Auramine O,2465-27-2,0.682822176037953,0.863901734718932,5.2840736520537,89.5006996513074,cell viability|percent mortality 1dpf,TRUE
Diethylstilbestrol,56-53-1,0.73792879463306,0.964799022934011,4.69825114746026,95.0000000002442,percent mortality 5dpf|percent mortality 4dpf|percent mortality 1dpf,TRUE
Berberine chloride,633-65-8,0.66804900069531,0.899676894560179,4.11972191050543,55.181493354376,percent mortality 2dpf|percent mortality 4dpf|cell viability,TRUE
6-Hydroxydopamine hydrochloride,28094-15-7,0.737223663104326,1.16978613705784,2.20602240577592,49.0956551265331,cell viability,TRUE
Estradiol,50-28-2,0.764271867224117,1.02587828191651,3.64762657124196,100.164453938676,percent mortality 5dpf,TRUE
1-Ethyl-3-methylimidazolium diethylphosphate,848641-69-0,0.756525387535111,0.866577260547945,8.67084296991511,9.66999182103038,cell viability,TRUE
Firemaster 550,860302-33-6,0.611270008139769,1.34966219845987,1.29232475904932,62.1998293966664,percent mortality 2dpf,TRUE
Tricresyl phosphate,1330-78-5,0.929990895159828,1.21276657477525,3.60068035223996,83.3466548329122,percent mortality 4dpf|percent mortality 5dpf,TRUE
"Bis(2-ethylhexyl) 3,4,5,6- tetrabromophthalate (TBPH)",26040-51-7,0.960412854849053,1.36435916798464,2.46114659577217,102.951428354652,percent mortality 5dpf|percent mortality 1dpf,TRUE
"Phenol, isopropylated, phosphate (3:1)",68937-41-7,1.01582666509435,1.33084757574279,3.02929833148571,72.3977845119515,percent mortality 5dpf|percent mortality 1dpf,TRUE
Parathion,56-38-2,1.30727165726323,1.48993229777508,5.22412768708882,98.3321470105542,percent mortality 4dpf,TRUE
Acenaphthylene,208-96-8,1.34465850826095,1.57957937090165,4.3898823563365,104.614976171297,percent mortality 4dpf|percent mortality 2dpf,TRUE
Acenaphthene,83-32-9,1.31021600029429,1.61123508763354,3.17043958374484,73.4711248887837,percent mortality 2dpf|percent mortality 4dpf,TRUE
Verapamil,52-53-9,-3.03029072310311,-2.07604821366378,1,100,SH-S5Y5 viability,TRUE
Roxithromycin,80214-83-1,-2.87392457310311,-1.91968206366378,1,100,SH-S5Y5 viability,TRUE
Paraoxon-ethyl,311-45-5,-2.06329098310311,-1.10904847366378,1,100,SH-S5Y5 viability,TRUE
N-Methyl-2-pyrrolidone,872-50-4,-0.0537265541031052,0.90051595533622,1,100,SH-S5Y5 viability,TRUE
Mebendazole,31431-39-7,-3.66010791910311,-2.70586540966378,1,100,SH-S5Y5 viability,TRUE
Ifosfamide,3778-73-2,-1.00960612410311,-0.0553636146637806,1,100,SH-S5Y5 viability,TRUE
Fipronil,120068-37-3,-3.04268817210311,-2.08844566266378,1,100,SH-S5Y5 viability,TRUE
alpha-Endosulfan,959-98-8,-3.20924322710311,-2.25500071766378,1,100,SH-S5Y5 viability,TRUE
Dieldrin,60-57-1,-3.14106788010311,-2.18682537066378,1,100,SH-S5Y5 viability,TRUE
Diazoxon,962-58-3,-1.65321421110311,-0.698971701663781,1,100,SH-S5Y5 viability,TRUE
"",117-81-7,-3.82811024210311,-2.87386773266378,1,100,SH-S5Y5 viability,TRUE
Deethylatrazine,6190-65-4,-2.03685862910311,-1.08261611966378,1,100,SH-S5Y5 viability,TRUE
Clarithromycin,81103-11-9,-2.68513592510311,-1.73089341566378,1,100,SH-S5Y5 viability,TRUE
Chlorpyrifos oxon,5598-15-2,-2.61400313210311,-1.65976062266378,1,100,SH-S5Y5 viability,TRUE
Bromoxynil,1689-84-5,-2.52656901110311,-1.57232650166378,1,100,SH-S5Y5 viability,TRUE
Bisphenol A,1980-05-07,-2.44952189410311,-1.49527938466378,1,100,SH-S5Y5 viability,TRUE
Bifenthrin,82657-04-3,-3.72359417710311,-2.76935166766378,1,100,SH-S5Y5 viability,TRUE
Bicalutamide,90357-06-5,-2.77883741510311,-1.82459490566378,1,100,SH-S5Y5 viability,TRUE
Benzothiazole,95-16-9,-1.70779990910311,-0.753557399663781,1,100,SH-S5Y5 viability,TRUE
Ampyrone,1983-07-08,-1.15495794110311,-0.20071543166378,1,100,SH-S5Y5 viability,TRUE
4-Chloro-3-methylphenol,59-50-7,-2.22426355310311,-1.27002104366378,1,100,SH-S5Y5 viability,TRUE
3-Nitroaniline,1999-09-02,-1.85122205210311,-0.896979542663781,1,100,SH-S5Y5 viability,TRUE
2-Phenylphenol,90-43-7,-2.18067658210311,-1.22643407266378,1,100,SH-S5Y5 viability,TRUE
2-Butoxyethanol,111-76-2,-0.819500040103106,0.134742469336219,1,100,SH-S5Y5 viability,TRUE
2-Allylphenol,1745-81-9,-1.89132187210311,-0.937079362663781,1,100,SH-S5Y5 viability,TRUE
"1,2-Benzisothiazolin-3-one",2634-33-5,-4.21919883710311,-3.26495632766378,1,100,SH-S5Y5 viability,TRUE
3-Hydroxycarbofuran,16655-82-6,-2.54750291710311,-1.59326040766378,1,100,SH-S5Y5 viability,TRUE
Citalopram,59729-33-8,-3.08123959010311,-2.12699708066378,1,100,SH-S5Y5 viability,TRUE
Sertraline,79617-96-2,-3.97382924110311,-3.01958673166378,1,100,SH-S5Y5 viability,TRUE
Fipronil sulfone,120068-36-2,-3.55289794910311,-2.59865543966378,1,100,SH-S5Y5 viability,TRUE
Diquat,2764-72-9,-3.67783668610311,-2.72359417666378,1,100,SH-S5Y5 viability,TRUE
Narciclasine,29477-83-6,-5.53430146110311,-4.58005895166378,1,100,SH-S5Y5 viability,TRUE
2(4-morpholinyl)benzothiazole,4225-26-7,-2.06593644010311,-1.11169393066378,1,100,SH-S5Y5 viability,TRUE
Paraquat,4685-14-7,-2.13792460110311,-1.18368209166378,1,100,SH-S5Y5 viability,TRUE
Cycloheximide,66-81-9,-2.87278916210311,-1.91854665266378,1,100,SH-S5Y5 viability,TRUE
